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Abstract 
With an ever-expanding protein engineering toolbox different mutational 
techniques can be used to engineer new or altered function into protein scaffolds 
without the restriction of sampling just simple substitution mutagenesis. These 
include approaches that target backbone as well as side chain changes, such as single 
amino acid deletions or whole domain insertion. The problem with utilizing these 
mutational approaches is the difficulty in predicting both local and global structural 
changes on changing the backbone conformation. The aim of this thesis is to 
demonstrate the tolerance and beneficial influence of backbone targeted mutations 
using a mutant library-based screening approach, and to provide an understanding of 
their mechanism of action. 
A directed evolution transposon-based approach was used to generate libraries of 
single amino acid deletion and whole domain insertions into enhanced green 
fluorescent protein (EGFP). The later involved the insertion of cyt b562 as the donating 
insert domain. Library analysis revealed a wide range of sites were sampled across the 
backbone of EGFP.  
Library screening revealed widespread tolerance of EGFP to single amino acid 
deletions. Using the crystal structure of EGFP determined here, it was found that that 
loop regions where particularly tolerant. Two variants with residues G4 or A227 
deleted conferred increased protein fluorescence to cell cultures with respect to 
EGFP. Spectral characterization and unfolding experiments identified that rather than 
altering the fluorescent properties of EGFP the mutations elicited their effects through 
altered protein folding and stability.  
Screening of the domain insert library revealed that sites spread along the 
backbone of EGFP were tolerant to cyt b562 insertion. Particularly tolerant were loops 
and the C-terminal end of #-strand 7, with the linker sequences playing a key role. 
One integral domain fusion scaffold, termed CG6, was identified in which the 
functions of the two individual domains were highly coupled. CG6 exhibited almost 
100% fluorescence quenching upon the binding of haem to the cyt b562 domain. CG6 
was also shown to potentially act as a sensor for redox state and reactive oxygen 
species such as H2O2 via a haem-dissociation dependent mechanism. The structure of 
CG6, determined by X-ray crystallography, provided the molecular basis for the 
functional coupling of the two domains. Critical was the side-by-side domain 
arrangement caused by differential linker lengths at the pivot position re-enforced by 
a domain-domain interface that placed the chromophores within 17-18Å of each 
other. 
Further rational design of a cyt b562-EGFP integral fusion scaffold (CG15) was 
performed to create novel ratiometric fluorescent redox sensors, termed CG15CC 
variants. The CG15CC variants have been shown to have the most reducing redox 
midpoint potentials of any protein based redox sensor studied to date. One of the 
CG15CC variants also has the fastest redox kinetics observed to date. 
The survey of the tolerance and influence of single amino acid deletions in EGFP 
conducted here has highlighted the potential beneficial nature of deletion mutagenesis 
and has helped provide a molecular understanding of their effect. Through domain 
insertion mutagenesis and retrospective structure analysis the mechanism behind the 
functional coupling of two domains has been described and will also help guide future 
work in the development of novel biomolecular switches.  
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Chapter 1: Introduction 
1.1 Protein structure and function relationship 
Proteins are the most functionally diverse of all the macromolecules found in 
Nature. They are comprised from 20 naturally occurring amino acids [1], and in some 
rare instances pyrolysine [2] or selenocysteine [3]. The central dogma in molecular 
biology is that DNA via mRNA encodes the order and composition of amino acids in 
a given polypeptide chain. The amino acid sequence in turn determines the structure 
and thus function of a protein; the 3D arrangement of the amino acids brings together 
amino acids from different regions of amino acid sequence required for the functional 
conformation of a protein.  
The natural protein repertoire displays extraordinary plasticity in terms of both 
their structure and function. Proteins can take on many different folds (topologies) 
and have a wide range of functions such as enzymes catalyzing biological reactions, 
structural cellular components, cellular signaling and in immune response. 
The central relationship between protein sequence and structure/function give 
proteins the inherent characteristic of “programmability”. Over the last 20-30 years, 
protein sequence, structural and functional diversity has been increased in the lab 
through the use of protein engineering to introduce changes to a target protein. This 
has proved critical to our molecular understanding of proteins as we can now directly 
interact and influence a protein rather than being simply passive observers. It has also 
allowed proteins to be adapted and optimized for a particular application.  
 
1.2 Protein Engineering 
1.2.1 General 
In 1978 an oligonucleotide mutational method was first demonstrated for 
altering specific bases in a target gene [4]. This discovery allowed point mutations to 
be introduced leading to the specific substitution of one target residue to another. This 
in turn was used as a tool to study the molecular basis of catalysis, substrate 
specificity, stability and folding of enzymes [5]. One of the first enzymes to be 
targeted for protein mutagenesis was #-lactamase [6], which confers #-lactam 
antibiotic resistance to bacteria. Further site directed mutagenesis identified numerous 
variants of #-lactamase with altered catalytic activity [7, 8], substrate specificity [7, 9, 
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10] and resistance to inhibitors [7, 10], as well as elucidating the catalytic mechanism 
[11, 12]. 
Since its establishment, site directed mutagenesis (SDM) normally based on 
amino acid substitution, has become a widely used approach to study and adapt 
proteins. One such protein that has been a target for SDM is the Aequorea victoria 
green fluorescent protein (GFP), a workhorse for cell biology studies. Substitution 
mutagenesis has been used to alter the fluorescent characteristics of GFP to generate 
different color variants such as blue [13], cyan and yellow fluorescent proteins [14].  
However, amino acid substitutions simply change one side chain for another, 
which may restrict the sequence and conformational space a particular protein can 
sample. With an ever-expanding protein engineering toolbox different mutational 
techniques can be used to engineer new or altered function into protein scaffolds that 
may not be accessible by simple substitution mutagenesis. This includes deletion of a 
single amino acid to the insertion of whole protein domains.  
 
1.2.2 Insertion and deletion (InDel) mutagenesis 
Insertion and deletion mutations (InDel) are sampled during natural protein 
evolution but are generally overlooked as a useful tool for protein engineering. This is 
due to the fundamental difference between substitution and InDel mutations. A 
substitution mutation only affects the side chain of the residue being mutated but 
leaves the backbone relatively unperturbed. InDel events however involve the loss or 
gain of amino acids and therefore alter the length of the protein backbone. The 
problem with mutations that change the backbone structure is that their effects can be 
difficult to predict due to the local and global structural changes caused by insertion 
or removal of an amino acid from the polypeptide. Dogma suggests that loops are 
likely to be more tolerant to Indel mutations due to the inherent conformational 
flexibility of these regions, whilst InDel mutations in secondary structures can result 
in registry shifts (Fig 1.1), which could be considered detrimental to protein structure 
and therefore function [15].  
Whilst both insertion and deletion mutations effect the length of the 
polypeptide chain insertion mutations generally result in increased conformational 
flexibility and can be accommodated by ‘looping out’ of the polypeptide chain in 
secondary structures or loops. Deletion mutagenesis however introduces increased 
xxx  
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Fig 1.1 Effect of single amino acid deletions on secondary structure registry. a, Deletion 
of a single amino acid (blue circle) from a loop region connecting two ordered secondary 
structural elements (red rectangles) is usually accommodated by loop shortening. Deletion of 
an amino acid (red/blue circle) from b, a #-strand or c, an $-helix results in registry shifts. 
Amino acids are coloured red or blue to distinguish between different faces of a secondary 
structure. 
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conformational constraints on a polypeptide chain and therefore can be considered to 
be more detrimental to protein structure and function. Amino acid deletions are also 
sampled more regularly during natural evolution than insertion mutations due to the 
mechanism by which Indel mutations are introduced into a gene (described in more 
detail below). Therefore the effects of deletion mutations have been focused on in this 
study. 
As mentioned above deletion of an amino acid from loops are generally 
tolerated due to increased conformational flexibility in these regions of a protein and 
are accommodated through loop shortening (Fig 1.1 a). Deletion of an amino acid 
from a #-strand could cause the local rearrangement of amino acids in the strand, 
resulting in a shift of the side chains from one face of the #-strand to the other (Fig 
1.1 b), potentially having knock on effects to global structure. For example if the side 
chains on one face of a surface exposed #-strand were predominantly polar and those 
on the opposite face were predominantly hydrophobic and buried in the core of the 
protein, an amino acid deletion may cause a register shift in some of the hydrophobic 
side chains. The result could be hydrophobic residues becoming solvent exposed and 
the polar side chains being buried into the core of the protein (Fig 1.1 b). A similar 
effect may be seen if an amino acid were to be deleted from an $-helix, the potential 
result being a rotation of all the side chain positions around the $-helix (Fig 1.1 c). As 
well as affecting registry in organized secondary structures deletion of an amino acid 
could also result in the loss of secondary structure resulting in the formation of a loop 
in its place.  
During natural protein evolution it has been shown that deletion mutations are 
more prevalent than insertions [16, 17], which can be explained by the DNA repair 
mechanism [17]. Either through DNA damage or replication slippage a looped out 
piece of ssDNA can form, mismatching to its complementary strand, normally at sites 
in a gene where repeat sequences are present [18]. This DNA loop is more susceptible 
to cleavage and after DNA repair can result in the insertion or deletion of base pairs 
from the gene of interest (Fig 1.2). However as outlined in Fig 1.2 deletion mutations 
can be up to 3 times more prevalent than insertion mutations. 
InDel mutations can commonly give rise to frame shifts altering the coding 
sequence of an entire gene because they can result in a shift of all the subsequent 
xxxx 
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Fig 1.2 Mutational model to explain an excess of deletion mutations. Damaged DNA 
resulting in the loss of one or more nucleotides can result in looping out of the DNA by slip 
mispairing. The potential removal of the extrahelical loop leads to an excess of deletion 
mutations with respect to insertion mutations. 
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nucleotides changing the codon sequence. However, InDel events that occur in 
multiples of 3 maintain the reading frame but with the insertion or deletion of amino 
acids. 
Despite the dogma that deletion mutations can be deleterious to protein 
structure and function they have recently been shown to have positive effects on 
protein function even when they occur in secondary structures [19]. InDel mutations 
have been shown to shape the human antibody repertoire by varying epitope surfaces 
of the heavy and light chains of variable regions on immunoglobulins [18]. InDel 
mutations also play a key role in the evolution of HIV envelope proteins (encoded by 
the env gene) early in transmission to new hosts allowing the virus to rapidly adapt to 
its new environment [20].  
More recently, protein engineering using deletion mutagenesis has shown 
beneficial effects of single amino acid deletions. Work carried out on TEM-1 !-
lactamase identified many single amino acid deletions that were tolerated within loops 
and organized secondary structures (Fig 1.3), with several variants displaying 
increased activity to extended spectrum !-lactam antibiotic susbtrates (Ceftazidime) 
[19, 21]. 
Given that InDel mutations can influence protein structure in a manner distinct 
from that of substitutions, sampling them during protein engineering studies will 
allow sampling new sequence and conformational space. This in turn may allow the 
generation of useful protein variants not accessible using substitutions alone.  
 
1.2.3 Integral domain fusion architecture 
A protein domain is a structural unit capable of functioning independently of 
the rest of the polypeptide chain. Many proteins are comprised of multiple domains, 
with each domain having a discrete function [22, 23]. Structural assignment to gene 
sequences of complete genomes showed that almost two thirds of prokaryotic and 
80% or eukaryotic proteins comprise of multiple domains [24]. 
The majority of multi-domain proteins are organised in a head to tail fashion 
with the C-terminal end of one domain leading on to the N-terminus of the next [24] 
(Fig 1.4 a). However, a significant minority (9%) exhibits integral fusion architecture 
with one protein domain inserted within another (Fig 1.4 b) [24, 25]. Integral fusion 
xxxxxxXXX  
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Fig 1.3 Tolerated single amino acid deletions in TEM-1 !-lactamase resulting in 
increased activity towards ceftazidime. Crystal structure of TEM-1 #-lactamase 
(pdb:1BTL) in cartoon representation with the active site serine (S70) shown in spacefill with 
the rest of the active site residues shown as sticks. Positions of tolerated single amino acid 
deletions are highlighted by blue spheres and labeled, where " after a residue number 
signifies that residue is deleted. 
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Fig 1.4 Schematic of domain organisation in multi-domain proteins. a, Head-to-tail fusion 
of two domains (A: blue and B: orange). b, Integral fusion domain architecture with the insert 
domain (A: blue) within the parent domain (Bi, Bii: orange). c, Binding of a signal molecule 
(yellow) to the insert domain triggers a change in conformation of the parent domain. N and 
C represent the N and C-termini. 
  
!"
#"
$"
$"
$"
%"
%&"
%&&"
!" #"
!"
#"
$"
!"
#"
%&"
%&&"
%&"
%&&"
a 
b 
c 
 9 
architecture decreases the degrees of freedom the ‘insert’ domain has with respect to 
the accepting or ‘parent’ domain, thereby intimately linking the two structures. This 
intimate linkage has the potential to communicate stimulus-induced changes in one 
domain through to the other therefore coupling the structure and function of the two 
proteins (Fig 1.4 c). Analysis of integral domain fusion architecture of natural 
proteins identified the N- and C-termini of the inserted domain to be juxtaposed with 
an average distance of ~8 Å from one another, so as not to disrupt the overall 
structure of the parent domain. This therefore has been considered a prerequisite when 
considering a protein domain for insertion into another. 
A classic example of a domain insert protein arrangement found in nature is 
the GroEL-GroES chaperone system [26, 27]. The GroEL component is comprised of 
3 individual domains, the apical, intermediate and equatorial domain (Fig 1.5). The 
apical domain is inserted with the intermediate domain, which is in turn inserted 
within the equatorial domain (Fig 1.5). Communication between the apical and 
equatorial domain is critical for chaperone function. Polypeptides with a non-native 
structure bind to a hydrophobic patch on the apical domain with concomitant binding 
of ATP between the equatorial and intermediate domain [26]. Binding of the 
cochaperone GroES encapsulates the non-native polypeptide triggering a 
conformational change (Fig 1.5) resulting in an increase in the size of the cavity, 
which becomes hydrophilic in nature, thereby releasing the non-native polyeptide into 
the cavity to commence folding [26]. ATP hydrolysis results in the dissociation of 
GroES and release of the polypeptide [26]. The integral domain architecture of GroEL 
is a prerequisite for its conformational switching between a protein capturing to 
protein folding machine. 
 
1.2.4 Engineering artificial biomolecular switches with integral domain fusion 
architecture 
The ability to construct integral fusion proteins that can modulate the function 
of one domain by a desired input signal at second domain is an attractive approach for 
generating novel protein scaffolds for uses in both natural and artificial contexts [28, 
29]. Designed protein switches could be used for in vivo and in vitro sensing of 
cellular metabolites or redox state [30, 31], as a drug delivery mechanism triggered by 
specific cellular conditions [28, 32], as a modulator of signal transduction pathways 
[22] or as energy transfer scaffolds [33].  
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Fig 1.5 Domain insert architecture of the molecular chaperone GroEL. Surface 
representation (grey) of the multi subunit GroEL with the equatorial (orange), intermediate 
(blue) and apical (yellow) domains highlighted. Inset, cartoon representation of a single 
GroEL subunit with a schematic representation of the integral domain architecture shown 
beside for GroEL in a, the trans state and b, the cis state. In the cis state the GroEL complex 
is bound to the accessory complex GroES (pale green). The conformational switch is 
triggered by ATP (bright green) binding between the equatorial and intermediate domains. 
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There has been limited success using rational design approaches for the 
creation of integral fusion proteins that exhibit functional coupling, often resulting in 
only modest switching magnitudes [32, 34, 35]. The majority of attempts have 
focused on domain insertion into dynamic loop regions of the parent (accepting) 
domain so as not to disrupt the tertiary structure and therefore the function of the 
parent domain [34-36].  
However, if the functions of two normally disparate proteins are to be linked 
simple tolerance to a domain insertion is not enough. Predicting sites within a parent 
domain that will not only tolerate the insertion of a whole domain but also retain the 
functions of both domains whilst exhibiting functional coupling with large switching 
magnitudes is very difficult to achieve. This is because insertion of one domain into a 
dynamic loop of an accepting domain may be tolerated but to the detriment of 
functional coupling. A conformational change in the insert domain may be 
accommodated within the dynamic loop into which the domain is inserted and 
therefore may not be propogated through to the accepting domain. On the other hand 
domain insertion into an ordered secondary structure within the accepting domain is 
less likely to be tolerated but conformational changes in the insert domain are more 
likely to be propogated through to the accepting domain modulating its function. 
An attractive prospect would be to use directed evolution approaches to 
sample many insertion sites within a parent domain and screen a library for variants 
displaying switching characteristics. This has been shown previously by coupling 
various binding events to the activity of !-lactamase [31, 32, 37]. For example, using 
a transposon-based directed evolution approach, integral domain fusion libraries have 
been generated by inserting the E. coli periplasmic protein cyt b562 (Section 1.5) 
randomly throughout TEM-1 #-lactamase. Several positions within TEM-1 #-
lactamase were identified that were tolerant to cyt b562 domain insertion. The 
functions of both domains were retained in the cyt b562-TEM-1 #-lactamase integral 
fusion scaffolds with functional coupling observed for many of the variants (Fig 1.6). 
A few variants were identified with up to a 128-fold switch in activity against 
ampicillin when the cyt b562 ligand, haem, was bound to the integral fusion scaffolds. 
The domain insertion position can also dictate the nature of the functional 
couple observed in integral domain fusion scaffolds; a signal induced conformational 
xxxxxxx  
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Fig 1.6 Tolerated cyt b562 domain insertion positions in TEM-1 !-lactamase. Cartoon 
representation of TEM-1 #-lactamase (PDB: 1BTL, green) with the active site serine shown 
in spacefill (CPK colouring) and the rest of the active site residues shown as sticks. Spheres 
represent positions within TEM-1 #-lactamase tolerant to cyt b562 domain insertion. Cyt b562 
insertion positions resulting in positive or negative modulation of TEM-1 #-lactamase activity 
in the presence of haem are shown by blue or red spheres respectively. Yellow spheres 
represent insertion positions where no significant functional coupling was observed between 
the two domains.  
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change in the insert domain could modulate the function of the parent domain in a 
positive or negative manner. For example many cyt b562-TEM-1 #-lactamase integral 
fusion scaffolds were identified that negatively modulated the TEM-1 #-lactamase 
activity towards ampicillin in the presence of haem with one variant identified that 
contained two cyt b562 domain inserts and positively modulated TEM-1 #-lactamase 
activity towards ampicillin (Fig 1.6). 
 
1.3 Directed evolution versus rational design 
With an ever-expanding protein engineering toolbox it is possible to design 
and construct proteins with altered or improved characteristics and to create novel 
artificial protein scaffolds to perform functions not sampled by the natural protein 
repertoire. The two main methods of achieving this is by rational site directed 
mutagenesis or by directed evolution. The limitation of rational protein engineering is 
often requiring prior knowledge of the target protein structure and function in order to 
aid the engineering process.  
The advancement of directed evolution approaches along with improved 
screening techniques allows libraries of proteins containing mutations randomly 
introduced throughout the polypeptide to be created, with variants exhibiting desired 
characteristics identified for further characterization [38]. The benefit of using a 
directed evolution approach is that a detailed knowledge of protein structure or 
function is not always required. Several directed evolution techniques have been 
developed for creating libraries of mutant protein variants including oligonucleotide 
based methods, enzyme or chemical mediated DNA cleavage and transposon based 
approaches [38, 39]. 
 
1.3.1 Transposon-based directed evolution approaches 
 Recent mutagenesis approaches based on the use of an engineered transposon 
termed Mu has allowed sampling of single amino acid deletions, codon replacements 
(including for unnatural amino acid incorporation) and whole domain insertion.  
 
1.3.1.1 General structure of Mu transposable elements. 
 A transposon is a mobile piece of DNA that can be inserted into a target DNA 
molecule catalyzed by a transposase protein. The Mu transposon from the 
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bacteriophage Mu has specific inverted repeat sequences at both its 5’ and 3’ ends, 
unique to the Mu transposable element [40]. The four terminal regions are specific 
transposase binding motifs, known as transposase recognition elements (TREs). In 
Mu they are termed L1, L2, R1 and R2 for the left end (5’) or right end (3’) TREs 
respectively (Fig 1.7). The DNA carried between the TREs is essentially non-specific 
to the transposition reaction and can be any chosen coding sequence such as antibiotic 
resistance markers for selection of positive insertion events or a DNA cassette 
encoding desired peptides for insertion (Table 1.1), whole domains [41, 42] or the 
whole Mu genome [40]. 
 
1.3.1.2 Mu transposition mechanism 
Although the exact details of the transposition mechanism vary between 
different transposon/transposase systems the overall mechanism is shared across a 
number of class II transposable elements. The class II transposons (Mu) can be 
efficiently inserted into a target DNA sequence via a ‘cut and paste’ or by ‘cleaved 
donor’ meachanism, dependent on whether the transposon comes from a donor DNA 
or is pre-cleaved respectively (Fig 1.7). The ‘cut and paste’ mechanism of 
transposition follows three major reaction steps: (1) donor transposon DNA cleavage, 
(2) a strand transfer reaction and (3) DNA repair [40]. The ‘cleaved donor’ 
mechanism of transposition follows the same reaction steps as the ‘cut and paste’ 
mechanism except the first stage concerns the formation of a type I transpososome 
complex, termed the cleaved donor complex (CDC), with a pre-cleaved transposon 
[40, 43] (Fig 1.7). 
 In the first step of the ‘cut and paste’ mechanism the transposase binds to the 
TREs and the donor transposon DNA is specifically cleaved, by the transposase 
nuclease activity, exposing 3’-OH termini at both ends of the transposon (Fig 1.7) 
[40, 43]. The first step of the ‘cleaved donor’ mechanism is the formation of a type I 
transpososome complex with a pre-cleaved transposon already with exposed 3’-OH 
groups (Fig 1.7). 
The transpososome complex is a stable protein bound DNA complex formed 
by transposase binding to the TREs of transposons and subsequently forming stable 
transposase oligomers. Several in vitro transposon systems have been shown to be 
able to form stable transpososome complexes including the Mu, Tn5, Tn7 and Tn10 
xxxx  
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Fig 1.7 Schematic of transposition mechanism. Step 1 a, A cleaved donor transpososome 
complex (CDC) is formed by MuA transposase (blue circle) binding to transposon 
recognition elements (L1, L2, R1 and R2:grey) at the 5’ and 3’ ends of the transposon 
(orange) and forming tetramers. Step 1 b, The transposon can originate from donor DNA 
(dark blue), which is cleaved by the transposase revealing the transposon 3’-OH groups (‘cut 
and paste’ mechanism), or can be pre-cleaved (‘cleaved donor’ mechanism). The CDC 
complex then binds target DNA (green) forming a strand transfer transpososome complex 
(STC). Step 2, The strand transfer reaction takes place producing a staggered cut (red arrow) 
in the target gene connecting the transposon to the target gene. Due to the staggered cut target 
site duplications are produced (yellow). Step 3, Cellular DNA repair mechanisms fill the gaps 
in the target gene completing the transposition reaction.  
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systems [40]. Transpososome complexes can be comprised of transposase dimers 
bound to the TREs seen in the Tn5, Tn7 and Tn10 systems [44] or transposase 
tetramers bound to the TREs as in the Mu transposon system described here [43, 44]. 
The second step for both mechanisms is the strand transfer reaction, which 
firstly involves the binding of target DNA by the CDC forming a type II 
transpososome complex [40] termed the strand transfer complex (STC) (Fig 1.7) [43]. 
Most transposases demonstrate some degree of target site specificity but are still 
capable of efficiently inserting transposons at many target sites, an exception being 
the Tn7 transposon, which transposes with high efficiency to a specific site within its 
bacterial host chromosome [45]. The strand transfer reaction involves the cleavage of 
the target DNA and joining of phosphoester bonds resulting in connection of the 
transposon to the target DNA (Fig 1.7) [40]. The strand transfer reaction is achieved 
by a one-step mechanism by which the exposed 3’-OH groups of the transposon act as 
nucleophiles attacking phosphoester bonds in the target DNA, resulting in the 
connection of the 5’-phosphoryl groups of the target DNA to the 3’-OH groups of the 
transposon [40].  
 The cleavage sites introduced into the target DNA during the strand transfer 
reaction are usually staggered due to the relative locations of the exposed transposon 
3’-OH groups in the STC with respect to the target DNA [46]. The staggered cleavage 
of the target DNA is responsible for the target site duplications flanking the 
transposon (Fig 1.7). The length of the target site duplications is dependent on the 
distance of the free 3’-OH groups of the transposon from one another and differs 
depending which transposon system is being used. There is a 5 bp staggered cleavage 
of the target gene when using the Mu/MuA system. The 5’ to 3’ exonuclease activity 
of DNA polymerase I repairs the missing nucleotides reconstituting the target DNA 
completing the transposition process (Fig 1.7) [40]. 
 
1.3.1.3 Use of transposons in directed evolution 
Several transposon-based techniques have been utilized to create libraries with 
insertion events randomly positioned throughout target genes. This relies on the 
transposon system being used having a low target site specificity. The majority of the 
methods utilize imperfect restriction digestion, after transposition, to remove the bulk 
of the transposon from the target gene [47]. The limitation of these methods is that the 
position of the restriction sites in the transposon often result in the TREs and/or target 
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site duplications left behind in the target gene (Fig 1.8). Depending on the transposon 
used and the method of transposon removal DNA sequences left behind can range 
from 12 - 279 bp. Religation of the single breaks in the target DNA, introduced after 
transposon removal, can result in the coding sequence producing proteins with 
peptide insertions ranging from 4 – 93 a.a (Table 1.1). 
This technique can be useful for probing general sites within proteins that are 
tolerant to peptide insertions. However, there is no control over the inserted DNA 
(TREs and target site duplication) and therefore the resulting encoded peptide 
insertions are restricted to that encoded by elements of the transposon. Designed DNA 
cassettes (e.g. encoding desired protein sequences) can be ligated into the random 
breaks generated after transposon removal, however the linkers connecting the 
peptides or domains to the target protein would again be encoded by the TREs and 
target site duplications (Fig 1.8). 
There are other methods available for the development of randomly 
introduced breaks in a target gene. Many of these techniques utilize enzymatic or 
chemical cleavage of DNA, by DNAseI or Ce(IV)-EDTA respectively, to introduce 
random breaks in a target gene into which DNA cassettes can then be inserted [39, 
48] or potentially used in downstream processes to introduce deletion mutations [39, 
48]. However, it is notoriously difficult to generate single cuts in DNA using DNaseI 
and digestion with this nonspecific nuclease regularly produces tandem duplications 
and nested deletions of unpredictable sizes within the parent gene [32].  
A recently developed transposon-based directed evolution approach [19, 21, 
31] can be used to sample different mutagenesis events not normally sampled by 
traditional approaches: triplet nucleotide deletion (TND) [19, 21], codon replacement 
[49], domain insertion [31, 37] and unnatural amino acid incorporation [50] (Fig 1.9). 
This method utilizes the bacteriophage transposon, Mu, and transposase, MuA, which 
has very low target site preference and can efficiently insert Mu transposons 
randomly throughout target genes [51]. An engineered Mu transposon, termed 
MuDel, containing MlyI restriction sites 1 bp from its 5’ and 3’ ends has been 
generated for the purposes of sampling various downstream mutagenesis events. The 
major advantage of this transposon-based technique over the previously described 
methods is that MlyI restriction digestion after transposition removes MuDel from the 
library DNA along with its TREs and the target site duplication. A triplet nucleotide 
xxx  
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Fig 1.8 Transposon removal by restriction digestion. Step 1, Restriction digestion removes 
the bulk of the transposon (orange) or TREs (grey), depending on the location of the 
restriction sites, from the target gene (green). This imperfect restriction digestion can leave 
behind part of the TREs and the target site duplication (yellow). Step 2a, Religation of the 
target gene results in the insertion of part of the transposon, TREs and the target site 
duplication, of varying sizes depending on the transposon system and removal method used 
(see Table 1.1). Step 2b, Designed DNA cassettes (red) can be ligated into the random breaks 
produced after transposon removal. 
 
 
 
 
 
Table 1.1 Transposon systems for peptide insertions 
Transposon 
derivatives 
Insertion size 
(a.a) Method of transposon removal Ref 
IS21 4 or 11 BglII or SalI restriction [52] 
Tn4430 5 KpnI restriction [53] 
Tn7 5 PmeI restriction [54] 
Mini Mu 5 NotI restriction [55] 
Tn5 24 or 31 NotI or BamHI restriction [56, 57] 
Tn3 45, 89 or 93 Cre-loxP site specific recombination [58, 59] 
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Fig 1.9 Schematic of MuDel transposon based method to library production. Step 1, In 
vitro transposition of MuDel (orange) into a target gene (green) results in a library of random 
insertions with target site duplications (yellow). Step 2, MlyI restriction digestion removes 
MuDel from the transposon insertion library, including the TREs (grey), target site 
duplication and a triplet nucleotide from the target gene, resulting in an insertion site library. 
Step 3a, Religation of the insertion site library results in a triplet nucleotide deletion (TND: 
purple line) library, for sampling single amino acid deletions. Step 3b, Insertion of DNA 
cassettes encoding a whole protein domain (red) and designed linker sequences (blue), with a 
kanamycin resistance gene (black) for positive selection, into the random breaks in the 
insertion site library produces a domain insertion library. Step 3c, Insertion of a DNA cassette 
termed Subseq (pale blue with bright green line) into the insertion site library, followed by 
removal of the bulk of subseq (pale blue) results in a triplet nucleotide exchange (TriNEx) 
library, for sampling substitution mutations (bright green line) or incorporation of amber stop 
codons (TAG) for non-natural amino acid incorporation. Step 4, The resulting libraries are 
then screened for protein variants with desired characteristics. 
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from the target gene is also removed upon MlyI restriction digestion. The mechanism 
by which this occurs is described in detail in Chapter 3. 
The resulting sub library has random breaks throughout the target gene and 
can be recircularized to produce a triplet nucleotide deletion (TND) library [19]. A 
DNA cassette encoding a whole protein domain can be ligated into the random breaks 
for the construction of integral domain fusion scaffolds [37]. Alternatively a DNA 
cassette, termed Subseq can be inserted within the random breaks in the target gene. 
Subseq has MlyI restriction sites critically placed to remove the bulk of the cassette 
leaving a triplet nucleotide behind in the target gene resulting in triplet nucleotide 
exchange (TriNEx) [49, 50] (Fig 1.9). 
 
1.4 Green fluorescent protein (GFP) 
1.4.1 General 
The discovery of GFP from the jellyfish Aequorea victoria has revolutionized 
real time imaging in live cells [60, 61]. The 27 kDa, 238-residue protein is termed an 
autofluorescent protein as it exhibits green fluorescence without the need for any 
additional cofactors. All that is required for fluorescence is correctly folded protein 
and O2, which allows the autocatalytic covalent rearrangement of residues S65, Y66 
and G67 to form the chromophore: 4-(p-hydroxybenzylidene)imidazolidin-5-one [62]. 
The autocatalytic formation of the chromophore makes GFP an efficient genetically 
encoded fluorescent marker [62]. As such it has been used extensively as a tool in cell 
biology to study gene expression, protein localization, protein trafficking and protein-
protein interactions [62]. While there were many envisaged uses of wild type GFP, 
the inherent properties were not optimized for use in cell biology. Thus, GFP has also 
been extensively engineered to adapt it for various different uses. This includes, new 
colour variants, improved brightness, increased stability and biosensing [63].  
 
1.4.2 Chromophore maturation 
For chromophore maturation to proceed the polypeptide must undergo four 
distinct processes: mainchain rearangement (folding), cyclisation, oxidation and 
dehydration [62, 64, 65]. Work by several research groups have helped to identify the 
roles of conserved residues, Y66, G67, R96 and E222 in the mechanism of 
chromophore maturation [66]. There are historically two proposed mechanisms by 
xxx  
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Fig 1.10 Two proposed mechanisms for GFP chromophore maturation. Mainchain 
rearrangement and cyclisation is either followed by dehydration then oxidation (Mechanism 
A) or oxidation then dehydration (Mechanism B). Figure adapted from [66] 
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which the chromophore matures (Fig 1.10) [66]. The first mechanism proposes main 
chain cyclisation is followed by dehydration of the S65 carbonyl carbon followed by 
oxidation of the Y66 C$-C# bond introducing full conjugation to the chromophore. 
Whilst the second proposed mechanism follows main chain cyclisation, oxidation 
then dehydration [66]. 
Both mechanisms start with the folding of the protein into the native #-barrel 
structure with the a distorted $-helix formed to promote main chain reorganization 
through placement of the carbonyl carbon of S65 in close proximity to the amide 
nitrogen of G67 (Fig 1.10) [64]. Nucleophilic attack by the amide nitrogen of G67 on 
the carbonyl carbon of S65 occurs in the precyclized structure forming an 
imidazalone ring [64]. Conserved residues R96 and E222 have both been implicated 
in the main chain cyclisation reaction. E222 acts as a general base increasing the 
nucleophilicity of the G67 amide nitrogen [66], whilst R96 acts to stabilize proposed 
enolate intermediates during the main chain cyclisation reaction [64] 
Computational methods have shown that the main chain cyclisation reaction is 
energetically unfavourable and therefore requires trapping in a cyclysed conformation 
either by oxidation or dehydration [67]. It was long thought that the chromophore 
maturation reaction progressed down the dehydration then oxidation pathway [62]. 
However, it has recently been shown that the oxidation step can precede dehydration 
[65]. Oxidation of the enolate intermediate by molecular oxygen results in the 
production of H2O2 in a 1:1 stoichiometry to mature chromophore [65] (Fig 1.10).  
Experiments following the increase in fluorescence and the production of 
H2O2 during maturation showed there was a lag between H2O2 production and 
fluorescence maturation [65]. The loss of 2 Da from accumulated intermediates, 
determined from MALDI-MS of tryptic peptides, confirmed oxidation as being the 
second step in chromophore maturation [65]. This implies oxidation takes place 
before dehydration resulting in full conjugation of the chromophore, giving rise to 
fluorescence. It is highly probable that the chromophore matures by both mechanisms 
but under highly aerobic conditions the predominant mechanism follows the 
cyclisation-oxidation-dehydration route. 
xxxxxxxxx  
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Fig 1.11 Green fluorescent protein structure. a, !-barrel fold of S65T-GFP (pdb:1EMA) 
comprising of 11 !-strands (dark green) with the chromophore (light green spheres) in the 
middle of the !-barrel. b, Cartoon representation of !-strands 3 and 4 (green) leading into the 
central $-helix (red) containing the chromophore (green sticks). The rest of the !-barrel has 
been cut away to reveal the chromophore. c, The two longest loops in GFP (red spacefill) 
form caps over the two ends of the !-barrel protecting the chromophore from the external 
environment. 
  
a b c 
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1.4.3 GFP tertiary structure 
GFP forms a #-barrel (or !-can) structure comprising 11 antiparallel #-strands 
(Fig 1.11 a) with a distorted $-helix running through the core. The chromophore 
forming residues reside on the distorted $-helix protected from the external 
environment by the #-barrel (Fig 1.11 b). The majority of the #-strands forming the #-
barrel are connected by short loops between 3 – 6 residues long. There are two longer 
loops that span the ends of the #-barrel acting as caps, further protecting the 
chromophore from the external environment (Fig 1.11 c). The chromophore of GFP is 
therefore encapsulated by the proteins #-barrel structure and is sensitive to the 
external environment with fluorescence being quenched upon exposure to the external 
solvent [68]. The chromophore therefore acts as a sensitive probe for the state of the 
protein. This has led to the exploitation of GFPs to sense changes in their local 
environment through engineering of efficient biosensors. The chromophore sensitivity 
to its local environment makes it a model protein for engineering studies as the effect 
of mutations can be easily observed.  
The GFP chromophore forms an extensive hydrogen-bonding network with 
residues and structured water molecules, in particular Q69, R96, N146, H148, R168, 
T203, S205 and E222 (Fig 1.12 a) [62]. The hydrogen-bonding network promotes a 
protonated form of the chromophore (Fig 1.12 a). The hydroxyl group of S65 is 
capable of donating a hydrogen bond to the carboxylate group of E222 which in turn 
participates in a hydrogen bond to the hydroxyl group of S205. The hydroxyl group of 
S205 forms a hyrdogen bond to the phenyl group of the chromophore through a 
conserved water molecule which is also coordinated by the mainchain carbonyl of 
N146. In this conformation E222 carries a negative charge and due to electrostatic 
repulsion results in the chromophore being protonated.  
In the S65T mutant, the additional methyl group on the side chain of T65 
results in the T65 hydroxyl being in a different position to that of the corresponding 
hydroxyl group of S65 in wt GFP, due to steric reasons. This results in the T65 
hydroxyl group donating a hydrogen bond to the main chain carbonyl of V61. This in 
turn results in the E222 carboxylate group being protonated and therefore neutral in 
the ground state. Other residues solvating the chromophore (H148, T203, S205) 
promote the ionization of the chromophore tyrosyl group, giving rise to altered 
xxxxxx 
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Fig 1.12 Hydrogen bonding network in the chromophore local environment. There are extensive hydrogen bonding networks between the mature 
chromophore and surrounding residues in both a, wild type GFP and b, S65T-GFP. Hydrogen bonds are shown as dashed lines with the length of the 
bonds shown in Å. Figure taken from [69] 
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spectral properties (Fig 1.12 b). Due to the close proximity (~3.7Å) of the E222 side 
chain to the chromophore, electrostatic repulsion would forbid both species being in 
an anionic form simultaneously.  
The wt GFP and S65T-GFP chromophores have different spectral 
characteristics being excited at either ~395 nm or ~490 nm respectively. However 
both chromophores emit fluorescence at ~509 nm. This is due to an anionic form of 
the chromophore in the excited state for both wt GFP and S65T-GFP. Excitation at 
395 nm results in the deprotonation of the chromophore in the excited state. This is 
why regardless of whether the chromophore is protonated (Fig 1.11 a) or deprotonated 
(Fig 1.12 b) in the ground state the emission is always at ~509 nm due to a 
deprotonated form of thc chromophore in the excited state. 
 
1.4.4 Engineering GFP 
As previously mentioned site directed mutagenesis of GFP has generated 
many colour variants with enhanced fluorescence and stability [23]. Substitution of 
residue Tyr66 in GFP to either histidine or tryptophan gives rise to blue or cyan 
fluorescence respectively [14], while substitution of Thr203 for a tyrosine results in !-
stacking with the GFP chromophore consequently red shifting emission to give 
yellow fluorescence [70]. Further substitution mutations have also yielded variants 
with improved folding characteristics and stability resulting in improved brightness 
[71]. 
 The two main problems with wild-type GFP were decreased folding 
efficiency when expressed above room temperature and its excitation by light in the 
UV range, which is potentially harmful to living cells. Given the obvious interest in 
fluorescent proteins that can efficiently fold at higher temperatures, GFP has been 
extensively engineered to identify mutations that confer improved folding and 
brightness [62]. One of the first advances in the use of GFP was the generation of 
enhanced GFP (EGFP). EGFP exhibits increased folding efficiency at 37°C and is 
excited by ~490 nm light. It is still one of the most widely used GFP variants.  
EGFP has two substitution mutations compared to the wt GFP; F64L and 
S65T. F64L increases the rate of folding and stability at 37°C, whilst S65T alters the 
spectral characteristics [24] and increases the oxidation rate during chromophore 
maturation ~4-fold [72]. S65T suppresses the major excitation peak at 375 nm 
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observed for wt GFP and increases the minor excitation peak at 475 nm ~5-fold with 
a red shift to ~488 nm [62]. The altered spectral properties conferred by the S65T 
mutation are due to promotion of the anionic form of the chromophore (Section 1.4.2, 
Fig 1.12) [69].  
 
1.5 Cytochrome b562  
Cytochrome b562 (Cyt b562) is a 106 amino acid 4 helix bundle protein, found 
in the periplasm of Eschericia coli. It binds a single haem molecule non-covalently, 
with the S! atom of a methionine (Met 7) and the N" atom of a histidine (His 102) 
coordinating the iron moiety [73-75] (Fig 1.13). The antiparallel #-helices form a left-
handed bundle separated by 3 interconnecting loops [74]. The haem moiety is situated 
towards the terminal end of the bundle in a hydrophobic pocket formed by the folded 
protein [74]. Cyt b562 undergoes a major change in conformation on binding haem 
most notably at the C-terminal helix, which changes from a dynamic unordered 
structure to a structurally ordered !-helix [73] (Fig 1.13). The apo-cyt b562 is 
essentially a partially folded protein and the binding of haem to cyt b562 more than 
doubles the stability of the protein, increasing the free energy of denaturation by over 
3 kcal mol-1 [76]. Haem also binds to cyt b562 in a redox dependent manor with tighter 
binding of reduced haem (~10 pM) than oxidized haem (~10 nM). Bound haem has 
also been shown to be sensitive to oxidative modification [77]. 
In the holo-cyt b562 protein the N- and C-termini are relatively close to one 
another (~17 $). In the majority of naturally occurring discontinuous multi-domain 
proteins the insert domain has its N and C-termini in close proximity (~8 $) so as not 
to disrupt the structure and therefore the function of the parent domain [24]. This 
therefore makes cyt b562 a potentially suitable candidate protein for domain insertion. 
 
1.5.1 Cytochrome b562 as a sensing domain. 
 The haem binding properties of cyt b562 opens up the possibility of its use as a 
potential sensor domain. Haem is a biologically important small molecule that acts as 
a cofactor to many different proteins encompassing a wide range of roles such as; 
oxygen transport [78], catalysis [79], electron transfer [80] and sensing. It also acts as 
an efficient fluorescence quencher [81], including that of EGFP [33, 82]. 
xxxxx  
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Fig 1.13 Structure of apo and holo-cyt b562. In the apo form the C-terminal region of cyt b562 
(pdb:1APC) is unstructured and dynamic. Binding of haem non covalently between its axial 
ligands, a methionine (M7) and histidine (H102), results in a large conformational 
rearrangement of the C-terminal region into a structured !-helix. Inset, close up view of haem 
coordinated between its axial ligands 
 
  
!"#$%
&'%!()*%
!"#$%
+%
,%
+%
,%
!()*%
&'%
 29 
Haem when free in solution can be severely toxic with high levels of free 
haem leading to organ, tissue and cellular injury [83]. Free haem can lead to the 
oxidation, covalent crosslinking and aggregation of proteins and has been implicated 
in many pathological states [83]. Therefore construction of a haem sensor would be 
extremely useful for characterizing levels of free haem in disease states. 
The redox-dependent binding of haem, conformational changes upon haem 
binding and the fact that the N- and C-termini are in close proximity to one another 
makes cyt b562 an attractive candidate as a sensing insert domain. Cyt b562 has been 
used in previous work to link the redox dependent haem binding events to other 
disparate functions such as DNA binding [84], antibiotic resistance or even as a 
bio/nanoelectronics component (Fig 1.14) [31, 37].  
Attachment of the DNA-binding basic helix region of the leucine zipper 
protein GCN4 to the N- and C-termini of cyt b562 (NCBHRb562) conferred site-specific 
DNA binding activity (Fig 1.14 a) [84]. Further mutagenesis of the loop connecting !-
helices 2 and 3 of cyt b562 in the NCBHRb562 constructs resulted in haem-dependent 
DNA binding affinity [84]. 
 The use of cyt b562 as an insert domain has also been demonstrated [31, 37]. 
Insertion of the cyt b562 domain into various positions throughout TEM-1 "-lactamase 
resulted in integral fusion scaffolds with haem dependent antibiotic resistance (Fig 
1.14 b). The redox properties of cyt b562 are also being exploited for potential use in 
molecular electronics, with electrochemical gating providing a route to modulate 
current flow through the protein (Fig 1.14 c) [85, 86]. 
 The presence of haem bound to cyt b562 in close proximity to the chromophore 
of EGFP has been shown to quench fluorescence through energy transfer [33]. The 
quenching of fluorescence by haem proximity to the fluorophore, in conjunction with 
the conformational changes on redox dependent haem binding may act synergistically 
to modulate GFP fluorescence. 
 
1.6 Scope of the present project 
This thesis focuses on the use of a recently developed transposon based 
directed evolution approach to sample mutational events in proteins not currently used 
in the available protein engineering toolbox; single amino acid mutagenesis and 
xxxxx  
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Fig 1.14 Models of engineered proteins involving cyt b562. a, An engineered DNA binding 
cyt b562 with haem dependent DNA affinity. b, An integral domain fusion scaffold of cyt b562 
(red) inserted within TEM-1 !-lactamase (blue) conferring haem dependent antibiotic 
resistance. c, Gold-thiol interactions of an engineered cyt b562 for the use as a protein based 
single molecule transistor. 
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domain insertion. The thesis will then explore the tolerance and impact of these 
mutational events, and how novel proteins with useful properties can be generated. 
As described in Section 1.2.1 substitution mutations are extensively used to 
engineer new or improved function into proteins. However, single amino acid deletion 
mutagenesis is rarely used as a protein-engineering tool due to the dogma that 
mutational events affecting the protein backbone can be detrimental to structure and 
therefore function. It is also difficult to predict the structural outcome of an amino 
acid deletion event therefore requires a directed evolution approach to survey for 
tolerated mutation positions, which as of now there has not been a suitable technique 
to introduce deletion mutations randomly throughout a target gene.  
The practice of domain insertion as a protein-engineering tool to develop 
novel protein scaffolds to act as artificial biomolecular switches is also largely 
underused. Both of these mutational techniques share a common theme in that they 
both alter the protein backbone by either shortening it or by fragmenting the 
continuity of the polypeptide chain. 
 Due to the nature of the mutations being introduced, altering the peptide 
backbone, it is very difficult to rationally design positions within a target protein that 
will be tolerant to the effects on the local and global structure. This problem is 
confounded by a lack of detailed structural information concerning the effects of 
amino acid deletion mutagenesis or domain insertion. Therefore to identify sites 
within a target protein that are tolerant to alterations of the backbone structure a 
transposon based directed evolution approach has been taken to develop libraries of 
mutant proteins of which can be screened for desired characteristics.  
 In this study the genetically encoded auto fluorescent protein EGFP has been 
used as a target protein to study the effects of single amino acid deletion mutagenesis 
and to assess its tolerance to cyt b562 domain insertion, for the construction of 
potential novel energy transfer scaffolds.  
 In the first experimental chapter of this thesis (Chapter 3), work is presented 
on the construction of a transposon insertion library exhibiting insertions randomly 
positioned throughout the egfp gene. The processes behind the construction and 
subsequent screening of triplet nucleotide deletion (TND) and domain insertion sub 
libraries have also been described. DNA sequence analysis of isolated variants from 
both of the sub libraries will help towards identifying a possible target site consensus 
sequence for the engineered Mu transposon, MuDel, which as of yet has not been 
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investigated in detail. The outcome of this work was the generation of a diverse 
transposon insertion library within egfp, with the construction of two sub libraries for 
the sampling of single amino acid deletion mutations or cyt b562 domain insertions in 
EGFP. Sequence analysis implied MuDel has very low target site specificity with no 
obvious target site consensus sequence. 
 Chapter 4 investigates the tolerance and impact of EGFP to single amino acid 
deletion mutagenesis. Variants with altered or improved properties (e.g. fluorescence 
characteristics, stability, cellular production) that were identified from the TND 
library were further characterised. The crystal structure for EGFP has also been 
solved, which during the course of this thesis had not been done before, and will help 
to describe the effects of single amino acid deletions at the molecular level. High-
resolution structure determination of EGFP highlighted the effects of the F64L and 
S65T mutations at the molecular level. Variants were also identified from the library 
with improved folding and stability characteristics, resulting in increased cellular 
fluorescence.  
 Chapter 5 investigates the tolerance and effect of EGFP to cyt b562 domain 
insertion. A novel variant identified from the library was characterized in much 
greater detail and provides the basis for Chapter 6. The work in this chapter 
highlighted the importance of domain insertion position and the magnitude of 
functional coupling between the two domains. Two variants were also identified that 
have altered spectral properties and lead to the development of ratiometric fluorescent 
redox sensors providing the basis for Chapter 7. 
 Chapter 6 describes the crystal structure determination of a novel cyt b562-
EGFP integral fusion scaffold, identified in Chapter 5, with interesting haem mediated 
quenching characteristics to ascertain at the molecular level reasons behind the 
observed properties. This will further aid our understanding of integral domain 
fusions at a molecular level for future scaffold design. Further biophysical 
characterization of this variant has also been described to identify how whole domain 
insertion has affected the structure and stability of EGFP. 
 The final chapter concerns using a rational approach to design a cyt b562-EGFP 
chimera, identified in Chapter 5, to further develop ratiometric fluorescent redox 
sensing properties. The redox characteristics for the resulting mutants have been 
investigated by redox buffer titration and determination of redox kinetics. These 
experiments examined the influence of the introduced mutations on the redox sensing 
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capabilities of a cyt b562-EGFP scaffold (CG15). A CG15 double cysteine mutant was 
identified with the most reducing midpoint described to date and the fastest response 
rates to the natural cellular reactive oxygen species (ROS) H2O2. 
 The combination of directed evolution, rational design, in silico design and X-
ray crystal structure determination performed in this thesis can be used to help build a 
picture of the structural effects of mutations that alter the backbone of a protein. This 
will in turn aid future design processes for the tailoring of more specific protein 
constructs. 
 
  
 34 
Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
Deionised or MilliQTM (MQ) water were used throughout. Ampicillin 
(Melford, Ipswich, Suffolk), kanamycin or chloramphenicol (Duchefa Biochemie, 
Melford, Ipswich, Suffolk) were made as a 100, 25 or 40 mg/ml stock solution 
respectively and filter sterilized with a 0.22 µm filter unit (Thermo Fisher Scientific, 
Loughborough, Leicestershire, UK). The stock solutions were used to supplement 
bacterial growth media by dilution to an appropriate working concentration of 100 
µg/ml ampicillin, 20 or 40 µg/ml chloramphenicol or 25 µg/ml kanamycin. Isopropyl 
!-D-1-thiogalactopyranoside (IPTG) (Melford, Ipswich, Suffolk) was made as a 100 
mM stock solution and filter sterilized with a 0.22 µm filter unit (Thermo Fisher 
Scientific, Loughborough, Leicestershire, UK). The stock solution was used to 
supplement bacterial growth media by dilution to an appropriate final concentration.  
Haem (Sigma-Aldrich, Dorset, UK) was prepared as a 10 mM stock solution 
by suspension into 0.5 M NaOH (Sigma-Aldrich, Dorset, UK) and diluted into dH2O 
to working concentrations as required. NaOH is used to ionize haem in aqueous 
solution to prevent aggregation.  
KNO3 (BDH AnalaR, VWR International Ltd., Poole, UK) was prepared as a 
100 mM stock solution in dH2O and diluted into a protein sample to an appropriate 
working concentration of 1 mM. Ascorbic acid (Sigma-Aldrich, Dorset, UK) was 
prepared as a 100 mM stock solution in dH2O and diluted into a protein sample to an 
appropriate working concentration of 1 mM. KNO3 and ascorbic acid are used to 
generate oxidizing and reducing conditions respectively.  
H2O2 (30% (v/v)) or NaHClO (Sigma-Aldrich, Dorset, UK) was diluted into 
dH2O as necessary. Dithiothreitol (reduced DTT) (Melford, Ipswich, Suffolk) and 
trans-4,5-dihydroxy-1,2-dithione (oxidized DTT) (Sigma-Aldrich, Dorset, UK) stock 
solutions of 10 mM were prepared in dH2O and diluted as necessary to make redox 
buffers for redox midpoint determination.  
Agarose (Melford, Ipswich, Suffolk) was of molecular biology grade and 
prepared by boiling 1.0-2.0 % (w/v) in TAE (Tris Acetate EDTA). Acrylamide and 
N,N’-methylene bis-acrylamide at a 37.5:1 (w/w) ratio in a (40% w/v) solution 
(Sigma-Aldrich, Dorset, UK) was used for poly acrylamide electrophoresis (PAGE) 
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(Section 2.5.1). SDS, APS (Sigma-Aldrich, Dorset, UK) and !-mercaptoethanol 
(Melford, Ipswich, Suffolk) were used for SDS-PAGE at concentrations stated in 
Table 2.3. Ammonium sulphate and guanidine hydrochloride (Melford, Ipswich, 
Suffolk) were used for protein precipitation or equilibrium unfolding analysis 
respectively.   
 
2.1.2 Chromatographic columns 
All chromatographic columns used were supplied by GE Healthcare and used 
in conjunction with an ÄKTApurifier FPLC. ResourceTM Q, MonoTM Q and 
HiLoadTM SuperdexTM 75 pg (preparative grade) columns were used for protein 
purification whilst SuperdexTM 75 GL and SuperdexTM 200 GL columns were used for 
analytical size exclusion chromatography. 
 
2.1.3 Bacterial cell strains 
All DNA libraries were grown in E. coli NovaBlue GigaSinglesTM cells 
(Merck), E. coli DH5! cells (New England Biolabs) were used for carrying and 
amplifying DNA generated from recombinant methods and all protein expression 
work was conducted within E. coli BL21-Gold (DE3) cells (Stratagene) or E. coli 
TUNERTM (DE3) cells (Novagen) as specified (Table 2.1). 
 
Table 2.1. Species, strains and genotype of bacteria used within different techniques. 
Species Strain Genotype 
E. coli NovaBlue 
GigaSingles™ 
endA1 hsdR17 (rK12-mK12+) supE44 thi-1 recA1 
gyrA96 relA1 lac F’[proA+B+ lacIq Z"M15::Tn10 
(TcR)] 
 
E. coli DH5! F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
"80dlacZ#M15 #(lacZYA-argF)U169, hsdR17(rK- 
mK+), $– 
   
E. coli  BL21-Gold 
(DE3)  
F– ompT hsdS(r – m –) dcm+ Tetr gal $(DE3) endA Hte 
   
E. coli TUNER™ 
(DE3) 
F– ompT hsdSB (rB– mB–) gal dcm lacY1(DE3) 
 
 
2.1.4 Bacterial growth media 
Luaria Bertani (LB) broth medium and LB Agar plates were prepared by 
dissolving 20 g of granulated LB-Broth (Melford, Ipswich, Suffolk, UK) or 35 g 
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powdered LB Agar (Sigma Aldrich, Dorset, UK) respectively in 1 L of ultra pure 
water. M9 minimal medium was comprised of 48 mM Na2HPO4, 22 mM KH2PO4, 8.5 
mM NaCl, 1.8 mM NH4Cl, 2 mM MgSO4, 0.1 mM CaCl2 and 22 mM glucose. M9 
minimal media agar plates were prepared as above supplemented with 1.5% agar 
(Sigma-Aldrich, Dorset, UK). SOC medium was comprised of 2% (w/v) Bacto 
Tryptone, 0.5% (w/v) Bacto Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4. After sterilisation using an autoclave the media was 
supplemented with 20 mM glucose. All media were sterilized by autoclave at 121 °C. 
 
2.1.5 Molecular weight standard markers 
DNA molecular standard markers (100 bp, 1 kb) and broad range prestained 
protein standard marker were obtained from New England Biolabs (NEB, 
Hertfordshire, UK) and stored at -20 °C. Protein standards were boiled for 5 mins 
before use. 
 
2.2 Molecular biology and recombinant DNA methods 
2.2.1 Purification of DNA 
When using DNA purification kits, the manufactures guidelines were 
followed. DNA concentrations and 260/280 nm ratios after purification were 
estimated using a NanoDrop® ND-1000 UV-Vis spectrophotometer (Thermo Fisher 
Scientific, Loughborough, Leicestershire, UK) 
 
2.2.1.1 From bacterial cell cultures 
All large scale preparations (midipreps) of plasmid DNA, using 50 ml of 
bacterial culture, were carried out using Qiagen midiprep kits. Small scale 
preparations (minipreps), using < 5 ml of bacterial culture were carried out using 
Qiagen miniprep kits. Both methods involve alkaline/SDS lysis of pelleted cells 
followed by neutralization with a 1-3 M solution of sodium acetate, pH <5.5. The 
DNA was bound to a silica membrane in the presence of high salt, washed and eluted 
off the membrane with 10 mM Tris-HCl buffer, pH 8.5. 
 
 37 
2.2.1.2 From agarose gel  
Purification of DNA from agarose gel slices was performed using the 
QIAquick® gel extraction kit (Qiagen). Guanidine thiocyanate acts as the chaotropic 
salt and together with a 50 °C incubation disrupts the agarose gel matrix leading to 
solubilisation of the agarose. The DNA liberated from the agarose binds to a silica 
membrane when at a pH < 7.5, is washed then eluted with 10 mM Tris-HCl buffer, 
pH 8.5. 
 
2.2.1.3 From PCR reactions 
Purification of double stranded DNA products from PCR reactions was 
performed using the QIAquick® PCR purification kit (Qiagen). Guanidine 
hydrochloride and isopropanol denature polymerases in the PCR reaction mix and 
allow the efficient binding of DNA >100 bp to a silica membrane when at a pH<7.5. 
Bound DNA is washed and eluted with 10 mM Tris-HCl buffer, pH 8.5. 
 
2.2.1.4 From other enzymatic reactions 
Purification of DNA products from other recombinant DNA methods was 
performed using a MinElute® reaction cleanup kit (Qiagen). Optimum binding of 
DNA fragments between 70 bp – 4 kb to a silica membrane is achieved at a pH <7.5. 
Elution in a small volume (10 µl) of 10 mM Tris-HCl buffer, pH 8.5, results in 
concentrated pure DNA samples ready for subsequent reactions. 
 
2.2.2 Agarose gel electrophoresis 
Analysis and separation of DNA fragments was carried out by agarose gel 
electrophoresis. Agarose (0.7 – 2% (w/v)) was suspended in TAE buffer (40 mM 
Tris-acetate pH 9.5 and 1 mM EDTA) with ethidium bromide (0.5 µg/ml). A 1/6 
dilution of a stock solution loading buffer (Tris pH 8.0, 40% sucrose (w/v), 0.01% 
(w/v) bromophenol blue) was added to DNA samples prior to loading onto the gel. 
Electrophoresis was then performed at 100 V for 30 - 50 mins. DNA bands were 
visualised using an UV-transilluminator (GelDoc-It Imaging System, Ultra-Violet 
Products Ltd, Cambridge, UK). Approximate molecular weights were determined 
using DNA molecular size standards (Section 2.1.5) by comparing the distance 
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travelled on the gel of the DNA fragments in the sample with the fragments in the 
marker. 
 
2.2.3 PCR with GoTaq polymerase 
DNA amplification with GoTaq DNA polymerase (1.25 U) (Promega Ltd, 
Southampton, UK) was carried out in 50 mM KCl, 10 mM Tris-HCL pH 9.0, 0.1% 
(v/v) Triton!X-100 and 1.5 mM MgCl2 with 0.2 mM dNTPs, 2 µM of each primer, 
template DNA (< 20 ng) made to a total volume of 50 µl. Reactions were placed in a 
TC-412 thermo cycler (Techne) and raised to 95 °C for 10 min. The following cycle 
was repeated 25 times: the temperature was taken to 95 °C for 30 sec for double 
stranded DNA to denature: The temperature was dropped to 55-65 °C for 30 sec to 
allow the primers to anneal to the template DNA: The temperature was then taken to 
72 °C for 1 min/kb of template DNA to allow DNA chain elongation by the 
polymerase. After 25 cycles the temperature was held at 72 °C for 5 min to complete 
elongation before being held at 4 °C until removed from the thermo cycler. The 
reaction (2 µl) was analysed by agarose gel electrophoresis (1.0-2.0%  (w/v)) (see 
2.2.2). Colony screening by PCR follows the above method with a selected colony 
suspended within the PCR reaction mix in place of template DNA.  
 
2.2.4 PCR with Phusion polymerase 
DNA amplification with Phusion High Fidelity DNA polymerase (1 U) 
(Finnzymes, Braintree, Essex, UK) was carried out in 10 mM Tris-HCL, pH 8.8, 50 
mM MgCl2 and 0.1% (v/v) Triton!X-100 with 0.2 mM dNTPs, 2 µM of each primer, 
template DNA (< 20 ng) made to a total volume of 50 µl. Reactions were placed in a 
TC-412 thermo cycler (Techne) and raised to 98 °C for 30 sec. The following cycle 
was repeated 30 times: the temperature was taken to 98 °C for 15 sec for double 
stranded DNA to denature: The temperature was dropped to 55-65 °C for 15 sec to 
allow the primers to anneal to the template DNA: The temperature was then taken to 
72 °C for 30 sec/kb of template DNA to allow DNA chain elongation by the 
polymerase. After 30 cycles the temperature was held at 72 °C for 5 min to complete 
elongation before being held at 4 °C until removed from the thermo cycler. The 
reaction (2 µl) was analysed by agarose gel electrophoresis (1.0-2.0%  (w/v)) (see 
2.2.2).  
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2.2.5 Oligonucleotides for PCR 
The sequence of oligonucleotides (synthesisied by Integrated DNA 
Technologies, www.IDTDNA.com) used as part of this work are given in Table 2.2.  
 
2.2.6 Restriction digestion 
NdeI (1 U/µg DNA), MlyI (1 U/µg DNA) and XhoI (1 U/µg DNA) (New 
England Biolabs) restriction digests were performed in 1 x NEBuffer 4 
(50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 
1 mM DTT, pH 7.9) supplemented with 0.1 mg/ml bovine serum albumin (BSA) 
(New England Biolabs) in a total reaction volume of 50 µl , and incubated at 37°C (1 
hr/µg DNA). NdeI and XhoI were heat inactivated at 65 °C for 20 mins. PstI (1 U/µg 
DNA) (Promega) restriction digests were performed in 1 x Buffer H (90 mM Tris-
HCL pH 7.5, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT) supplemented with a final 
concentration of 0.1 mg/ml acetlylated BSA (Promega) made to a total reaction 
volume of 50 µl with sterile distilled water and incubated at 37°C (1 hr/µg DNA). The 
PstI was heat denatured at 65 °C for 15 mins.  
 
2.2.7 Phosphorylation and dephosphorylation 
Phosphorylation of the 5’ ends of linear DNA was performed using T4 
polynucleotide kinase (10 U/µl) (NEB). Linear DNA (usually from PCR reactions) 
was supplemented with 1 µl of T4 polynucleotide kinase, 1 x T4 polynucleotide 
kinase reaction buffer (7 mM Tris-HCl, 1 mM MgCl2, 0.5 mM DTT pH 7.6) (New 
England Biolabs) and ATP to a final reaction concentration of 1 mM. The reaction 
was incubated at 37 °C for 1 hr then heat inactivated at 65 °C for 20 mins. 
Dephosphorylation of the 5’ ends of linear DNA was performed by the 
addition of ApexTM Heat-Labile Alkaline Phosphatase (1 µl/µg DNA) (Epicentre) to 
restriction endonuclease digestion reactions (see 2.2.6) and incubated at 37 °C for the 
duration of the restriction digest. The phosphatase was heat inactivated by incubating 
the reaction mixture at 70 °C for 5 mins.  
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Table 2.2. The name and DNA sequence of oligonucleotides used for PCR based applications. 
Name Sequence (5’ to 3’)a 
AJBgfp009 AGCAGACATATGGTGAGCAAGGGCGAGGAGC 
AJBgfp010 ATACTCGAGTTACTTGTACAGCTCGTCCATGCCG 
DDJdi029 CTGACTCTTATACACATCTAATACCTGTGACGGAAGATC 
DDJdi030 CTGACTCTTATACACATCTCTCAGGCATTTGAGAAGCACAC 
AS1Primer CTGACTCTTATACACAAGTCGCGAAAGCGTTTCACGATA 
DDJdi023 GGCGGTAGCGCAGATCTTGAAGACAATATGGA 
DDJdi024 GCTGCCACCCCTATACTTCTGGTGATAGGCGT 
JAJA003 NGGTGGGAGCGCAGATCTTGAAGACAATATGGA 
JAJA004 NNGCTCCCACCCCTATACTTCTGGTGATAGGCGT 
JAJA005 NNGGTGGGAGCGCAGATCTTGAAGACAATATGGA 
JAJA006 NGCTCCCACCCCTATACTTCTGGTGATAGGCGT 
WREcbf005 NNSGCAGATCTTGAAGACAATATGGAAACCC 
WREcbf006 SNNACGATACTTCTGGTGATAGGCGT 
WREcbf007 SNNSGATCTTGAAGACAATATGGAAACCC 
WREcbf008 NNSNNACGATACTTCTGGTGATAGGCGT 
WREcbf009 NSNNSGATCTTGAAGACAATATGGAAACCC 
WREcbf010 NSNNACGATACTTCTGGTGATAGGCGT 
pEXP-F TGCTCACATGTGCGTAGAGG 
DDJdi013 GTCTCATGAGCGGA 
AJBEGFP119-F GGTCCTGTGCTGCTGCCC 
AJBEGFP120-R GCCGATTGGGGTGTTCTG 
AJBEGFP121-F GGGATCACTCTCGGCATGGAC 
AJBEGFP122-R GGCGGTCACGAACTCCAGCA 
JAJA052 GTAGTTGTACTCCAGCTTGTGCCCCAG          
JAJA053 TGCGGTGGGAGCGCAGATCTTGAAG                  
JAJA054 GAAGTTCACCTTGATGCCGTTCTTCT 
JAJA055 TGCATCCGCCACAACATCGAGGAC 
JAJA056 GATCTTGAAGTTCACCTTGATGCCGTT            
JAJA057 TGCCACAACATCGAGGACGGCAG 
JAJA058 GGTGCTCAGGTAGTGGTTGTCGGGCA                 
JAJA059 TGCTCCGCCCTGAGCAAAGACC 
JAJA065 GTCGCCCATATGGTGAGCAAGGAGGAGCTGTT 
aN refers to A, G, C or T nucleotides, S refers to C or G nucleotides. 
 
  
 41 
2.2.8 Ligation 
DNA ligations were carried out using Quick T4 DNA ligase (1 µl/reaction) 
(New England Biolabs) in 1 x quick ligation reaction buffer (66mM Tris-HCL, 10 
mM MgCl2, 1 mM DTT, 1 mM ATP, 15% (w/v) PEG 6000, pH 7.6) (New England 
Biolabs). Ligation of an insert gene into a plasmid was performed using 50 ng of 
vector DNA with a 3-fold molar excess of insert in a total reaction volume of 20 µl. 
Recircularisation (intramolecular) ligation of linear DNA was performed with 50 ng 
of the linear plasmid. Ligation reactions were incubated at 25°C for 20 mins then the 
DNA purified using a MinElute kit (Qiagen) (see 2.2.1.4) to remove any residual PEG 
that may reduce efficiency of the subsequent transformation by electroporation.  
 
2.2.9 Preparation of electro competent cells 
An LB broth (10 ml) (see 2.1.4) overnight culture was prepared from a single 
E. coli (Table 2.1) colony and incubated in a shaking incubator (200 rpm) at 37 °C 
overnight. The 10 ml overnight culture was diluted into two 500 ml cultures of LB 
broth (see 2.1.4) and grown to an A600 of 0.4-0.8. The cells are harvested by 
centrifugation (1500 x g for 15 mins at 4 °C). The pellet was resuspended in 1l of ice-
cold sterile water and harvested by centrifugation (1500 x g for 20 mins at 4 °C). The 
pellet was resuspended in 500 ml of ice cold sterile water and the previous harvesting 
step was repeated. The pellet was resuspended in 250 ml of ice-cold sterile water and 
harvested according to the last step. The pellet was resuspended in ~100 ml ice-cold 
sterile 10% glycerol and harvested as before. The pellet size was estimated and 
resuspended in an equal volume of 10% glycerol. The cells were divided into 40 µl 
aliquots, snap frozen in liquid nitrogen and stored at -80 °C.  
 
2.2.10 Transformation by electroporation 
Electrocompetent cells stored at -80°C were thawed on ice. DNA (10 ng – 20 
ng) was added to an aliquot of thawed cells (40 µl), mixed and transferred to a pre-
chilled, sterile electroporation cuvette and subjected to a 4.5 – 5 ms electrical pulse at 
12.5 kV.cm-1 field strength using a gene pulser (Bio-Rad laboratories Ltd., UK) with 
capacitance and resistance set to 25 µF and 200 !, respectively. The cells were 
recovered by the addition of 960 µl room temperature SOC (see 2.1.4) in a sterile tube 
and incubated (37 °C at 200 rpm) for 1 hr. After recovery the cells were plated on LB 
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agar (see 2.1.4) supplemented with suitable antibiotics and IPTG if required (see 
2.1.1). 
 
2.2.11 Transformation by heat shock 
E. coli NovaBlue Giga Singles cells (see 2.1.3) stored at -80 °C were thawed 
on ice. The cells were gently flicked to resuspend evenly. DNA (10 ng – 20 ng) was 
added to the cells (50 µl), gently mixed and stored on ice for 5 mins. The cells were 
heated in a water bath for 30 sec at 42 °C then put back on ice for 2 mins. The cells 
were recovered by the addition of 950 µl room temperature SOC (see 2.1.4) in a 
sterile tube and incubated (37 °C at 200 rpm) for 1 hr. After recovery the cells are 
plated on LB agar (see 2.1.4) supplemented with suitable antibiotics (see 2.1.1). 
 
2.2.12 MuDel, OE-Tn5 and ME-4A-Tn5 preparation. 
Construction of MuDel by PCR and cloning into pENT was previously 
described [21]. To prepare MuDel for in vitro transposition it was liberated from the 
plasmid pENT-MuDel by BglII restriction digestion, kindly supplied by Dr Wayne 
Edwards. OE-Tn5 was constructed by amplification of MuDel as template DNA by 
phusion PCR (see 2.2.4) with primer AS1primer (Table 2.2). ME-4A-Tn5 was 
constructed by amplification of MuDel as template DNA by phusion PCR (see 2.2.4) 
with primers DDJdi029 and DDJdi030 (Table 2.2). After amplification both OE-Tn5 
and ME-4A-Tn5 were purified from their respective PCR reactions using a 
QIAquick® PCR purification kit (see 2.2.1.3). Both OE-Tn5 and ME-4A-Tn5 
transposons were phosphorylated (see 2.2.7) before use and the reaction cleaned up 
with a MinElute® reaction cleanup kit (see 2.2.1.4). 
 
2.2.13 In Vitro MuDel transposition 
In vitro transposition reactions using the MuDel transposon were performed 
using HyperMuTM MuA Transposase (1 µl/ reaction) (Epicentre) in a 1 x reaction 
buffer (0.15 M potassium acetate, 0.05 M Tris-acetate pH 7.5, 0.01 M magnesium 
acetate and 4 mM spermidine) with 300 ng of target DNA (pNOM-XP3-EGFP, see 
2.2.15) and 40 ng MuDel transposon (see 2.2.12) made to a total reaction volume of 
20 µl with dH2O. The reaction was incubated at 37 °C for 3 hrs. The reaction was 
terminated by the addition of 1 x stop solution (0.1% SDS) followed by incubation at 
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70 °C for 10 mins. E. coli NovaBlue Giga Singles cells (Table 2.1) were transformed 
(see 2.2.11) with 1 µl of transposition reaction mixture. 
 
2.2.14 In Vitro Tn5 transposition 
In vitro transposition reactions using the Tn5 transposons (see 2.2.12) using 
EZ-Tn5TM Transposase (1 µl/reaction) (Epicentre) was performed in a 1 x  reaction 
buffer (0.15 M potassium acetate, 0.05 M Tris-acetate pH 7.5, 0.01 M magnesium 
acetate and 4 mM spermidine) with 200 ng of target DNA and a molar equivalent of 
Tn5 transposon, made up to a final reaction volume of 20 µl. The reaction was 
incubated at 37 °C for 3 hrs. The reaction was terminated by the addition of 1 x stop 
solution (0.1% SDS) followed by incubation at 70 °C for 10 mins. E. coli NovaBlue 
Giga Singles cells (Table 2.1) were transformed (see 2.2.11) with 1 µl of transposition 
reaction mixture. 
 
2.2.15 Cloning of EGFP into pNOM-XP3  
The gene encoding EGFP (EGFP) from plasmid pEGFP-N3 (Clontech) was 
amplified by PCR with GoTaq polymerase (see 2.2.3) at an annealing temperature of 
60 °C using primers AJBgfp009, which incorporates a NdeI restriction site to the 5’ 
end of EGFP, and AJBgfp010 (Table 2.1), which incorporates a XhoI site to the 3’ 
end of EGFP (N-EGFP-X). N-EGFP-X was digested with NdeI and XhoI (see 2.2.6) 
and purified using a QIAquick PCR purification kit (Qiagen) (see 2.2.1.3). Vector 
pNOM-XP3 was digested with NdeI and XhoI (see 2.2.6) and separated on a 1.0% 
(w/v) agarose gel (see 2.2.2). The DNA band at an expected size of 2143 bp was cut 
from the gel and extracted using a QIAquick gel extraction kit (Qiagen) (2.2.1.2). 
Digested N-EGFP-X and pNOM-XP3 were ligated (see 2.2.8) together to produce 
vector pNOM-XP3-EGFP used to transform electrocompetent (see 2.2.10) E. coli 
DH5! cells (Table 2.1), plated on LB agar (see 2.1.4) supplemented with ampicillin 
(see 2.1.1) and incubated at 37 °C overnight. Colony screening by PCR (see 2.2.3) 
using primers pEXP-F and DDJdi013 (Table 2.2) was carried out to assess whether 
EGFP cloning into pNOM-XP3 was successful. NdeI and XhoI restriction digestion 
(see 2.2.6) of pNOM-XP3-EGFP was performed and separated on a 1.0% (w/v) 
agarose gel (see 2.2.2) to confirm the restriction sites had been maintained, as they are 
required for a later library construction step (see 2.3.2). 
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2.2.16 DNA Sequencing 
DNA samples were sequenced at the Cardiff University Molecular Biology 
support units DNA sequencing core. Sample preparation and submission was carried 
out as to the specifications found online at http://probe.biosi.cf.ac.uk/seq/. 
 
2.3 Library construction 
 The entire library construction process has been outlined in Figure 2.1 with 
reference to materials and methods sections at each stage. 
 
2.3.1 Transposon insertion library construction 
In vitro transposition into pNOM-XP3-EGFP with MuDel (see 2.2.13) or Tn5 
(see 2.2.14) transposons was performed and used to transform NovaBlue 
GigaSinglesTM (transformation efficiency > 109 cfu/µg DNA) (see 2.2.11). A single 
LB agar plate (see 2.1.4) supplemented with 20 µg/ml chloramphenicol (see 2.1.1) 
was prepared for each transformed transposition, a percentage of cells were plated and 
the rest used to inoculate 1l LB broth (see 2.1.4) supplemented with 20 µg/ml 
chloramphenicol (see 2.1.1) and incubated at 37°C overnight shaking at 200 rpm. 
Pooled library DNA was purified from the liquid cell cultures (see 2.2.4) and stored at 
-20 °C. The pooled DNA libraries are named based on the target gene and transposon 
used to generate them: pNOM-XP3-EGFP!MuDel, pNOM-XP3-EGFP!OE-Tn5 or 
pNOM-XP3-EGFP!ME-4A-Tn5.  
 
2.3.2 Isolation of variants with transposons within egfp 
Restriction digestion of library DNA (3 µg) with NdeI and XhoI (see 2.2.6) 
was separated by agarose gel electrophoresis (see 2.2.2). Restriction digest produces 4 
DNA fragments: vector with or without a transposon and EGFP with or without a 
transposon. The two bands corresponding to vector without a transposon and EGFP 
with a transposon were isolated and gel extracted (see 2.2.1.2). The two purified 
fragments were ligated (see 2.2.8) together and used to transform (see 2.2.11) E. coli 
NovaBlue Giga Singles cells (Table 2.1). A percentage of the transformed cells were 
grown on LB agar (see 2.1.4) supplemented with 20 µg/ml chloramphenicol (see 
2.1.1) and the rest were used to inoculate 1L LB broth (see 2.1.4) supplemented with 
20 µg/ml chloramphenicol (see 2.1.1) and incubated as described in section 2.3.1. 
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Pooled library DNA was purified from the liquid cell cultures (see 2.2.1.1) and stored 
at -20 °C. Libraries with transposons within EGFP were named, as before, after the 
target gene and the transposon EGFP!MuDel and EGFP!OE-Tn5 (Fig 7). 
 
2.3.3 Triplet nucleotide deletion (TND) library construction 
MlyI restriction digestion (see 2.2.6) was performed on EGFP!MuDel DNA (3 
µg) to remove MuDel from the pooled plasmid library and analysed by 1.0% (w/v) 
agarose gel electrophoresis (see 2.2.2). The linear library DNA was purified from the 
agarose gel using a QIAquick® gel purification kit (see 2.2.1.2). The purified linear 
library DNA was recircularised by intramolecular ligation with Quick T4 DNA ligase 
(see 2.2.8) and the reaction cleaned up with a MinElute reaction cleanup kit (see 
2.2.1.4). The ligation reaction mixture (1 µl) was used to transform (see 2.2.10) E. 
coli BL21-Gold (DE3) cells (Table 2.1). The transformed cells were grown on LB 
agar plates (see 2.1.4) supplemented with 100 µg/ml ampicillin and 150 µM IPTG 
(see 2.1.1) and incubated at 37 °C for 24 hrs then stored at 4 °C. Colonies presenting a 
green colour phenotype upon illumination on a UV transilluminator and colonies with 
no colour phenotype were selected for a colony PCR screen (see 2.2.3) with primers 
pEXP-F and DDJ013 (Table 2.2). The PCR products produced (2 µl) were analysed 
by agarose gel electrophoresis (see 2.2.2) and the rest purified using a QIAquick PCR 
purification kit (see 2.2.1.3) for DNA sequence analysis, to identify the nature of the 
triplet nucleotide deletions. 
 
2.3.4 Production of cybC cassettes 
A cyt b562 DNA cassette (cybC) was constructed in previous work [6] that 
contains a kanamycin resistance gene (kanr) flanked by PstI restriction sites in its 
open reading frame (cybC-kanr). This allows for selection of successful cloning of the 
DNA cassette into the insertion site library. CybC-kanr cassettes were produced by 
PCR (see 2.2.4) with oligonucleotides coding for GGS or random single amino acid 
(X) linkers attached to the 5’ and 3’ ends of the cassette (cybC-kanr-GGS, cybC-kanr-
X). Vector pWRE-22 containing the cybC-kanr cassette was used as a template at an 
annealing temperature of 62 °C. Additional random nucleotides were also added to 
the 5’ or 3’ end of some of the cassettes to be able to sample out-of-frame insertion 
positions and therefore utilize all three reading frames (cybC-kanr-GGS1, cybC-kanr-
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GGS2, cybC-kanr-GGS3, cybC-kanr-X1, cybC-kanr-X2, cybC-kanr-X3). Primer 
combinations and generated cassettes produced are depicted in Table 3.2, Chapter 3 
with oligonucleotide sequences in Table 2.2. All six cybC cassettes were 
phosphorylated (see 2.2.7) and subsequently purified with a MinElute reaction 
cleanup kit (see 2.2.1.4). 
 
2.3.5 Domain insertion library construction 
The EGFP!MuDel library digested with MlyI (see 2.3.3) was dephosphorylated 
(see 2.2.7), to avoid intramolecular ligation, and separated by agarose gel 
electrophoresis (1.0% (w/v)) (see 2.2.2). The dephosphorylated linear library DNA 
was purified from the agarose gel using a QIAquick® gel purification kit (see 
2.2.1.2). CybC-kanr-GGS and cybC-kanr-X cassettes in all three reading frames (see 
2.3.4) were ligated (see 2.2.8) with the previously prepared linear library DNA in 6 
separate ligation reactions.  
The ligation products were used to transform E. coli BL21-Gold (DE3) cells 
(Table 2.1), by electroporation (see 2.2.10), a percentage of which were grown on LB 
agar (see 2.1.4) supplemented with 25 µg/ml kanamycin (see 2.1.1). The rest of the 
transformed cells were used to inoculate separate 50 ml LB broth (see 2.1.4) cultures 
supplemented with 25 µg/ml kanamycin (see 2.1.1), incubated at 37 °C shaking (200 
rpm) overnight. The DNA from all six cybC libraries (GGS1, GGS2, GGS3, X1, X2, 
X3) was purified from the cell cultures (see 2.2.1.1) and stored at -20 °C. A 
proportional quantity of library DNA from each reading frame was pooled dependent 
on the number of variants obtained from each liquid culture. This way no particular 
reading frame is over represented within the pooled libraries (GGSpool or Xpool).  
GGSpool or Xpool (500 ng) were restriction digested with PstI (see 2.2.6) to 
remove the kanamycin resistance gene from the libraries. The restriction digests were 
separated by agarose gel electrophoresis (1.0% (w/v)) (see 2.2.2) and the DNA bands 
corresponding to linear library DNA isolated and purified by gel extraction (see 
2.2.1.2). The purified library DNA was recircularised by intramolecular ligation (see 
2.2.8) producing cybC-EGFP-GGS and cybC-EGFP-X libraries, used to transform E. 
coli TUNERTM (DE3) cells (Table 2.1) by electroporation (see 2.2.10). The 
transformed cells were grown on LB agar (see 2.1.4) supplemented with 100 µg/ml 
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ampicillin and 150 µM IPTG (see 2.1.1), and incubated for 24 hrs at 37 °C then stored 
at 4 °C. 
 
2.3.6 Library screening  
After the 37 °C overnight incubation colonies presenting a green colour 
phenotype was visualized by excitation with a UV-transilluminator. Fluorescent 
colonies were noted and the plates stored at 4 °C. This process was repeated two more 
times after 24 hrs and 72 hrs at 4 °C. Colonies that presented a green colour 
phenotype after the initial 37 °C incubation and colonies that gained a green colour 
phenotype after 24 hrs and 72 hrs at 4 °C were screened by colony PCR (see 2.2.3). A 
plasmid specific primer, pEXP-F, and a cybC specific primer, WREcbr012, (Table 
2.2) were used at an annealing temperature of 60 °C. PCR products between 456 bp 
and 1167 bp can be produced depending on the position of insertion within EGFP 
(see Fig 3.9, Chapter 3). DNA for sequencing the chimeric genes, to identify the 
nature of the insertions, was generated by PCR (see 2.2.3) with primers pEXP-F and 
DDJdi013 (Table 2.2) at an annealing temperature of 60 °C. 
 
2.4 Rational design by site-directed mutagenesis 
2.4.1 Cloning of eyfp into pNOM-XP3 and construction of the single amino acid 
deletion mutant eYFP!G4 
The gene coding for enhanced yellow fluorescent protein (eyfp) was amplified 
by PCR with GoTaq polymerase (see 2.2.3) using the plasmid pEYFP-N1 (Clontech) 
as template DNA with primers AJBgfp009 and AJBgfp010 (Table 2.2). The primers 
add NdeI and XhoI restriction sites to the 5’ and 3’ end of eyfp respectively. The DNA 
product was purified from the PCR reaction using a QIAquick PCR purification kit 
(see 2.2.1.3). The purified DNA fragment was then digested with NdeI and XhoI 
restriction endonucleases (see 2.2.6) and purified using a MinElute reaction cleanup 
kit (see 2.2.1.4). pNOM-XP3 linearised by NdeI and XhoI restriction digestion (see 
2.2.6 and 2.2.15) was used in an intermolecular ligation (see 2.2.8) with the digested 
eyfp DNA fragment to produce pNOM-XP3-eyfp. E. coli BL21-Gold (DE3) (Table 
2.1) were transformed, by electroporation (see 2.2.10), with 1 µl of the ligation 
reaction and plated on LB agar plates (see 2.1.4) supplemented with 100 µg/ml 
xxxxxxx  
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Fig 2.1. Schematic of TND and domain insertion library construction with references to 
method sections. Vector (black), transposons (orange), EGFP (green), cybC (red), kanamycin 
resistance gene (kanr) (black), nucleotides coding for GGS or random single amino acid 
linkers (grey).  
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ampicillin and 150 µM IPTG (see 2.1.1). A positive clone was selected by its yellow 
colour phenotype, after illumination with a UV transilluminator, and the presence of 
eyfp within pNOM-XP3 confirmed by DNA sequence analysis (see 2.2.16). 
Site directed mutagenesis was used to remove the triplet nucleotide coding for 
glycine 4 (G4) in eYFP (enhanced yellow fluorescent protein) to assess the 
transferability of this mutation to a different fluorescent protein. PCR was carried out 
using GoTaq polymerase (see 2.2.3) with pEYFP-N1 (Clontech) as template DNA 
and primers JAJA065 and AJBgfp010 (Table 2.2). The primers incorporate NdeI and 
XhoI restriction sites to the 5’ and 3’ end respectively while removing the triplet 
nucleotide coding for G4 (JAJA065). The PCR fragment was then cloned into 
pNOM-XP3 as described above to produce pNOM-XP3-eyfp-G4!. 
 
2.4.2 Construction of double TND mutations 
The double amino acid deletion variant EGFP G4! D190! was constructed 
using the Phusion site directed mutagenesis kit (New England Biolabs) (see 2.2.4) 
with primers AJBEGFP119-F and AJBEGFP120-F (Table 2.2) and pNOM-XP3-
EGFP-G4! as template DNA (Fig 2.3). PCR products were analysed by 1.0 % (w/v) 
agarose gel electrophoresis (see 2.2.2) with subsequent extraction of the DNA product 
using a QIAquick® gel extraction kit (see 2.2.1.2) (Fig 2.2). 
The DNA fragment was phosphorylated (see 2.2.7) and recircularized by 
intramolecular ligation with Quick T4 DNA ligase (see 2.2.8). The double amino acid 
deletion variant EGFP G4! A227! was constructed as described above but with 
primers AJBEGFP121-F and AJBEGFP122-R (Table 2.2). The ligation reactions (1 
µl) were used to transform E. coli BL21-Gold (DE3) cells (Table 2.1) by 
electroporation (see 2.2.10).  
The transformed cells were grown on LB agar plates (see 2.1.4) supplemented 
with 100 µg/ml ampicillin and 150 µM IPTG (see 2.1.1) and incubated overnight at 
37 °C. Colonies presenting a green colour phenotype were selected for a colony PCR 
screen (see 2.2.4) with primers pEXP-F and DDJ013 to produce a DNA fragment for 
sequence analysis (see 2.2.16) to confirm the presence of the desired mutations. 
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Fig 2.2. Site directed mutagenesis strategy for construction of double TND variants. 
Stage 1, Primers (black arrows) anneal to the target gene (pNOM-XP3-EGFP-G4!: green, 
TND:red cross), back to back, with the desired triplet nucleotide to be removed, not coded for 
by either primer. Stage 2, Extension by Phusion polymerase (see 2.2.4) (black dotted line) 
produces a linear DNA product missing the triplet nucleotide. Stage 3, The PCR product is 
separated by 1.0% (w/v) agarose gel electrophoresis (see 2.2.2) and purified from the agarose 
gel with a QIAquick gel extraction kit (see 2.2.1.2). Stage 4a, The Purified linear DNA 
fragment is phosphorylated (see 2.2.7). Stage 4b, The purified linear DNA fragment is 
recircularised by intramolecular ligation with Quick T4 DNA ligase (see 2.2.8) resulting in a 
double triplet nucleotide deletion (red crosses) variant of EGFP.  
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2.4.3 Constuction of CG15 double cysteine mutants 
The cyt b562-EGFP chimera, CG15, identified by library screening (see 2.3.6), 
has a single cysteine residue at position 147 introduced as a secondary point mutation 
of S147 due to an out of frame cybC cassette insertion into the EGFP insertion library 
(see 2.3.5). Site directed mutagenesis was used to introduce secondary cysteine point 
mutations to construct four different CG15 double cysteine mutants (CG15CC) (Fig 
2.3).  
The phusion site directed mutagenesis kit was used (see 2.2.4) with pNOM-
XP3-CG15 as template DNA with primers JAJA052 and JAJA053 for N146C 
mutation, JAJA054 and JAJA055 for K166C mutation, JAJA056 and JAJA057 for 
R168C mutation or JAJA058 and JAJA059 for Q204C mutation (Table 2.2). PCR 
products were separated by agarose gel electrophoresis (1.0% (w/v)) (see 2.2.2) and 
purified from the agarose gel with a QIAquick gel extraction kit (see 2.2.1.2). The 
DNA fragments were phosphorylated (2.2.7) and used in intramolecular ligation 
reactions (see 2.2.8) to recircularise the plasmids.  
The ligation reactions (1 µl) were used to transform E. coli BL21-Gold (DE3) 
cells (Table 2.1) by electroporation (see 2.2.10). The transformed cells were grown on 
LB agar plates (see 2.1.4) supplemented with 100 µg/ml ampicillin and 150 µM IPTG 
(see 2.1.1) and incubated overnight at 37 °C. Colonies presenting a green colour 
phenotype were selected for a colony PCR screen (see 2.2.4) with primers pEXP-F 
and DDJ013 to produce a DNA fragment for sequence analysis (see 2.2.16) to 
confirm the presence of the desired mutations. 
 
2.5 Methods for protein production, purification and analysis 
2.5.1 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed using the mini-PROTEAN 3 electrophoresis 
system (Bio-RAD, Hertfordshire, UK). The resolving and stacking gels were 
comprised of the components listed in Table 2.3. Sample loading buffer (6x) 
contained 2% (w/v) SDS, 0.2 M Tris-HCL pH 6.8, 0.04% (w/v) bromophenol blue, 
8% (w/v) glycerol and 10% (v/v) !-mercaptoethanol. The electrophoresis buffer 
contained 28.8 g glycine, 8.0 g Tris Base made up to 2 L with distilled water and SDS 
to 0.1% (w/v). Protein samples (usually 0.1-0.25 µg) or whole cell extracts (see 2.5.2) 
were dissolved in sample buffer (1X final concentration), heated at 95 °C for 10 mins   
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Fig 2.3. Site directed mutagenesis strategy for construction of CG15 double cysteine 
variants. Stage 1, Primers (black arrow, and black arrow with TGC codon) anneal to the 
target gene (pNOM-XP3-CG15: green/red/grey, not to scale, TGC codon:yellow plus sign), 
back to back, with the desired TGC codon coded by one primer. Stage 2, Extension by 
Phusion polymerase (see 2.2.4) (black dotted line) produces a linear DNA product with the 
TGC point mutation. Stage 3, The PCR product is separated by 1.0% (w/v) agarose gel 
electrophoresis (see 2.2.2) and purified from the agarose gel with a QIAquick gel extraction 
kit (see 2.2.1.2). Stage 4a, The Purified linear DNA fragment is phosphorylated (see 2.2.7). 
Stage 4b, The purified linear DNA fragment is recircularised by intramolecular ligation with 
Quick T4 DNA ligase (see 2.2.8) resulting in a CG15 gene coding for a double cysteine 
(yellow plus signs) variant. 
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and applied to the gels. The gels were run according to the manufactures 
recommendations. 
The gels were stained using 50% (v/v) methanol, 10% (v/v) acetic acid with 
R250 Coomassie blue (0.1% (w/v)) and destained using 20% (v/v) methanol, 10% 
(v/v) acetic acid. Protein standards (Fig 3.1c) were run on every gel for molecular size 
comparison.  
 
Table 2.3. Concentrations for components of SDS-PAGE resolving and stacking gels. 
Component Resolving Gel Stacking Gel 
Acrylamide/bis-Acrylamidea 12.5% (w/v) 5% (w/v) 
Tris-HCL 0.375 mM, pH8.8 65 mM, pH6.8 
SDS 0.1% (w/v) 0.2% (w/v) 
APS 0.05% (w/v) 0.1% (w/v) 
TEMED 0.02% (w/v) 0.02% (w/v) 
aAcrylamide and N,N’-methylene bis acrylamide (40% w/v) solution in a ratio of 37.5:1 
(w/w). 
 
 
2.5.2 Preparation of culture aliquots for SDS-PAGE analysis 
Cell aliquots (1 ml) were harvested in a microfuge at 13000 rpm for 2 min and 
the supernatant discarded. The pellets were resuspended in 1 x SDS sample loading 
buffer (Section 2.5.1) to an apparent O.D.600 of 10, to standardize the number of cells 
between samples, and heated to 95 °C for 10 mins. 
 
2.5.3 Expression of EGFP and single amino acid deletion mutants 
LB Broth (15 ml) (see 2.1.4) supplemented with 100 µg/ml ampicillin (see 
2.1.1) was inoculated with a single E. coli BL21-Gold (DE3) colony (Table 2.1) 
containing a relevant plasmid (pNOM-XP3 containing the EGFP gene or TND EGFP 
genes (see 2.3.3)) and incubated overnight (37 °C shaking at 200 rpm). Some of the 
overnight culture (5 ml) was used to inoculate 1 l of LB broth (see 2.1.4) 
supplemented with 100 µg/ml ampicillin (see 2.1.1), which was incubated (37 °C 
shaking at 200 rpm) until an O.D.600 of 0.4-0.8 was reached. Sterile IPTG (1 mM, 
final concentration) (see 2.1.1) was added, to induce protein expression, and 
incubated for 24 hrs at 37 °C. After induction the 1 l culture was harvested by 
centrifugation (3000 x g for 20 mins) and the pellet resuspended in 25 ml 50 mM 
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Tris-HCl, pH 8.0 at 25 °C, 1 mM PMSF and 1 mM EDTA ready for the cells to be 
lysed by French Press (see 2.5.5). 
 
2.5.4 Expression of cyt b562-EGFP chimera proteins 
LB Broth (15 ml) (see 2.1.4) supplemented with 100 µg/ml ampicillin (see 
2.1.1) was inoculated with a single E. coli TUNERTM (DE3) colony (Table 2.1) 
containing a relevant plasmid (pNOM-XP3-EGFP, pNOM-XP3-CG1 through to 
pNOM-CG12, pNOM-XP3-CG15 or pNOM-XP3-CG15CC) (see 2.3.5 and 2.4.3) and 
incubated for 6 hrs (37 °C shaking at 200 rpm). A 1/100 dilution of the starter culture 
(10 ml) was used to inoculate 1 l M9 minimal media (see 2.1.4) supplemented with 
100 µg/ml ampicillin (see 2.1.1) and grown (20 °C at 200 rpm) overnight until an 
optical density of A600 = 0.4 was achieved. The overnight culture was supplemented 
with 22mM glycerol and protein expression was induced by the addition of IPTG to a 
final concentration of 300 µM (see 2.1.1) and incubated for 48 hrs (20 °C at 200 rpm). 
After induction the 1 l culture was harvested by centrifugation (3000 x g for 20 mins) 
and the cell pellet resuspended in 25 ml 50 mM Tris-HCl pH 8.0 at 25 °C, 1 mM 
PMSF and 1 mM EDTA ready for the cells to be lysed by French Press (see 2.5.5). 
 
2.5.5 Cell lysis by French Press 
E. coli BL21-Gold (DE3) or TUNERTM (DE3) cells (Table 2.1) were lysed 
using a French pressure cell press. A cell suspension (see 2.5.3 and 2.5.4) was put in a 
chilled pressure cell. Pressure (1010 psi) was applied to the pressure cell and the cell 
suspension was released through an aperture at a flow rate of ~1 drop/sec and 
collected. This process was repeated to assure complete cell lysis. The lysate was then 
centrifuged, at 10,000 rpm in a Beckman JA-20 rotor for 20 min, to pellet any cell 
debris and the supernatant was decanted and stored at 4 °C. 
 
2.5.6 Buffer exchange by dialysis. 
Any ammonium sulphate remaining in a sample after protein precipitation (see 
2.5.8) was removed from the sample by dialysis. Excess salt left in the protein sample 
inhibited binding to ion exchange chromatography columns. Protein samples (5 ml) 
were buffer exchanged by overnight incubation in dialysis membrane (MWCO: 12-14 
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kDa, Spectra Por) suspended in 4 l of 50 mM Tris-HCl, pH 8.0 at 25 °C (Buffer A) 
under constant stirring. 
 
2.5.7 Protein sample concentration and buffer exchange 
Protein samples were concentrated and buffer exchanged using 15 ml 
Amicon® Ultra Centrifugal concentrators (MWCO: 10 kDa, Merck Millipore) in a 
T41 spin out rotor, for an IEC CL30R centrifuge (Thermo Fisher Scientific), at 4100 
rpm. The buffer used for buffer exchange was dependent on the intended application 
of the protein sample. 
 
2.5.8 Protein purification 
The supernatant from cell lysate (see 2.5.5) was subjected to fractionation with 
ammonium sulphate precipitation. Ammonium sulphate was added to 45% saturation 
at 4 °C with constant stirring, using a magnet flea, for 30 min. The precipitate was 
removed by centrifugation at 10,000 rpm in a Beckman JA-20 rotor for 40 min. The 
supernatant was then taken up to 75% saturation at 4 °C with constant stirring for 30 
min. The suspension was centrifuged at 10,000 rpm in a Beckman JA-20 rotor for 40 
min and the resulting pellet resuspended in Buffer A (5 ml). The sample was buffer 
exchanged into fresh Buffer A by dialysis (see 2.5.6) to remove any remaining 
ammonium sulphate. A precipitate formed during dialysis and was removed by 
centrifugation at 10,000 rpm in a Beckman JA-20 rotor for 20 min.  
The supernatant was applied to a Resource Q anion exchange column (5 ml 
bed volume, flow rate 2 ml/min) equilibrated with Buffer A. Target proteins were 
eluted using a gradient from 0 mM to 500 mM NaCl in Buffer A over five column 
volumes. Fractions were monitored for absorbance at 280 nm and 488 nm, and 
analysed by SDS-PAGE (see 2.5.1). Fractions containing the target protein were 
pooled and concentrated using Amicon® Ultra centrifugal concentrators (see 2.5.7).  
The concentrated sample was made up to 2 ml with Buffer A supplemented 
with 150 mM NaCl (Buffer B) and applied to a HiLoadTM SuperdexTM 75 pg gel 
filtration column (120 ml bed volume, flow rate 0.5 ml/min) (see 2.1.2). Fractions 
were monitored for absorbance at 280 nm and 488 nm, and analysed by SDS-PAGE 
(see 2.5.1).  
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Wild type EGFP and single amino acid deletion mutants were deemed to be 
>95% pure at this stage and fractions containing the target proteins were pooled and 
buffer exchanged into Buffer A (see 2.5.7). Fractions containing chimeric proteins 
after gel filtration were pooled, concentrated and buffer-exchanged into Buffer A (2 
ml) (see 2.5.7).  
The samples were applied to a Mono Q ion exchange column (2 ml bed 
volume, flow rate 1 ml/min) (see 2.1.2) equilibrated with Buffer A. Chimeric proteins 
wee eluted with a gradient from 0 mM to 500 mM NaCl in Buffer A over ten column 
volumes. Fractions were monitored for absorbance at 280 nm and 488 nm, and 
analysed by SDS-PAGE (see 2.5.1). Fractions containing pure protein were pooled, 
concentrated and buffer-exchanged into Buffer A (2 ml) (see 2.5.7).  
 
2.5.7 Determination of protein concentration: colorimetric assay 
Protein concentration was determined with the DC Protein assay kit (Bio-Rad) 
using bovine serum albumin (BSA) (NEB) as a protein standard. The assay was 
performed as to the manufactures guidelines for use in a microplate assay. 
 
2.6 Methods for the analysis of EGFP, single amino acid deletion mutants of 
EGFP and cyt b562-EGFP chimeric proteins 
2.6.1 Spectroscopy techniques 
2.6.1.1 Fluorescent spectral scans 
All fluorescence studies were performed using a Cary Eclipse fluorescence 
spectrophotometer (Varian). Excitation and emission spectra of cell lysates (Section 
2.5.5) were measured in a cuvette of dimensions 5 x 5 mm, 10 nm excitation and 
emission band pass at a scan rate of 600 nm/min. Excitation scans were measured by 
monitoring emission at 511 nm and emission was measured after excitation at 488 
nm. Samples were prepared by dilution into Buffer B to give a final emission intensity 
of 500 a.u. at 511 nm. 
Whole cell fluorescence spectroscopy was performed on E. coli BL21-Gold 
(DE3) (Table 2.1) cell cultures after expression of EGFP or single amino acid deletion 
variants of EGFP. Expression cultures were harvested by centrifugation (1500 x g for 
10 mins) and all supernatant removed and discarded. The cell pellet was resuspended 
in 50 mM Tris-HCl, pH 8.0 at 25 °C, 150 mM NaCl and 10% (v/v) glycerol to an 
O.D.600 = 0.1 in a 1 cm pathlength cuvette. The resuspended cells were transferred to 
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a cuvette with 5 x 5 mm dimensions and excitation and emission spectra measured as 
described above. 
 
2.6.1.2 Haem titration fluorescent quenching analysis 
Crude cell lysates (see 2.5.5) were diluted into Buffer B supplemented with 1 
mM ascorbic acid or KNO3 (Section 2.1.1) to give reducing or oxidising conditions 
respectively, with starting fluorescence emission intensities of 100 a.u. at 511 nm. 
Haem solutions (Section 2.1.1) were titrated into the protein sample as necessary. 
Single wavelength measurements were taken with excitation at 488 nm monitoring 
emission at 511 nm with excitation and emission band pass of 10 nm in a cuvette of 
dimensions 5 x 5 mm. After addition of haem, the samples were mixed and incubated 
at room temperature (25 °C) for 10 mins before measurements were taken.  
 
2.6.1.3 CG1 and CG6 redox mediated fluorescent switching 
For fluorescence switching from oxidizing to reducing conditions or from 
reducing to oxidizing conditions crude cell lysates (Section 2.5.5) were measured in a 
cuvette with 5 x 5 mm dimensions, excitation and emission band passes of 10 nm 
monitoring fluorescence at 511 nm after excitation at 488 nm. For oxidizing to 
reducing conditions crude cell lysates were diluted into Buffer B with 1 mM KNO3 
(Section 2.1.1) to give a starting fluorescence emission of 100 a.u. at 511 nm, after 
excitation at 488 nm. Haem (Section 2.1.1) was titrated into the solution so that 
protein and haem concentration in the sample were equal (determined to be 20 nM). 
Ascorbic acid (10 mM) was added to the sample and the fluorescence emission at 511 
nm monitored for 6 hrs. 
Switching from reducing to oxidising conditions was monitored in the same 
way as above except that 1 mM ascorbic acid (see 2.1.4) was added to the initial 
sample instead of KNO3. Haem (20 nM) was titrated into the sample and after 10 min 
incubation H2O2 (between 0.0-0.02 % (w/v)) (see 2.1.4) was added. Fluorescence 
emission at 511 nm was monitored at 25 °C for 20 hrs after excitation at 488 nm. 
Switching from reducing to oxidisng conditions was also performed with 
purified CG6 protein samples (20 nM) (see 2.5.8) in Buffer B with different oxidizing 
agents. The experiment was run as before but with the addition of either 0.02% (w/v) 
H2O2, 0.02% (v/v) NaOCl, or 10 mM KNO3 to induce oxidizing conditions. 
Switching from reducing to oxidizing conditions was also performed with purified 
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CG1 (20 nM), as with CG6 above, with 0.02% (w/v) H2O2 to induce oxidizing 
conditions. 
Kinetic rate constants were determined by fitting the fluorescence intensity 
data to a single exponential function (Equation 17) 
 
2.6.1.4 Monitoring UV-Vis absorption spectra for H2O2 induced CG6 switching 
UV-Vis absorption spectra were measured alongside the fluorescence 
measurements on CG6 switching from reducing to oxidizing conditions induced by 
H2O2 (see 2.6.1.3). Purified CG6 (8 µM) in Buffer B was measured in a 1 cm 
pathlength cuvette with a Hewlett Packard diode array spectrophotometer (Agilent). 
UV-Vis absorption spectra was measured of apo CG6, 10 min after the addition of a 
slight excess of haem (10 µM) and 2 hrs, 4 hrs and 20 hrs after the addition of 0.02% 
(w/v) H2O2. 
 
2.6.1.5 Absorbance extinction coefficient determination 
Absorbance extinction coefficients were calculated by two methods with 
averages of all the values taken (minimum of three measurements). UV-Vis 
absorbance spectra were recorded with either a Hewlett Packard diode array 
spectrophotometer (Agilent) or a Jasco V-660 spectrophotometer (Jasco), both with a 
1 cm path length quartz cuvette. Protein samples were diluted into Buffer B to a final 
concentration of 5 µM and spectra measured between 200-800 nm. The absorbance 
value at !max was used in Equation 1 to give an extinction coefficient with M-1cm-1 
units, where " is extinction coefficient, A is the absorbance value, c is the 
concentration and l is the pathlength. Alternatively protein samples were diluted in 
Buffer B to an A488 of 0.5 and the sample quantified by DC protein assay (see 2.5.7). 
The concentration value was then substituted into Equation 1 to give extinction 
coefficients with M-1cm-1. 
 
        Equation 1 
 
! =
A
c! l
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2.6.1.6 Holo cyt b562-EGFP chimera !max determination 
Apo cyt b562-EGFP chimeras were diluted in Buffer B to a final concentration 
of 5 µM with an equilmolar concentration of haem under either reducing conditions (1 
mM ascorbic acid) or oxidizing conditions (1 mM KNO3) and incubated for 30 mins 
at 4 °C. UV-Vis absorbance spectra were measured in a 1 cm pathlength cuvette with 
a Jasco V-660 spectrophotometer. 
 
2.6.1.7 Quantum yield determination 
Quantum yields for EGFP and apo-cyt b562-EGFP chimeras were calculated 
using fluorescein as a reference. Fluorescein (in 0.1 M NaOH) and the chimeras (in 
Buffer A) were prepared to an A488 of 0.05 in a 1 cm pathlength cuvette. Emission 
spectra were measured after excitation at 488 nm using a 5 x 5 mm dimension cuvette 
with excitation and emission band passes of 2.5 nm at 30 nm/min scan rate. Integrated 
emission intensity between 500 and 650 nm was calculated and used in Equation 2 to 
generate quantum yield values 
 !! ! !!" ! !"#$!!"#$!" ! !!!!!"!        Equation 2 
 
where !x and !st refer to the fluorescence quantum yield of the sample and fluorescein 
standard, respectively. Areax and Areast are the integrated emission intensities for the 
sample and fluorescein standard, respectively. "x and "st are the refractive index of 
the solvent for the sample and fluorescein standard, respectively. The refractive index 
correction here was negligible as 0.1 M NaOH and aqueous buffers differ in refractive 
index by <1%. 
 
2.6.1.8 Fluorescence lifetime determination 
Fluorescence lifetimes were determined by a time correlated single photon 
counting (TCSPC) technique using an FLS-920 fluorometer (Edinbugh Instruments) 
with a hydrogen nF900 nanosecond flashlamp excitation source, under 0.4 bar 
pressure, and a PMT-Hamamatsu R2658P detector. Samples were measured across 
512 channels (0.039 ns/channel) until one channel reached a maximum photon count 
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of 500 after excitation at 488 nm and emission monitored at 511 nm. An instrument 
response function (IRF) was measured with every sample measurement for 
reconvolution of the data for exponential curve fitting.  The IRF is a lifetime recorded 
for the instrument with no sample present. Protein samples were diluted into Buffer B 
to a final concentration of 6 µM in a 1 cm pathlength cuvette for measurement. The 
fluorescence lifetime data were fit to a single exponential decay (Equation 3) after 
IRF reconvolution of the data using Edinburgh instruments F900 software.  
 ! ! ! ! ! !!! !!!!!!!       Equation 3 
 
Where N(t) is the photon counts at time t, A is the value (photon counts) at which the 
decay plateaus, N0 is the photon counts at t = 0, t is the time (ns) and ! is the 
fluorescence lifetime. 
 
2.6.1.9 CD spectroscopy 
CD spectroscopy measurements were performed using a Chirascan CD 
spectrometer (Applied Photophysics), measuring CD spectra between 190 and 250 nm 
at a scan rate of 1nm/sec in a quartz cuvette with a 1 mm pathlength. Protein samples 
were buffer exchanged (see 2.5.7) into 10 mM sodium phosphate buffer at pH 8.0 and 
diluted to a final concentration of 5 µM. Fresh ascorbic acid was titrated into the 
sample to a final concentration of 1 mM and CD spectra measured, with an equivalent 
buffer containing no protein sample measured for baseline subtraction. Haem was 
then titrated into the sample to a final concentration of 5 µM and CD spectra 
measured.  
 
2.6.1.10 Redox midpoint determination for CG15 double cysteine mutants 
Protein samples (1 uM) were diluted into degassed Buffer B supplemented 
with 1 mM EDTA and 1 mM DTT redox buffers. Concentrations of oxidised and 
reduced DTT were reciprocally varied from 0:1 to 1:0 mM over ~27 concentration 
increments.  The samples (200 µl) were incubated in 96 well plates under each redox 
condition for 4 hrs at 30 °C in an airtight container under anaerobic conditions, 
produced by Anaerocult A (Merck), to reach equilibrium.  
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Excitation spectra were measured using the 96 well plate attachment for the 
Cary Eclipse fluorescence spectrophotometer (Varian) monitoring fluorescence at 530 
nm with excitation and emission band passes of 20 nm. Given that the excitation 
spectra for CG15 double cysteine mutants (CG15CC) is strongly and reversibly 
dependent on the redox state and that two excitation maxima varied with a well 
defined isosbestic point, the reactions between CG15CC variants and reduced or 
oxidized DTT could be analysed using a two state model. The equilibrium for the 
oxidation of reduced CG15CC variants and the corresponding Keq are given by reaction 
1 and Equation 4. 
 !"!"!"#!! ! !""!" !!" !"!"!"!! ! !""!"#    Reaction 1  
 !!" ! ! !!"!"!"!!!!!!""!"#!!!"!"!"#!! !!!!""!"!       Equation 4 
 
After equilibration between DTT redox buffers and a CG15CC variant the 
fractional amount of CG15CC reduced (R) could be calculated using Equation 5. 
 ! ! !!!!!"!!!!"#!!!"!       Equation 5 
 
Where F is the ratio between excitation intensity, at 488 nm and the isosbestic 
point, at a given DTT redox buffer ratio, Fox is the fluorescence ratio in 1 mM 
oxidized DTT and Fred is the fluorescence ratio in 1 mM reduced DTT. Using 
Equations 5 and 6 the actual concentrations of DTTred and DTTox , after equilibration 
with a CG15CC variant, can be determined. Where [DTTred 0] and [DTTox 0] are the 
starting concentrations and R is the fraction of reduced CG15CC variant calculated 
from Equation 5 
 
[!""!"#! ! !!""!"#!!! ! !! !!"!"!!!   Equation 6 !!""!"! ! !!""!"!!! ! !! !!"!"!!!    Equation 7 
 
 62 
By plotting the R values against the log [DTTred]/[DTTox] ratios and fitting 
the data to a titration curve determined by Equation 8, Keq for the CG15CC variant 
with DTT could be found. 
 ! ! !!""!"#!!!!""!"!!"#! !""!"# !!!""!"!      Equation 8 
 
The Keq value could then be used in the Nernst equation (Equation 9) to 
determine the redox midpoint potential for the CG15CC variant. 
 !!!!"!"!!!! ! !!!!!""!! ! !"!" ! ! !"!!"     Equation 9 
 
Where !!!!!""!!  is the standard reduction potential for the DTTred/DTTox 
couple (-0.323 V at pH 7.0 and 30 °C), R is the gas constant (8.315 J K-1 mol-1), T is 
the absolute temperature (303.15 K), n is the number of transferred electrons (2) and F 
is the Faraday constant (9.649 ! 104 C mol-1). 
 
2.6.1.11 Redox Kinetics 
In vitro rates for the reaction between CG15CC variants with either DTT or 
H2O2 were determined by the change in fluorescence excitation ratio over time after 
the addition of excess oxidizing or reducing agent. Excitation maxima (400/495 nm) 
intensities were measured over time while monitoring fluorescence emission at 530 
nm, with a 5 nm excitation band pass and 10 nm emission band pass, in a 5 x 5 mm 
dimension cuvette, using a Cary Eclipse fluorescence spectrophotometer (Varian).  
Protein samples (10 µM) were incubated in buffer B supplemented with 1 mM 
EDTA and either 1 mM DTT or H2O2 for 1 hr at 30 °C to fully reduce or oxidize the 
sample. For reduction kinetics the protein sample incubated in H2O2 was diluted to a 
final concentration of 0.5 µM in buffer B with 1 mM EDTA. Fluorescence excitation 
intensities were measured for 20 min after the addition of 1 mM DTT.  
For oxidation kinetics the protein sample incubated with DTT was diluted to a 
final concentration of 0.5 µM in Buffer B with 1 mM EDTA. Fluorescence excitation 
intensities were measured for 20 mins after the addition of 1 mM H2O2. The fraction 
of reduced CG15CC variants (R) was calculated from the excitation maxima ratios (see 
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Equation 5) and plot against time, with the pseudo first order rate constants calculated 
using a curve fit to Equation 10. 
 ! ! !! !!!!! ! !      Equation 10 
 
2.6.1.12 pH sensitivity 
To assess the effect of pH on CG15CC variant excitation peak ratio, samples 
were incubated in 50 mM phosphate buffers ranging from pH 4 to pH 9 for 24 hrs at 
25 °C and excitation spectra measured. Protein samples were diluted to a final 
concentration of 0.5 µM, in a 96 well plate (200 ul total volume), in a redox buffer 
supplemented with 1 mM EDTA and either 1 mM DTT or 1 mM H2O2, to fully reduce 
or oxidize the samples respectively. Fluorescent excitation spectra were measured 
while monitoring fluorescence emission at 530 nm with 20 nm excitation and 
emission band passes using a 96 well plate attachment for the Cary eclipse 
fluorescence spectrophotometer (Varian). The excitation peak ratio of the samples 
under reducing and oxidizing conditions were plot against pH to assess the effect of 
pH.  
 
2.6.1.13 Calculating haem binding affinity 
The haem binding affinity under oxidising conditions was calculated from the Haem-
mediated fluorescence quenching data. The value in the absence of haem (initial data 
point) was equal to 0 haem bound (apo-protein); the data point at the highest 
saturating haem concentration where no further decrease in fluorescence was 
observed was scaled to 1 (all binding sites occupied). The scaled data was plotted 
against haem concentration and least squares non-linear regression was used to fit the 
data to the following binding Equation: 
Holon = (Holomax[Haem])/(Kd + [Haem]) 
where Holon is the proportion of holo-protein derived from fluorescence quenching 
measurement (0-1), Holomax holo-protein fully occupied with haem. 
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2.6.2 Methods for biophysical characterization 
2.6.2.1 Size exclusion chromatography (SEC) 
To determine if EGFP, single amino acid deletion variants of EGFP, cyt b562-
EGFP chimeras or CG15CC variants form quaternary structures SEC analysis was 
performed. Biorad gel filtration standards (Biorad, Table 2.4) were applied to a 
SuperdexTM 75 or SuperdexTM 200 column (20 ml bed volume, flow rate 0.5 ml/min), 
as per the manufacturers guidelines, with protein elution monitored at 280 nm. Using 
Equation 11, Kav can be determined for each standard and plotted against LogMw to 
produce a standard curve, where Ve is the elution volume, Vt is the total volume and 
Vo is the void volume. The void volume was determined from the elution volume of 
protein aggregates (Table 2.4) and the total volume was determined from the elution 
volume of Vitamin B12.  
Protein samples were diluted in Buffer B to final concentrations of 25, 50 or 
100 µM (in 200 ul total volume) and applied to a Superdex 75 (EGFP and single 
amino acid deletion mutants of EGFP) or Superdex 200 column (EGFP or cyt b562-
EGFP chimeras) (20 ml bed volume, flow rate 0.5 ml/min). Elution volumes (Ve) 
were determined for each sample by the peak absorbance at 488 nm and Kav values 
calculated. Using the standard curve, estimated molecular weights could be 
determined for each protein sample. 
 !!" ! !!!!!!!!!!         Equation 11 
 
 
Table 2.4. Gel filtration standards and molecular weights 
 Protein Molecular weight (Mw, Da) 
Void volume (Vo) Protein aggregates NA 
Elution volume (Ve) Thyroglobulin (Bovine) 670, 000 
Elution volume (Ve) !-Globulin (Bovine) 158, 000 
Elution volume (Ve) Ovalbumin (Chicken) 44, 000 
Elution volume (Ve) Myoglobin (Horse) 17, 000 
Total volume (Vt) Vitamin B12 1,350 
 
2.6.2.2 TND guanidine hydrochloride equilibrium unfolding 
Wild type EGFP and single amino acid deletion variants of EGFP were diluted 
to a final concentration of 1 µM in 50 mM Tris-HCl, pH 8.0 at 25 °C supplemented 
with 150 mM NaCl, 10% (v/v) glycerol (TNG Buffer) and guanidine hydrochloride 
(0-6 M) (GdmCl), across 32 concentration increments. All samples were set up in 
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triplicate. Protein samples (200 µl) were incubated in 96 well plates with the required 
guanidine hydrochloride concentration for up to 250 hrs at 25 °C. Protein unfolding 
was monitored by fluorescence at 520 nm after excitation at 480 nm using a 
FLUOstar Omega 96 well plate reader (BMG Labtech).  
To estimate the apparent [GdmCl] at which 50% of the protein is folded and 
50% of the protein is unfolded (transition midpoint) from data measured at different 
incubation time points a five parameter asymmetric curve fitting function was used in 
the GraphPad Prism software (Equation 12). A two-state model (see below) could not 
be used to fit the data at the first three incubation time points for all protein samples 
measured due to a lack of data points in the transition region. 
 ! ! !! ! !!!!!!!!!!!" ! !"#! !! !"# ! !! ! ! !! !    Equation 12 
 
Where F is the fraction of folded protein, FD is the fraction of protein in the 
denatured state, FN is the fraction of protein in the native state, [D]50% is the midpoint 
of the unfolding transition and represents the concentration of denaturant at which 
50% of the protein is folded and 50% is unfolded, Z is a unitless slope factor or Hill 
slope.  
Equilibrium unfolding data measured after 250 hr incubation were fit to a two state 
model equation as follows although this was not used to generate !!!!!!!!  values.  
 
! ! !! ! !!!!! ! !! ! !!!!! ! !! ! !!!!! !"#!!! ! ! ! !"#!!"!! !"#!! ! ! ! !"#!!"  
 
Where F is the fraction of folded protein, FN and FD are the fraction of protein folded 
in the native (1) and denatured state (0) respectively, AN and BD are the slope of the 
native and denatured baselines respectively, m is a constant related to the dependence 
of !G on GdmCl concentration and [D] is the concentration of denaturant. [D]50% is 
the midpoint of the unfolding transition and represents the concentration of denaturant 
at which 50% of the protein is folded and 50% is unfolded. 
The linear extrapolation method (LEM) was used to calculate free energies of 
unfolding from the equilibrium unfolding data. Using Equation 13 the fraction of 
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denatured protein (FD) could be calculated from the fluorescence intensities at 
different GdmCl concentrations. 
 !! ! !!!!!!!!!        Equation 13 
 
Where Y is the fluorescence intensity at a given GdmCl concentration, YN is 
the fluorescence intensity of native protein (0 M GdmCl) and YD is the fluorescence 
intensity of denatured protein (6 M GdmCl). By substituting Equation 12 into the 
expression for the equilibrium constant of reaction 2, Keq values can be calculated at 
each GdmCl concentration with Equation 14: 
 ! !!"! !!!        Reaction 2 
 !!" ! !!!!"!!!!" ! !!!!!!      Equation 14 
 
The Keq values can then be used to calculate !!!!!!  values, at each GdmCl 
concentration, using Equation 15. 
 !!!!!! ! !!"#$!!!"!      Equation 15 
 
Where R is the gas constant (1.9858775 cal.K-1.mol-1) and T is the absolute 
temperature (310 K). As !!!!!!  values show a linear dependence on GdmCl 
concentrations the free energy of unfolding for a given protein (!!!!!!!! ) can be 
calculated by plotting !!!!!!  values against GdmCl concentration and fitting the data 
to Equation 16. 
 !!!!!! ! !!!!!!!! !!!!! ! !!"#$%!     Equation 16 
 
Where !!!!!!!!  is the free energy of denaturation at 0 M GdmCl and !!!! is the 
proportionality constant, with units of cal.mol-1 or cal.mol-1.M-1 respectively. 
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2.6.2.3 Cyt b562-EGFP chimera guanidine hydrochloride equilibrium unfolding 
Wild-type EGFP and the cyt b562-EGFP chimeras, CG1 and CG6, were diluted 
to a final concentration of 4 µM in TNG Buffer and GdmCl (0-6 M), across 32 
concentration increments in triplicate. Two equilibrium-unfolding experiments were 
performed for each protein sample under apo and holo conditions (equimolar 
concentration of haem) to see if haem bound to the chimeric proteins had an effect on 
stability. 
Haem was also added to the EGFP sample as a control to make sure that if any 
changes in stability were seen it was due to haem bound to the chimeras and not due 
to free haem in solution. Protein unfolding was monitored by absorbance at 488 nm 
for the EGFP domains and at 420 nm for the holo-cytochrome domains. Absorbance 
was measured instead of fluorescence, as haem quenches fluorescence when bound to 
the chimeric proteins, using a FLUOstar Omega 96 well plate reader (BMG Labtech). 
Data analysis and !!!!!!!!  values were calculated as described above (see 2.6.2.2). 
 
2.6.2.4 Protein unfolding and refolding kinetics 
Protein unfolding kinetics for EGFP and single amino acid deletion variants of 
EGFP were determined by rapid dilution, to a final concentration of 1 µM, into 6.4 M 
GdmCl in TNG Buffer and 1 mM DTT. Fluorescence was monitored for 20 min at 
510 nm after excitation at 488 nm in a 5 x 5 mm dimension cuvette with an excitation 
band pass of 2.5 nm and emission band pass of 5 nm using a Cary Eclipse 
fluorescence spectrophotometer (Varian). Protein samples were also rapidly diluted 
into TNG Buffer with no GdmCl and fluorescence monitored for data normalization 
and to take into account any photobleaching effects. To determine refolding kinetics, 
samples from the unfolding reaction were rapidly diluted (1/10) into TNG Buffer 
containing no GdmCl so that the final protein concentration was 100 nM and GdmCl 
was 0.64 M. Fluorescence was monitored for 20 min as before but with excitation and 
emission band passes of 5 nm. Unfolding experiments were carried out in duplicate 
except for the single amino acid deletion variant A227!, which was only carried out 
once, with data fit to Equation 17. All refolding experiments were carried out in 
triplicate and data fit to Equation 18. 
 ! ! !!! ! !!!!!!" ! !       Equation 17 
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 ! ! !! ! !!! !! !!!!! ! !!!! !! !!!!! !   Equation 18 
 
Where Y0 is the Y value when t = 0, P is the Y value at infinite time, F1 is a 
proportional value for the first rate constant, k1, and F2 is the proportional value for 
the second rate constant and k2. 
 
2.6.2.5 Thermal denaturation 
Melting temperatures (Tm) of EGFP, single amino acid deletion variants of 
EGFP and cyt b562-EGFP chimeras were determined by monitoring fluorescence with 
a Opticon 2 qPCR thermal cycler (MJ Research) while ramping the temperature from 
25-98 °C. Protein samples were diluted to a final concentration of 1 µM in 50 mM 
sodium phosphate buffer pH 8.0 (total volume 50 µl) and the temperature ramped at 
1°C/min. MJ Research Software supplied with the qPCR machine determined the 
melting temperature of the samples based on the collected fluorescence data. 
 
2.7 X-ray crystallography and structure determination 
2.7.1 Protein Crystalisation 
The EGFP, EGFP!D190, EGFP!A227 (10 mg/ml in 50 mM Tris-HCl, pH 8.0 
and 150 mM NaCl) and CG6 protein samples (10 mg/ml in 50 mM Tris-HCl, pH 8.0, 
150 mM NaCl and 256 µM haem) were screened for crystal formation by the sitting 
drop vapour diffusion method with incubation at 4 °C. Drops were set up with equal 
volumes of protein and precipitant solutions (0.5 µl each). The crystal of EGFP was 
obtained from 0.1 M MES/NaOH, pH 6.5, 200 mM calcium acetate and 20% (w/v) 
PEG 8000. A crystal was transferred to mother liquor supplemented with 13% (w/v) 
PEG 200 as a cryoprotectant and vitrified. The crystal of EGFP!D190 was obtained 
from 0.1 M Hepes/NaOH, pH 6.6, 200 mM ammonium sulphate and 2 M (K/Na)-
phosphate. A crystal was transferred to mother liquor supplemented with 16% (v/v) 
glycerol as a cryoprotectant and vitrified. The crystal of EGFP!A227 was obtained 
from 0.05 M MES/NaOH, pH 5.6, 100 mM ammonium sulphate, 10 mM magnesium 
chloride hexahydrate and 20% (w/v) PEG 8000. A crystal was transferred to mother 
liquor supplemented with 13% (w/v) PEG 200 as a cryoprotectant and vitrified. The 
crystal of holo-CG6 was obtained from 0.1 M MES/NaOH, pH 6.4, 200 mM 
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Magnesium acetate and 20% (w/v) PEG 8000. A crystal was transferred to mother 
liquor supplemented with 16% (v/v) glycerol as a cryoprotectant and vitrified. Data 
were collected on the Diamond Light Source beamline I02.  
 
2.7.2 Structure determination 
 Initial molecular replacement for the EGFP structure was performed using a 
previously determined GFP structure (PDB:2HQZ) as the search model, using the 
CCP4 program MOLREP [87]. The structure for EGFP was adjusted manually using 
COOT [88] and refinement of the completed molecule was carried out using the 
REFMAC program [89]. 
 Structural determination of the CG6 cyt b562-EGFP integral fusion domain 
scaffold was performed by Dr Matthias Bochtler and Dr Honorata Czapinska as 
follows. Holo-CG6 fusion protein crystallized in a nearly orthorhombic lattice. 
Reprocessing the data for a monoclinic lattice indicated cell constants of 64.76 Å x 
125.22 Å x 89.26 Å and !=90.37. The extinctions on the 0l0 reciprocal space axis 
further predicted that the correct space group was P1 2(1) 1. Assuming that the 
insertion of the cytochrome domain into GFP would leave the !-barrel structure of 
GFP intact, molecular replacement was attempted with a single GFP molecule (pdb-
accession code 2HQZ) as the search model, using the CCP4 program MOLREP. Then 
the cytochrome models were placed using MOLREP with fixed GFP molecules 
already in place. In order to pair correct GFP and cytochrome fragments, 
crystallographic symmetry mates were displayed. Pairings were supported by 
connecting density, as well as similar relative domain orientations. The structure with 
two fusion proteins was adjusted manually using COOT. The presence of a third 
molecule was suggested by a gap in the packing arrangement, and by the strong 
clustering of residual density, which was of approximately the right size and shape. 
Inspection indicated that the density for the GFP domain was poorer than for the 
cytochrome domain. Therefore, the cytochrome domain alone was used as a search 
model using the EPMR [90] and PHASER [91] programs. The resulting placement 
was identical and confirmed further by the anomalous signal for iron, with a peak at 
the expected site in the anomalous difference Fourier map. The GFP domain of the 
third molecule was located using a difference Fourier map calculated with phases for 
the already placed models. Connection of the GFP and cytochrome domains revealed 
that their relative orientation was slightly different from the other two conformations, 
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and that the GFP domain was less ordered than the cytochrome domain, explaining 
the earlier observations. Refinement of the completed molecule was carried out using 
the REFMAC program, with an adjusted library for the haem to enforce expected 
geometry and particularly planarity. Refinement was done with separate TLS 
parameters for the six domains in the asymmetric unit, with separate (standard 
weight) NCS restraints for GFP and cytochrome domains. 
 
2.7.3 Small angle X-ray scattering 
Small angle X-ray scattering data were collected at beamline X33 at the 
DORIS ring, DESY, Hamburg. Data were processed and background corrected in the 
usual manner. Small angle X-ray scattering data were recorded at various protein 
concentrations. As the dependence of relative intensities on the scattering vector was 
independent of protein concentration, all further analysis was done with the scattering 
data for the highest concentration. Scattering for given atomic coordinates were 
calculated and fitted to the experimental data using the CRYSOL program [92]. Ab 
Initio shape determination was done with the DAMMIF program [93]. All SAXS data 
analysis was performed by Dr Michal Gajda at EMBL. 
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Chapter 3: GFP library generation: random trinucleotide deletion and domain 
insertion 
3.1 Introduction 
With an ever-expanding protein engineering toolbox it is possible to construct 
and tailor proteins with desired or improved properties. The two main branches are 
rational site directed mutagenesis and directed evolution [94]. The limitation being 
rational mutagenesis approaches often require knowledge of the structure and function 
of the protein in order to aid the engineering process [94]. Recent development of in 
silico design approaches should greatly aid de novo rational protein design [95] but is 
still limited and requires “tuning” through random mutagenesis approaches. 
The advent of directed evolution approaches in conjunction with improved 
screening methods allows for libraries of variants with mutations scattered throughout 
the target protein to be produced and those with desired characteristics identified for 
further characterisation [5, 38, 39]. Here we describe a transposon based directed 
evolution approach which produces a library of random breaks throughout a target 
gene [19, 21, 31, 37, 49, 50] which can in turn be used to sample different 
mutagenesis events not normally sampled by traditional approaches: triplet nucleotide 
deletion (TND) [19, 21], domain insertion [31, 37] and triplet nucleotide exchange 
(TriNEx) [49] for unnatural amino acid incorporation [50].  
This method utilizes the bacteriophage transposon, Mu, and transposase, 
MuA, which has very low target site preference and can efficiently insert Mu 
transposons randomly throughout target genes [40, 43]. An engineered Mu 
transposon, termed MuDel, has been generated for the purposes of sampling various 
downstream mutagenesis events [21]. MuDel contains MlyI restriction sites 1 bp from 
its 5’ and 3’ termini for quick and easy removal of the transposon from the target 
DNA after transposition (Fig 3.1 a). Transposition with MuDel results in the 
duplication of 5 bp of the target gene around the insertion site due to the staggered 
nature with which the transposase cleaves the target DNA substrate (Fig 3.1 a) [43].  
MlyI restriction digestion cuts 5 bp outside of its recognition sequence 
resulting in 3 bp being deleted from the target gene (Fig 3.1 a). The resulting sub-
library has random breaks throughout the target gene and can be recircularised to 
produce a TND library, have DNA cassettes encoding whole protein domains 
xxxxxxxx  
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Fig 3.1. Schematic mechanism of transposon insertion and removal by MlyI restriction 
digestion. a, The MuDel system. Step 1, Transposition with MuDel (orange), containing a 
chloramphenicol resistance gene (CamR), by MuA transposase generates a 5 bp duplication of 
the target DNA (green) due to the staggered nature of target gene cleavage (red arrow). Step 
2, MlyI restriction digestion cuts 5 bp outside its recognition sequence (white) excising 
MuDel and deleting a triplet nucleotide from the target gene. b, Tn5 system. Step 1, 
Transposition with a Tn5 transposon (orange), containing CamR, by the Tn5 transposase 
generates a 9 bp duplication of the target DNA (green). Step 2, MlyI restriction digestion 
excises the Tn5 transposon, leaving a triplet nucleotide duplication of the target gene. c, Tn5 
Outward End (OE) and Mosaic End (ME) transposase recognition sequences differ at position 
3, 17 and 18 indicated in bold. An MlyI recognition sequence (red) is generated in ME-4A by 
mutating the thiamine at position 4 in the ME recognition sequence.  
   OE: CTGACTCTTATACACAAGT 
   ME: CTGTCTCTTATACACATCT 
ME-4A: CTGACTCTTATACACATCT 
CamR 
MlyI 
MlyI 
-N1N2N3N4N5N6       N4N5N6N7N8N9-!
-N1N2N3N4N5N6       N4N5N6N7N8N9-!
2. Tn5 removal 
(MlyI restriction digest) 
Tn5 
1. Tn5  
transposition 
Tn5 
-N1N2N3N4N5N6N7N8N9  C T G A C T C             G A G T C A G  N1N2N3N4N5N6N7N8N9-!
-N1N2N3N4N5N6N7N8N9  G A C T G A G            C T C A G T C  N1N2N3N4N5N6N7N8N9-!
-XnXnXn N1N2N3N4N5N6N7N8N9 XnXnXn-!
-XnXnXn N1N2N3N4N5N6N7N8N9 XnXnXn-!
CamR 
MlyI 
MlyI 
-N1     N5-!
-N1     N5-!
2. MuDel removal 
(MlyI restriction digest) 
MuDel 1. MuDel    transposition 
MuDel 
-N1N2N3N4N5  T G A C T C             G A G T C A  N1N2N3N4N5-!
-N1N2N3N4N5  A C T G A G            C T C A G T  N1N2N3N4N5-!
-XnXnXn N1N2N3N4N5 XnXnXn-!
-XnXnXn N1N2N3N4N5 XnXnXn-!
a 
b 
c 
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ligated into the random breaks or can have a triplet nucleotide replaced (TriNEx) (Fig 
1.8, Section 1.3.3.3) 
Another transposon to be investigated is the bacterial Tn5 transposon from the 
insertion sequence 4 (IS4) family [96]. This transposon generates a 9 bp duplication 
upon insertion into a target gene [97] (Fig 3.1b). There are two different Tn5 
transposase recognition sequences (TREs) that can be used, the wild type outward end 
(OE) recognition sequence [96] or the hyperactive mosaic end (ME) sequence (Fig 
3.1c) [97]. While the ME recognition site confers ~8 fold higher transposition 
efficiency [98], the OE recognition sequence already has a critical MlyI recognition 
sequence 2 bp from its 5’ and 3’ termini (Fig 3.1 c). The positioning of this MlyI site 
allows for a triplet nucleotide duplication to be introduced into a target gene as 
outlined in Figure 3.1b. This transposon method could therefore be used to potentially 
sample single amino acid duplications. Additionally a DNA cassette can be inserted to 
generate an alternate route to sample domain insertion variants. 
Mutation of a single nucleotide in the ME recognition sequence of Tn5 (ME-
4A Tn5) introduces the critical MlyI recognition sequence 2 bp from its 5’ and 3’ 
termini (Fig 3.1c). This allows for the two different Tn5 recognition sequences to be 
tested for transposition efficiency and their ability to produce diverse insertion 
libraries within a target gene. 
The target gene used in this study was egfp, encoding for enhanced green 
fluorescent protein (EGFP) [99]. Fluorescent proteins are used extensively across 
many different research disciplines with the engineering and development of 
improved or altered fluorescent variants always in high demand. EGFP is a desirable 
target protein for engineering as it is genetically encoded, requires no cofactors for 
fluorescence to mature and the fluorophore is sensitive to changes in its local 
environment [62]. The effects of mutational studies can therefore be easily screened 
for by monitoring changes in fluorescent characteristics. 
In this Chapter, the process of library construction will be described. The 
MuDel and Tn5 transposition efficiencies and insertion position diversity within the 
egfp target gene will be examined and compared. The sub-library of transposon 
inserted randomly within egfp will then form the basis for generating the main 
libraries of EGFP sampling single amino acid deletions, codon replacements and 
domain insertions.  
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3.2 Results 
3.2.1 Construction of pNOM-XP3-egfp 
A major step in the success of the transposon based directed evolution 
approach requires the removal of the transposon from a plasmid library by MlyI 
restriction digestion. It is therefore imperative that no other MlyI sites lie in the host 
plasmid or gene to prevent undesired side reactions. A plasmid previously described, 
pNOM [21], which has had all MlyI sites removed by site directed mutagenesis was 
converted from a simple cloning plasmid to an expression plasmid by inserting a 
modified T7 expression cassette (promoter, multiple cloning site (MCS) and 
terminator) sequence (from pET24c) in place of the pNOM MCS. The T7 promoter 
region was mutagenised to remove a MlyI site without loss of promoter function. This 
expression plasmid was constructed and supplied by Dr Wayne Edwards and was 
named pNOM-XP3 (Fig 3.2 a). 
The egfp gene was successfully cloned between the NdeI and XhoI restriction 
sites of pNOM-XP3 (Section 2.2.15), as confirmed by PCR analysis of colonies 
containing the pNOM-XP3-egfp plasmid (data not shown). An expected PCR product 
of 1146 bp was generated indicating successful cloning. Retention of the NdeI and 
XhoI restriction sites in pNOM-XP3-egfp critical for later steps in library construction 
was also confirmed by restriction analysis (Section 2.2.6). The restriction analysis 
produced the two expected DNA bands corresponding to egfp (723 bp) and pNOM-
XP3 vector (2143 bp) confirming that the restriction sites were retained (Fig 3.2 b).  
 
3.2.2 Transposition efficiency of ME-4A-Tn5, OE-Tn5 and MuDel transposons 
into pNOM-XP3-egfp 
The efficiency with which a transposase can incorporate a transposon into a 
target gene is of upmost importance in order to produce a library that samples a 
diverse number of insertion positions within a target gene. The transposition 
efficiency of the three transposons, ME-4A-Tn5, OE Tn5 and MuDel were 
investigated to assess the suitability of each transposon for further library production.  
In vitro transposition with MuDel, ME-4A-Tn5 and OE-Tn5 transposons 
(Section 2.2.13, 2.2.14) into pNOM-XP3-egfp was performed in three separate 
reactions. Highly competent (2.08 x 108 cfu/µg DNA) E. coli NovaBlue 
GigaSinglesTM cells were transformed with the individual transposition reactions, 
xxxxxx  
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Fig 3.2. pNOM-XP3-egfp cloning strategy and restriction digest analysis a. The egfp gene 
(green) with NdeI and XhoI restriction sites introduced by PCR to the 5’ and 3’ end of the 
gene respectively was inserted into the pNOM-XP3 vector between the NdeI and XhoI sites 
within the multiple cloning site (MCS) resulting in the expression plasmid pNOM-XP3-egfp. 
b. Restriction digest of pNOM-XP3-egfp with either NdeI or XhoI gave single products of 
2866 bp. Restriction with both NdeI and XhoI gave the two expected products of 2143 bp or 
723 bp. 
 
  
a 
b 
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with positive clones selected for on LB Agar plates supplemented with 40 µg/ml 
chloramphenicol. The three libraries produced 135,882, 18,500 and 103,815 cfu/µg 
DNA respectively. MuDel and OE-Tn5 transposition were the most efficient but ME-
4A-Tn5 transposition was up to 7 fold less efficient despite the wild type ME 
recognition sequence showing an 8-fold increase in transposition efficiency. All 
further work with the Tn5 transposon system was therefore performed with OE-Tn5 
due to the inefficiency of the ME-4A-Tn5 system. The transposon insertion libraries 
are named by the target DNA used in transposition and the transposon used to 
generate that library; pNOM-XP3-egfp!MuDel and pNOM-XP3-egfp!OE-Tn5. 
 
3.2.3 Transposon library size and diversity 
When producing transposon libraries within a target gene it is not only 
important to have enough insertion events, to theoretically cover every possible 
insertion position in the target gene, but also to have extensive diversity. It was 
therefore necessary to assess the number of different insertion events within the 
MuDel and OE-Tn5 libraries and the diversity of insertion positions throughout the 
target gene, pNOM-XP3-egfp.  
 
3.2.3.1 Determining library size 
The number of variants in the libraries was identified by plating a proportion 
of the E. coli cells transformed with a transposition reaction on LB Agar 
supplemented with 20 µg/ml of chloramphenicol, with the remaining cells used to 
inoculate LB broth supplemented with 20 µg/ml chloramphenicol. After overnight 
incubation at 37 °C the number of colonies on the LB Agar plates was used to infer 
the number of variants in the library isolated from the cell culture. The number of 
variants in the pNOM-XP3-egfp!MuDel and pNOM-XP3-egfp!OE-Tn5 libraries is 
discussed in Section 3.2.3.3 and 3.2.3.4 respectively. 
 
3.2.3.2 Determining library diversity 
The diversity of transposon insertions in the target plasmid pNOM-XP3-egfp 
was assessed using a restriction digestion method outlined in Figure 3.3 a. Briefly; the 
diversity of transposon insertion positions within the libraries was assessed by 
restriction digest analysis using XhoI and MlyI (Section 2.2.6). Firstly the plasmid 
library containing transposon insertions throughout pNOM-XP3-egfp was linearised 
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by an XhoI restriction digest so that subsequent MlyI digestion, to liberate the 
transposon from the library, would produce fragments ranging in sizes from 0 bp to 
~2860 bp (Fig 3.3 a). Analysis by agarose gel electrophoresis to visualize the 
fragmented libraries should produce an even DNA smear across the size range 
indicating extensive diversity. Increased band intensity in the DNA smear would 
therefore imply bias for particular transposon insertion sites within the target DNA. 
The pNOM-XP3-egfp!MuDel and pNOM-XP3-egfp!OE-Tn5 library diversities are 
discussed in Sections 3.2.3.3 and 3.2.3.4 respectively. 
 
3.2.3.3 MuDel library size and diversity 
The in vitro transposition of MuDel into the target gene pNOM-XP3-egfp 
(Section 2.3.1) produced 110 colonies from 1.5 % of the transformed cells when 
plated on LB agar supplemented with 20 µg/ml chloramphenicol. From these figures, 
the remaining 98.5% of transformed cells, which encompasses the library as a whole, 
can be said to contain about 7,590 variants. This provides enough variants to sample a 
wide range of transposon insertions throughout pNOM-XP3-egfp as the number of 
variants is over twice that of different potential insertion sites within the 2866 bp 
plasmid.  
The diversity of the pNOM-XP3-egfp!MuDel library was assessed by XhoI and 
MlyI restriction digest and analysed by agarose gel electrophoresis (Fig 3.3 b). 
Restriction digestion of the pNOM-XP3-egfp!MuDel library with XhoI alone produced 
a single fragment of ~4173 bp indicating that only a single transposition event had 
taken place per molecule of DNA (Fig 3.3 b) (double transposition events would 
produce a fragment of ~5480 bp). 
Restriction digestion with MlyI produced two fragments corresponding to 
excised MuDel (1310 bp) and the linearized library DNA (2863 bp) (Fig 3.3 b). 
Restriction digestion with both XhoI and MlyI resulted in DNA fragments ranging 
from ~0 bp to ~2863 bp, indicative of transposon insertions throughout the plasmid, 
and a 1310 bp fragment corresponding to MuDel (Fig 3.3 b). There are however a 
much higher proportion of fragments in the range of ~2000 bp to ~2863 bp indicated 
by increased DNA band intensity in this region of the agarose gel.   
 78 
 
 
 
 
 
 
Fig 3.3. Transposon insertion diversity analysis. a. Schematic of restriction digest analysis. 
Step 1, XhoI restriction digest linearizes the transposon plasmid libraries (vector: black, egfp: 
green, transposon: orange). Step 2, MlyI restriction digest liberates the transposon (1310 bp) 
leaving fragments ranging from 0 bp to ~2860 bp. Agarose gel electrophoresis analysis of b, 
pNOM-XP3-egfp!MuDel and c, pNOM-XP3-egfp!OE-Tn5 library restriction digest with MlyI 
and/or XhoI as indicated in the figure. 
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The increased number of fragments at these sizes implies that there is a much 
higher rate of transposon insertion into the target gene, egfp, and the DNA 
immediately flanking it, probably due to non-tolerated transposon insertions into the 
ampicillin selectable marker or origin of replication. 
A PCR screen of E. coli colonies (Section 2.2.3) from the MuDel library was 
performed using egfp specific primers AJB009 and AJB010 (Section 2.2.5) to assess 
the percentage of variants that had transposon insertions within the target gene, egfp 
(Fig 3.4). Of the 48 colonies screened 16 (33%) contained transposons within the 
target gene evident by the presence of a 2045 bp PCR product as opposed to a 738 bp 
fragment equivalent to the egfp gene alone (Fig 3.4). Given that the pNOM-XP3-
egfp!MuDel library had 7590 variants with the transposon inserted throughout the 
whole plasmid and that 33% contained a transposon within egfp, it can be said that the 
egfp!MuDel library (Section 3.2.4) has 2504 total variants with transposon insertions 
within egfp. 
This provides enough variants to sample a wide range of transposon insertions 
throughout egfp as the number of variants is over three times that of different potential 
insertion sites within the 720 bp gene.  
 
3.2.3.4 OE-Tn5 library size and diversity 
Transformation of E.coli NovaBlue GigaSinglesTM cells with the OE-Tn5 in 
vitro transposition into pNOM-XP3-egfp (Section 2.3.1) produced 347 colonies from 
2.5% of the transformed cells plated on LB agar supplemented with 20 µg/ml 
chloramphenicol. From these figures, the remaining 97.5% of transformed cells, 
which encompasses the library as a whole, can be said to contain about 13,533 
variants. Again, this library (pNOM-XP3-egfp!OE-Tn5) will provide enough variants to 
sample a wide range of transposon insertions within pNOM-XP3-egfp. 
The diversity of the pNOM-XP3-egfp!OE-Tn5 library was also assessed by XhoI 
and MlyI restriction digest and analysed by agarose gel electrophoresis (Fig 3.3 c). 
Restriction digestion with XhoI alone produced a single fragment of ~4173 bp 
indicating that only a single transposition event had taken place per molecule of DNA 
(Fig 3.3 c). Restriction digestion with MlyI produced two fragments corresponding to 
excised OE-Tn5 (1308 bp) and the linearized library DNA (2869 bp) (Fig 3.3 c).   
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Fig 3.4. Analysis of bacterial colonies for the presence of MuDel within egfp. Bacterial 
colonies formed after transformation of E. coli with the pNOM-XP3-egfp!MuDel library were 
screened by PCR (Section 2.2.3) with GoTaq polymerase and egfp specific primers to identify 
the proportion of MuDel insertions within the target gene egfp. Fragments of 2045 bp indicate 
a MuDel insertion has taken place within egfp, fragments of 738 bp indicate no insertion 
within egfp. 
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 Restriction digestion with both XhoI and MlyI resulted in DNA fragments 
ranging from ~0 bp to ~2869 bp, indicative of transposon insertions throughout the 
plasmid, and a 1308 bp fragment corresponding to OE-Tn5 (Fig 3.3 c). As with the 
pNOM-XP3-egfp!MuDel library the pNOM-XP3-egfp!OE-Tn5 library exhibited a higher 
proportion of transposon insertions within the target gene, egfp, and the flanking DNA 
indicated by an increase in band intensity of fragments in the size range of ~2000 bp 
and ~2869 bp (Fig 3.3 c). This again is probably due to non-tolerated transposon 
insertions into the ampicillin selectable marker or origin of replication.  
The pNOM-XP3-egfp!OE-Tn5 library also displayed more intense bands on the 
agarose gel analysis of the MlyI and XhoI double digest, corresponding to fragments 
of ~500 bp and ~700 bp. The increased number of DNA fragments of these two sizes 
implies the OE-Tn5 transposon has higher target site specificity than MuDel. 
Due to downstream library diversity analysis indicating that this library had 
potential bias in it (Section 3.2.5.2, Fig 3.6) and therefore would probably not be used, 
the number of variants in the library with transposon insertions within the target gene, 
egfp, was not determined. 
 
3.2.4 Isolation and cloning of transposon containing egfp 
The pNOM-XP3-egfp!MuDel and pNOM-XP3-egfp!OE-Tn5 libraries contain 
transposon insertions throughout the plasmid but insertion sites only within egfp are 
desired. Using a restriction digest method outlined in Fig 3.5 a, all the variants with 
MuDel and OE-Tn5 insertions within egfp can be extracted (Section 2.3.2).  
An XhoI and NdeI double digest was performed on the pNOM-XP3-
egfp!MuDel and pNOM-XP3-egfp!OE-Tn5 libraries to produce four distinct fragments; 
vector sequence with and without a transposon, and egfp with and without a 
transposon (Fig 3.5 a). The four fragments were separated by agarose gel 
electrophoresis (Fig 3.5 b) and the two fragments required, vector without a 
transposon and egfp containing a transposon were extracted (Section 2.2.1.2) and 
ligated together (Section 2.2.8). The ligation products were used to transform high 
efficiency competent cells (4 x 108 cfu/µg DNA); a percentage (1.6% or 5% for 
MuDel or OE-Tn5 respectively) were grown on LB agar plates supplemented with 20 
µg/ml chloramphenicol and the remaining cells were used to inoculate LB broth 
supplemented with 20 µg/ml chloramphenicol, so generating libraries with transposon   
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Fig 3.5. Approach for isolation of variants containing a transposon insertion into egfp. a. 
Schematic representation for isolation of desired fragments. Step 1. pNOM-XP3-egfp!MuDel 
and pNOM-XP3-egfp!OE-Tn5 (vector: black, gfp: green, transposon: orange) are digested with 
NdeI and XhoI producing four different sized DNA fragments: vector or egfp with and 
without a transposon insertion. Step 2.  The two DNA fragments representing egfp containing 
a transposon and the plasmid backbone are purified from an agarose gel and ligated together 
to produce egfp!MuDel and egfp!OE-Tn5 libraries. b. Restriction digest analysis of pNOM-XP3-
egfp!MuDel using NdeI and XhoI in combinations as indicated in the figure. 
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insertions just within egfp (egfp!MuDel and egfp!OE-Tn5) (Fig 3.5 a). 
The number of colonies observed on each LB agar plate was 450 and 424 for 
the MuDel and OE-Tn5 library ligation respectively. This implies that there are 
27,675 and 8,056 cells respectively that contain egfp-transposon variants in the liquid 
cultures. The library ligation producing the egfp!MuDel library resulted in ~10 fold 
more cells than number of variants in the library (2,504) giving confidence that all 
possible variants have been sampled. 
 
3.2.5 Diversity of egfp!MuDel and egfp!OE-Tn5 libraries 
After the isolation of variants containing transposon insertions just within egfp 
it was necessary to check that no diversity was lost from the libraries and that no bias 
had been introduced into the library. This is important for future screening steps 
(Section 3.2.6 and 3.7) so that a diverse number of sites are selected and that 
particular insertion positions do not dominate within the libraries. 
egfp!MuDel and egfp!OE-Tn5 library diversity was determined by XhoI and MlyI 
restriction digestion, as before (Section 3.2.3.2), and analysed by agarose gel 
electrophoresis (Fig 3.6). The egfp!MuDel and egfp!OE-Tn5 libraries only have 
transposon insertions within egfp therefore double restriction digest produces DNA 
fragments between two distinct size ranges, 0-713 bp and 2147-2860 bp, as outlined 
in Fig 3.6 a. 
 
3.2.5.1 egfp!MuDel library diversity 
Restriction digestion of the egfp!MuDel library with XhoI produced a single 
fragment of 4163 bp as expected showing that there is only a single transposon per 
molecule of DNA (Fig 3.6 b). Restriction digestion with MlyI resulted in the two 
expected fragments corresponding to linear library DNA (2863 bp) and excised 
MuDel (1310 bp) (Fig 3.6 b). The double restriction digest with MlyI and XhoI 
produced fragments between the two expected size ranges (0-713 bp and 2147-2860 
bp). 
The DNA smears generated on separation by agarose gel electrophoresis are 
smooth with no regions of greater intensity suggesting there is no obvious bias for a 
particular transposon insertion position within egfp.   
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Fig 3.6. Analysis of transposon insertion diversity for egfp!MuDel and egfp!OE-Tn5. 
a. Schematic representation of the diversity analysis process. When linearized egfp!MuDel and 
egfp!OE-Tn5 (vector: black, egfp: green, transposon: orange) are digested with MlyI the 
transposon (~1300 bp) is liberated leaving different DNA fragments between two distinct size 
ranges, 0-713 bp or 2147-2860 bp. Restriction digest analysis of the egfp!MuDel library by b, 
1.0% (w/v) agarose c, 2.0% (w/v) agarose and d, the egfp!OE-Tn5 library by 1.0% (w/v) 
agarose, with MlyI and/or XhoI as indicated in the figure. 
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Analysis of the double restriction digest by 2.0 % (w/v) agarose gel 
electrophoresis was performed to give better resolution of the smaller DNA fragments 
produced. The DNA smear only appears to span ~720 bp to ~200 bp and fragments 
smaller than this can’t be seen in the agarose gel image (Fig 3.6 c). This is due to the 
fragments being smaller and therefore not binding as much ethidium bromide (used to 
stain DNA, Section 2.2.2) as larger fragments, giving decreased band intensity.  
 
3.2.5.2 egfp!OE-Tn5 library diversity  
The undigested OE-Tn5 library, when analysed by agarose gel electrophoresis 
(Fig 3.6 c), appeared to consist of three plasmid forms presented by three band 
intensities at ~9000 bp, 3000 bp and ~1500 bp. Restriction digest by XhoI alone 
linearized the plasmids presenting at ~9000 bp and ~3000 bp in the undigested library 
however did not linearize the ~1500 bp form (Fig 3.6 c). The plasmid species giving 
rise to the band intensity at ~9000 bp is probably nicked plasmids in an open 
conformation rather than supercoiled. The plasmid species giving rise to the band 
intensity at ~1500 bp could be denatured supercoiled DNA, which can be resistant to 
some restriction digestion, often formed by an extended alkaline lysis step during 
plasmid isolation.  
Restriction digestion by MlyI excised the OE-Tn5 transposon (1308 bp) from 
the library DNA (4173 bp) as expected (Fig 3.6 c). The double restriction digest of the 
egfp!OE-Tn5 library with MlyI and XhoI produced one of the expected DNA smears 
(2147–2860 bp) when separated by agarose gel electrophoresis, however the DNA 
smear representing fragments within the size range of 0-713 bp appeared to be 
concentrated into three DNA fragments with sizes of ~500, ~800 and ~1000 bp (Fig 
3.6 c). This DNA band pattern was not expected and implies the library is biased for 
particular insertion positions. Due to the fact that the egfp!OE-Tn5 library had limited 
diversity all further library work was conducted with the MuDel library. 
 
3.2.6 Creation and analysis of a triplet nucleotide deletion library in egfp. 
To study the effects of single amino acid deletions on the structure and 
function of EGFP, the egfp!MuDel library was used to generate a triplet nucleotide 
deletion (TND) sub-library. Removal of MuDel from the egfp!MuDel library by MlyI 
xxx  
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Fig 3.7 Schematic representation for the construction and screening of an egfp triplet 
nucleotide deletion library. Step 1, MlyI restriction digestion removes MuDel (orange) and a 
triplet nucleotide from the pooled plasmid library, egfp!MuDel. Step 2, Separation of the library 
DNA from MuDel is performed by agarose gel electrophoresis with subsequent extraction 
and purification (Section 2.2.1.2) of the linear library. Step 3, Intramolecular ligation, with 
NEB Quick ligase (Section 2.2.8), recircularizes the plasmid library resulting in the loss of 3 
bp (red cross) from egfp (green). Step 4, Bacterial colonies transformed with the TND library 
are screened by their fluorescence. The bacterial colonies expressing an EGFP variant are 
excited by illumination on a UV transilluminator (Section 2.3.3) 
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restriction digestion, subsequent purification and intramolecular ligation of the 
linearized library (Fig 3.7) resulted in the deletion of contiguous triplet nucleotides at 
random positions in egfp (Section 3.1, Fig 3.1).  
Transformation of E. coli BL21 Gold (DE3) cells (Table 2.1) with the TND 
library and subsequent plating on M9 minimal media agar plates supplemented with 
100 µg/ml ampicillin and 150 µM IPTG produced colonies after 24 hr at 37 °C, 2.5% 
of which exhibited fluorescence when illuminated on a UV-transilluminater. The 
plates were then incubated for a further 2 weeks at 4 °C with the number of 
fluorescent colonies increasing to 10%. 
A total of 153 colonies were chosen based on their observable colour 
phenotype and the egfp gene isolated and sequenced: 88 fluorescent and 65 non-
fluorescent colonies. Of the 88 fluorescent variants selected 42 unique TNDs were 
identified and from the 65 non-fluorescent variants 45 were unique TNDs (87 total 
unique TNDs). A full list of these variants is shown in Table 4.3 and 4.4 in Chapter 4.  
MuDel can randomly insert itself into the target gene therefore the TND 
produced, after MlyI restriction and removal of the transposon, is not always in frame. 
This means that a TND can give rise to the deletion of an amino acid and cause a 
point mutation (Table 3.1). Out of frame TND can therefore give rise to a stop codon 
being introduced prematurely into egfp depending on the sequence surrounding the 
TND site (Table 3.1). 
From the 153 variants identified and the sequence determined only three 
variants resulted in an out-of-frame TND and subsequent stop codon being 
introduced. Sequence analysis indicated that from the 87 unique TNDs 53 (60%) were 
in the second and third open reading frame (ORF) with 29 of these TNDs producing 
secondary mutations. Analysis of all TND positions showed they were spread 
randomly throughout the target gene (Fig 3.8). There is an apparent clustering of 
TNDs within egfp that give rise to fluorescent or non-fluorescent versions of EGFP 
suggesting that some sites/regions are more or less tolerable to single amino acid 
deletion respectively. 
A detailed characterisation of fluorescent single amino acid deletion variants 
of EGFP selected from the TND library is described in Chapter 4. 
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Table 3.1. The possible DNA and protein mutations caused by TND with respect to 
MuDel insertion position within a codon.  
Wild type sequencea Deletion Sequenceb Amino Acid Mutation
c ORFd 
15GAG GAG CTG25  15GAG CTG22  E6! 1 
24TTC ACC GGG34 24TTC AGG31 T9! G10R 2 
678GCC GGG ATC688 678GCG ATC685 G228! 3 
546TAC CAG CAG556 546TAG CAG553 Y182STOP Q183! 3 
aWild type egfp sequence with the 5bp duplication caused by MuDel transposition highlighted 
in bold, with the triplet nucleotide to be deleted underlined. 
bThe resulting DNA sequence after TND, stop codon highlighted in red. 
cAmino acid mutation caused by TND, a ! after a residue number indicates that residue has 
been deleted. 
d Open reading frame (ORF) 
 
 
 
 
 
 
 
 
Fig 3.8. Triplet nucleotide deletion (TND) positions within egfp. Sequence analysis of 
fluorescent (blue triangles) and non-fluorescent variants (red triangles) selected during the 
screening process identified the position of the triplet nucleotide deleted from egfp (grey bar). 
Non-Fluorescent variants due to a TND and subsequent introduction of a premature stop 
codon are highlighted by black triangles. 
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3.2.7. Creation of libraries encoding domain insertion chimeras 
The random breaks produced within egfp after removal of MuDel by MlyI 
restriction digestion can have DNA cassettes, encoding another protein domain, 
ligated into the library. The resulting constructs encode integral domain fusion 
proteins with one protein domain (insert domain) randomly inserted throughout 
another (parent domain). Integral fusion proteins have the potential to act as 
biomolecular switches with the input domain modulating the function of the parent 
domain. The gene encoding cytochrome b562 (CybC) has been used here as a DNA 
cassette for insertion into the single breaks within egfp to encode cyt b562-EGFP 
integral fusion chimeras. 
MuDel was removed from the egfp!MuDel library by MlyI restriction digestion 
(Section 3.2.6) and separated from the library DNA by agarose gel electrophoresis 
(Fig 3.7). The linear egfp! library was purified from the agarose gel ready for the 
insertion of the DNA cassette cybC-Kanr and production of domain insertion libraries. 
The cybC-Kanr cassette comprises a kanamycin resistance gene, for selection 
of clones containing an insertion, straddled by two PstI restriction sites within a 
fragment of cybC encoding the cytochrome b562 (cyt b562) domain without its N-
terminal periplasmic location signal sequence (Fig 3.9) (supplied courtesy of Dr 
Wayne Edwards) [31].  
Previous studies of integral domain fusion proteins has shown that the length 
and flexibility of the linking peptides, connecting the two domains, has a strong 
influence on the insert domains ability to modulate the parent domains function. Two 
cybC-kanr cassettes were therefore generated by PCR (Section 2.3.4): one with DNA 
sequences coding for flexible Gly-Gly-Ser linkers at both N- and C-termini (cybC-
kanr-GGS-1) and a second with a degenerate nucleotide sequence (NNS) encoding a 
single random amino acid (X) at both N- and C-termini (cybC-kanr-X-1) (Table 3.4). 
As previously described (Section 3.2.6) MuDel can insert itself randomly 
within a target gene and therefore the random break produced upon MuDel removal 
from egfp, by MlyI restriction digestion, is not always in frame. Ligation of a DNA 
cassette into random breaks in the second or third reading frame would produce out of 
frame constructs with the likely introduction of a premature stop codon.   
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Fig 3.9 Schematic of cybC-kanr cassette. The cybC-kanr DNA cassette comprises the cybC 
gene (red), encoding the cyt b562 domain without its periplasmic location signal sequence, 
containing a kanamycin resistance gene (kanr:black) within PstI restriction sites. 
 
 
 
 
 
Table 3.2. Primer combinations for the generation of cybC-GGS and cybC-X cassettes 
in all three open reading frames. 
Primersa CybC cassette name ORF
b CybC Cassettesc 
DDJdi023 
DDJdi024 cybC-kan
r-GGS-1 I GGTGGGAGCGCA  CybC-kanr  AGGGGTGGGAGC 
    
JAJA003 
JAJA004 cybC-kan
r-GGS-2 II NNGGTGGGAGCGCA  CybC-kanr  AGGGGTGGGAGCN 
    
JAJA005 
JAJA006 cybC-kan
r-GGS-3 III NGGTGGGAGCGCA  CybC-kanr AGGGGTGGGAGCNN 
    
    
WREcbf005 
WREcbf006 cybC-kan
r-X-1 I NNSGCA  CybC-kanr  AGGNNS 
    
WREcbf007 
WREcbf008 cybC-kan
r-X-2 II NSNNSGCA  CybC-kanr  AGGNNSN 
    
WREcbf009 
WREcbf010 cybC-kan
r-X-3 III SNNSGCA  CybC-kanr  AGGNNSNN 
aPrimer sequences can be found in Table 2.2. 
b ORF refers to the open reading frame of each cassette. 
cCybC-kanr sequence contributing to the cassette is highlighted in white on a black 
background with linking sequences displayed as appendages. Random nucleotides 
maintaining the reading frame are underlined. N refers to A, C, G or T and S refers to a C or 
G.  
  
!"#!" !"#!"
$%&'()*+),%( )*+),+(
)*+),-%&'(
 91 
With the addition of single nucleotides to the 5’ and 3’ ends of the DNA 
cassette both the second and third reading frames can be sampled (Table 3.2) after 
insertion into out of frame breaks in the library. The DNA cassettes cybC-kanr-GGS-1 
and cybC-kanr-X-1 were used as PCR templates to generate cassettes in open reading 
frame (ORF) 2 and 3 (cybC-kanr-GGS-2, cybC-kanr-GGS-3, cybC-kanr-X-2, cybC-
kanr-X-3) (Section 2.3.4) by the addition of either one or two random nucleotides to 
the 5’ or 3’ ends (Table 3.2) (Fig 3.10 b). 
The six cybC cassettes were ligated into the linear egfp! library producing six 
separate DNA cassette insertion libraries (GGS1, GGS2, GGS3, X1, X2, X3) (Fig 
3.10). To make sure the cassette insertion libraries sizes were large enough to 
potentially cover insertions throughout egfp, E. coli DH5" bacteria transformed with 
the libraries (5%) were grown on six separate LB agar plates, supplemented with 25 
µg/ml kanamycin. The rest of the transformed cells (95%) were grown in LB Broth 
supplemented with 25 µg/ml kanamycin (Fig 3.10 a).  
The GGS1, GGS2 and GGS3 transformed cells returned 771, 352 and 226 
colonies respectively on the LB agar plates therefore each liquid culture can be said to 
comprise of 14,649, 6688, and 4294 variants respectively. The same procedure was 
applied to the X1, X2 and X3 libraries generating 63, 32 and 33 colonies, 
respectively, for a subset (5%) of the transformed cells extrapolating to 1197, 608 and 
627 variants in the three libraries. The X1, X2 and X3 libraries have far fewer variants 
than the GGS libraries but still all six contain enough variants to sample insertions 
throughout egfp. 
The GGS1 library had >2-two fold and >3-fold more variants than the GGS2 
and GGS3 libraries respectively as did the X1 library with almost 2 fold more variants 
than the X2 or X3 libraries. Knowing the number of variants in each of the libraries a 
proportional amount of DNA isolated from the GGS1, GGS2 and GGS3 was pooled 
together so that one particular reading frame did not over represent itself in the pooled 
library (GGSpool) (Fig 3.10 a). The same procedure was also carried out with the X1, 
X2 and X3 libraries to produce a second proportionally pooled library (Xpool).  
A PstI restriction digest of the GGSpool or Xpool libraries removed the 
kanamycin resistance gene from within the cybC-kanr cassettes (Fig 3.10 c). When 
separated by agarose gel electrophoresis two products are generated corresponding to 
xx  
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Fig 3.10 Schematic representation for the construction and screening of a domain 
insertion library. a, Step 1, Intermolecular ligations between the linear egfp! library (green) 
and cybC-kanr cassettes (cybC: red, kanr: black, linkers: grey) are used to transform E.coli 
DH5" cells. Transformed cells are grown on LB agar plates and in LB Broth to calculate the 
size of the libraries. Step 2, Plasmid libraries (GGS1, GGS2, GGS3, X1, X2 and X3) are 
purified from the liquid cultures and pooled so that each ORF is equally represented to 
produce libraries GGSpool and Xpool. Step 3, PstI restriction digestion removes the kanr gene 
(black) from the library. Step 4, Isolation and purification of the linear GGSpool and Xpool 
libraries. Step 5, Intramolecular ligation produces the domain insertion libraries cybC-eGFP-
GGS and cybC-egfp-X. Step 6, Bacterial colonies transformed with the domain insertion 
libraries are screened by their fluorescence after excitation with a UV transilluminator. b, 
CybC-kanr DNA cassettes analysed by agarose gel electrophoresis. c, PstI restriction digest of 
GGSpool separated by agarose gel electrophoresis.   
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the kanamycin resistance gene (1077 bp) and linear GGSpool or Xpool library DNA at 
~3200 bp (Fig 3.10 c). The library DNA was purified from the agarose gel followed 
by intramolecular ligation generating cybC-egfp-GGS or cybC-egfp-X plasmid 
libraries (Fig 3.10 a). The cybC-egfp-GGS or cybC-egfp-X libraries were used to 
transform E. coli TUNER™ (DE3) cells (Section 2.1.3, Table 2.1) and plated onto 
M9 minimal media agar plates supplemented with ampicillin (100 µg/ml) and IPTG 
(150 µM). 
 
3.2.8 Screening cybC-egfp-GGS and cybC-egfp-X libraries. 
E. coli TUNER™ (DE3) cells transformed with cybC-egfp-GGS or cybC-egfp-
X libraries were spread on M9 minimal media agar plates, supplemented with 
ampicillin (100 µg/ml) and IPTG (150 µM), and incubated at 37 °C for 24 hrs. The 
colonies were analysed by eye for a green colour phenotype on excitation with a UV 
transilluminator (Section 2.3.6) and selected along with colonies presenting no colour, 
upon excitation, for a PCR screen to estimate the cybC insertion positions within egfp.  
The plates were then stored at 4 °C with colonies selected for PCR colony screens 
after 24 hrs and 72 hrs. After the initial 24 hr incubation at 37 °C 5% of the cybC-
egfp-GGS or cybC-egfp-X colonies exhibited a green colour phenotype. After storage 
at 4 °C for up to 72 hrs an additional 1.5% of the colonies exhibited a green 
phenotype.  
Using a primer specific for pNOM-XP3 in combination with a primer specific 
for cybC a PCR product between 456 and 1167 bp in length, depending on the position 
cybC inserted within egfp, is generated (Fig 3.11 a). A PCR product of 456 bp 
indicated cybC was inserted towards the 5’ end of egfp whilst a product of 1167 bp 
indicated cybC was inserted towards the 3’ end of egfp (Fig 3.11 b). 
The PCR products produced from screening colonies transformed with cybC-
egfp-GGS or cybC-egfp-X libraries display a trend between the size of the product and 
the time at which the variant gained fluorescence. In both libraries colonies with a 
green phenotype after the first 24 hrs at 37 °C produce PCR products of ~450 bp or 
~1150 bp indicating insertions have taken place towards the 5’ and 3’ ends of egfp 
only (Fig 3.11 bi). The cybC-egfp-X variants only appeared to have insertions in the 5’ 
end of egfp where as the cybC-egfp-GGS variants had insertions within the 5’ and 3’ 
ends of egfp. 
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Fig 3.11. Analysis of cybC insertion within egfp. a, Screening of colonies containing cybC-
egfp-GGS and cybC-egfp-X by GoTaq PCR (Section 2.2.3) using primers pEXP-F (black 
arrow) specific for pNOM-XP3 and WREcbr012 (blue arrow) specific for CybC (Table 2.2) 
generates products between 456 bp and 1167 bp depending on the insertion position within 
egfp. b, Colony screen analysis of cybC-efgp-X (left panel) or cybC-egfp-GGS (right panel) 
libraries by 1.0% (w/v) agarose gel electrophoresis to estimate the site of CybC insertion 
within egfp. Products ~456 bp indicate an insertion towards the 5’ end of egfp and products 
~1167 bp indicate an insertion towards the 3’ end of egfp as shown in the figure. i, 
Fluorescent colonies screened after 24 hrs at 37°C. ii, Screened colonies that gained 
fluorescence after 24 hrs at 4°C. iii, Screened colonies that gained fluorescence after 72 hrs at 
4°C. iv, Screened non-fluorescent colonies. 
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Colonies that gained a green colour phenotype after 24 hrs at 4 °C produced 
PCR products that indicate some of the variants have cybC insertions away from the 
5’ and 3’ ends and more integral to egfp (Fig 3.9 bii). After 72 hrs at 4°C colonies 
containing cybC-egfp-GGS variants that gained a green colour phenotype produced 
PCR products that indicated the majority of the variants have cybC insertions integral 
to egfp.  
Although the cybC-egfp-X variants had some insertions towards the middle of 
egfp after 72 hrs at 4 °C the majority of variants screened still had insertions towards 
the 5’ end (Fig 3.9 b iii). Screening of non-fluorescent cybC-egfp-GGS and cybC-
egfp-X variants showed that insertions are taking place throughout egfp and the high 
abundance of 5’ end insertions in the cybC-egfp-X variants is not due to bias for a 
particular insertion site in the libraries (Fig 3.9 b iv). Due to the fact that the cybC-
egfp-X library produced lots of cybC insertions towards the 5’ end of egfp with very 
few variants having insertions integral to egfp all further work was carried out on 
cybC-egfp-GGS variants.  
Some of the colony PCR screens produce no PCR product due to the nature of 
the blunt end ligation between the cybC cassettes and the linear library; cybC can end 
up in a correct or reverse orientation. Therefore there is a 50% chance of every colony 
screened having cybC in the reverse orientation to egfp. This is seen in the non-
fluorescent cybC-egfp-GGS variants with 208 colonies being screened, 86 (41%) of 
which produced no PCR product inferring a reverse cybC orientation. 
Of the 55 fluorescent cybC-egfp-GGS variants screened ten (18%) produced 
no PCR product from the screen inferring a reverse cybC orientation. DNA sequence 
analysis of the screened fluorescent variants identified four more variants with cybC 
in the incorrect orientation. CybC in a reverse orientation usually introduces a 
premature stop codon resulting in a non-fluorescent protein, however 14 of the 
colonies screened with reverse CybC insertion in egfp presented a green colour 
phenotype.  
From the DNA sequence analysis and colony PCR screen the 25% reverse 
insertions identified in the fluorescent variants took place within 36 bp of the 5’ end 
of egfp. The last 36 bp of egfp code for an 11 amino acid C-terminal dynamic loop not 
required for fluorescence to mature, therefore a premature stop codon introduced in 
this region will still result in colonies presenting a green colour phenotype. These 
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variants however did not produce a mature cytochrome domain and therefore were 
discounted from the library and further characterisation. 
The colony PCR screen of 26 non-fluorescent cybC-egfp-X variants all 
produced PCR products except in two (7 %) instances. Of the 56 fluorescent cybC-
egfp-X variants screened by colony PCR 5 (9 %) produced no PCR product implying 
reverse cybC orientation. This is a much lower percentage than the 50% cybC reverse 
orientation expected from a blunt end ligation and that produced by the fluorescent 
cybC-egfp-GGS variants. 
This could be because preferential insertion of the cybC-kanr-X cassettes takes 
place in a particular orientation into the single breaks within the egfp library. In this 
instance there could be read through to the kanr gene within the cybC-kanr-X cassette, 
from other promoters in the same orientation in the pNOM-XP3 plasmid, giving cells 
greater resistance to kanamycin and a growth advantage over others. This 
phenomenon was not seen with the cybC-kanr-GGS cassettes though, which only 
differ in sequence by ~1% to the cybC-kanr-X cassettes. 
From the 55 fluorescent and 208 non-fluorescent cybC-egfp-GGS variants 
screened 37 and 116 were selected, respectively, for sequence analysis. 
  
3.2.9 Sequence analysis of cybC-egfp-GGS variants 
As previously stated (Section 3.2.6) the nature of MuDel insertion and 
removal can result in out of frame breaks in the egfp coding sequence. This means 
that there is a 33% chance of a cybC cassette being in frame once ligated into the 
random breaks. An out of frame cybC cassette also results in premature stop codons 
being introduced into the gene usually resulting in a non-fluorescent variant.  
Out of the non-fluorescent variants it is expected that 50% could have cybC in 
the reverse orientation and only 33% having cybC in the correct reading frame. This 
means of the 208 non-fluorescent colonies screened, by PCR, only 16% of the 
screened variants will be in the correct orientation and in the correct reading frame. 
From the 208 variants screened by PCR 86 (41%) variants had the cybC cassette in 
the incorrect orientation, evident from a lack of PCR products for these variants (data 
not shown). From the 116 non-fluorescent variants selected for sequence analysis 33 
(28%) were determined to be in frame (Fig 3.12). Therefore from the total 208 
variants screened 33 (16%) were deemed to be in frame and have cybC in the correct 
orientation within egfp, which was expected.  
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DNA sequence analysis of the 37 fluorescent variants identified 6 (16%) that 
contained the cybC cassette out of frame (Fig 3.12) and four variants were identified 
during sequence analysis with cybC in a reverse orientation. All out of frame or 
reverse orientation cybC insertions were located within the last 36 bp of egfp. As 
mentioned previously (Section 3.8) this region of egfp encodes a C-terminal dynamic 
loop in EGFP not required for fluorescence. Therefore incorporation of a premature 
stop codon, due to out of frame or reverse orientation cybC insertions, at the 3’ end of 
egfp can still result in fluorescent proteins that lack the mature cytochrome domain.  
After sequence analysis of both fluorescent and non-fluorescent variants 83 
unique sites within egfp were sampled for domain insertion. A more detailed analysis 
and characterisation of these variants has been carried out in Chapter 5 and 6. 
 
3.2.10 MuDel target site specificity 
MuDel has been shown in many instances to be able to insert itself throughout 
a target gene producing a diverse number of insertion sites. Until now there hasn’t 
been enough sequence data to identify if a target site-specific consensus sequence 
exists with which the MuDel/MuA system has a higher preference for. Screening and 
DNA sequencing data from the TND and domain insertion libraries yielded 152 
unique insertion sites throughout egfp. Sequence analysis of the 152 unique 5 bp 
stretches of the target gene duplicated upon MuDel transposition was performed to try 
to identify a target site preference.  
Using an online sequence analysis tool, called Weblogo, the propensity with 
which a particular nucleotide appears at one of the five possible positions is presented 
by a graphical representation of a frequency plot (Fig 3.13). From the graphical 
representation of the sequences there isn’t a clear consensus sequence although there 
are a higher proportion of G/C rich pentamer sequences implying MuDel may have a 
higher target site preference for G/C rich stretches of DNA.  
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Fig 3.12. CybC insertion positions within egfp. Sequence analysis of fluorescent (blue 
triangles) and non-fluorescent variants (red triangles) selected during the screening process 
identified the position of the triplet nucleotide deleted from egfp (grey bar). Reverse cybC 
insertions or out of frame cybC insertions resulting in fluorescent variants are highlighted by 
orange and yellow triangles respectively. Non-Fluorescent variants due to an out of frame cyt 
b insertion and subsequent introduction of a premature stop codon are highlighted by green 
triangles. 
 
 
 
 
Fig 3.13 MuDel target site sequence analysis. A graphical representation of the frequency at 
which nucleotides appear at one of the 5 positions of the target site duplication, introduced 
during MuDel transposition (Section 3.1, Fig 3.1). The graphical representation was produced 
using the WebLogo application (http://weblogo.threeplusone.com/create.cgi) from 152 unique 
sequences sampled by MuDel from the TND and domain insertion libraries. 
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3.3 Discussion 
Directed evolution approaches towards protein engineering have many 
benefits over rational design. Structural knowledge of the target protein is not 
required, many different variants can be produced at the same time and residues 
sampled that may not usually be targeted using rational design. However, directed 
evolution is normally restricted to sampling simple mutation events such as base 
substitutions, which restricts the sequence space hence conformational space a protein 
will sample [100]. Here it is demonstrated that using a transposon-based approach, 
mutations that affect the protein backbone as well as side chain can be sampled by 
directed evolution.  
 
3.3.1 Comparison of MuDel, ME-4A-Tn5 and OE-Tn5 transposon systems 
Here we have described and compared three transposon-based systems; 
MuDel, ME-4A-Tn5 and OE-Tn5. Due to the mechanism by which the transposons 
insert themselves into the target gene and the subsequent removal by MlyI restriction 
digestion two libraries can be made with either a triplet nucleotide deletion or a triplet 
nucleotide duplication of a target gene (Section 3.1, Fig 3.1). This alone can be used 
for studying the effects of single amino acid deletions (MuDel system) or single 
amino acid duplications (Tn5 system) within target proteins.  
Two Tn5 transposon systems were used here to test the efficiency of the two 
different transposons OE-Tn5 and ME-4A-Tn5. The two transposons only differed in 
sequence by two nucleotides within their respective transposase recognition elements 
(TREs) (Fig 3.1 c). The ME-4A-Tn5 transposon was developed from a hyperactive 
ME-Tn5 transposon, which shows up to 8-fold increased transposition efficiency with 
respect to the OE-Tn5 transposon [98]. However the single nucleotide mutation in the 
ME-4A-Tn5 transposons TREs used in this study, to introduce the required MlyI 
restriction site, reduced its transposition efficiency by 5-fold with respect to that of the 
OE-Tn5 transposon (Section 3.2.2). 
The decrease in activity of the ME-4A transposition reaction could be 
attributed to the change in the base pair at position 4 of the transposase recognition 
sequence from a thymine to an adenine [98]. It has been shown that the C5 methyl 
group on thymine 4 of the ME recognition sequence is required for efficient 
transpososome complex formation (a pre transposition DNA/protein complex, Section 
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1.3.3.2) and that alteration of the thiamine base to the corresponding OE sequence 
(adenine) results in reduced transposition efficiency [98]. 
Despite the OE-Tn5 transposon system having similar transposition 
efficiencies to the MuDel system (Section 3.2.2) further library production steps 
indicted that the OE-Tn5 libraries contained bias for particular transposon insertion 
positions within the target gene, egfp (Fig 3.6 d). For this reason the OE-Tn5 library 
was not used to sample potential triplet nucleotide duplications within egfp. Previous 
studies have identified significant target site preference for Tn5 transposons at GC 
rich target DNA sequences [101, 102]. Engineering of the DNA binding domains in 
the Tn5 transposase could potentially alleviate its target site specificity and make it a 
more useful system for creating directly evolved libraries. 
The MuDel system was taken forward and used to produce two further 
libraries, a triplet nucleotide deletion library (Section 3.2.6) and a domain insertion 
library (Section 3.2.7). In contrast to the Tn5 system both individual libraries sampled 
a diverse range of insertion positions (Fig 3.8 and 3.12) within egfp with no obvious 
bias for any specific position (Fig 3.6 b and c). Sequence analysis of the 5 bp target 
site duplications, introduced due to the transposition mechanism (Fig 3.1), from the 
152 target sites sampled across the TND and domain insertion libraries failed to 
identify a specific consensus sequence for which MuDel has a higher preference (Fig 
3.13). This further reinforces the benefits of the MuDel system over the Tn5 systems 
investigated here. 
 
3.3.2 Directed evolution approaches for sampling deletion mutations and domain 
insertion 
Until recently the most common way of introducing single amino acid 
deletions was by rational design, requiring structural knowledge of the target protein 
[39], and the requirement of separate oligonucleotides for every mutation required. 
Advancement in directed evolution strategies has established a few alternative 
methods for sampling deletion mutations for example random insertion and deletion 
mutagenesis (RID) [48]. The RID mutagenesis method to date has only been used for 
insertion and substitution mutagenesis but could potentially be used for sampling 
deletion mutations [48]. The limitation of this method is the use of Ce(IV)-EDTA to 
chemically cleave the target DNA as multiple nicks can be introduced into the target 
gene and the procedure is complicated and time exhaustive. On top of this the 
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resulting libraries produced by RID mutagenesis exhibit extensive bias for sites 
sampled within a target gene [48]. 
What is integral to all of these procedures (MuDel or Tn5 transposition and 
RID) is the generation of single random breaks throughout the target gene. There are 
already several techniques available to achieve random breaks within a target gene, 
such as the non-specific nuclease activity of DNaseI, RID mutagenesis, and other 
transposon based techniques. However it is notoriously difficult to get single breaks 
within a target gene using DNAseI, as with Ce(IV)-EDTA chemical cleavage, 
regularly producing tandem repeats and nested deletions of uncontrollable sizes. 
Other transposon-based methods can be used to introduce random breaks throughout 
target genes. However, for the majority of these methods removal of the bulk of the 
transposon by restriction digestion results in the transposase recognition elements 
(TREs) and the target site duplication left behind in the target gene (Chapter 1, 
Section 1.3.1.3). This reduces the ability to design and control the size and 
composition of the DNA inserted.  
The strength of the MuDel method described here is the ability to sample a 
diverse number of insertion positions and introduce a controlled triplet nucleotide 
deletion from the target gene leaving a library of blunt ended breaks (Fig 3.7). Unlike 
with other transposon based methods the MuDel TREs and target site duplication are 
removed from the library upon MlyI restriction digestion. As mentioned previously 
this gives the freedom and control for downstream mutagenesis techniques to sample 
single amino acid deletions, domain insertions or for the incorporation of non-natural 
amino acids to increase the chemical diversity of proteins. 
The MuDel insertion library created within egfp described here has been used 
for the incorporation of non-natural amino acids into EGFP [50]. The single break 
generated, after removal of MuDel from the library, had a DNA cassette (Subseq) 
comprising a kanamycin resistance gene flanked by MlyI restriction sites with an 
amber stop codon (TAG) at its 5’ end ligated into the library. The MlyI restriction 
sites were critically placed so as to remove the kanamycin resistance genes but 
leaving the TAG codons within the egfp library. Using an amber suppression 
technique [50] a non-natural amino acid can be incorporated at the position of an in 
frame TAG codon during translation. This technology allows for new chemistry to be 
sampled in proteins not accessible given the 20 naturally occurring amino acids. 
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 Owing to the nature of MuDel transposition and subsequent removal by MlyI 
restriction digestion the single random breaks produced within a target gene are not 
always in frame. However, when creating domain insertion libraries the linking 
sequences separating the two domains can be encoded within the DNA cassette inserts 
(Section 3.2.7 and Table 3.2). This opens the possibility to sample out of frame 
insertion sites within the libraries by adding one or two random nucleotides to the 5’ 
or 3’ ends of the DNA cassettes, increasing the potential library sample size 3-fold. 
Design of the sequences that link two domains in a discontinuous domain 
architecture is often given little thought even though they have been shown to play an 
essential role in the functional coupling of resulting integral domain fusion scaffolds 
[31, 37]. Here we investigated the effects different length linkers play on the tolerance 
of EGFP to cyt b562 domain insertion. Single random amino acid linkers (X) and 
longer more flexible tripeptide linkers (GlyGlySer) were encoded at the 5’ and 3’ 
ends of the cybC cassettes (Table 3.2), used for insertion into the blunt ended breaks 
within the linear egfp! library (Section 3.2.7). It was evident from PCR screens of 
colonies containing the cybC-egfp-GGS and cybC-egfp-X libraries that EGFP was 
more tolerant to the integral insertion of cyt b562 when the two domains were 
separated by the longer GlyGlySer linkers (Fig 3.11). This is probably due to the 
inherent difference between the flexibility the different linkers would impart on the 
integral domain constructs; the longer more flexible linkers will provide the flexibility 
for the parent domain to fold into its native structure, whilst shorter more rigid linkers 
would reduce the conformational flexibility required for the parent domain to fold. 
It was also observed that EGFP was more tolerable to cyt b562 domain 
insertions towards its C-terminus evident by the high proportion of cybC insertions 
towards the 3’ end of egfp (Fig 3.11). This is not due to bias in the library for 
insertions positions at the 3’ end of the egfp gene but due to the nature of the C-
terminal region of EGFP. The last 36 bp of egfp encode an 11 amino acid dynamic 
loop that is not required for fluorescence to mature [62] and is therefore highly 
tolerant to domain insertions. 
 
Between the two libraries (TND and domain insertion) described in this Chapter, 139 
unique sites were sampled for the potential mutagenesis of egfp. With further 
screening of the TND and domain insertion libraries it is highly probable that more 
unique sites would be identified within the egfp library for sampling mutational 
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events. With the development of improved high throughput screening methods and 
approaches the number of novel variants that can be identified from diverse libraries 
will increase, allowing the full potential of directly evolved protein libraries to be 
exploited. Further analysis and characterisation of identified fluorescent variants from 
the TND library and the domain insertion library will be discussed in Chapters 4, 5 
and 6. 
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Chapter 4: Characterization and analysis of single amino acid deletion mutants 
of EGFP 
4.1 Introduction 
Substitution mutations have been utilized extensively for over 20 years to 
engineer proteins with new or improved properties and to study mechanisms, folding 
and stability [5]. Substitution mutations only alter the side chain and therefore leave 
the protein backbone unaltered. Sampling InDel mutations so as to target the protein 
backbone would allow new sequence space and hence conformational arrangements 
to be sampled [19, 39, 100]. Insertion and deletion (InDel) mutations are sampled 
during protein evolution [15, 16, 103], as is evident by length variations between 
homologous proteins (Fig 4.1). Due to selection pressures InDel mutations usually 
occur in segments of 3 base pairs, or multiples thereof, so as to maintain the original 
open reading frame of the gene [16]. Given this requirement, InDel mutations at the 
protein level are sampled less often in nature than substitution mutations that only 
require DNA point mutations.  
The problem with mutations that change the backbone is that their effects can 
be difficult to predict due to the local and global structural rearrangements required to 
accept removal of an amino acid from the polypeptide [100]. Dogma suggests that 
loops are likely to be more tolerant to InDel mutations due to the inherent 
conformational flexibility of these regions, whilst InDel mutations in secondary 
structures can result in registry shifts (Chapter 1, Fig 1.1) [15]. However, there are 
very few studies that survey the effects of Indel mutations on protein structure and 
function. Single amino acid deletion mutagenesis was performed on the antibiotic 
resistance protein, TEM-1 !-lactamase. A wide variety of residues were identified that 
tolerated deletion and some variants even displayed altered properties such as 
improved activity towards normally poor substrates [19, 21]. 
Given that InDel mutagenesis is not a commonly adopted strategy in protein 
engineering, the impact of such an important class of mutations on the protein 
structure-function-folding relationship has not been fully explored. Thus, the 
established dogma of the generally limited structural sampling and perceived 
detrimental effect on protein stability persists. This is exacerbated by the lack of 
directed evolution approaches to sample InDel mutations that would allow sampling 
xx  
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 Species     Protein 
E. coli       TEM-1     KILESFRPE(38)  VLSRIDAG(62)  DLVE--YSP(82) 
B. cereus     !-Lac 3   QTVA-YHAD(88)  LLR--QNS(110) DLSN--YNP(130) 
S. cellul.    !-Lac.    ASLL-HRAH(79)  VLRDLDHD(103) DVTKSGHAP(125) 
M. tuber.     !-Lac.    AAIE-YRAD(77)  VLH--QNP(99)  DIRS--ISP(119) 
S. melil.     !-Lac.    AICV--NGE(65)  VMQAVDDR(89)  DLSVN-IQP(110) 
                              . .      ::            *:      *  
 
 
Fig 4.1 Sequence allignments for homologous !-lactamases. Length variations for 
homologous proteins highlight the importance of InDel mutations in the protein evolution 
process. Selected stretches of sequence !-lactamases were aligned using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). * indicates identical residues, : indicates 
conserved residues, . indicates semi-conserved residues. Red sequence corresponds to 
residues in a !-strand, blue sequence corresponds to residues in an "-helix and green sequence 
corresponds to a region in TEM-1 !-lactamase important for binding the !-lactamase inhibitor 
protein BLIP. !-lac 3 stands for class A !-lactamase III, !-lac stands for !-lactamase with no 
defined name. 
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of single amino acid deletions across the polypeptide backbone and variants screened 
for tolerance and improved activity. A directed evolution approach would allow a 
broader sampling of InDel mutations allowing variants with altered properties to be 
observed and analysed thus allowing the effect of the mutation rationalized.  
Therefore the aim of this Chapter is to improve our understanding of the 
impact of the most common Indel event, the single amino acid deletion [16] on EGFP 
function, structure and folding. A survey of tolerated and non-tolerated single amino 
acid deletion events was undertaken using a directed evolution approach and to 
identify variants with altered and beneficial properties. The transposon-based directed 
evolution approach has already been described in Chapter 3. Selected EGFP variants 
were then analysed in more detail, including determining their structural and folding 
properties. On commencement of this project, no structure was available for EGFP 
despite its wide-ranging use as a tool in cell biology. Therefore, to allow a true 
interpretation of our observed deletions in terms of EGFP structure, the 3D atomic 
resolution structure of EGFP was solved by X-ray crystallography.  
 
4.2 Results 
4.2.1 EGFP crystallization and structure determination 
Prior to this study the atomic level tertiary structure for EGFP had not been 
determined, which is surprising given its widespread use as a tool in cell biology. To 
address this and to provide a suitable structural model for analysis of the effect of 
deletion mutations, the crystal structure of EGFP was solved. EGFP protein samples 
(10 mg/ml in 50 mM Tris HCl, pH 8.0, 150 mM NaCl) were screened for crystal 
formation using the sitting drop vapour diffusion method at 4 °C. The crystals for 
EGFP were obtained from 0.1 M MES/NaOH, pH 6.5, 0.2 M calcium acetate and 
18% PEG 8000. The crystallographic statistics are shown in Table 4.1. Crystals grew 
in the space group P212121 and contained a single molecule in the asymmetric unit. 
The EGFP crystals gave good diffraction with an optimum resolution of 1.35 Å. 
Structure determination was carried out by molecular replacement with a previously 
solved GFP structure (PDB:2HQZ) using the CCP4 program MOLREP. Structure 
refinement was performed with the program REFMAC (Section 2.7.2). An R-Free 
value of 17.8% for the refined EGFP structure implied the model was a good 
representation of the experimental data.  
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Table 4.1. Data collection and refinement statistics. 
 
Data collection statistics 
 
Space group P2(1)2(1)2(1) 
a (Å) 51.1 
b (Å) 62.2 
c (Å) 69.6 
Resolution range (Å) 40 - 1.35 
Total reflections 225405 
Unique reflections 49477 
Completeness (%) (last shell) 99.9 (99.8) 
I/! (last shell) 5.0 (2.0) 
R(sym) (%) (last shell) 9.3 (38.6) 
B(iso) from Wilson (Å2) 9.1 
Refinement statistics 
Protein atoms excluding H  1808 
Solvent molecules 368 
R-factor (%) 15.3 
R-free (%) 17.8 
Rmsd bond lengths (Å) 0.006 
Rmsd angles (°) 1.2 
Ramachandran core region (%) 92.7 
Ramachandran allowed region (%) 7.3 
Ramachandran additionally allowed region (%) 0.0 
Ramachandran disallowed region (%) 0.0 
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Superposition of the structure obtained for EGFP on wt GFP (pdb: 1GFL) 
shows that the structures are very similar (Fig 4.2) with an RMSD of 0.33 Å across all 
backbone atoms (0.95 Å across all atoms), indicating that the F64L and S65T 
mutations of EGFP do not effect the overall protein structure but have more subtle 
effects. Secondary structure prediction taking into account hydrogen bond energies 
and main chain dihedral angles [104] showed the secondary structure boundaries 
between wt GFP and EGFP are very similar except for a difference in the predicted 
secondary structure adjacent to the chromophore (Table 4.2). In wt GFP the central 
helix running through the core of the !-barrel is predicted to be a mixture of a 310 
helix and an "-helix, whilst in EGFP the entire helix is predicted to be a 310 helix. 
This would imply the central helix in EGFP is packed better into the core of the !-
barrel, which is potentially a consequence of the F64L mutation. 
 
4.2.1.1 Structural effect of the F64L mutation in EGFP 
Given the high resolution of the structure, the exact placement of side chains can be 
defined with high confidence enhancing the molecular description of EGFP. The 
F64L mutation confers increased folding efficiency to GFP at 37 °C, however, the 
structural consequences of this mutation had not been investigated prior to this study. 
The most obvious effect of the F64L mutation comprises the exchange of the bulky 
phenylalanine side chain for a smaller leucine side chain in the central chromophore 
containing "-helix. The substitution causes the tighter packing of !-strand 2 into the 
core of the !-barrel structure, with the largest deviation being between the C? atom of 
residue V29 (~0.59Å) from wt GFP and EGFP (Fig 4.2). The V29 residue shifts in 
position closer to the chromophore given the additional space made available by loss 
of the bulky F64 side chain. There is also a slight shift of residue W57 away from the 
surface of the protein towards L64 with an RMSD over the side chain atoms of 0.42 Å 
(Fig 4.2). The movement of W57 towards the core of the protein is confirmed by a 
decrease in its solvent accessible surface area in EGFP (12.82 Å2) with respect to wt 
GFP (15.16 Å2) (solvent accessible surface area calculated as per [105]). Another 
noticeable effect was a rotation of the L18 isobutyl side chain away from the edge of 
the !-barrel towards the core of the protein with a 1.82 Å RMSD between the wt GFP 
xx  
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Table 4.2 Secondary structure prediction 
Residuea Secondary structure prediction
b 
EGFP wt GFPc 
K52 Coil Coil 
L53 Coil Coil 
P54 Coil Coil 
V55 Coil Coil 
P56 Coil Coil 
W57 310 helix 310 helix 
P58 310 helix 310 helix 
T59 310 helix 310 helix 
L60 310 helix 310 helix 
V61 310 helix !-helix 
T62 310 helix !-helix 
T63 310 helix !-helix 
L64/F64 Coil !-helix 
Cro Chromophore Chromophore 
V68 Coil Turn 
Q69 310 helix 310 helix 
C70 310 helix 310 helix 
F71 310 helix 310 helix 
S72 Coil Coil 
a Residue numbering as for GFP [106] 
b Secondary structure prediction determined as per [104] 
c wt GFP PDB:1GFL 
Grey shading highlights the residues that comprise the central helix 
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Fig 4.2 Structural effect of the F64L mutation in EGFP. Cartoon representation of EGFP 
(green) superposed on wt GFP (red, pdb:1GFL) shows that the overall structures are very 
similar. Inset: The subtle structural effects of the F64L mutation are a shift in the position of 
W57 towards L64 the closer packing of V29 towards L64, and a rotation of the L18 side 
chain towards the core of the protein.  
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and EGFP L18 side chain atoms. The repositioning of these residues could potentially 
be influencing the folding of EGFP at 37 °C by instigating better packing of the 
hydrophobic residues surrounding the central helix and of the central helix itself. 
 
4.2.1.2 Structural effect of the S65T mutation in EGFP. 
The S65T mutation has proved to be a more general mutation that can be 
transplanted to other green fluorescent protein variants to alter their spectral 
properties (!ex shift from 375 nm to ~480 nm) [69, 72], increase the rate of oxidation 
during chromophore maturation and increase the brightness of the fluorescent proteins 
[72]. Analysis of the local environment around the chromophore can explain the 
molecular basis for the observed spectral properties (Fig 4.3 a). The 2Fo-Fc electron 
density map produced after molecular replacement and structural refinement shows a 
tridental density for E222, which was successfully modeled as two conformations of 
the carboxylate side chain (Fig 4.3 b). Due to the S65T mutation, the hydroxyl group 
of T65 in EGFP occupies a different position to the corresponding hydroxyl group of 
S65 in wt GFP (Chapter 1, Fig 1.12), probably for steric reasons given the additional 
methyl group of T65. Consequently the hydroxyl group of T65 donates a hydrogen 
bond to the backbone carbonyl of V61. This results in the carboxylate of E222 being 
able to occupy two conformations (Fig 3 a, i and ii). 
In both conformations the E222 O"1 is hydrogen bonded to two conserved 
water molecules, whilst in one conformation the E222 O"2 donates a hydrogen bond to 
the hydroxyl group of S205 (Fig 4.3 a i) and in its second conformation it donates a 
hydrogen bond to the hydroxyl group of T65 (Fig 4.3 a ii). In order for E222 to donate 
hydrogen bonds its carboxylate group must be protonated and therefore neutral. This 
allows charge stabilization on the deprotonated tyrosyl group of Y66 by hydrogen-
bonding interactions from H148, T203 and a conserved water molecule coordinated 
between the backbone carbonyl group of N146 and the side chain hydroxyl group of 
S205. The neutral charge on E222 also removes any potential electrostatic clashes 
between the negative charges on E222 and the chromophore, thus allowing the 
chromophore to be deprotonated in the ground state. This explains why EGFP has a 
single excitation peak corresponding to the deprotonated state. 
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Fig 4.3 Effect of the S65T mutation in EGFP. a, Cartoon representation of EGFP (green) with 
the chromophore and surrounding residues shown as sticks. The S65T mutation in EGFP results in 
E222 populating two conformations donating a hydrogen bond (black dotted lines) to i, S205 or ii, 
T65. All residues are shown in stick representation with the central ? -helix in cartoon 
representation, Cro signifies cromophore, W signifies water molecules. b, F0-Fc electron density 
map for the chromophore and residue E222 (sticks) contoured to 1!. The tridental density for E222 
was successfully modeled by two side chain conformations (yellow or green).  
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4.2.2 Analysis of tolerated and non-tolerated single amino acid deletion positions 
in EGFP 
The construction of a triplet nucleotide deletion library within egfp, for 
sampling single amino acid deletion mutations in EGFP, has been described in detail 
in Chapter 3. E.coli BL21 (DE3) Gold cells transformed with plasmids coding for 
EGFP single amino acid deletion variants (EGFP!), were grown on M9 minimal 
media agar plates (Section 2.1.4) supplemented with 100 µg/ml ampicillin and 150 
µM IPTG, at 37 °C for 24 hr. After overnight incubation colonies presenting a green 
colour phenotype were noted and incubated for a further 24 hrs at 25 °C, followed by 
incubation at 4 °C for up to 2 weeks. 
After incubation for 2 weeks at 4 °C colonies presenting a green colour 
phenotype when illuminated on a UV-transilluminator were selected for DNA 
sequence analysis of the EGFP! genes. From DNA sequence analysis of the EGFP! 
gene from 89 colonies that displayed green fluorescence, 42 unique variants were 
observed (Table 4.3). Of the 66 colonies that did not fluoresce, DNA sequence 
analysis revealed 45 unique variants (Table 4.4). Analysis of the single amino acid 
deletion positions within the secondary (Fig 4.4) and tertiary structure (Fig 4.5) 
revealed a clear difference in the clustering of mutations giving rise to fluorescent and 
non-fluorescent variants.  
EGFP is comprised of 43% loops, 11% "-helices and 46% #-strands, therefore 
if all ordered secondary structures and loops comprising EGFP were equally tolerant 
to single amino acid deletion the proportion of variants identified in these structures 
should be the same. However, the majority of the mutations giving rise to fluorescent 
variants were found in the connecting loops (60%), as expected, with the rest equally 
distributed across "-helices (19%) and the termini of #-strands (21%) (Fig 4.4 a). This 
indicates that the loops in EGFP are more tolerant to single amino acid deletion whilst 
#-strands are less tolerant. There are also 2-fold more tolerated deletions from "-
helices than would be expected. In particular there are a high proportion of amino acid 
deletions tolerated C-terminally of #-strands 7 and 11, and in the loops connecting #-
strands 7, 8, 9 and 10, all of which are adjacent to one another (Fig 4.4 a) in the 
tertiary structure.  
Of the 45 unique mutations giving rise to non-fluorescent variants 71% were 
clustered to the middle of #-strands, 18% were located in loops and 11% in "-helices 
xxxxxxxxx  
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Table 4.3 Tolerated TNDs in egfp and subsequent amino acid mutations 
Nucleotide deletiona Amino acid Mutationb Frequency Secondary structurec 
3GTG AGC10 V1! S2G 2 N-terminus 
9AAG GGC16 K3N G4" 4 H1 
12GGC GAG19 G4" 8 H1 
12GGC GAG19 E5" 2 H1 
18GAG22 E6" 1 H1 
27ACC GGG34 T9" G10R 6 H1 
27ACC GGG34 G10" 2 Loop H1-S1 
36GTG40 V12" 1 S1 
75CAC79 H25! 2 S2 
114ACC118 T38" 3 Loop S2-S3 
144TGC148 C48" 1 S3 
147ACC151 T50" 1 Loop S3-H2 
150ACC GGC157 T50" G51S 2 Loop S3-H2 
159CTG CCC166 L53" 1 Loop S3-H2 
225CCC GAC232 P75" D76H 2 H3 
225GAC229 D76" 2 H3 
237AAG241 K79" 1 H3 
396GAG GAC403 E132D D133! 1 Loop S6-S7 
411GGG415 G138" 2 Loop S6-S7 
459ATG GCC466 M153! A154T 2 S7 
462GCC GAC469 A154" 5 S7 
465GAC469 D155! 4 S7 
474AAG AAC481 K158" 1 Loop S7-S8 
480GGC484 G160" 1 S8 
513ATC GAG520 I171M E172! 3 Loop S8-S9 
522GGC526 G174" 2 Loop S8-S9 
525AGC529 S175" 1 Loop S8-S9 
567GGC GAC574 G189" 1 Loop S9-S10 
570GAC GGC577  D190" 1 Loop S9-S10 
576CCC GTG583 P192! V193L 3 Loop S9-S10 
588CCC592 P196! 1 Loop S9-S10 
591GAC595 D197! 1 Loop S9-S10 
594AAC598 N198 ! 1 Loop S9-S10 
633CCC AAC640 P211" N212H 3 Loop S10-S11 
678GCC GCC GGG687 A226" A227" 1 S11 
681GCC GGG688 A227" 5 S11 
681GCC GGG688 G228" 2 C-terminus 
690ACT CTC697 L231! 1 C-terminus 
699ATG GAC706 M233" D234N 2 C-terminus 
702GAC GAG709 D234E E235! 2 C-terminus 
705GAG709 E235! 1 C-terminus 
711TAC715 Y237! 1 C-terminus 
a Numbers refer to gene sequence numbering for egfp developed by [107] 
b " after a residue number signifies that residue has been deleted, protein numbering as per 
GFP [106] 
c Secondary structure elements as defined in Fig 4.4, helices (H), strands (S). 
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Table 4.4 Non-tolerated TNDs in egfp and subsequent amino acid mutations 
Nucleotide deletion Amino acid Mutation Frequency Secondary structure 
9AAG GGC16 K3! G4S 1 H1 
60GGC GAC67 G20! 3 S1 
81TTC AGC88 F27! S28C 1 S2 
90TCC GGC97 S30! G31C 3 S2 
99GGC GAG106 E34! 2 S2 
105GGC GAT112 D36! 1 S2 
135AAG TTC142 K45! F46I 1 S3 
168CCC TGG175 W57! 1 H2 
171TGG174 W57! 3 H2 
189ACC CTG196 L64! 1 Loop H2-H3 
192CTG ACC199 L64! T65P 2 Loop H2-H3/Cro 
198TAC GGC205 Y66! G67C 1 Cro 
216AGC220 S72! 1 H3 
219CGC223 R73! 1 Loop H3-H4 
261GCC265 A87! 2 H5 
279GTC CAG286 V93! Q94E 1 S4 
282CAG286 Q94! 1 S4 
300TTC AAG307 F100! K101STOP 1 S4 
309GAC GGC316 D103! 1 Loop S4-S5 
321AAG ACC328 K107! 1 S5 
330GCC GAG337 A110! 3 S5 
330GCC GAG337 E111! 1 S5 
360GTG364 V120! 3 S6 
360GTG AAC367 V120! N121D 1 S6 
381GGC ATC388 G127! I128V 1 S6 
390TTC AAG397 F130! K131STOP 1 Loop S6-S7 
411CTG415 L137! 1 Loop S6-S7 
435TAC439 Y145! 1 Loop S6-S7 
444CAC448 H148! 3 S7 
450GTC TAT457 V150! Y151D 3 S7 
450GTC TAT457 Y151! 2 S7 
486AAG490 K162! 1 S8 
507CAC511 H169! 3 S8 
510AAC ATC516 N170! 1 S8 
540GAC544 D180! 1 S9 
546TAC CAG553 Y182STOP Q183! 2 S9 
561CCC565 P187! 1 S9 
600TAC CTG607 Y200STOP L201! 1 S10 
609ACC CAG616 Q204! 1 S10 
615TCC GCC622 A206! 1 S10 
618GCC CTG625 L207! 1 S10 
621CTG AGC628 L207! S208R 1 S10 
654ATG GTC661 M218I V219! 1 S11 
660CTG664 L220! 1 S11 
663CTG667 L221! 1 S11 
a Numbers refer to gene sequence numbering for egfp developed by [107] 
b ! after a residue number signifies that residue has been deleted, protein numbering as per 
GFP [106] 
c Secondary structure elements as defined in Fig 4.4, helices (H), strands (S). 
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Fig 4.4 Mapping deletion mutations with respect to EGFP secondary structure. The 
secondary structure arrangement and overall topology of EGFP shows the arrangement of !-
strands (green), "-helices (red) and loops (black) a. Tolerated single amino acid deletions are 
indicated by blue triangles with an area particularly tolerant to deletion mutations surrounded 
by a dotted line. b. Non-Tolerated amino acid deletions are indicated by red triangles. Black 
tringles show the position of premature stop codons introduced due to out of frame triplet 
nucleotide deletions. 
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Fig 4.5. Map of single amino acid deletions onto the tertiary structure of EGFP. Cartoon 
representation of EGFP (green) with tolerated deletions indicated by blue spheres (top) and 
non-tolerated deletions (bottom) indicated by red spheres.  
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(Fig 4.4 b). Deletion mutations were observed in four variants in the central !-helix 
containing the residues that form the chromophore (T65, Y66 and G67), resulting in 
non-fluorescent variants. 
Due to the nature with which MuDel inserts itself randomly throughout a 
target gene and subsequent removal, by MlyI restriction digestion, the triplet 
nucleotide deletion (TND) is not always in frame. This means that a TND can give 
rise to the deletion of an amino acid and cause a point mutation (Table 4.3 and 4.3). 
Out of frame TND can therefore give rise to a stop codon being introduced 
prematurely into egfp depending on the sequence surrounding the TND site (Table 
4.4). From the 45 non-tolerated deletions analysed four were due to the introduction 
of premature stop codons and production of truncated protein (Table 4.4).  
Loop regions connecting secondary structures are usually the most tolerant 
structures to mutagenesis as amino acid deletions are normally accommodated by 
loop shortening (Chapter 1, Fig 1.1). However, deletions in loops were also found to 
have a negative impact on EGFP (Table 4.4). L137 and Y145 both reside in the 
longest loop in EGFP yet their deletion removed the ability of EGFP to confer a 
fluorescence phenotype on E. coli. However, removal of D133 or G138 in the same 
loop did not result in an inactive protein (Table 4.3). Deletion of D103, also situated 
in a loop connecting "-strands 4 and 5, was detrimental to fluorescence. 
One variant identified had two amino acids deleted (A226 and A227) from the 
C-terminal end of the last "-strand of EGFP, whilst maintaining fluorescence. This 
two amino acid deletion could have been produced from a double transposon insertion 
event or by MlyI restriction endonuclease non-specifically removing additional 
nucleotides upon MuDel removal. The latter is more probable given that extended 
incubation with MlyI or if the enzyme is not fresh can result in star activity and non-
specific DNA cleavage.  
Observing the tolerated and non-tolerated deletion positions in the tertiary 
structure of EGFP shows the clustering of tolerated deletions to the two ends of the "-
barrel, primarily in loops connecting secondary structures (Fig 4.5) 
 
4.2.3 Fluorescence properties of active EGFP deletion variants  
The deletion variants that conferred cellular fluorescence were analysed 
further to assess if mutations influence the fluorescence properties of EGFP. Variants 
were expressed in E.coli BL21-Gold (DE3) cells (Table 2.1) overnight at 25 °C in M9 
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minimal media supplemented with 100 µg/ml ampicillin and 150 µM IPTG. 
Excitation and emission spectra were measured by whole cell fluorescence analysis 
(Section 2.6.1.1) of culture samples.  
All cultures were diluted to an O.D.600 = 0.1 in TNG (50 mM Tris-HCl, pH 
8.0, 150 mM NaCl, 10% (v/v) glycerol) buffer so that any differences in fluorescence 
intensity between the variants would be a reflection of expression levels or increased 
brightness (product of extinction coefficient and quantum yield) and not cell density. 
All of the variants had similar excitation and emission spectra to EGFP, ~488 nm and 
~510 nm respectively, but with differing intensities (Fig 4.6 and Table 4.5). In 
particular two of the single amino acid deletion variants, EGFPD190! and EGFPA227! 
exhibited increased fluorescence (~1.5 and ~1.8 fold respectively) with respect to 
EGFP (Fig 4.6 and Table 4.5). EGFPA227! was also identified five times during library 
screening as colonies expressing this variant observed on a UV transilluminator, had a 
brighter green colour phenotype with respect to other variants. 
Another variant, EGFPG4!, was identified 8 times during the library screen due 
to colonies expressing this variant having a significantly brighter green colour 
phenotype, when illuminated with a UV-transilluminator, than other variants (Section 
4.2.4, Fig 4.9 b). The deleted residue, G4, is distant from the chromophore and only a 
couple of residues into the first "-helix of EGFP (Fig 4.7). Further analysis and 
characterization of this variant has been performed in Sections 4.2.4 onwards. 
A fourth variant, EGFPK158!, was selected for further study because the 
deletion site is located in a distorted type-I #-turn between two antiparellel #-strands 
(S7 and S8) (Fig 4.7). Despite the deletion from this secondary structure EGFPK158! 
maintained similar levels of fluorescence with respect to EGFP (Fig 4.6 and Table 
4.4). The three variants identified as having improved fluorescence properties 
(EGFPG4!, EGFPD190! and EGFPA227!) and variant EGFPK158! were selected for more 
detailed expression studies and further characterization. 
 
4.2.4 Protein expression studies 
Protein expression studies were performed on EGFP and the selected single 
amino acid deletion variants to determine if the mutations had affected the levels of 
expressed protein. The four variants selected were EGFPG4!, EGFPD190!, EGFPK158! 
and EGFPA227!, with EGFP included as a control. These four variants all have single 
amino acid deletions situated towards the bottom of the #-barrel (Fig 4.7).   
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Fig 4.6 Excitation and emission spectra of EGFP and selected EGFP! variants. 
Excitation (left panel) and emission (right panel) spectra were measured by whole cell 
fluorescence analysis of cultures expressing EGFP and EGFP! variants. Cultures were 
normalized by cell density so that any differences in fluorescence intensity would be 
attributed to differences in expression levels or altered spectral properties. 
 
 
Table 4.5 Fluorescent properties of EGFP and EGFP! variants 
Mutation "ex (nm) "em (nm) 
Fold change in 
fluorescencea 
EGFP 488 512 1.0 
K3N G4# 486 511 0.4 
G4# 487 511 0.9 
E6# 487 512 1.1 
T9# G10R 486 511 0.7 
T38# 488 511 0.1 
C48# 488 511 0.2 
T50# G51S 488 511 0.4 
L53# 489 509 0.3 
P75# D76H 487 512 0.2 
D76# 487 512 1.0 
E132# 488 510 0.2 
A154# 487 511 0.6 
K158# 486 511 0.8 
G160# 487 511 0.8 
G174# 487 511 0.2 
S175# 486 511 0.4 
G189# 488 510 0.3 
D190# 487 511 1.4 
P211# N212H 488 511 0.2 
A226# A227# 487 511 1.4 
A227# 487 511 1.8 
G228# 487 510 0.2 
M233# D234N 486 511 0.5 
a Fold difference in fluorescence determined with respect to EGFP fluorescence 
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Fig 4.7. Selected amino acid deletion positions in the tertiary structure of EGFP. Cartoon 
representation of EGFP (green) with amino acid deletion positions of selected variants 
indicated by blue spheres. Inset, Residue K158 is located in a tight !-turn (white cartoon) 
comprised of just 4 residues (stick representation of backbone atoms only). 
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Expression studies were performed using E. coli BL21-Gold (DE3) cells in 
LB broth supplemented with 100 µg/ml ampicillin, induced with 150 µM IPTG, at 
two different temperatures (25 °C or 37 °C). As temperature can affect folding 
efficiency, sampling two different temperatures would allow production levels of 
functional protein to be assessed with respect to EGFP, which was constructed to 
generate more fluorescent protein at 37 °C. 
Whole cell fluorescence analysis (Section 2.6.1.1) was performed on cultures 
grown in triplicate for 18 hr at 37 °C or 28 hr at 25 °C. Mean excitation and emission 
spectra for each variant, at both temperatures, indicated that all the deletion variants 
exhibited increased fluorescence with respect to EGFP (Fig 4.8). With respect to 
EGFP, at 37 °C EGFPK158! fluorescence was only marginally higher (~1.1 fold), 
EGFPD190! and EGFPG4! fluorescence was  ~1.4 or ~1.7 fold higher respectively. 
EGFPA227! was the best performer with ~ 2.6 fold greater fluorescence intensity than 
EGFP (Fig 4.8 a). 
At 25 °C cultures producing EGFPK158! and EGFPD190! had similar 
fluorescence intensities to cultures grown at 37 °C with increased fluorescence 
intensity of ~1.2-fold with respect to EGFP (Fig 4.8 b). In contrast, the increase in 
fluorescence intensity for EGFPA227! seen at 37°C was reduced at 25 °C to ~1.3-fold 
with respect to EGFP (Fig 4.8 b). This 2-fold decrease in fluorescence intensity 
relative to EGFP at the different temperatures could be a consequence of reduced 
protein expression levels at lower temperatures or the increase in EGFP folding 
efficiency. EGFPG4! however exhibited almost a 4-fold increase in fluorescence 
intensity compared to EGFP when grown at 25 °C (Fig 4.8 b). 
To investigate the temperature relationship between protein production and 
fluorescence for EGFPG4! SDS-PAGE and western blot analysis was performed on 
whole cell, soluble and insoluble fractions from culture grown at 37°C (Fig 4.9 a). 
Cultures expressing the four different variants were harvested by centrifugation 
(Section 2.5.2) and the cell pellets resuspended to an apparent O.D.600 = 10 to 
normalize the number of cells across all the samples. Any observed increase in 
protein band density would therefore be a reflection of protein quantity and not the 
number of cells used to prepare the sample.   
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Fig 4.8. Fluorescence intensity of whole cell samples. Excitation (left panel) and emission 
(right panel) spectra measured by whole cell fluorescence analysis using cultures expressing 
EGFP and selected EGFP! variants (as annotated on spectra) at a, 37 °C or b, 25 °C  
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Fig 4.9 Analysis of cellular production of EGFP deletion variants. a. SDS-PAGE (top panels) and western blot (bottom panels) analysis of whole 
cell, soluble and insoluble fractions from a 37 °C expression of EGFP and EGFP! variants (red arrow) as indicated in the figure. Antibodies specific 
for EGFP were used for western blot analysis. b. Cellular fluorescence of colonies expressing EGFP, EGFP single and double deletion variants, EYFP 
and EYFPG4! streaked out on LB agar plates supplemented 150 µM IPTG illuminated with a UV transilluminator. 
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The SDS-PAGE analysis showed that EGFPG4! was produced to a much higher 
level than EGFP and the other variants, indicated by greater protein band density on 
the gel for the whole cell sample (Fig 4.9 a). The majority of the protein appears to be 
insoluble at 37 °C as can be seen in the gel for the insoluble fraction (Fig 4.9 a) and 
explains the decreased fluorescence observed in cultures expressing G4! at 37 °C.  
The SDS-PAGE analysis also showed that EGFP and EGFPA227! were 
produced to similar levels, indicated by similar protein band density on the gel for the 
whole cell sample (Fig 4.9 a). However, the SDS-PAGE and Western blot analysis of 
soluble and insoluble fractions for EGFP and EGFPA227! showed that there was more 
EGFPA227! in the soluble fraction and less in the insoluble fraction with respect to 
EGFP (Fig 4.9 a). Although the EGFPK158! deletion is located in a tight "-turn in the 
tertiary structure of EGFP (Fig 4.7) it didn’t appear, from the expression studies, to 
benefit protein production (Fig 4.9 a) or fluorescence intensity (Fig 4.8), therefore no 
further analysis was carried out on this variant. 
Given that EGFPG4! gets produced to such high levels, based on increased band 
intensity (Fig 4.9 a) on the SDS-PAGE gel, temperatures may be influencing the 
amount of correctly folded soluble G4! and would explain the four fold increase in 
fluorescence with respect to EGFP seen in cultures grown at 25 °C. However, SDS-
PAGE and Western blot analysis of culture samples expressing EGFPG4! at 25 °C 
would be required to confirm this. 
As mentioned previously (see 4.2.4) colonies grown on LB agar expressing 
EGFPG4! had a much brighter green colour phenotype than any other variant (Fig 4.9 
b). This contradicts the previous findings that expression of EGFPG4! in liquid cultures 
at 37 °C produced ~1.7-fold increase in fluorescence with respect to EGFP. 
To investigate if the property of increased cellular fluorescence observed for 
EGFPG4! is a transferrable trait, double amino acid deletion mutants EGFPG4!D190! and 
EGFPG4!A227! were constructed (Section 2.4.2). The G4! mutation was also engineered 
into enhanced yellow fluorescent protein (EYFP) to assess if the mutation was EGFP 
specific or transferrable to other colour variant fluorescent proteins (Section 2.4.1). 
E.coli BL21-Gold (DE3) cells were transformed with relevant plasmids 
containing the genes for different deletion variants and were grown on LB agar plates 
overnight at 37 °C. Single colonies were selected and resuspended in 200 µl of LB 
broth and incubated in a shaking incubator for 2 hrs. The cultures were then streaked 
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onto LB agar plates supplemented 150 µM IPTG and incubated overnight at 37 °C. 
Coloured phenotypes were noted after illumination of the streaked out cultures with a 
UV-transilluminator (Fig 4.9 b).  
All colonies producing variants carrying the G4! mutation resulted in a 
brighter colour phenotype than variants without the mutation. Although the double 
amino acid deletion variants are not as fluorescent as EGFPG4! variant they are more 
fluorescent than their single amino acid deletion counterparts (Fig 4.9 b). The G4! 
mutation is also transferrable to EYFP, increasing the intensity of the cellular colour 
phenotype (Fig 4.9 b). The transferability of the G4! mutation to other fluorescent 
proteins highlights this mutation as being beneficial. In order to determine how the 
mutations are affecting EGFP fluorescence, EGFP, EGFPG4!, EGFPD190! and 
EGFPA227! were expressed (Section 2.5.3) and purified (Section 2.5.8) for further 
characterization. 
 
4.2.5 Fluorescent characterisation of EGFP and EGFP! variants. 
To determine if the increased fluorescence of EGFPG4!, EGFPD190! and 
EGFPA227! with respect to EGFP was due to a difference in the production level of 
soluble protein or if the proteins fluorescent characteristics had been altered, a detailed 
characterization of their fluorescence properties was performed. All of the deletion 
variants have similar spectral characteristics to EGFP with !em and !ex almost identical 
(Table 4.6). 
Minor changes in extinction coefficient or quantum yield were observed, thus, 
the brightness of the three variants are comparable to that of EGFP (Table 4.6). The 
fluorescence lifetimes for the deletion variants are also comparable to that of EGFP 
indicating the mutations have not substantially effected the surrounding environment 
of the chromophore (Table 4.6, Fig 4.10). This confirmed that the effect of altered 
fluorescence intensity observed in the expression studies is due to increased protein 
production levels and solubility due to efficient folding and not due to altered spectral 
characteristics.  
xx  
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Table 4.6. Spectral characteristics of EGFP and EGFP! variants 
Mutation ! ex (nm)
 a ! em (nm)
 a " (M
-1
cm
-1
)b #c 
Brightnessd 
(M
-1
cm
-1
) 
$ (ns)e 
EGFP 488 511 55000 0.60 33000 2.54±0.04 
G4 487 512 53070 0.59 31300 2.64±0.05 
D190 486 510 53430 0.58 30990 2.56±0.05 
A227 487 511 51850 0.61 31630 2.44±0.04 
a !
 ex and ! em determined from mean fluorescence spectra (Fig 4.8) 
b Extinction coefficient determined from single absorbance measurement 
c Quantum yield determined from integrated fluorescence emission against a fluorescein standard 
d Brightness = extinction coefficient x quantum yield 
e Fluorescence lifetimes are mean values with errors calculated from the standard deviation of 3 
measurements 
 
 
 
 
Table 4.7 Size exclusion chromatography analysis 
Mutation Concentration (µM) 
Elution 
volume 
(ml)a 
Calculated Mw 
(Da)b 
Average 
Mw 
(Da)c 
Estimated 
Mw (Da)d 
EGFP 
10 11.50 24600 
25600 26941 
25 11.46 25100 
50 11.42 25800 
100 11.35 26800 
      
G4 
10 11.50 24600 
25700 26884 
25 11.45 25300 
50 11.42 25800 
100 11.34 27000 
      
D190 
10 11.59 23300 
24200 26826 
25 11.56 23800 
50 11.53 24300 
100 11.45 25200 
      
A227 
10 11.60 23300 
23400 26870 
25 11.63 22900 
50 11.59 23500 
100 11.57 23700 
aElution volumes determined from peak absorbance at 488 nm (Fig 4.11) 
bMolecular weights calculated using standard curve (Appendix A) 
cAverage calculated molecular weights over the different concentrations 
dEstimated molecular weight from primary sequence  
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Fig 4.10. Fluorescence lifetime analysis of EGFP deletion variants. Photon counts (black 
dots) measured over 20 ns are fit to single exponential decay functions (green line) with the 
instrument response functions (IRF) (red dots). Residuals for the single exponential decay fits 
to the data are plotted below each of the decay curves for EGFP and EGFP! variants as 
indicated in the figure. 
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4.2.6 Biophysical characterization of EGFP and EGFP! variants 
4.2.6.1 Analytical size exclusion chromatography 
The propensity for fluorescent proteins (FPs) to dimerize is an unwanted 
attribute if they are to be used in vivo as fusion partners, as dimerization can alter 
spectral properties [62, 108], could promote protein aggregation [109], affect results 
from protein-protein interaction experiments [63] and hinder their use as Forster 
resonance energy transfer (FRET) partners [110]. With this in mind it was important to 
investigate the oligomeric states of EGFP and the EGFP! variants. This was 
performed by analytical size exclusion chromatography (SEC) using a SuperdexTM 75 
gel filtration column (Section 2.6.2.1). A standard curve for the relationship between 
molecular weight and elution volume from the column was determined using BioRad 
gel filtration standards (Appendix A), so that the elution volume for EGFP and EGFP! 
variants, at different concentrations, could be related to the molecular weight of that 
species under native conditions. 
EGFP and EGFP! samples were applied to the column at 10, 25, 50 or 100 µM 
concentrations. The elution of proteins from the column was monitored by absorbance 
at 488 nm and the elution volumes (Table 4.7) determined from the absorbance peak 
(Fig 4.11). EGFP, EGFPG4! and EGFPD190! all exhibited a decrease in elution volume 
(~0.14 - 0.16 ml), with increasing protein concentration (from 10 – 100 µM) (Table 
4.7), relating to an increase in calculated molecular weight by ~10% (~24.5 - ~27 
kDa).  
The change in elution volume with increasing protein concentration suggests 
there may be a weak tendency for EGFP, EGFPG4! and EGFPD190! to dimerize. If there 
was a strong tendency for EGFP or the EGFP! variants to dimerize an elution volume 
of ~10.2 ml would be expected. The shape of the elution profiles for EGFP, EGFPG4! 
and EGFPD190! exhibit slight asymmetry indicating that any dimer interactions possibly 
taking place have rapid association/dissociation rate constants, as slow rates would 
present as two defined elution peaks in the elution profile.  
EGFPA227!, in contrast to EGFP and the other deletion variants, showed almost 
no change in elution volume (Table 4.7) with increasing protein concentration. The 
elution volume for EGFPA227! (~11.6 ml) inferred a calculated molecular weight of 
~23.4 kDa (Table 4.7), almost 3.4 kDa smaller than the theoretical molecular weight of 
26.8 kDa calculated from its amino acid sequence. The elution volumes for EGFPD190!   
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Fig 4.11 Size exclusion chromatography of EGFP or EGFP! variants. Samples of variants 
(as indicated in figure) were applied to a SuperdexTM 75 gel filtration column and the elution of 
the protein samples monitored by absorbance at 488 nm. Protein concentrations of 10 µM 
(solid black line), 25 µM (long dashed line), 50 µM (medium dashed line) or 100 µM (short 
dashed line) were applied to the column. 
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(~11.60 - ~11.45 ml) also equate to smaller calculated molecular weights (~23.3 - 
~25.2 kDa) than the theoretical molecular weight calculated from their primary 
sequence (~26.8 kDa). Although estimated molecular weights can be calculated from 
the elution volume, analytical SEC is actually a measure of hydrodynamic volume. The 
difference between the theoretical and calculated molecular weights could therefore be 
a reflection of EGFPD190! and EGFPA227! being more compact than EGFP or EGFPG4!. 
 
4.2.6.2 Guanidinium chloride induced equilibrium unfolding 
To assess the deletion mutations effect on EGFP stability, guanidinium chloride 
(GdmCl) induced equilibrium unfolding experiments were performed (Fig 4.12). The 
chromophore of EGFP is very sensitive to its environment with protein unfolding and 
exposure to aqueous solvent significantly reducing fluorescence intensity. Thus, the 
chromophore is a sensitive probe to monitor protein unfolding at different 
concentrations of GdmCl over a wide range of equilibration times (2.5 – 250 hr).  
Unlike usual GdmCl denaturation studies of small monomeric proteins, which 
reach equilibrium quickly, EGFP and EGFP! variants take up to two weeks to 
approach equilibrium (Fig 4.12 a-e). Although unusual, this phenomenon has been 
seen in studies of many fluorescent proteins [71, 111-113]. The very slow kinetics to 
equilibrium unfolding in GdmCl is thought to be attributed to high folding/unfolding 
energy barriers 
It therefore must be emphasized that any analysis of the GdmCl unfolding data 
does not assume that the system has reached full equilibrium but is approaching 
equilibrium. Due to a limited number of data points above concentrations of 3.5 M 
GdmCl it was not possible to fit the measured unfolding data up to 22 hrs of incubation 
to either a two-state or three-state model. Therefore the unfolding data for EGFP and 
EGFP! acquired after 2.5, 5, 22, 48, 120 and 250 hr incubations in GdmCl were fit to 
an asymmetric five-parameter Equation (GraphPad Prism) to estimate apparent 
[GdmCl] at which 50% of the protein sample is in the native state and 50% is in the 
denatured state ([GdmCl]50%app]) (Fig 4.12 a-d). 
The [GdmCl]50%app values were plot against incubation time to estimate 
equilibrium kinetics (Fig 4.12 e). After fitting the data to a single exponential decay 
(Section 2.6.2.4, Equation 17) it was apparent that the GdmCl unfolding of the EGFP 
and EGFP! variants had approached equilibrium (Fig 4.12 e) by 250 hrs.  
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Fig 4.12 Guanidinium chloride induced equilibrium unfolding and equilibrium kinetics. 
Fluorescence emission at 520 nm after excitation at 480 nm was monitored for a, EGFP, b, 
G4!, c, D190! and d, A227! over 250 hrs (as indicated in the figures) and data were fit to an 
asymmetric 5 parameter Equation (GraphPad Prism). e, Apparent [GdmCl]50% values (the 
[GdmCl] at which 50% of the samples are in the native and 50% in the denatured states) were 
plot against time and fit to single exponential decay curves to assure equilibrium had been 
reached before calculating free energies of denaturation (!!!!!!!! ).  
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The unfolding data for EGFP and EGFP! variants after 250 hrs incubation in 
GdmCl were further analysed by a two-state unfolding model (Fig 4.13 a) (Section 
2.6.2.2). Previous equilibrium unfolding studies of fluorescent proteins has indicated 
that an unfolding intermediate exists [113, 114] and the equilibrium unfolding data for 
GFPs is best fit to a three-state model. Despite this, a three-state model did not 
converge on the data obtained here possibly due to an intermediate state being 
indistinguishable from the denatured state by monitoring fluorescence under the 
conditions used (pH 8.0 and 37°C) for denaturation. Therefore given that the data 
collected here did fit well to a two state model (R2>0.98) (Fig 4.13 a), thermodynamic 
parameters determined from this fit could be used for a direct comparison between 
samples. 
Given that there is a linear relationship between !!!!!!  and [GdmCl] (Fig 4.13 
b) the free energy of denaturation in water !!!!!!!!  and the dependence of !!!!!!  on 
[GdmCl] (m-value) could be inferred from Equation 16 (Section 2.6.2.2) (Table 4.5). 
The free energy of denaturation calculated for EGFP (5.28 kcal mol-1) agrees closely to 
previous equilibrium unfolding experiments performed (5.16 kcal mol-1) [111]. The 
G4! mutation conferred increased stability to EGFP with a !!!!!!!!  of 6.46 kcal mol-1 
even though the [GdmCl]50%app is marginally lower (~ 0.18 M) (Table 4.8). 
Although the [GdmCl]50%app for EGFPG4! is lower than EGFP the !!!!!!  
dependency on [GdmCl] (m-value) is greater. The m-value for EGFP was calculated to 
be 1.95 kcal mol-1 M-1 whilst for EGFPG4! the m-value is 2.61 kcal mol-1 M-1. This 
results in an increased !!!!!!!!  for EGFPG4!. There are several possible causes for this: 
1, the denatured protein is less compact and has less structure than that of denatured 
EGFP or 2, an increase in m-value could reflect a change in the degree to which an 
intermediate state is populated during the unfolding. The A227! mutation also 
increased overall stability of EGFP from 5.28 kcal mol-1 to 5.81 kcal mol-1. 
Although the D190! mutation appears to decrease the [GdmCl]50%app quite 
substantially (~ 0.52 M) the increased cooperativity of unfolding (m-value of 2.23 kcal 
mol-1 M-1) with respect to EGFP results in this variant having the same overall stability 
as EGFP (within error) (Table 4.8).  
xxxxxx  
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Fig 4.13. Equilibrium unfolding and linear dependence of !G on [GdmCl]. a, Equilibrium 
unfolding data, after 250 hr incubation, were fit to a 2 state model taking into account sloping 
baselines inherent to spectroscopic measurements of protein samples in GdmCl. b, The linear 
dependence of !G on [GdmCl] (m-value) was used to calculate free energies of denaturation 
(!!!!!!!! ). 
 
 
 
 
 
 
 
 
Table 4.8. Equilibrium unfolding, unfolding and refolding kinetic parameters and 
melting temperature. 
Variant [GdmCl]50% (M)a 
!!!!!!!!  
(kcal mol-1)b 
m-value 
(kcal mol-1 M-1)c 
 
kU (min-1)d 
kfast 
(10-2 s-1)e 
kslow 
(10-2 s-1)e 
Tm 
(°C) 
EGFP 2.74 5.28±0.36 1.95±0.13 2.09±0.00 4.32±0.08 1.00±0.02 84 
G4! 2.56 6.46±0.41 2.61±0.15 2.15±0.01 3.78±0.25 1.15±0.05 83 
D190! 2.22 5.10±0.57 2.32±0.23 1.81±0.02 2.96±0.06 0.92±0.17 82 
A227! 2.68 5.81±0.37 2.23±0.13 4.59±0.01 3.93±0.15 0.89±0.04 84 
aConcentration of GdmCl at which 50% of the protein sample is in the native and denatured 
state, determined from a 2 state model (Section 2.6.2.2). 
bFree energy of denaturation (!!!!!! ! !!!!!!!! !!!!"#$%!! 
cMeasure of dependence of !G on denaturant concentration determined from the slope of the 
plots in Fig 4.13 b. 
d Rate constant from single exponential fit of unfolding progress curves (Fig 4.14 a) 
e Rate constants from two exponential fits of refolding progress curves (Fig 4.14 b) 
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However, great care must be taken when interpreting these results. The 
presence of an unfolding intermediate and the degree to which it is populated can result 
in a decreased m-value from data analysis with a 2-state model, underestimating the 
calculated !!!!!!!!  value. Comparison of the [GdmCl]50% values may be a more reliable 
measure of stability in this case. 
 
4.2.6.3 Unfolding and refolding kinetics. 
None of the single amino acid deletion mutations have reduced overall stability of 
EGFP (Table 4.8). In the case of G4! and A227! mutation, stability has been 
improved. To complement the equilibrium studies, the rate at which deletion mutation 
variants unfold and refold was investigated. 
Fluorescence was monitored for EGFP and the three deletion variants after 
rapid dilution of native protein into 6.8 M GdmCl (unfolding) or fully denatured 
protein into fresh buffer (refolding) (Fig 4.14). The data was fit to a single or double 
exponential function for unfolding and refolding experiments respectively (Section 
2.6.2.4, Equations 17 and 18 respectively) (Fig 4.14).  
Unfolding kinetics for fluorescent proteins are very slow (min – hr) in 
comparison to other small globular proteins, therefore it is possible to accurately 
measure and follow the unfolding of fluorescent proteins after rapid dilution into 
GdmCl. The unfolding rates of EGFP and EGFPG4! were similar (~2 min-1) (Table 4.8) 
and agreed with previous findings that EGFP becomes fully unfolded after ~2 mins in 
6.2 - 6.5M GdmCl [111]. The unfolding rate for EGFPD190! was only marginally 
decreased with respect to EGFP, however, the unfolding rate of A227! was ~4.5 min-1, 
2 fold higher than that of EGFP.  
Refolding kinetics of denatured EGFP or EGFP! variants was performed by 
rapid dilution into fresh TNG buffer to a final concentration of 100 µM and 0.68 M 
GdmCl. There was a marked difference in total amount of fluorescence recovered (Fig 
4.14). Both EGFP and EGFPD190! were similar, recovering 77% and 79%, respectively, 
of their initial fluorescence. EGFPA227! was slightly higher, with 85% of its initial 
fluorescence recovered. However, EGFPG4! recovered up to 100% of its initial 
fluorescence before denaturation, suggesting that the full population of protein 
molecules regained their native structure.  
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Fig 4.14. Unfolding and refolding kinetics of EGFP and the deletion variants. a, Unfolding 
kinetics. Rate constants were determined from a single exponential decay function to 
fluorescence data (excitation at 488 nm, emission at 510 nm), monitored over time, after 
dilution of EGFP or EGFP! variants (as indicated in figure) into 6.8M GdmCl. b, Refolding 
kinetics. Rate constants were determined from double exponential functions fit to fluorescence 
data monitored over time after dilution of fully unfolded EGFP or EGFP! variants into fresh 
TNG buffer. Residuals for curves fit to the data are shown below their respective graph 
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The refolding kinetics of EGFP, EGFPG4!, EGFPD190! and EGFPA227! show an 
initial fast phase with rate constants (kfast) of ~4.3 x 10-2 s-1, ~3.7 x 10-2 s-1, ~2.9 x 10-2 s-
1 and 3.9 x 10-2 s-1 respectively (Table 4.8). The fast initial phase was followed by a 
slow refolding phase with rate constants (kslow) of ~1 x 10-2 s-1, ~1.1 x 10-2 s-1, ~0.9 x 
10-2 s-1 and ~0.9 x 10-2 s-1 respectively (Table 4.8). Cis/trans isomerization has been 
shown to be a rate-limiting step in protein folding [115, 116] and is thought to be the 
reason for the slow refolding phase. 
From the refolding kinetics generated here, it appears that all the deletion 
mutations have decreased the fast rate constants (kfast). The G4! mutation appears to 
increase the cis/trans isomerization rate as is evident from an increase in the slow rate 
constant by up to 20% with respect to EGFP (Table 4.8), although this is still only a 
minor change.  
 
4.2.6.4 Thermal denaturation 
Temperature plays a major role during protein folding with lower temperatures 
promoting correctly folded proteins; given that !G is related to entropic considerations 
and temperature. Many fluorescent proteins have been shown to be thermosensitive 
(Section 4.2.4) [117, 118], with respect to folding, quite often resulting in misfolding 
and aggregation above temperatures of ~ 37°C. However, once folded the "-barrel 
structure of fluorescent proteins is remarkably resistant to thermal denaturation [119, 
120], up to temperatures of ~85°C. To assess the effect of the deletion mutations on the 
thermostability of EGFP, protein samples were slowly heated (1°C/min) from room 
temperature (25°C) to 98°C whilst monitoring fluorescence using a qPCR 
thermocycler (Section 2.6.2.5) (Fig 4.15). 
Apparent melting temperatures (Tmapp) were determined from the fluorescence 
data and show that the deletion variants were very similar to that of EGFP, with Tmapp 
of 82-84°C (Table 4.8) and therefore retain the high thermal stability of EGFP. 
However, the thermal denaturation of EGFP and the EGFP! variants was irreversible 
(data not shown) therefore implying the potential formation of aggregates making it 
difficult to generate accurate thermodynamic data. This can result in decreased Tmapp 
values when calculated using the method described here. 
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Fig 4.15. Thermal denaturation of EGFP and EGFP! variants. Fluorescence emission was 
monitored during temperature ramping from 25-98 °C at 1 °C/min using a qPCR thermal 
cycler. Melting temperatures (Tmapp) are listed in Table 4.8.  
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4.2.7 EGFPD190! and EGFPA227! crystallography 
 In order to determine the effects the single amino acid deletion mutations have 
on the EGFP structure at the molecular level the EGFPD190! and EGFPA227! (10 mg/ml 
in 50 mM Tris-HCl, pH 8.0 and 150 mM NaCl) were screened for crystal formation by 
the sitting drop vapour diffusion method at 4°C. 
 A crystal of EGFP!D190 was obtained from 0.1 M Hepes/NaOH, pH 6.6, 200 
mM ammonium sulphate and 2 M (K/Na)-Phosphate and a crystal of EGFP!A227 was 
obtained from 0.05 M MES/NaOH, pH 5.6, 100 mM ammonium sulphate, 10 mM 
magnesium chloride hexahydrate and 20% (w/v) PEG 8000.  
 However, due to time constraints the crystal structures have not yet been 
refined to a high enough resolution from the X-Ray diffraction data. Preliminary 
structures have been generated but the R-values for EGFPD190! and EGFPA227! are 
36.8% and 28.6%. Therefore, in their current state these structures were considered of 
limited value. 
 
4.3 Discussion 
As mentioned previously predicting the effects of a single amino acid deletion 
and where it will be tolerated within a target protein is currently very difficult and 
generally avoided when undertaking rational protein design. Therefore, a directed 
evolution approach provides us with the opportunity to survey protein tolerance to 
single amino acid deletion. Using the directed evolution approach described in Chapter 
3 the tolerance and impact of single amino acid deletions on EGFP have been 
investigated. This has included the identification of variants resulting in improved 
cellular fluorescence and altered folding properties. 
GFP has been shown to tolerate insertion of short peptides [121], long peptides 
[121] and whole domains [34] but was intolerant to site directed deletions from the 
loops connecting secondary structures [122, 123]. This implies that GFP is almost a 
‘size-minimized’ protein intolerant to loop shortening, as is also evident from its 
compact structure with high resistance to heat [122, 123], denaturing agents [113, 114] 
and proteolysis [124]. However, to date amino acid deletion mutagenesis of GFP has 
only been studied by N- and C-terminal truncations [122, 123, 125], shortening of the 
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longest loop connecting !-strands 6 and 7 [122], and deletion of residues from three 
other loops (residues 76-81, 83-88 and 191-195) [123].  
Deletion of the terminal amino acids from GFP identified the minimal domain 
requirement for the protein to fold to its fluorescent form [123, 125], whilst deletion of 
amino acids from the longest loop linking !-strands 6 and 7 from GFP has showed this 
region is intolerant to shortening by single amino acid deletion [122]. A survey of GFP 
tolerance to single amino acid deletions throughout its structure has not been 
performed until now.  
 
4.3.1 The crystal structure of EGFP. 
 Prior to this study the crystal structure for EGFP was yet to be determined 
despite its very wide use as a tool in cell biology. The high resolution (1.35 Å) 
structure determined here (Fig 4.2) has helped to identify the structural effects of the 
S65T and F64L mutations in EGFP and how they confer increased folding stability at 
37 °C and alter the spectral properties with respect to wt GFP. The structure of EGFP 
was very similar to that of wt GFP with superposed structures having an RMSD across 
backbone atoms of only 0.33 Å. 
 Mutation of the bulky side chain of F64 for the smaller leucine side chain 
results in the better packing of hydrophobic core residues, especially residues L18, 
V29, and W57 that lie close to the chromophore (Fig 4.2). L64 together with these 
three residues form a hydrophobic interaction network, with W57 normally partially 
exposed becoming more buried (12.82 Å2 surface exposed) compared to wt GFP 
(15.16 Å2 surface exposed). This improved packing is a potential reason for the 
increased folding stability at 37 °C.  
 The T65 side chain in the EGFP structure determined here is in the same 
orientation as previously determined S65T-GFP structures [69]. However, in contrast 
to other S65T-GFP structures the electron density of the E222 carboxylate side chain in 
EGFP suggests that it occupies two distinct conformations. Both conformations result 
in the promotion of an anionic form of the chromophore, This is due to the E222 
carboxylate group being neutral therefore allowing charge stabilisation on the phenyl 
group of the chromophore by H148, T203 and a conserved water molecule coordinated 
between residues N146 and S205. However, given the heterogeneity in the local 
environment of the chromophore due to the alternate conformations of E222 it would 
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be expected that this would be reflected by spectral heterogeneity. This is not the case 
as is evident from single exponential fluorescence lifetime decays and is potentially 
due to the E222 carboxylate being neutral, therefore small alterations in its 
conformation is not likely to effect the electrostatic environment surrounding the 
chromophore. 
 The two side chain conformations observed for E222 could be a 
crystallographic artifact and both may not be populated in solution. Alternatively both 
conformations may exist but could be in a dynamic equilibrium and transiently 
exchanging between the two conformations. A third possibility could be that upon 
folding the E222 side chain is trapped in one conformation or the other. Further 
structural analysis by NMR could potentially identify how dynamic the E222 side 
chain is in solution and whether the two conformations observed in the crystal structure 
are true. 
 
4.3.2 Tolerance of EGFP to single amino acid deletion.  
The use of the transposon-based directed evolution approach on the target 
EGFP has provided to date one of the most comprehensive lists of residues tolerant or 
intolerant to single amino acid deletions: 42 unique single amino acid deletions were 
tolerated (Table 4.3) and 45 non-tolerant positions were also identified throughout 
EGFP (Table 4.4). This is in contrast to previous amino acid deletion studies, which 
suggested EGFP to be largely intolerant to amino acid deletions [122, 123]. 
Analysis of the tolerated and non-tolerated amino acid deletion positions by 
mapping to the secondary structure topology (Fig 4.4) and tertiary structure of EGFP 
(Fig 4.5) showed a clear divide between regions tolerable and non-tolerable to deletion 
mutagenesis. Our results here agree to an extent with the dogma that deletion 
mutations are better tolerated in loops rather than ordered secondary structure. The 
majority (60%) of the tolerated amino acid deletions were situated in loops while the 
majority (71%) of non-tolerated amino acid deletions located towards the middle of !-
strands. This can be explained by removal of a single amino acid from a secondary 
structure causing registry shifts in the strands (Chapter 1, Fig 1.1). Given that EGFP 
fluorescence relies on its stable regular structure, altering the registry of the !-strands 
would have obvious detrimental effects.  
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Although the majority of tolerated amino acid deletions were located in the 
loop regions, 21% were situated towards the termini of !-strands, in particular towards 
the end of !-strands 7 and 8 (Fig 4.4). There is also a high tolerance to amino acid 
deletions in the loops adjacent to these sites (Fig 4.4) possibly identifying this region of 
EGFP as being particularly tolerant to mutagenesis. !-strands may be more tolerant to 
single amino acid deletions positioned towards their N- and C-termini as a registry 
shift may be accommodated by a small loss of secondary structure and replacement by 
a loop, which may not affect the overall structure of the protein. 
Although the loops connecting secondary structures were most tolerant to 
single amino acid deletions only two mutations, D133" and G138", were identified in 
the longest loop connecting !-strands 6 and 7 of EGFP, which resulted in maintained 
fluorescence. The longest loop in EGFP (I128-L141) forms a cap over one end of the 
!-barrel, protecting the chromophore from the external environment (Fig 4.16 a), and 
has been shown previously to be intolerant to amino acid deletion [122]. There are 
several residues (F130, I136, L137, L141 and Y145) with buried side chains or 
backbone atoms acting as anchor points for the loop to the top of the !-barrel (Fig 4.16 
b). Disruption of these anchor points could destabilize the protein structure or result in 
misfolding. Deletion of both L137 or Y145, situated in the longest loop, was 
detrimental to EGFP fluorescence (Table 4.4) agreeing with previous findings [122].  
However, in contrast to previous studies deletion of D133 or G138 were 
tolerated. This could potentially be due to the fact that these residues are surface 
exposed (Fig 4.16 b) and therefore their deletion may not disrupt the anchor points 
formed by the buried residues. 
Besides buried side chains, residues in the longest loop make hydrogen-
bonding interactions with residues in adjacent loops, potentially further stabilizing 
overall EGFP stability. Residue D103 is situated in a loop connecting !-strands 4 and 5 
adjacent to the N-terminal end of the longest loop (Fig 4.16 c), deletion of which 
resulted in loss of fluorescence. The D103 side chain carboxylate forms a hydrogen 
bond to the amide nitrogen of K131 situated in the longest loop (Fig 4.16 b). Deletion 
of D103 would result in the loss of this stabilizing interaction and could potentially 
destabilize both the longest loop and the loop connecting !-strands 4 and 5. This in 
turn could affect protein folding and stability explaining the loss of fluorescence in the 
D103 deletion mutant.  
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Fig 4.16 Buried residues and stabilizing interactions in the longest loop of EGFP. a, The 
longest loop (residues I128-L141, red spacefill) in EGFP (green cartoon) forms a cap over the 
end of the !-barrel protecting the chromophore (sticks) from the external environment. b, 
Buried residues act as anchor points for the longest loop. Deletion of the buried residue L137 
(red) or Y145 (N-terminal end of the longest loop: red) result in loss of fluorescence. Deletion 
of solvent exposed residues D133 or G138 from the longest loop are tolerated. c, Stabilizing 
hydrogen bond (black dashed line) interaction between D103 and K131 (green or red sticks 
respectively). Deletion of D103 results in loss of fluorescence. 
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Amino acid deletions were also identified in the central !-helix, containing the 
chromophore forming residues, running through the core of the "-barrel structure 
(Table 4.4). All of the deletions in this region resulted in loss of fluorescence. 
Deletions in and around the chromophore forming residues are likely to disrupt correct 
folding and packing around the chromophore and therefore affect the maturation 
process, with the probability of producing non-fluorescent variants. 
There was a high proportion of single amino acid deletions tolerated in other !-
helix secondary structures (H1 and H3, Fig 4.4), in particular in the first !-helix. This 
is potentially due to the fact that truncation of the first five amino acid residues can be 
tolerated and fluorescence can still mature [125], therefore any structural disruption of 
this !-helix due to a single amino acid deletion is also likely to be tolerated. 
The third !-helix (H3) in EGFP is part of one of the longer loops that spans one  
end of the "-barrel and whilst important the structure is not conserved across all 
fluorescent proteins. This loop spanning the end of the "-barrel in some structures of 
fluorescent proteins is one long distorted helix structure, in some is split into two 
helices and in others is a single short helical segment. Given that this helix differs 
greatly between different fluorescent protein structures implies a degree of flexibility 
and therefore is the likely reason it is more tolerant to single amino acid deletions than 
other secondary structures in EGFP. 
The fact that tolerated and non-tolerated amino acid deletions have been 
identified in loops and in organized secondary structures highlights the necessity of a 
directed evolution approach. However from the survey of tolerated and non-tolerated 
single amino acid deletion mutations carried out here it is possible to devise some very 
preliminary rules for rationally introducing deletion mutations. 
 
1. Loop regions connecting secondary structures are more likely to tolerate the 
deletion of amino acids. 
 
2. Deletion of amino acids from "-strands are more likely to be tolerated when 
positioned towards the termini of that secondary structure 
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3. Deletion of amino acids from helix structures are also more likely to tolerate 
deletions from their termini although may also tolerate deletions from the middle of the 
structure dependent on the structural importance of the !-helix. 
 
It is important to state that without crystal structure determination of all the 
amino acid deletion mutants of EGFP it is very difficult to characterize the exact effect 
of the deletions at the molecular level and thus it is still difficult to devise defined rules 
for introducing deletion mutations rationally. The rules defined here are to be used 
with caution given the lack of structural information but also they are dependent on the 
protein being studied, in particular rules 2 and 3. Deletion of amino acids from 
organized secondary structures although may be tolerated in EGFP towards their 
termini may not in other proteins. It is therefore important to have a detailed 
knowledge of the protein structure to be studied and to make educated decisions on 
whether the organized secondary structures are likely to be important for structural 
stability or function. 
 
4.3.3 Identification of novel EGFP variants through single amino acid deletion 
mutagenesis. 
 Whole cell fluorescence analysis of cultures producing the tolerated amino acid 
deletion variants of EGFP (Fig 4.6, Fig 4.8), and the observation of brighter colour 
phenotypes in colonies grown on LB Agar (Fig 4.9 b) identified three single amino 
acid deletions, G4", D190" and A227" that produced a marked increase in 
fluorescence with respect to EGFP. At 37 °C EGFPA227" exhibited a 2.6-fold increase 
in fluorescence with respect to EGFP. However, the G4" mutation resulted in an 
increase in EGFP fluorescence when expressed in cell culture at 25 °C and 37 °C (~4-
fold or ~1.7 fold respectively) (Fig 4.8). The effect of the G4! mutation was not just 
specific to EGFP as transfer of this mutation to EYFP also resulted in increased 
cellular fluorescence (Fig 4.9 b). Therefore, the G4! could be considered to be having 
a generic effect on GFP protein and should be incorporated into other variants to 
improve cellular fluoresence.  
 Although the identified deletion mutations increased fluorescence when 
expressed in cell culture the effects of the deletion mutations were not mediated 
through changes to the spectral properties as was evident from calculated brightness 
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values comparable to that of EGFP (Table 4.6). The effect is likely to be manifested 
through changes in protein stability and folding. Guanidine hydrochloride induced 
equilibrium unfolding experiments (Fig 4.12) showed that, with respect to EGFP, the 
EGFPG4! variant has increased stability by ~1.18 kcal.mol-1M-1 and that the EGFPA227! 
variant has marginally increased stability by ~0.53 kcal.mol-1M-1, despite having 
similar [GdmCl]50%app values (~2.5 – ~2.7 M) (Table 4.8). The increase in stability is 
due to an increase in cooperativity with which EGFPG4! and EGFPA227! unfold (~1.3-
fold) with respect to EGFP, evident from the increased m-values (Fig 4.12 and Table 
4.8). The increased stability for the EGFPG4! variant may be due to the formation of 
additional stabilizing interactions. A lysine residue adjacent to G4 in EGFP (K3) may 
move to a more favorable position within the first "-helix and form stabilizing 
interactions between its #-amino group and other residues in its immediate vicinity. 
Structural determination of EGFPG4! would greatly aid in confirming this notion and 
would help towards identifying the molecular basis for its increased stability. 
The data measured here were best fit to a 2 state unfolding model. However, if 
the data were to be fit to a 3-state model two m-values would be determined for a 
transition from a native to an intermediate state and from the intermediate state to the 
denatured state. This would allow a more accurate determination of the nature of EGFP 
unfolding with respect to the stability and degree of remaining structure of the 
intermediate state. Further equilibrium unfolding experiments would be required to 
assess a three state unfolding model for EGFP and the EGFP! variants. Performing the 
experiments at lower pH or higher temperature may help toward identifying an 
unfolding intermediate as seen in other equilibrium unfolding studies [113, 126].  
Given that other GFP proteins have been shown to unfold by a three state 
model [113, 114] it is expected that unfolding kinetics would reflect this with two rate 
constants, one for the native to intermediate state and one for the intermediate to 
denatured state. However this would only be true for a system in which the formation 
of the intermediate from the native state was described by the fast rate constant with 
the formation of the denatured state from the intermediate being described by the slow 
rate constant. If the formation of the intermediate from the native state is described by 
a low rate constant it is unlikely that the fast rate constant would be distinguishable. A 
single unfolding kinetic rate constant was determined here for the unfolding of EGFP 
and the EGFP! variants (Fig 4.14 and Table 4.8). This is probably due to the protein 
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unfolding being performed in 6.8 M GdmCl. At this high concentration of GdmCl it is 
unlikely that any unfolding intermediates will be occupied, or they will unfold so 
rapidly to the denatured state that a rate constant for their formation, from the native 
state, will be unidentifiable by fitting to a double exponential decay function. 
Unfolding kinetic studies of a GFP variant (GFP mut2) at lower concentrations of 
GdmCl (< 5 M) have previously been shown to fit well to double exponential decay 
processes, but above 5 M GdmCl only a single exponential decay can be resolved from 
the data [127, 128]. 
The EGFP! variants exhibited similar unfolding kinetic rate constants (~2 min-
1) to that of EGFP (Table 4.8 and Fig 4.14) except for EGFPA227!, which unfolded with 
a more than two-fold faster rate constant (4.59 min-1). This was an unusual result given 
that EGFPA227! was found to be more stable than EGFP from equilibrium unfolding 
studies (Fig 4.12 and Table 4.8), which suggests that the two-state analysis for 
equilibrium unfolding is insufficient for determining EGFP stability. A more detailed 
study on unfolding kinetics for this variant at varying concentrations of GdmCl would 
be required to confirm the result seen here and to ascertain a dependence between 
unfolding rates and [GdmCl].  
In agreement with previous work on protein refolding kinetics [71, 115, 128] 
EGFP and the EGFP! variants refolding data was best fit to a double exponential 
function. In contrast to refolding kinetics determined for urea denatured EGFP in 
previous studies [115], the fast and slow rate constants determined here are three-fold 
and >six-fold faster respectively (Table 4.8). The amount of fluorescence intensity 
recovered by EGFP (77%) (Fig 4.14) did agree with the previous findings for refolding 
studies [115], in contrast to EGFPG4! which was capable of recovering up to 100% of 
its initial fluorescence (Fig 4.14). 
The EGFPG4!, EGFPD190! and EGFPA227! variants all showed a decrease in the 
fast rate constant by up to 30% with respect to EGFP. The slow rate constants for 
EGFPD190! and EGFPA227! were also decreased by up to 11% whilst the G4! variant 
resulted in an increase of kslow by up to 20% (Table 4.8). The two rate constants are 
thought to arise from cis/trans isomerization of the peptide bond between Met88 and 
Pro89 (M88-P89) [115]. In the native protein this peptide bond is in the cis 
configuration however in the denatured state the bond can exist in both configurations, 
cis or trans. Usually trans peptide bonds are favoured over cis in unfolded proteins 
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(trans:cis, 1000:1) however in an X-Pro peptide bond this ratio can drop to 3:1, due to 
the restricted torsion angles of proline residues making both isomers almost 
energetically favorable [115, 116]. 
The initial fast refolding phase is thought to be due to unfolded protein with the 
M88-P89 peptide bond already in the cis conformation whilst the slow rate is thought 
to be due to this peptide bond being in the trans configuration and therefore requiring 
isomerization for correct folding [115]. Residue G4 is in close proximity to the M88-
P89 peptide bond (Fig 4.17). Deletion of G4 may cause favorable interactions between 
other residues surrounding the M88-P89 peptide bond promoting cis/trans 
isomerization during folding, therefore increasing the slow rate constant (kslow) with 
respect to EGFP. 
However, the kinetics of refolding calculated here can only be attributed to the folding 
of the !-barrel around the chromophore and protection from the external environment 
for fluorescence to be regained. The fact that the deletion variants increased the levels 
of fluorescence during the expression studies (Section 4.2.4) may partly be due to the 
altered rates of folding of the !-barrel (Table 4.8), however the effect of the deletion 
mutations on the rate at which the chromophore forms have not been determined here. 
Further work would be required to see if the deletion mutations have an effect on 
chromophore maturation, which could also play a major role in the rate of fluorescence 
development. 
Determining the structures for the single amino acid deletion variants of EGFP 
would help a lot towards understanding the mechanisms by which they are affecting 
folding and stability. Determination of the EGFPD190" and EGFPA227" variant atomic 
resolution structures is still ongoing. Attempts to crystalize EGFPG4" have been made 
but to date crystallization conditions are still to be identified that provide crystals for 
structure determination. 
 
4.3.4 Effect of single amino acid deletion mutations on the oligomeric state of 
EGFP 
GFPs can form weakly associated dimers at increased concentrations with a 
dissociation constant (Kd) of ~100 µM [108]. Under certain crystalisation conditions 
wild-type GFP crystalized as a dimer identifying extensive dimerization contacts 
xxxxxx  
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Fig 4.17. Location of G4 in EGFP with respect to the native M88-P89 cis-peptide bond. 
G4 is adjacent to P89 (blue spheres) in the tertiary structure of EGFP. Deletion of G4 would 
result in an altered environment around the native cis-peptide bond between M88 and P89 
(inset) possibly influencing the rate of cis/trans isomerization during folding.  
 
 
Fig 4.18. GFP dimerization interface. The dimer interface of wild-type GFP (pdb:1GFL) is 
comprised of 3 hydrophobic residues from each monomer (yellow spheres and inset) with the 
majority of the interactions being contributed from hydrophilic residues (red spheres). A227 
(blue sphere) is positioned at the periphery of the dimerization interface.  
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between three hydrophobic residues (A206, L221 and F223) and many hydrophilic 
contacts (Fig 4.17). The single substitution mutation A206K has been shown to 
suppress the tendency for GFPs to dimerize. Analytical size exclusion chromatography 
showed that the EGFPG4! and EGFPD190! had similar oligomeric properties to that of 
EGFP (Fig 4.11) with a small shift in elution volume (~0.15 ml) with increasing 
protein concentration.  
In contrast EGFPA227! showed no change in elution volume with increasing 
protein concentration (Fig 4.11) implying a decrease in the tendency of this variant to 
form weakly associated dimers. Although A227 is not considered to be a residue that 
contributes to the dimerization of GFPs it is in close proximity to the residues that do 
form the dimerization interface (Fig 4.18), possibly decreasing the propensity for 
EGFP to form weak dimers when deleted. 
 
4.3.5 Conclusion 
Contrary to current dogma, it has been shown here that deletion of a single 
amino acid can be tolerated at a wide variety of positions, including secondary 
structure. Furthermore, it has been shown that variants with beneficial properties can 
be generated validating the use of deletion mutations as an approach to engineer useful 
properties into a protein. Many of the identified mutations may be considered to be 
non-intuitive so the use of a directed evolution approach has allowed a non-biased 
assessment of the impact of deletion mutations. Contrary to the thought that amino acid 
deletions destabilize a protein, the basis for variants with improved cellular 
fluorescence was at the level of protein stability and folding.  
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Chapter 5: Characterisation and analysis of cytb562-EGFP integral fusion 
scaffolds 
5.1 Introduction 
Construction of tailored protein scaffolds not currently present in nature is 
integral to synthetic biology and bionanotechnology [129-132]. The generation of 
protein scaffolds linking the disparate functions of two unrelated proteins [132-134] is 
particularly attractive as subsequent chimeras have the potential to act as biomolecular 
switches, encompassing: sensors, modulators, transducers and energy transfer 
components for use in natural and artificial contexts. 
Single polypeptide chains that fold into multi-domain architectures are common 
in nature, with the relative arrangement of individual domains generally important for 
functional linkage [23]. Most multi-domain proteins are linked in a ‘head-to-tail’ 
manner with the C-terminus of one domain linked directly to the N-terminus of the 
next [25]. A significant minority (9%) exhibit integral fusion architecture with one 
protein domain inserted within another [24, 25].  
Integral fusion architecture decreases the degrees of freedom the ‘insert’ 
domain has with respect to the accepting or ‘parent’ domain, thereby intimately linking 
the two structures. This intimate linkage has the potential to communicate stimulus-
induced changes in one domain through to the other therefore coupling the structure 
and function of the two normally disparate proteins. A classic example in nature is the 
concept of allostery where binding to a regulatory site distant from the active site can 
modulate the function (in a positive or negative manner) through propagated structural 
changes [135].  
Our limited understanding of the functional linkage, between the two domains, 
of engineered domain insert protein scaffolds is exacerbated by a lack of detailed 
structural information. This ultimately makes identifying sites within a parent protein 
that will not only tolerate the insertion of a domain but also retain and link the 
functions of the two domains very difficult. There has been limited success using 
rational design approaches [32, 34, 35], with this technique relying on a detailed 
knowledge of both protein structures, often resulting in only modest switching 
magnitudes.  
Directed evolution provides an alternative approach and has been applied in a 
few cases to generate libraries of integral domain inserts from which variants with 
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switching characteristics have been identified [31, 37, 136, 137]. The limitation of 
previously used directed evolution methods are that random breaks introduced into the 
target DNA, into which genes encoding whole domains were inserted, were generated 
using DNAseI. It is notoriously difficult to generate single random breaks into target 
DNA with DNAseI and digestion with this nuclease resulting in tandem duplications 
and nested deletions of unpredictable sizes within the parent gene [32]. DNAseI also 
shows considerable target site specificity resulting in DNA libraries with bias [48].  
Here we have used a transposon based directed evolution approach to introduce 
defined random breaks throughout a target gene, egfp, coding for enhanced green 
fluorescent protein (EGFP), into which DNA cassettes coding for cytochrome b562 (cyt 
b562) were inserted (Chapter 3, Section 3.2.7). The subsequent library of cyt b562-EGFP 
integral fusion proteins was screened for the functional coupling of their normally 
disparate functions for the use as an efficient energy transfer component and the 
potential to act as a sensor for redox state.  
EGFP is a perfect model protein for studying integral fusion scaffold design as 
it has intrinsic auto fluorescence upon folding making domain insertion tolerance and 
coupling easy to determine. Furthermore, EGFP is one of the most common tools used 
in cell biology for studying gene expression, protein localisation, protein trafficking 
and protein-protein interactions to name a few. The chromophore is very sensitive to 
changes in its local environment and therefore functional coupling can easily be 
detected by changes in fluorescence characteristics upon the binding of an effector or 
other input.  
Cyt b562 is a four helix bundle protein that binds haem non-covalently with a 
methionine (Met 7) and histidine (His 102) co-ordinating the iron moiety [73-75]. Cyt 
b562 undergoes a major change in conformation on binding haem most notably at the C-
terminal helix, changing from a dynamic unordered structure to a structurally ordered 
!-helix [73]. This conformational change, upon haem binding, has the potential to act 
as the structural switch with which to modulate a parent domains function, in this case 
EGFP fluorescence.  
In naturally evolved integral fusion scaffold proteins the N- and C-termini of 
the insert domain are generally juxtaposed with an average distance of ~8 Å from one 
another [24]. The N-and C-termini of apo-cyt b562 are ~12 Å from one another making 
it a suitable candidate for an insert domain in an artificial integral fusion scaffold.  
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Haem is a biologically important small molecule that acts as a cofactor to many 
different proteins encompassing a wide range of roles such as; oxygen transport [78], 
catalysis [79], electron transfer [80] and sensing. Haem has also been shown to be an 
efficient fluorescence quencher [81], including that of EGFP [82, 138], with quenching 
occurring via energy transfer to the haem moiety bound to cyt b562, the efficiency of 
which is dependent on the proximity and orientation of the two chromophores to one 
another. Haem affinity for cyt b562 is also dependent on the iron oxidation state [76] 
with bound haem being sensitive to oxidative modification [77] making it a potential 
sensor for changes in redox conditions.  
 
5.2 Results 
5.2.1 Library construction 
The first step is to identify sites within EGFP that tolerate domain insertion. 
Several factors can influence tolerance: (1) frame of trinucleotide deletion, (2) frame of 
domain cassette insert, (3) domain insert position within the structure of EGFP and (4) 
nature of linker sequence separating the two domains. The first two are dependent on 
the MuDel transposon approach to library construction (Chapter 3) that can be 
overcome through experimental modification with relation to the domain cassette 
insert and variant screening. This will allow a wider number of variants to be 
constructed and thus sampled increasing the likelihood of identifying useful variants. 
The last two are more difficult to predict so can only be addressed through variant 
screening. The benefit of the MuDel transposon based approach is that the nature of 
break is always defined (in comparison to DNaseI) so making the construction of the 
crucial linker segments easier to incorporate into the library design process. 
The linkers joining the two domains in an integral domain scaffold can be 
crucial to achieving functional coupling and the switching magnitude that can be 
achieved. Two different types of linkers were used in this study: short single random 
amino acid linkers (X) or longer more flexible Gly-Gly-Ser linkers as outlined in 
Chapter 3. Screening of the cyt b562-EGFP libraries with either X or Gly-Gly-Ser 
linkers identified a greater tolerance of EGFP to cyt b562 domain insertion when the 
two domains were separated by the longer more flexible linkers (Chapter 3, Section 
3.2.8). Therefore, only variants from the cybC-egfp-GGS library were selected for 
further characterisation. 
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In order to sample all possible open reading frames (ORF) in the library, cybC 
cassettes were designed with additional random nucleotides at the 5’ and 3’ ends to 
maintain the reading frame of cybC in ORFs 2 or 3 (Fig 5.1). Due to the random 
nucleotides at the 5’ and 3’ end of the ORF 2 and 3 cybC DNA cassettes, substitution 
mutations can also be introduced into EGFP when sampling a random break in egfp in 
these reading frames (Fig 5.1). 
Consequently genes encoding cyt b562-EGFP integral domain fusions with Gly-
Gly-Ser linkers were isolated from E. coli cells and had their DNA sequence 
determined to identify the nature of the cybC DNA cassette insertion into egfp. 
 
5.2.2 Analysis of tolerated and non-tolerated cytochrome b562 domain insertions in 
EGFP. 
The library of integral domain insertion variants was screened for EGFP 
tolerance to domain insertion. The library was used to transform E. coli TUNER™ 
(DE3) cells (Table 2.1) subsequently grown overnight at 37 °C on M9 minimal media 
agar plates supplemented with 100 µg/ml ampicillin and 150 µM IPTG followed by 
storage at 4 °C for up to 72 hrs. Colonies that displayed a green fluorescent phenotype 
upon excitation with a UV-transilluminator (n = 37) (Section 2.3.6) were selected and 
the gene encoding the integral fusion protein sequenced (Section 2.2.16). A variant 
egfp gene from 116 non-fluorescent colonies was also sequenced to determine what 
gave rise to inactive EGFP. 
The DNA sequence of 36 different variants from the cybC-egfp domain 
insertion library that conferred cellular fluorescence (Table 5.1) and 116 different 
variants that conferred no observable colour phenotype (Table 5.2) were analysed. Of 
the 36 variants that conferred cellular fluorescence, 26 were identified to contain an in-
frame cybC insertion sampling 15 different insertion positions within egfp. From the 15 
different insertion positions sampled 23 unique cyt b562-EGFP integral domain 
scaffolds were generated (Table 5.1). The disparity between the number of different 
insertion sites sampled and the number of unique variants identified arises due to 
different linker sequence being sampled at the same insertion site (Table 5.1).   
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Fig 5.1 Sampling cybC insertion sites in all ORFs and subsequent mutations sampled. Due 
to the nature of MuDel insertion and subsequent removal, a triplet nucleotide (white sequence) 
is deleted from egfp (green) and results in a random break in the target gene that is not always 
in frame. Insertion of a cybC DNA cassette (red) encoding Gly-Gly-Ser linkers (blue) into the 
random breaks generates cybC-egfp-GGS DNA constructs that encode cyt b562-EGFP integral 
fusion proteins. In order to sample the random breaks in ORF 2 and 3 cybC DNA cassettes 
with additional random nucleotides (yellow sequence) are used to maintain the reading frame. 
The resulting cybC-egfp-GGS DNA constructs therefore encode for cyt b562-EGFP integral 
fusion proteins that can also have substitution mutations (black background with white 
sequence) flanking the cyt b562. Representative DNA and encoded protein sequences of ORF 1 
(top panel), 2 (middle panel) and 3 (bottom panel) cybC insertions are of variants NFCG28 
(Table 5.2), CG14 and CG8 (Table 5.1) respectively.  
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Table 5.1 DNA Sequence and amino acid mutations of fluorescent integral cyt b562-EGFP 
fusion proteins. 
Variant Nucleotides deleteda 
Amino acid 
mutationsb 
Secondary 
Structurec ORF
d Fusion proteine 
CG1 ATG GTG7 V1*M N-LP 2 GFP1-GGS-AD-cytb-YR-GGSM-2GFP 
CG2 12GGC GAG19 E5Q H1 3 GFP4-GGS-AD-cytb-YR-GGSQ-6GFP 
CG3 27ACC GGG34 T9A H1 2 GFP8-AGGS-AD-cytb-YR-GGS-10GFP 
CG4 27ACC GGG34 G10R LP H1-S1 3 GFP9-GGS-AD-cytb-YR-GGSR-11GFP 
CG25 27ACC GGG34 G10K LP H1-S1 3 GFP9-GGS-AD-cytb-YR-GGSK-11GFP 
CG5 90TCC GGC97 - S2 2 GFP30-GGS-AD-cytb-YR-GGS-31GFP 
CG6 117TAC GGC124 Y39F LP S2-S3 2 GFP38-FGGS-AD-cytb-YR-G-40GFP 
CG7 150ACC GGC157 T50N, G51S LP S3-H3 2 GFP49-NGGS-AD-cytb-YR-GGSS-52GFP 
CG8 438AAC AGC445 N146K, S147T LP S6-S7 3 GFP145-KGGS-AD-cytb-YR-GGST-148GFP 
CG15 438AAC AGC445 S147C LP S6-S7 3 GFP146-GGS-AD-cytb-YR-GGSC-148GFP 
CG26 456ATC ATG463 M153L S7 2 GFP152-GGS-AD-cytb-YR-GGSL-154GFP 
CG17 456ATC ATG463 M153L S7 3 GFP152-GGS-AD-cytb-YR-GGSL-154GFP 
CG9 462GCC GAC469 A154G S7 2 GFP153-GGGS-AD-cytb-YR-GGS-155GFP 
CG14 462GCC GAC469 A154V, D155N S7 2 GFP153-VGGS-AD-cytb-YR-GGSN-156GFP 
CG19 462GCC GAC469 - S7 2 GFP154-GGS-AD-cytb-YR-GGS-155GFP 
CG23 462GCC GAC469 A154G, D155H S7 2 GFP153-GGGS-AD-cytb-YR-GGSH-156GFP 
CG13 462GCC GAC469 D155N S7 2 GFP154-GGS-AD-cytb-YR-GGSN-156GFP 
CG10 462GCC GAC469 D155N S7 3 GFP154-GGS-AD-cytb-YR-GGSN-156GFP 
CG18 522GGC AGC529 G174V, S175C LP S8-S9 2 GFP173-VGGS-AD-cytb-YR-GGSC-178GFP 
CG11 693CTC GGC700 - C-LP 2 GFP231-GGS-AD-cytb-YR-GGS-232GFP 
CG22 693CTC GGC700 L231H, G232S C-LP 2 GFP230-HGGS-AD-cytb-YR-GGSS-233GFP 
CG21 693CTC GGC700 G232S C-LP 2 GFP231-GGS-AD-cytb-YR-GGSS-233GFP 
CG20 708CTG TAC715 L236P, Y237N C-LP 2 GFP235-PGGS-AD-cytb-YR-GGSN-238GFP 
CG12 711TAC AAG718 Y237W, K238Q C-LP 2 GFP236-WGGS-AD-cytb-YR-GGSQ 
aDNA sequence numbering as per the egfp gene [107] 
bAmino acid numbering as per GFP [106], V2 of EGFP is numbered V1*. 
cLP signifies loop, H signifies !-helix, S signifies "-strand, N- or C- signify N- or C- 
terminal respectively. 
d ORF is the open reading frame into which the cybC DNA cassette is inserted 
ePosition of insertion within GFP denoted by subscript. Mutated residues in black, non-
underlined. Linker sequences black underlined. The sequence segment representing cyt b is 
in red with just the terminal residues shown, the rest of the sequence is denoted by ‘cytb’ 
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Table 5.2 DNA Sequence and amino acid mutations of non-fluorescent integral cyt b562-
EGFP fusion proteins. 
Variant Nucleotides deleteda 
Amino caid 
mutationsb 
Secondary 
structurec ORF
d Fusion proteine 
NFCG38 45CTG GTC52 L15P S1 2 GFP14-PGGS-AD-cytb-YR-GGS-16GFP 
NFCG26 82TTC AGC89 F27S, S28G S2 2 GFP26-SGGS-AD-cytb-YR-GGSG-29GFP 
NFCG3 82TTC AGC89 F27S S2 2 GFP26-SGGS-AD-cytb-YR-GGS-28GFP 
NFCG17 91TCC GGC98 S30Y S2 2 GFP29-YGGS-AD-cytb-YR-GGS-31GFP 
NFCG5 112GCC ACC119 A37V LP S2-S3 2 GFP36-VGGS-AD-cytb-YR-GGS-2GFP 
NFCG13 127CTG ACC134 L42P, T43P S3 2 GFP41-PGGS-AD-cytb-YR-GGSP-43GFP 
NFCG1 142ATC TGC149 C48S S3 2 GFP47-GGS-AD-cytb-YR-GGSS-49GFP 
NFCG23 142ATC TGC149 C48D S3 3 GFP47-GGS-AD-cytb-YR-GGSD-49GFP 
NFCG24 170CCC TGG177 W57S H2 3 GFP56-GGS-AD-cytb-YR-GGSS-58GFP 
NFCG7 171TGG175 W57! H2 1 GFP56-GGS-AD-cytb-YR-GGS-58GFP 
NFCG6 189ACC193 T63! H2 1 GFP62-GGS-AD-cytb-YR-GGS-64GFP 
NFCG16 227CCC GAC234 - H3 3 GFP75-GGS-AD-cytb-YR-GGS-76GFP 
NFCG14 236ATG AAG243 M78I, K79E H3 3 GFP77-IGGS-AD-cytb-YR-GGSE-80GFP 
NFCG25 239AAG CAG246 K79N, Q80K H3 3 GFP78-NGGS-AD-cytb-YR-GGSK-81GFP 
NFCG11 259TCC GCC266 S86C, A87P H4 2 GFP85-CGGS-AD-cytb-YR-GGSP-88GFP 
NFCG8 259TCC GCC266 S86W H4 2 GFP85-WGGS-AD-cytb-YR-GGS-87GFP 
NFCG10 355ACC CTG362 T118N S6 2 GFP117-NGGS-AD-cytb-YR-GGS-119GFP 
NFCG28 357CTG361 L119! S6 1 GFP118-GGS-AD-cytb-YR-GGS-120GFP 
NFCG34 375CTG AAG382 K126Q S6 3 GFP125-GGS-AD-cytb-YR-GGSQ-127GFP 
NFCG36 411CTG GGG418 L137Q, G138W LP S6-S7 2 GFP136-QGGS-AD-cytb-YR-GGSW-139GFP 
NFCG12 411CTG GGG418 L137P LP S6-S7 2 GFP136-PGGS-AD-cytb-YR-GGS-138GFP 
NFCG9 414GGG418 G138! LP S6-S7 1 GFP137-GGS-AD-cytb-YR-GGS-139GFP 
NFCG37 423CTG GAG430 L141P LP S6-S7 2 GFP140-PGGS-AD-cytb-YR-GGS-142GFP 
NFCG33 489GTG AAC496 V163A, N164D S8 2 GFP162-AGGS-AD-cytb-YR-GGSD-165GFP 
NFCG19 489GTG AAC496 V163G S8 2 GFP162-GGGS-AD-cytb-YR-GGS-164GFP 
NFCG2 535CTC GCC542 L178P, A179T S9 2 GFP177-PGGS-AD-cytb-YR-GGST-180GFP 
NFCG29 537GCC GAC544 D180S S9 3 GFP179-GGS-AD-cytb-YR-GGSS-181GFP 
NFCG15 562CCC ATC569 P187R, I188L S9 2 GFP186-RGGS-AD-cytb-YR-GGSL-189GFP 
NFCG21 577CCC GTG584 P192Q, V193M LP S9-
S10 
2 GFP191-QGGS-AD-cytb-YR-GGSM-194GFP 
NFCG4 577CCC GTG584 P192H, V193L LP S9-
S10 
2 GFP191-HGGS-AD-cytb-YR-GGSL-194GFP 
NFCG32 621CTG AGC628 L207P, S208G S10 2 GFP206-PGGS-AD-cytb-YR-GGSG-209GFP 
NFCG30 645CGC GAT652 D216Y S11 3 GFP215-GGS-AD-cytb-YR-GGSY-217GFP 
aDNA sequence numbering as per the egfp gene [107] 
bAmino acid numbering as per GFP [106], V2 of EGFP is numbered V1*. 
cLP signifies loop, H signifies !-helix, S signifies "-strand, N- or C- signify N- or C- 
terminal respectively. 
d ORF is the open reading frame into which the cybC DNA cassette is inserted 
ePosition of insertion within GFP denoted by subscript. Mutated residues in black, non-
underlined. Linker sequences black underlined. The sequence segment representing cyt b is 
in red with just the terminal residues shown, the rest of the sequence is denoted by ‘cytb’ 
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All 23 unique variants identified contained the cybC cassette insertion in ORF 2 
and 3 with no fluorescent variants being sampled in ORF 1 (Table 5.1). This could 
potentially be due to the fact that the additional random nucleotides in the cybC DNA 
cassettes for ORF 2 and 3 encode for an additional amino acid making the linkers 
slightly longer (Fig 5.1). Very few variants, that retained fluorescence, were identified 
during library screening of cyt b562-EGFP chimeras with a random single amino acid 
linker separating the two domains (Section 3.2.8). This is thought to be due to the 
reduced conformational flexibility, inherent to shorter linkers, impeding the correct 
folding of the EGFP domain allowing fluorescence to mature. The additional amino 
acid coded for by the random nucleotides in ORF 2 and 3 cybC cassettes (Fig 5.1) may 
provide the additional flexibility in the linking peptides between cyt b562 and EGFP 
required for the EGFP domain to fold correctly.  
From the DNA sequence analysis of the 36 fluorescent variants, 10 were 
identified to have a cybC DNA cassette insertion either out-of-frame or in the reverse 
orientation; six variants had the cybC cassette insertion out of frame and four had a 
cybC cassette in the reverse orientation. Out of frame insertions can occur due to the 
mechanism of MuDel removal by MlyI as outlined in Section 5.2.1. Due to the nature 
of blunt end ligations the cybC DNA cassette can also be inserted in a reverse 
orientation with respect to egfp. 
Despite having an out of frame or reverse cybC cassette insertion all 10 
chimeras retained fluorescence. DNA sequence analysis of these 10 variants identified 
the cybC insertion was within the last 36 bp of the egfp gene, the last 33 bp of which 
encodes an 11 amino acid dynamic C-terminal loop not required for fluorescence to 
mature (Fig 5.2) [123, 125]. Given that this region of EGFP is not required for 
fluorescence to mature the insertion of a cybC DNA cassette out of frame or in a 
reverse orientation to egfp can still result in the EGFP portion of the construct folding 
and gaining fluorescence. However, all of these variants lack a mature cyt b562 domain 
and were therefore excluded from the library with no further analysis or 
characterisation being performed. 
Of the 15 unique insertion sites identified resulting in fluorescent variants, 60% 
were located in loops, 27% were located in !-strands and 13% were located in 
xxxxxxx  
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Fig 5.2 Sequence alignment of out of frame and reverse orientation cybC cassette 
insertions in egfp. Sequence alignments for fluorescent variants identified from the cybC-
egfp-GGS library with either a cybC cassette insertion out-of-frame (top panel) with egfp 
(green) or with a cybC cassette in a reverse orientation (bottom panel) to egfp. The last 33 bp 
of egfp (red) encode for an 11 amino acid C-terminal dynamic loop not required for 
fluorescence to mature. Numbers above codons refer to the amino acid they code for in EGFP. 
Blue sequence corresponds to DNA encoding the Gly-Gly-Ser linkers, pink sequence 
corresponds to the first codon of the cybC gene (for out of frame) or last codon of cybC gene 
(reverse orientation). Non-highlighted sequence corresponds to random nucleotides encoded 
by the ORF 2 and 3 cybC DNA cassettes (Fig 5.1) 
  
 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 
EGFP CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG 
F30 CTG GAG TTC GTG ACC GTG GTG GGA GC GCA 
F05 CTG GAG TTC GTG ACC GCC GAG GTG GGA GCG CA 
F06 CTG GAG TTC GTG ACC GCC GCT CGG TGG GAG CGC A 
F15 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAG TGG TGG GAG CGC A 
F22 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC CGG TGG GAG CGC A 
F23 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC CTG GTG GGA GCG CA !!!
 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 
EGFP CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG 
F28 CTG GAG TTC GTG ACC GCT GCT CCC ACC CCT 
F38 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CGC TGC CAC CCC T 
F33 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CCT GCT CCC ACC CCT 
F29 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AGC TCC CAC CCC T 
 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 
EGFP C GA CT T C AAG
30 TG TG A GC GCA 
05 AG T GGA G G A 
F06 CTG GAG TTC GTG ACC GCC GCT CGG TGG GAG CGC A 
F15 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAG TGG TGG GAG CGC A 
F22 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC CGG TGG GAG CGC A 
F23 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC CTG GTG GGA GCG CA !!!
 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 
EGFP AG
F28 CTG GAG TTC GTG ACC GCT GCT CCC ACC CCT 
F38 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CGC TGC CAC CCC T 
F33 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CCT GCT CCC ACC CCT 
F29 CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AGC TCC CAC CCC T 
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!-helices (Table 5.1, Fig 5.3 and Fig 5.4). One of insertion sites (A154) was sampled 
five times with each cyt b562 insertion resulting in different combinations of secondary 
point mutations at the N-and C-terminal ends of the linker sequence (CG9, CG13, 
CG14, CG19, CG23) (Table 5.1). 
 Insertion sites with a single amino acid either side of residue A154 (CG17, 
CG10) were also observed suggesting this region of EGFP may be highly tolerant to 
domain insertion. This region located at the C-terminal end of "-strand 7 (Fig 5.3, Fig 
5.4) corresponds to the same !-strand observed in Chapter 4 to be tolerant to single 
amino acid deletion (Fig 4.4). Variant CG5 has cyt b562 inserted at residue S30 of 
EGFP, which is situated towards the middle of "-strand 2 (Fig 5.5). Library screening 
also identified two variants, CG1 and CG12, which are effectively classical N- and C-
terminal fusions between cyt b562 and EGFP (Table 5.1). 
Most of the tolerated insertion positions within the primary sequence of EGFP 
are distant from the chromophore forming residues. However, in the tertiary structure 
of EGFP some of the insertion sites are in close proximity to the mature chromophore 
(CG5, CG6, CG8, CG15), in particular variants CG8 and CG15, which have cyt b562 
inserted adjacent to the tyrosyl group of the chromophore (Section 5.2.4, Fig 5.5). 
Mutation around this site has previously been shown to modify the protonation state of 
the chromophore, therefore altering the spectral characteristics [34, 139, 140]. 
DNA sequence analysis of 116 non-fluorescent variants identified 33 (28%), 
with cybC inserted in frame with egfp, sampling 28 unique insertion sites. The rest of 
the variants (83) contained a cybC DNA cassette insertion out-of-frame to egfp 
resulting in premature stop codons being introduced. For this reason in depth sequence 
analysis of these variants was not performed but the cybC insertion positions have been 
included in Appendix B. In-frame cybC DNA cassette insertion into egfp resulting in 
cyt b562 domain insertion into "-strands made up the majority of sites sampled (54%), 
with 21% identified in loops and 25% located in !-helices (Table 5.2, Fig 5.3, Fig 5.4).  
As with the TND library (Chapter 4) there is a higher percentage of non-
tolerated insertions into ordered secondary structures with less insertion sites sampled 
in the loop regions. There were three non-tolerated cyt b562 domain insertions identified 
in the chromophore containing central !-helix. Domain insertions into this !-helix 
would always result in non-fluorescent variants for the obvious reason that the "-barrel 
xxxxxxx  
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Fig 5.3 Secondary structure topology for EGFP. The secondary structure topology of EGFP 
shows the arrangement of ?-strands (green), !-helices (red) and loops (black) with respect to 
one another in the folded protein. a, Tolerated cyt b562 domain insertions resulting in 
fluorescent variants are indicated by blue triangles. b, Non-tolerated cyt b562 domain insertions 
resulting in non-fluorescent variants are indicated by red triangles. 
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Fig 5.4 Tolerated and non-tolerated cyt b562 insertion positions in the tertiary structure of 
EGFP. Cartoon representation of EGFP (green) with tolerated cyt b562 insertion positions 
indicated by blue spheres and non-tolerated insertions indicated by red spheres.  
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structure would not be able to fold around another domain, therefore inhibiting 
chromophore maturation. Non-tolerated domain insertions were also identified in the 
longest loop of EGFP, which has been shown to play an important structural role for 
EGFP. Disruption of this loop by insertion of another whole domain may therefore 
reduce the structural stability or impede correct folding of EGFP. 
 
5.2.3 Sequence analysis of fluorescent and non-fluroescent cyt b562-EGFP fusion 
variants. 
Secondary substitution mutations due to cybC insertion into ORF 2 and 3 of 
egfp (Fig 5.1) were identified in 87% of the fluorescent variants. Single substitution 
mutations were sampled in 12 (52%) of the variants, three of which were at the N-
terminal side of cyt b562 with the other nine being at the C-terminal side (Table 5.1). 
Double substitution mutations, occurring at both N and C-terminal sides of cyt b562, 
took place in eight (35%) of the variants (Table 5.1). In 74% of the cases (21) the 
substitution mutations were conservative (44%) or semi-conservative (30%). All of the 
non-conserved substitution mutations (6) were at positions where the residues are 
solvent accessible and in all but 2 cases the substitution mutations were from glycines 
or hydrophobic residues to charged or polar residues.  
CybC insertions within egfp resulting in non-fluorescent variants were sampled 
in ORF 1 (13%) but less than expected, one-third, possibly indicating that this reading 
frame is under represented in the library. Secondary point mutations, due to cybC DNA 
cassette insertion into egfp, sampling ORF 2 and 3, were identified in 27 (84%) of the 
non-fluorescent variants. In contrast to the fluorescent variants much lower percentages 
of the substitution mutations were conserved or semi conserved (29% and 21% 
respectively). A high proportion of the substitution mutations (26%) involved the 
substitution of proline residues. Substitution of two solvent exposed proline residues in 
three different variants (NFCG4, NFCG15, NFCG21) to charged or polar residues 
were identified and six different variants had residues replaced by a proline. Due to the 
restricted backbone torsion angles inherent to proline, efficient and correct folding of 
the chimeric proteins may be affected.  
One unique insertion site was sampled by both a fluorescent variant (CG5) and 
a non-fluorescent variant (NFCG17) (Table 5.1 and 5.2) the only difference being a 
single substitution mutation, S30Y, in the non-fluorescent variant. The side chain of 
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S30 is solvent exposed therefore substitution for the bulky side chain of tyrosine may 
hinder correct folding and potentially promote aggregation during folding.  
DNA sequence analysis revealed that CG6 was the only variant not to contain 
the full GlyGlySer linker at the C-terminus of cyt b562; the C–terminal Gly-Ser are not 
present leaving only a single glycine as the C-terminal linker between cyt b562 and 
EGFP.  
 
5.2.4. Spectral characterisation of selected cyt b562-EGFP integral fusion variants. 
Cyt b562-EGFP domain insertion variants CG1-CG12 and CG15 (Fig 5.5 and 
Table 5.1) were selected for more detailed spectral characterisation to investigate their 
fluorescence and absorbance properties. The properties of EGFP fluorescence and cyt 
b562 absorbance spectra are related to their function and any potential coupling between 
the two domains.  
To characterise the spectral properties of EGFP and the selected cyt b562-EGFP 
chimeras, protein was produced in E. coli TUNER™ (DE3) cell cultures grown in M9 
minimal media (Section 2.5.4). A limited growth media is required for expression of 
the cyt b562-EGFP chimeras to produce protein in the apo form, as when produced by 
E. coli in rich media (LB) a high proportion of the protein is in the holo haem bound 
form, which hinders haem titration studies (Section 2.6.1.2). Excitation and emission 
spectra of the relevant proteins in crude cell lysates were then measured to identify if 
cyt b562 domain insertions have altered the spectral properties of the EGFP domain. 
The majority of the cyt b562-EGFP variants had excitation and emission spectra 
comparable to that of EGFP with excitation and emission maxima of ~488 nm and 
~511 nm respectively (Figure 5.6 and Table 5.3). Cyt b562-EGFP chimeras CG8 and 
CG15 both exhibited altered spectral characteristics with excitation maxima (!ex) at 
two different wavelengths: ~400 nm and ~488 nm (Fig 5.7). They also had a slightly 
red shifted emission maxima of ~ 513 nm (Fig 5.7 and Table 5.3), when excited at 400 
nm. The altered spectral properties are due to a change in the proportion of the 
chromophore being in the protonated state. The 400 nm excitation maximum is thought 
to be due to the phenol group of Tyr66 being protonated whilst the 488 nm excitation 
maximum is thought to be due to deprotonation of the phenol group (Fig 5.7) [62].  
  
 
 
 
Fig 5.5 Selected cyt b insertion positions within EGFP. Selected positions within the tertiary structure of EGFP (green cartoon) tolerant to cyt b562 insertion 
(blue spheres) are highlighted. Variants CG8 and CG15 have cyt b insertions tolerated between residues N146 and S147, in very close proximity to the 
chromophore (sticks in CPK).  
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Fig 5.6 Excitation and emission spectra for EGFP and selected cyt b562-EGFP chimeras. Excitation spectra (left panel) were measure while monitoring 
emission at 510 nm and emission spectra (right panel) were measure after excitation at 488 nm.   
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Fig 5.7 Excitation and emission spectra for cyt b562-EGFP chimeras CG8 and CG15. Excitation spectra (left panel) were measure while monitoring 
emission at 510 nm and emission spectra (right panel) were measure after excitation at either 400 nm (solid lines) or 488 nm (dotted lines). Chemical 
structures for the chromophore in the protonated and deprotonated state are shown above the excitation maximum they are thought to be responsible for. 
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 In order to establish if cyt b562 domain insertion had affected the fluorescent 
properties (molar extinction coefficient, quantum yield) of EGFP, measurements on 
purified protein samples were performed. EGFP and the cyt b562-EGFP integral fusion 
scaffolds were produced in E. coli TUNER™ cells as described above and in section 
2.5.4. The cell cultures containing the different cyt b562-EGFP integral fusion 
scaffolds were lysed by French press and clarified by centrifugation (Section 2.5.5). 
The cyt b562-EGFP integral fusion scaffolds were deemed to be in the soluble fraction 
after cell lysis by their observable green colour. The samples were then purified using 
a combination of techniques; (1) fractionation by ammonium sulphate precipitation, 
(2) anion exchange chromatography, (3) gel filtration and (4) another round of anion 
exchange. A detailed description of each purification step has been covered in section 
2.5.8. 
Molar absorption extinction coefficients and quantum yields were determined 
for selected cyt b562-EGFP chimeras (Table 5.3) to see if cyt b562 domain insertion had 
altered the EGFP derived spectral properties. The molar absorption extinction 
coefficients for the majority of the variants were comparable to that of EGFP (55,000 
M-1cm-1) (Table 5.3). Both CG6 and CG12 showed a small decrease in molar 
extinction coefficient to ~46,500 M-1cm-1 and ~46,600 M-1cm-1 respectively (Table 
5.3). Given that the molar extinction coefficients for these variants are very similar to 
that of EGFP indicates that the cyt b562 domain insertion has not affected the overall 
structure of EGFP.  
In contrast both CG8 and CG15 showed decreased molar absorption extinction 
coefficients at ~400 and ~ 488 nm (Table 5.3). The molar absorption extinction 
coefficients for CG8 are ~27,100 M-1cm-1 and ~18,900 M-1cm-1 at 400 or 488 nm 
respectively whilst for CG15 they are ~26,500 M-1cm-1 and ~19,800 M-1cm-1. It is not 
surprising that the molar absorption extinction coefficients have been affected given 
that the cyt b562 domain is inserted between residues N146 and S147 of EGFP, 
adjacent to the phenolate group of the chromophore (Fig 5.5).  
For the majority of the cyt b562-EGFP integral fusion scaffolds the quantum 
yield was very similar to that of EGFP (0.6) (Table 5.3). Therefore, brightness values 
for CG1, CG4, CG5 and CG10 were comparable to that of EGFP (33,000 M-1cm-1) 
showing that domain insertion had not affected the fluorescence properties in these 
xxxxx 
 
 
Table 5.3 Spectral characteristics for EGFP and cyt b562-EGFP chimeras8 
Variant !ex (nm)a 
!em 
(nm)a " (M
-1cm-1)b #c Brightness (M-1cm-1)d 
Fluorescence lifetime (ns)e 
Fold differencef 
Holo-chimera 
!max (Ox/Red) 
(nm)g 
HaemOx Kd 
(nM)h 
$apo $holo 
eGFP 488 510 55000 0.6 33000 2.47 2.48 - - - 
CG1 487 508 54550±3950 0.61 33275 2.38 1.64 1.5 417/426 11.5±1.4 
CG2 486 510 - - - - - 2.5 - 105.7±16.5 
CG3 487 510 - - - - - 1.3 - 17.0±2.8 
CG4 486 510 54290±3180 0.59 32030 2.5 1.57 1.9 418/426 16.5±3.2 
CG5 487 509 54350±5990 0.63 34240 2.51 1.67 1.8 418/426 49.3±11.7 
CG6 488 510 46510±2790 0.64 29770 2.47 - >25 422/426 11.0±1.8 
CG8 400 (487) 
514 
(513) 
27140±3310 0.34 6820 - - 1.7 418/426 38.2±5.5 (18920±5210) 
CG9 486 510 - - - - - 1.5 - 13.7±0.5 
CG10 486 510 53700±2190 0.59 31680 2.37 0.6 1.6 418/426 12.1±0.5 
CG11 486 511 - - - - - 1.4 - 8.6±0.2 
CG12 486 511 46570±2590 0.61 28410 2.39 1.8 1.7 415/426 11.8±1.0 
CG15 488 (402) 
512 
(515) 
19810±2980 0.37 8050 - - 1.7 - 417/426 - (26537±1750) 
Cyt b562 - - - - - - - - 418/427[141] ~10[76] 
a !
 ex and ! em determined from fluorescence spectra. Red values in brackets refer to the less intense maxima 
b Extinction coefficient determined from minimum of 3 absorbance measurements at 488 nm, error is a single standard deviation. Red values in brackets are 
extinction coefficients determined at the corresponding !ex in brackets. 
c Quantum yield determined from integrated fluorescence emission after excitation at 488 nm against a fluorescein standard. 
d Brightness = extinction coefficient x quantum yield, 
e Fluorescence lifetimes are mean values with errors calculated from the standard deviation of 3 measurements where $apo and $holo are the fluorescence lifetimes in the 
absence and presence of equimolar haem respectively 
f Fold difference in fluorescence emission at 510 nm after excitation at 488 nm with equimolar concentrations of protein:haem under oxidising or reducing conditions. 
g !max values determined from UV-visible absorption spectra 
h Kd determined from haem mediated fluorescence quenching data under oxidising conditions 
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variants. CG6 and CG12 had slightly reduced brightness (29,770 and 28410 M-1cm-1 
respectively). due to a decrease in the EGFP chromophore molar absorbance 
coefficient (Table 5.3). 
The quantum yields determined at 488 nm for variants CG8 and CG15 were 
decreased by almost two-fold with respect to EGFP (Table 5.3). This is probably due 
to disruption of the local structure around residues N146 and S147 in the EGFP 
domain due to cyt b562 domain insertion, consequently allowing solvent to access the 
interior of the !-barrel partially quenching the excitated state chromophore. Therefore, 
variants CG8 and CG15 have much lower brightness compared to that of EGFP (6820 
and 8050 M-1cm-1 respectively) due to greatly decreased molar absorption extinction 
coefficients and reduced quantum yields upon excitation at 488 nm (Table 5.3). In 
order to establish the brightness for CG8 and CG15 at 400 nm, quantum yield 
determination would be required against a 9-aminoacridine standard, which absorbs 
maximally at 400 nm, rather than the fluorescein standard used here.  
 
5.2.3 Confirming cyt b562 domain integrity in cyt b562-EGFP integral fusion 
scaffolds 
The observed fluorescence for the selected cyt b562-EGFP integral fusion 
scaffolds indicates that the EGFP domain was correctly folded; the !-barrel structure 
is a prerequisite for fluorescence [142]. However, to determine if the inserted cyt b562 
domain was correctly folded and if insertion into EGFP alters the haem binding 
properties, UV-Visible spectroscopy was used to analyse the variants in the presence 
and absence of haem. Wild type cyt b562 has characteristic UV-Visible absorption 
spectra when haem is bound under oxidising conditions with a "max of 418 nm (Table 
5.3). When haem is bound to cyt b562 under reducing conditions there is an increased 
absorption and red shifted "max to 427 nm (Table 5.3) with two smaller absorption 
maxima at 531 and 562 nm [141]. 
Insertion of cyt b562 into EGFP has not had an effect on the cyt b562 domains 
ability to bind haem and all variants display classic absorption characteristics, for both 
domains, when under oxidising and reducing conditions (Table 5.3). The UV-visible 
absporption spectrum for EGFP shows the classic absorbance maximum at 488 nm 
(Fig 5.8). Addition of haem to EGFP at an equimolar concentration under oxidising 
xxx 
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Fig 5.8 UV-visible absorption spectra for EGFP and cyt b562-EGFP chimeras. Absorption 
spectra were measured for 5 µM of purified apo-protein samples (black lines) and in the 
presence of equimolar haem under oxidising (solid red line) or reducing (dotted red line) 
conditions. Titration of haem with EGFP presents the two characteristic absorption spectra: 
EGFP and free haem in solution. The terminal fusion, between cyt b562 and EGFP (CG1) and 
the integral fusion CG6 exhibit characteristic absorption spectra for EGFP and for haem 
bound to cyt b562 under reducing and oxidising conditions.  
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and reducing conditions presented a mixture of the EGFP spectra and the absorbance 
spectra for free haem in solution, showing that haem does not bind to EGFP alone 
(Fig 5.8). 
All of the selected cyt b562-EGFP chimeras bind haem as is evident from the 
characteristic absorption spectra of haem bound to cytochrome (Fig 5.8) with !max 
values of ~417 nm and ~427 nm for oxidising and reducing conditions respectively 
(Table 5.3). Variant CG6 had a slightly red shifted !max, under oxidising conditions, 
of 5 nm with respect to wild-type cyt b562 and the other cyt b562-EGFP chimeras 
(Table 5.3, Fig 5.8). This may imply that the local environment around the haem is 
altered in CG6 with respect to wild type cyt b562 and the other cyt b562-EGFP 
chimeras. 
 
5.2.4 Effect of haem binding on EGFP derived fluorescence. 
Haem binding to cyt b562 should result in quenching of EGFP fluorescence 
through energy transfer [82]. To investigate the extent and efficiency of haem binding 
to the cyt b562 domain on EGFP fluorescence, haem was titrated into crude cell lysates 
containing the chimeric proteins and the fluorescence monitored at 511 nm on 
excitation at 488 nm. Titration of haem resulted in a general decrease in fluorescence 
intensity (Fig 5.9). However, there were differences in the extent of decrease between 
different variants and whether reducing or oxidising conditions were used.  
The extent of quenching of EGFP fluorescence on haem titration was 
dependent on the chimera (Fig 5.9). Under reducing conditions, the terminal fusion 
chimeras CG1 and CG12 retained 37% and 28% of their fluorescence in a five-fold 
excess of haem. Thus, total energy transfer was not possible in these chimeras, which 
represent the traditional approach to the construction of GFP fusions. CG11, with cyt 
b562 inserted close to the EGFP C-terminus, showed similar results to the terminal 
fusion proteins with its fluorescence maximally quenched by 58% when 15 nM haem 
was added under reducing conditions (Fig 5.9). 
CG7 has cyt b562 inserted within a loop connecting "-strand 3 to the central #-
helix containing the chromophore and also showed similar results to the terminal 
fusion proteins. In the presence of ~1.5 fold more haem than the terminal fusions CG7 
xxxxxxx  
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Fig 5.9 Haem-dependent fluorescence changes of cyt b562-EGFP chimeras. Decrease in 
fluorescence on haem addition under reducing (solid line) and oxidising (dashed line) 
conditions. Haem mediated fluorescence quenching results for variants CG7 - CG12 are 
shown on the next page. 
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Fig 5.9 continued. Haem-dependent fluorescence changes of cyt b562-EGFP chimeras. 
Decrease in fluorescence on haem addition under reducing (solid line) and oxidising (dashed 
line) conditions. 
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showed maximal quenching of 60% under reducing conditions (Fig 5.9). CG9 and 
CG10 have cyt b562 inserted only a single amino acid away from one another (Table 
5.1) at the C-terminal end of !-strand 7. Both were maximally quenched in the 
presence of similar concentrations of reduced haem as the terminal fusion proteins, 20 
nM and 25 nM for CG9 and CG10 respectively, retaining 38% and 30% of their 
fluorescence respectively (Fig 5.9).  
Variants CG3 and CG5 were maximally quenched by 76% and 75% 
respectively although required two-fold and three-fold more haem to achieve full 
quenching with respect to the terminal fusions CG1 and CG12, implying that the 
haem binding characteristics for these variants have been altered by cyt b562 domain 
insertion into EGFP (Fig 5.9).  
Variant CG6 showed the most promising haem mediated switching 
characteristics with only 3% of its total fluorescence remaining on the addition of 20 
nM reduced haem (Fig 5.9). CG6 reaches maximal fluorescence quenching at similar 
concentrations of reduced haem to that of the terminal fusions, implying that insertion 
of cyt b562 at Y39 of EGFP has not affected haem-binding affinities. 
The fluorescence of variant CG2, with cyt b562 positioned within the first !-
helix of EGFP (Fig 5.5), was also quenched to a much greater extent than the other 
integral fusion variants. Only 7% of fluorescence intensity remained in the presence 
of excess haem  (Fig 5.9). However, ten-fold more haem was required to reach this 
maximal quenching with respect to CG1. CG4 was another variant that displayed a far 
greater extent of fluorescence quenching than the other variants, with only 7% of 
fluorescence intensity observed in excess haem (Fig 5.9). However, as with CG2 a 
higher concentration (three-fold) of haem was required to reach full quenching. This 
suggests that haem binding to the cyt b562 domain or the fluorescent properties of the 
EGFP domain have been altered by domain insertion and are compromised in CG2 
and CG4 compared to CG6 and the terminal fusion variants. 
 
5.2.5 Redox mediated fluorescence quenching. 
All variants exhibited a difference in concentration-dependence haem 
mediated quenching under reducing and oxidising conditions (Fig 5.9). Under 
reducing conditions, the decrease in fluorescence at 511 nm on increasing haem 
concentration did not follow that of a typical equilibrium binding curve profile (Fig 
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5.9). There is a rapid decrease in fluorescence during titration of reduced haem with 
the chimeras exhibiting a sharp transition at the point where it is estimated that 
protein and haem concentration are at a 1:1 ratio (Fig 5.10 a). At this ratio all binding 
sites are considered to be occupied by haem. Given that all protein samples were 
normalised to a starting fluorescence intensity of 100 a.u, confirmed to be ~20 nM for 
the majority of variants, the high affinity of reduced haem for the wild type cyt b562 
(~10 pM) appears to have been retained by most of the cyt b562-EGFP integral fusion 
scaffolds. 
Under oxidising conditions the haem mediated quenching profiles resemble 
those under equilibrium (Fig 5.9). As mentioned previously, observation that some of 
the variants required higher concentrations of haem to reach maximal quenching 
implies that the haem binding characteristics of these variants have been 
compromised by insertion of cyt b562 into EGFP. This was confirmed by calculating 
Kd values for oxidised haem binding to the cyt b562-EGFP variants from the 
fluorescence titration data (Table 5.3) (Section 2.6.1.13). CG1, CG12 and CG6 all had 
comparable Kd values (~11 nM) to that of wild type cyt b562 (~10 nM) confirming 
these variants had maintained the high affinity for oxidised haem.  
Variants CG5 and CG8 showed a marked decrease in haem affinity for the cyt 
b562 as was apparent from their Kd values of ~49 nM and ~38 nM respectively. In 
particular variant CG2 exhibited an almost ten-fold increase in its Kd value (~105 nM) 
with respect to wt cyt b562 (Table 5.3). 
Comparison of the remaining fluorescence intensity of each variant under 
reducing and oxidising conditions, when the apparent [protein]:[haem] = 1:1 (Fig 5.10 
a), was performed to assess the potential for the chimeras to act as redox sensors. All 
variants showed between a ~1.5 to ~1.9 fold difference in the levels of remaining 
fluorescence (Fig 5.10 b, Table 5.3), apart from variant CG6 which showed up to a 
>25-fold difference in remaining fluorescence between oxidising and reducing 
conditions.  
Variants CG2, CG4 and CG6 all have insertion positions clustered together in 
the tertiary structure of EGFP (Fig 5.5) and all result in almost 100% quenching of 
fluorescence when titrated with haem to saturation. However, the near 100% 
quenching upon haem binding, the >25 fold difference in remaining fluorescence 
between oxidising and reducing conditions, whilst maintaining similar haem binding   
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Fig 5.10 Differential haem mediated quenching under oxidising and reducing conditions. 
a. Comparison between the remaining fluorescence under oxidising and reducing conditions 
was carried out when an apparent [protein]:[haem] of 1:1 was reached. The example titration 
curves used are for the cyt b562-EGFP chimera CG6 b. Remaining fluorescence intensity 
under oxidising and reducing conditions for all cyt b562-EGFP variants.  
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affinities to wt cyt b562 makes CG6 an attractive variant for the use as a tailor made 
energy transfer component with the potential to act as a redox sensor. 
 
5.2.6 Oxidant induced fluorescence switching. 
Given that variant CG6 exhibited the largest difference (>25 fold) between 
fluorescence under oxidising and reducing conditions (Fig 5.10 b, Table 5.3), it could 
be considered as a sensor for redox conditions. Therefore, the ability of CG6 to 
monitor changes to redox conditions was assessed in vitro. A slight excess of haem 
(30 nM) was added to CG6 (20 nM) under reducing conditions (1 mM ascorbic acid) 
inducing rapid almost total quenching of fluorescence (Fig 5.11 a). Different oxidants 
were then applied to holo-CG6 to assess its ability to sense changes in redox 
conditions by haem dissociation and monitoring gain in signal through relieving 
fluorescence quenching (Fig 5.11 a and b). KNO3 or NaOCl had no effect on 
fluorescence intensity (Fig 5.11 b) but the common biologically important reactive 
oxygen species (ROS), H2O2, relieved quenching eventually restoring the original 
level of fluorescence (Fig 5.11 a). 
When no oxidant was added the fluorescence intensity essentially remained 
zero for CG6 (Fig 5.11 a). As the other oxidants used, KNO3 and NaOCl, did not 
relieve quenching, CG6 could potentially act as a H2O2 specific sensor. UV-Visible 
absorption spectra confirmed that haem was bound to CG6 before the addition of 
H2O2 (Fig 5.11 c). Absorption spectra measured 2 hrs and 20 hrs after the addition of 
H2O2 confirmed the dissociation of haem from CG6 (Fig 5.11 c). As haem showed 
little dissociation from CG6 in the presence of KNO3 or NaOCl, H2O2 may be 
exerting its effect by chemical modification of haem rather than altering the iron 
moiety redox state. Oxidative cleavage of haem has been seen in previous studies 
[77]. 
In comparison, CG1 only lost 54 % of fluorescence on haem addition in the 
presence of 1 mM ascorbate. On the addition of H2O2 a rapid recovery of fluorescence 
(Fig 5.11 d) was observed. Fluorescence data obtained from the oxidant induced 
fluorescence switching of CG1 and CG6 on the addition of H2O2 were fit to a single 
exponential function (Section 2.6.1.3) to determine the rate of fluorescence gain. CG6 
exhibited a rate constant for the gain in fluorescence signal after the addition of H2O2 
of 0.52 min-1 where as CG1 showed a rate constant >14-fold faster of 7.47 min-1.  
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Fig 5.11 Oxidant induced fluorescent switching. a, Addition of a slight excess of haem (30 
nM) to CG6 (20 nM) under reducing conditions (1 mM ascorbic acid) induced rapid 
fluorescence quenching followed by the addition of 0.02% (v/v) H2O2 to induce oxidising 
conditions (dotted line). CG6 fluorescence in the absence of added oxidant added is shown as 
a black line. b, addition of oxidants, KNO3 (black line) or NaOCl (red line). c, UV-visible 
absorption spectra for CG6 measured before (solid line) and 10 minutes after the addition of 
haem (long dashed line). Spectra were then measured 2 hrs (short dashed line) and 20 hrs 
(dotted line) after the addition of H2O2. d, Addition of a slight excess of haem (30 nM) to 
CG1 (20 nM) under reducing conditions (1 mM ascorbic acid) induced rapid fluorescence 
quenching followed by the addition of 0.02% (v/v) H2O2 to induce oxidising conditions 
(dotted line). 
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This could be due to the different orientations of the cyt b562 domains in the 
CG1 terminal fusion and the CG6 integral fusion to EGFP; in the terminal fusion the 
two domains are probably highly dynamic with respect to one another allowing the 
solvent to freely access the bound haem moiety, where as in CG6 the cyt b562 domain 
may be positioned such that the bound haem moiety is less solvent exposed. 
Control titrations of ascorbic acid or H2O2 with apo-CG6 were carried out to 
confirm that these reagents had no effect on CG6 fluorescence emission (Fig 5.12) 
and that the changes in fluorescence seen in the oxidant induced switching 
experiments was due to haem dissociation. 
 
5.2.7 Effect of haem binding on EGFP derived fluorescence lifetimes 
To further investigate the effects of haem binding on the EGFP derived 
fluorescence properties of the cyt b562-EGFP integral fusion scaffolds, fluorescence 
lifetimes were measured in the absence and presence of equimolar concentrations of 
haem under reducing conditions. In the absence of haem, all cyt b562-EGFP chimeras 
have comparable fluorescence lifetimes to that of EGFP (~2.47 ns) (Table 5.3). This 
implies that the cyt b562 domain insertions are well tolerated in EGFP and there has 
been little disruption of the chromophores local environment.  
In the presence of haem, the fluorescence lifetime for EGFP was not altered 
(Fig 5.13), agreeing with previous results (Fig 5.8) and control titrations (Section 
5.2.8, Fig 5.14) that haem does not bind to EGFP alone or quench EGFP fluorescence 
when in solution. Binding of haem to the cyt b562-EGFP chimeras resulted in a 
decrease in fluorescence lifetime (Table 5.3 and Fig 5.13). The majority of the 
chimeras displayed ~1.6 fold decrease in their fluorescence lifetimes with CG10 
showing a marked decrease of almost four-fold (Fig 5.13 and Table 5.3). The 
fluorescence lifetime for holo-CG6 could not be measured as the fluorescence signal 
is essentially zero in the presence of haem due to near 100% quenching.  
However, variant CG4, which also showed >95% quenching on haem binding 
(Fig 5.9), only showed a decrease in its fluorescence lifetime of ~1.5 fold. These 
results agree with the notion that the haem binding properties of the cyt b562 domain in 
CG4 have been affected by insertion into EGFP, as a fluorescence lifetime was still 
detectable in the presence of equimolar reduced haem.  
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Fig 5.12. Effect of ascorbic acid or H2O2 on the fluorescence emission of apo CG6. a, 
CG6 fluorescence emission spectra in the absence (black line) and presence (red dashed line) 
of 1 mM ascorbic acid. b, CG6 fluorescence emission spectra in the absence (black line) and 
presence (red dashed line) of 0.02% (v/v) H2O2. Emission spectra were measured after 
excitation at 488 nm. 
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Fig 5.13 Fluorescence lifetime measurements of apo and holo cyt b562-EGFP variants. 
Fluorescence lifetime measurements were made by fitting single exponential functions 
(green) to fluorescence lifetime data (black dots) after data reconvolution with the instrument 
response function (red dots). Fluorescence decays for EGFP, CG1 and CG10 are shown here 
in the absence and presence of equimolar concentrations of haem. Haem had no effect on the 
fluorescence lifetime of EGFP concurrent with previous haem effects on EGFP.  
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Given that CG10 had 30% remaining fluorescence in the presence of an excess of 
reduced haem (Fig 5.9), similar to that of other variants (Fig 5.9), the observation that 
its fluorescence lifetime decreases four-fold with equimolar reduced haem (Table 5.3 
and Fig 5.13) implies there may be a structural change upon haem binding coupled to 
the quenching effects. 
The observation that CG6 fluorescence intensity is quenched by almost 100% 
in the presence of equimolar concentrations of reduced haem with an undetectable 
fluorescence lifetime, under the same conditions, identifies it as an artificial protein 
scaffold capable of 100% energy transfer between its two chromophores. This 
artificial protein scaffold exhibits similar energy transfer efficiencies to naturally 
occurring light harvesting systems.  
 
5.2.8 EGFP control titrations. 
To show that the observed changes in fluorescence seen in all titration 
experiments are due to haem binding to the cyt b562 domains of the chimeric proteins 
and not any other reagents, control titrations were performed with EGFP. The 
addition of haem to wild-type EGFP resulted in no change in fluorescence (Fig 5.14 
a). Addition of NaOH (used to dissolve haem) (Fig 5.14 b), KNO3 (Fig 5.14 c) or 
ascorbic acid (Fig 5.14 e) (used to give oxidising or reducing conditions, respectively) 
to EGFP resulted in no change in fluorescence. Therefore any changes seen in 
chimera fluorescence can be attributed to haem binding to the cyt b562 domains. 
 
5.3 Discussion. 
Integral to synthetic biology is the construction of artificial protein scaffolds 
for the use as genetically encoded biomolecular switches [129, 130]. The functional 
coupling of two disparate proteins would be most advantageous for the creation of a 
diverse number of artificial protein scaffolds for uses in natural and synthetic 
applications [132-134]. Biomolecular switches are sampled by nature during 
evolution, quite often with integral domain fusion architecture (~9% of known 
structures in the PDB) [24, 25].  
Insertion of one protein domain into another creates an intimate structural 
linkage by which changes in one domain can be communicated through to another. 
xxx  
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Fig 5.14. Emission spectra for EGFP under various conditions. Emission spectra for 
EGFP were measured in the absence (black line) and presence (red dashed line) of a, haem (1 
uM), b, NaOH (50 uM), c, ascorbic acid (1 mM) or d, KNO3 (1 mM) to confirm any changes 
in fluorescence seen during haem titration is due to haem binding to the cyt b562 domains and 
not due to other reagents used in the experiments. Fluorescence was monitored at 510 nm 
after excitation at 488 nm for EGFP alone (black line) or in the presence of reagent (red line).  
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The nature of integral fusion architecture also can fix the position of one domain with 
respect to another in contrast to domains terminally fused together, which have the 
potential to move and rotate freely with respect to one another. The process of 
identifying sites within a target protein that will not only tolerate the insertion of 
another protein domain but also will functionally link the two is very difficult.  
Rational design of new protein scaffolds by domain insertion has seen some 
success but with resulting chimeras exhibiting only modest switching magnitudes [32, 
34, 35]. Directed evolution approaches to creating artificial protein scaffolds allows 
for chimeras with desired characteristics to be identified out of diverse libraries of 
constructs. Previous studies linking the haem binding properties of cyt b562 to the 
antibiotic resistance protein TEM-1 !-lactamase (TEM-1) using a directed evolution 
approach not only identified sites within TEM-1 tolerant to cyt b562 domain insertion 
that may not have been identified using a rational approach but also identified variants 
with impressive switching magnitudes of up to 128-fold [31, 37].  
Using a directed evolution approach here we have described the construction 
and characterisation of integral fusion protein scaffolds, between cyt b562 and EGFP, 
which act as efficient energy transfer scaffolds and redox-dependent switches. A 
diverse number of insertion sites within EGFP tolerant to cyt b562 insertion were 
identified. As expected the majority of the tolerated insertion positions were located 
in the loop regions connecting the secondary structures thereby not disrupting the !-
barrel fold of EGFP. However, several insertion sites were identified in !-strands, "-
helices and a tight turn that may not have been chosen by rational design approaches. 
The power of the directed evolution approach described earlier (Chapter 3) to 
implement domain insertion is the ability to design peptides that link the two domains 
at the site of insertion. Where as other available transposon based techniques that 
involve carrying the DNA cassette encoding the insert domain within the transposon 
results in the linker sequences being encoded by the transposase recognition elements 
and the target site duplication [41, 42]. Previous work has shown that length, 
flexibility and hydrophilicity of the linking peptides can play a major role in the 
tolerance to domain insertion and switching magnitude obtained from functionally 
coupled variants [31, 37, 143]. Short linkers have been shown to reduce the tolerance 
of EGFP to cyt b562 insertion (Chapter 3, Section 3.2.8) probably due to reduced 
conformational flexibility for the correct and efficient folding of the EGFP domain. 
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However, short linkers were also shown to have a positive effect on the switching 
magnitudes obtained from cyt b562-TEM-1 integral fusion chimeras [31, 37].  
DNA sequence analysis identified one variant, CG6, which had the GlyGlySer 
tripeptide linker at the N-terminal end of the cyt b562 domain but just a single Gly 
residue at the C-terminal end of cyt b562 (Table 5.1). The difference in linker length 
separating the two domains of this integral fusion scaffold, with respect to the other 
cyt b562-EGFP chimeras, could account for the increased levels of fluorescent 
quenching (up to 100%) upon haem binding. This is potentially due to the shorter 
linker reducing the conformational flexibility between the two domains and orienting 
the cyt b562 domain in an optimal position such that the two chromophores (EGFP 
chromophore and haem) are in close proximity for optimal energy transfer. The nature 
and consequence of this shorter linker is described in more detail in Chapter 6.  
 
5.3.1 Tolerance of EGFP to cyt b562 domain insertion 
Unlike with the TND library variants there is less of a clear boundary between 
tolerated and non-tolerated insertion sites when viewed with respect to the secondary 
structure topology (Fig 5.4) and tertiary structure (Fig 5.5) of EGFP. In the TND 
library (Chapter 4) there was a very obvious divide between amino acid deletions 
being tolerated in loops and towards the ends of the !-barrel structure, with the non-
tolerated deletions concentrated to the !-strands (Chapter 4, Fig 4.4 and Fig 4.5).  
Tolerated domain insertions were identified in ordered secondary structures 
(Fig 5.3), and non-tolerated domain insertions identified in the loops towards the end 
of the !-barrel. Domain insertion can be considered a major mutational event that 
breaks up the continuity of the peptide backbone of the accepting domain. Without a 
very detailed knowledge of the accepting domain it is almost impossible to identify 
sites that will or wont tolerate a domain insertion, retain the functions of both domains 
and result in functional coupling of the two domains. Although dogma suggests loops 
are more tolerant to mutational events due to their inherent conformational flexibility 
they may also be crucial in forming on pathway folding intermediates, or stabilizing 
the parent domain.  
For these reasons it is important to use a directed evolution approach to 
domain insertion so that variants can be identified that do retain functionality and 
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exhibit functional coupling. Screening through libraries of proteins also allows for the 
identification of variants that exhibit the highest switching magnitudes.  
 
5.3.2 Effect of cyt b562 domain insertion on EGFP spectral characteristics 
Apart from cyt b562 domain insertions adjacent to the chromophore (CG8 and 
CG15) of EGFP, the spectral properties remained unaltered for all variants with only 
minor decreases in brightness due to reduced molar absorption coefficients or 
quantum yields. This implies that cyt b562 domain insertion is well tolerated in the 
variants studied here with little disruption to the overall fold of the EGFP domain or 
the chromophores local environment.  
In the case of CG8 and CG15, cyt b562 domain insertion between residues 
N146 and S147 in !-strand 7 of EGFP (Fig 5.5) resulted in altered spectral properties 
(Fig 5.7). There is a complex hydrogen bonding network involving residues in !-
strands adjacent to the chromophore and the chromophore itself (Chapter 1, Fig 1.12 
b) [62]. The hydrogen-bonding network in EGFP maintains the chromophore in the 
deprotonated state resulting in a single excitation maximum at 488 nm. Disruption of 
the hydrogen-bonding network can promote the protonation of the phenolate of Tyr66 
giving rise to the 400 nm excitation maximum [62]. Given that residues N146 and 
H148 are important for stabilizing the phenolate in its anionic form it wouldn't be 
surprising if cyt b562 domain insertion between N146C and S147 had affected the 
hydrogen-bonding network and therefore altered the spectral properties.  
 
5.3.3 Effect of haem binding on EGFP derived fluorescence properties 
The functionality of the cyt b562 domain was maintained in all variants, 
confirmed by UV-visible absorption spectroscopy (Fig 5.8), with functional coupling 
also observed for all variants (Fig 5.9). In the presence of haem, EGFP derived 
fluorescence for all of the cyt b562-EGFP integral fusion scaffolds was quenched (Fig 
5.9). The extent to which the fluorescence was quenched for each variant was 
dependent on the position of cyt b562 domain insertion. 
Binding of haem to the cyt b562-EGFP integral fusion scaffolds also resulted in 
a decrease of the EGFP derived fluorescence lifetimes (Fig 5.13). The majority of the 
variants exhibited a ~1.5 fold decrease in their fluorescence lifetime in the presence of 
equimolar haem (Table 5.3), except for variant CG10 which showed a ~four-fold 
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decrease in its fluorescence lifetime (Fig 5.13, Table 5.3). Given that variant CG10 
was quenched to a similar extent as other cyt b562-EGFP chimeras in the presence of 
equimolar haem (Fig 5.9) it stands to reason that the increased fold change in 
fluorescence lifetime upon haem binding may be mediated through structural effects 
as well as quenching via energy transfer.  
The cyt b562 domain of CG10 is inserted between residues A154 and D155 at 
the end of !-strand 7 (Fig 5.15). There are two residues, N146 and H148 that are a 
part of !-strand 7 and form part of the extensive hydrogen bonding system with the 
fluorophore (Fig 5.15 and Fig 1.12 b). Possible structural changes upon binding of 
haem to the cyt b562 domain of CG10 may be propagated down !-strand 7 disrupting 
the structural integrity of the !-barrel, and affecting the hydrogen bonding network 
between residues in !-strand 7 and the chromophore (Fig 5.15). Alterations in the 
hydrogen bonding nework upon haem binding may be apparent by changes in the 
spectral characteristics of CG10 however given that haem quenches fluorescence 
these may not be detectable.  
Previous studies on changes to a cyan fluorescent proteins (CFP) fluorescent 
lifetime upon interaction with ATP highlighted the importance of the residue H148 on 
maintaining the fluorescence lifetime properties [144]. Therefore similar mechanisms 
may be taking effect in CG10 altering its fluorescence lifetime. It would be interesting 
to investigate the fluorescence lifetimes of variants CG8 and CG15, which also have a 
cyt b562 domain inserted within !-strand 7 but in closer proximity to H148 than in 
CG10, to see if similar decreases in fluorescence lifetimes are detected for these 
variants. 
 
5.3.4 CG6 redox sensing properties 
The results from haem mediated effects on fluorescence intensity (Fig 5.9) and 
fluorescence lifetime (Section 5.2.7) identified variant CG6 as an optimal energy 
transfer scaffold with respect to the other cyt b562-EGFP chimeras. Previous attempts 
to construct artificial energy transfer scaffolds [33, 82, 138], by terminal fusion of 
fluorescent proteins to cyt b562 domains, have only resulted in systems with a modest 
65% energy transfer efficiency. The energy transfer scaffold, CG6, identified here can  
xxxxxxxxxx  
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Fig 5.15 CG10 cyt b domain insertion position in eGFP. a, Variant CG10 has a cyt b562 
domain inserted at D155 (blue sphere) of EGFP (cartoon). D155 is the last residue in !-strand 
7 (orange), which contains important residues (sticks, CPK) for maintaining the hydrogen 
bonding network with the chromophore. b, Part of the hydrogen bonding network (black 
dashed lines) between residues in !-strands 7 and 8, a highly conserved water molecule (red 
sphere) and the chromophore. The chromophore and residues are shown as sticks in CPK 
colouring, whilst !-strands 7 and 8 are shown in orange or green cartoon mode respectively. 
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mediate up to 100% energy transfer from the excited state chromophore of EGFP to 
the haem bound moiety in the cyt b562 domain (Fig 5.9 and section 5.2.7), similar 
efficiencies to that of naturally occurring light harvesting systems.  
Apart from the CG6 scaffold having the potential to be used as a sensor of 
haem or as an efficient energy transfer scaffold, it has the potential to act as a sensor 
for the natural cellular ROS, H2O2. In the presence of equimolar or an excess of haem 
essentially 100% of CG6 fluorescence is quenched (Fig 5.9 and Fig 5.11 a). On the 
addition of 0.02% (v/v) H2O2 fluorescence recovery of CG6 was observed at a rate of 
~0.5 min-1, until 100% of CG6 starting fluorescence was recovered (Fig 5.11 a). 
Addition of other oxidising reagents to holo-CG6 elicited no gain in fluorescence 
making CG6 potentially H2O2 specific.  
 However CG6 did display a ~14 fold slower rate of fluorescence recovery 
with respect to the terminal fusion CG1. This is potentially due to differences in the 
solvent accessibility of the bound haem moiety to the solvent and therefore the 
oxidising effects of H2O2. The structural and biophysical characterisation of CG6, to 
help determine the mechanisms of functional coupling at the molecular level, have 
been performed and the results discussed in Chapter 6. 
 
5.3.5 Conclusion 
 Using a novel transposon based directed evolution approach to construct 
integral domain fusion scaffolds between cyt b562 and EGFP it has been possible to 
identify a variant CG6 with a 100% energy transfer efficiency that retains the high 
haem binding affinities of wt cyt b562 whilst maintaining EGFP derived fluorescence 
properties. The power of the directed evolution approach allows for the linking 
peptides between the two domains to be designed giving greater control over the 
resulting constructs and the large switching magnitudes observed between 
functionally coupled integral fusion scaffolds.  
 Unlike with the survey of tolerated single amino acid deletions throughout 
EGFP there is a less clear boundary between where in GFP will be tolerable or 
intolerable to domain insertion or which positions will give the best functional 
coupling between the two domains used. Therefore establishing a set of rules for 
identifying potential targets within a parent domain for domain insertion is more 
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difficult. It can be said that domain insertions are less likely to be tolerated within 
ordered secondary structures and more likely to be tolerated within loop regions.  
 Given the disruptive nature of a domain insertion on a parent domain even 
insertion positions within loops can potentially be detrimental to parent domain 
function. Very small differences of insertion position (one amino acid apart) can also 
have a profound effect on the efficiency of functional coupling observed, as was 
evident between variant CG3 and CG4 where CG4 resulted in 95% maximal 
quenching and CG3 only achieved ~75% maximal quenching in the presence of haem 
(Fig 5.9). This highlights the necessity and power of a directed evolution strategy over 
a rational design approach, paving the way for advancements in the construction of 
novel artificial biomolecular switches. 
  
 
 
192 
Chapter 6: Structure and biophysical characterization of the energy transfer 
scaffold, CG6 
6.1 Introduction 
In Chapter 5 an integral fusion protein termed CG6 was constructed in which 
cyt b562 was inserted between residues Y39 and G40 of EGFP. This particular variant 
displayed high efficiency energy transfer between the EGFP chromophore and the 
haem bound to cyt b562, as evident by virtually total fluorescence quenching in the 
holo-protein. Haem is a known efficient quencher of fluorescence [81], including that 
of EGFP [33, 82], with quenching occurring via energy transfer to the haem moiety. 
Energy transfer efficiency between two chromophores is dependent on their proximity 
and orientation with respect to one another [145].  
 Domain insertion can generate intimate structural and spatial linkage between 
domains to facilitate functional coupling, as demonstrated in Chapter 5 with the 
generation of CG6, and is an emerging protein engineering strategy for linking 
unrelated protein function. However, our molecular understanding of functional 
linkage in engineered domain insert protein scaffolds is hindered by the lack of 
detailed structural information. This in turns limits our ability to construct these 
potentially useful protein scaffolds and understand how functional coupling occurs. 
To date, most success has been achieved using directed evolution mutagenesis 
approaches to sample diverse domain insert positions and linking sequence followed 
by selection for coupled functionality.  
 To understand the molecular basis for increased energy transfer efficiency and 
the oxidant induced fluorescence switching properties observed for CG6, this Chapter 
will provide a detailed biophysical and structural characterisation of CG6. This will 
include determination of the 3D atomic resolution structure by X-ray crystallography. 
Such an analysis of CG6 will further our knowledge at the molecular level on the 
functional coupling of two disparate proteins and the effect domain insertion has on 
protein stability. 
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6.2 Results 
6.2.1 Biophysical charaterisation of CG6 
6.2.1.1 Haem-dependent structural changes probed by CD spectroscopy 
 To determine if there was any structural change upon haem binding to apo-
CG6, circular dichroism (CD) spectra of CG6 were measured in the presence and 
absence of haem. There were no major structural changes on haem binding to CG6 
(Fig 6.1 a). The CD spectrum of CG6 is dramatically different to EGFP, with CG6 
containing an increased helical signature content (as indicated by the troughs at 210 
and 222 nm), as to be expected upon insertion of the largely helical cyt b562 into the 
predominantly !-sheet EGFP (Fig 6.1 a). The troughs around 208 and 220 nm were 
slightly deeper for holo-CG6 compared to apo-CG6 suggesting a small increase in 
helical character but on the whole, the two forms of CG6 appeared to have very 
similar structures.  
 CD spectra for CG1, essentially a head-to-tail fusion between cyt b562 and 
EGFP (Chapter 5), were also measured in the absence and presence of haem (Fig 6.1 
b). CG1 is a control to assess if there was any difference in the overall nature of 
secondary structure character between a head-to-tail fusion scaffold or a domain 
insertion fusion scaffold. As with CG6 there were no major structural changes upon 
haem binding to CG1. The CD spectrum for CG1 was also dramatically different to 
EGFP, with CG1 containing an increased helical signature content (as indicated by 
the troughs at 210 and 222 nm), due to the fusion of the largely helical cyt b562 to the 
N terminus of the predominantly !-sheet EGFP (Fig 6.1 b). The CD spectrum for 
holo-CG1 also suggested a small increase in helical character, evident from deeper 
troughs around 208 and 220 nm. As with CG6, the apo- and holo- forms of CG1 
appeared to have very similar structures. 
 Comparison of the CD spectra for CG1 and CG6 (Fig 6.1 c) shows there is 
very little difference in the secondary structure signature between the two cyt b562-
EGFP chimeras. Given that the CD spectra are very similar between the terminal 
fusion (CG1) and the integral fusion (CG6) of cyt b562 with EGFP implies that the 
overall structures of both domains have not been significantly altered. 
 
xxxxxxx  
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Fig 6.1 Effect of haem on the secondary structure characteristics of CG1 and CG6. 
Circular dichroism spectroscopy was performed for a, CG6 and b, CG1 (5 µM samples) in the 
absence (solid black line) and presence (dashed black line) of equimolar haem. CD spectra for 
EGFP (red line) was also measured as a comparison to the fusion scaffolds CG1 and CG6. c, 
Overlay of CD spectra for CG1 (red) with CG6 (black) in the absence (solid lines) and 
presence (dashed lines) of equimolar haem.  
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6.2.1.2 Analytical size exclusion chromatography 
Analytical size exclusion chromatography was performed on CG1 and CG6 to 
determine if cyt b562 fusion to the N-terminus of EGFP (CG1) or integral fusion 
within EGFP (CG6) has an effect on the quaternary structure of EGFP. The effect of 
haem binding on the oligomeric nature of the chimeras was also investigated.  
A standard curve for the relationship between molecular weight and elution 
volume from the column was determined using the BioRad gel filtration standards 
(Section 2.6.2.1), so that the elution volume for EGFP, CG1 or CG6, at different 
concentrations, could be related to the molecular weight of that species under native 
conditions (Appendix C). 
 The elution profile for CG6 (Fig 6.2 c) confirmed that it is monomeric in both 
its apo and holo forms. The apo and holo CG6 eluted at similar volumes (~15.2 ml), 
equivalent to an apparent molecular weight of 38 kDa, close to that of its theoretical 
monomeric molecular weight (38.9 kDa) (Table 6.1). There is a very slight increase in 
elution volume for holo-CG6 with respect to apo-CG6 (up to ~0.04 ml), equivalent to 
a decrease in calculated molecular weight of ~ 500 Da, even though the theoretical 
molecular weight is increased due to the bound haem (~616 Da). This slight decrease 
in hydrodynamic volume implies that holo-CG6 has a slightly more compact structure 
with respect to apo-CG6. 
 The elution profile for CG1 showed two elution peaks; a major peak at ~15.9 
ml and a minor peak at ~16.06 ml (Fig 6.2 b). The protein in the CG1 samples eluting 
at ~16.06 ml is similar to that of the elution volume for EGFP (~16.2 ml) (Fig 6.2 a) 
and is equivalent to a molecular weight of ~25.7 kDa, very close to the theoretical 
molecular weight for EGFP (26.9 kDa) (Table 6.1). This protein species 
corresponding to the minor peak for CG1 is most probably a degradation product of 
CG1 and represents the EGFP domain without the cyt b562 domain fused to its 
xxxxxxxxx  
 
 
196 
 
Fig 6.2 Size exclusion chromatography of EGFP, CG1 and CG6. Samples of a, EGFP b, 
CG1 or c, CG6 were applied to a SuperdexTM 200 gel filtration column and the elution of the 
protein samples monitored by absorbance at 488 nm. Protein concentrations of 10 µM (solid 
black line), 25 µM (dashed line) or 50 µM (dotted line) were applied to the column in the 
absence (black) and presence (red) of equimolar haem. 
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Table 6.1 Size exclusion chromatography analysis 
Variant Concentration (µM) 
Elution 
volume 
(ml)a 
Calculated 
Mw (Da)b 
Average 
Mw (Da)c 
Theoretical 
Mw (Da)d 
EGFP 
10 16.23 23700 
24000 26941 25 16.23 23800 
50 16.18 24400 
      
Apo-CG1 
10 14.93 43800 
44800 39138 25 14.86 45100 
50 14.84 45500 
      
Holo-CG1 
10 14.93 43700 
43800 39754 25 14.93 43700 
50 14.92 44000 
      
Apo-CG6 
10 15.19 38700 
38900 38945 25 15.18 38800 
50 15.16 39200 
      
Holo-CG6 
10 15.20 38500 
38500 39562 25 15.19 38500 
50 15.19 38500 
aElution volumes determined from peak absorbance at 488 nm (Fig 6.2) 
bMolecular weights calculated using standard curve (Appendix C) 
cAverage calculated molecular weights over the different concentrations 
dEstimated molecular weight from primary sequence 
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N-terminus. The major absorption peak for CG1, with an elution volume of ~15.9 ml, 
is equivalent to a protein species with an estimated molecular weight of ~44.3 kDa, 
up to 5.5 kDa larger than the theoretical molecular weight for CG1 (~39.1 kDa) 
(Table 6.1). Given that a CG1 dimer would have a theoretical molecular weight of 
~78.3 kDa and an estimated elution volume of ~13.68 ml the major absorption peak 
observed for CG1 (~14.9 ml) is likely to represent a monomeric form with an 
increased hydrodynamic volume.  
 As with CG6, the elution volumes between apo-CG1 and holo-CG1 differed 
by up to ~0.09 ml, with an average estimated molecular weight for apo-CG1 being 1 
kDa heavier than holo-CG1 (Table 6.1). This could be indicative of a more compact 
CG1 and CG6 structure when in the holo-form.  
 
6.2.1.3 Guanidinium chloride induced equilibrium unfolding 
To assess the effect of cyt b562 domain insertion on EGFP stability in the CG6 
construct, guanidinium chloride (GdmCl) induced equilibrium unfolding experiments 
were performed (Fig 6.3). Furthermore, the effect of haem binding on stability was 
also probed through comparison of unfolding of apo- and holo-protein. CG1 was used 
as a control to investigate the role of a standard head-to-tail fusion arrangement. 
EGFP was also denatured in the absence and presence of haem as a control to confirm 
that free haem in solution does not affect the stability of the EGFP domains.  
Unfolding of EGFP, CG1 and CG6 had to be monitored by absorbance at 488 
nm, rather than fluorescence emission at 520 nm, as in the holo forms both CG1 and 
CG6 have their fluorescence quenched (Chapter 5, Fig. 5.9). The !max for EGFP in its 
native form is at ~488 nm. Upon unfolding of the "-barrel structure in GdmCl the 
absorbance at 488 nm decreases whilst an absorption maxima increases at ~375 nm 
[142]. Given that fully denatured EGFP essentially has no absorbance at 488 nm it is 
possible to monitor its unfolding via the chromophore absorbance. 
 Protein samples (4 µM) were incubated in a range of GdmCl concentrations 
(0–6 M) at 37 °C in 96-well plates. Absorption at 488 nm was measured after 2.5, 5, 
22, 48, 120 and 250 hrs. The fraction of denatured protein was calculated from the 
absorption data at 488 nm using Equation 13 (Section 2.6.2.2). To make sure 
xxxxxxxxxx  
 
 
199 
 
 
 
 
Fig 6.3 Guanidinium chloride induced equilibrium unfolding. Equilibrium unfolding data 
for a, EGFP, b, CG1 and c, CG6 at different time points as indicated in the figure. Data was 
collected in the absence (left panels) and presence (right panels) of equimolar haem. The data 
were fit to a 5-parameter asymmetric equation (Section 2.6.2.2). 
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Fig 6.4 Equilibrium unfolding rate determination for EGFP, CG1 and CG6. Apparent 
[GdmCl]50% values determined from the 5-parameter asymmetric fit to the equilibrium 
unfolding data (Fig 6.3) were plot against incubation time and fit with a single exponential 
decay. 
 
 
 
Table 6.2 Equilibrium unfolding parameters and melting temperature 
Variant keq
a 
(10-2 hr-1) 
[GdmCl]50%b 
(M) 
!!!!!!!! c 
(kcal mol-1) 
m-valued 
(kcal mol-1 M-1) Tm
app (°C) 
EGFP - Haem 2.08±0.36 2.68±0.02 5.05±0.49 1.957±0.185 84 
EGFP + Haem 1.74±0.20 2.68±0.01 5.16±0.50 1.953±0.190 - 
Apo-CG1 2.55±0.72 2.75±0.01 5.64±0.41 2.070±0.152 84 
Holo-CG1 2.73±0.77 2.79±0.01 5.49±0.38 1.980±0.141 - 
Apo-CG6 4.83±0.94 1.55±0.01 5.67±0.33 3.873±0.195 74 
Holo-CG6 4.55±0.90 1.54±0.01 5.56±0.50 3.742±0.303 - 
aEquilibrium unfolding rate constant determined from a single exponential decay (Fig 6.4) 
bConcentration of GdmCl at which 50% of the protein sample is in the native and denatured 
state at equilibrium, determined from a 2 state model (Section 2.6.2.2). 
cFree energy of denaturation (!!!!!! ! !!!!!!!! !!!!"#$%!! 
dMeasure of dependence of !G on denaturant concentration determined from the slope of the 
plots in Fig 6.5 b. 
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equilibrium had been approached the apparent [GdmCl] at which half of the protein 
was in the denatured state ([GdmCl]50%app) was determined from an asymmetric 5 
parameter fit (Section 2.6.2.2) (Fig 6.3) and plotted against incubation time (Fig 6.4). 
The [GdmCl]50%app values against time were fit to single exponential decay 
curves (Section 2.6.2.4, Equation 17) and show that, like other fluorescent proteins, 
both EGFP and CG1 took an extended period of time (up to 250 hr) to reach 
equilibrium, independent of whether haem was present or not (Fig 6.4). In contrast 
CG6 had reached equilibrium ~two-fold quicker (by ~100 hr) than EGFP and CG1 
(Fig 6.4 and Table 6.2). The [GdmCl]50% at 250 hr for CG6 (1.5 M) was also lower 
than that of EGFP (~2.7 M) and CG1 (~2.7 M) by ~1.2 M (Table 6.2). 
Haem appeared to have no effect on [GdmCl]50% and very little effect on the 
equilibrium rate constants. As was expected fusion of cyt b562 to the N-terminus of 
EGFP (CG1) does not appear to alter the stability of EGFP, as the [GdmCl]50% values 
are almost identical to that of EGFP alone (Table 6.2) and both EGFP and CG1 reach 
equilibrium after similar incubation times in GdmCl (~250 hr).  
As EGFP, CG1 and CG6 all appeared to have approached equilibrium after 
250 hr (Fig 6.4) the equilibrium unfolding data from the 250 hr incubation were fit to 
a two-state model (Section 2.6.2.2) (Fig 6.5 a). It must be stressed that although it 
appears that all samples have approached equilibrium that it is not assumed that the 
system is at equilibrium. Nevertheless, thermodynamic parameters can be established 
for comparison between individual samples used here. The data for EGFP, CG1 and 
CG6 all fit to a two-state model (R2 > 0.98) despite previous studies showing that 
equilibrium unfolding data for GFPs is best fit by a three-state model. A three-state 
model was tested here but did not converge on the data. As explained in Chapter 4 for 
the equilibrium unfolding of the single amino acid deletion variants of EGFP (Section 
4.2.6.2), an unfolding intermediate may be indistinguishable from the native or 
denatured states under the conditions at which the equilibrium unfolding experiments 
were run (pH 8.0 at 37 °C).  
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Fig 6.5 Equilibrium unfolding and linear dependence of !G on [GdmCl]. a, Equilibrium 
unfolding data, after 250 hr incubation, were fit to a 2 state model taking into account sloping 
baselines inherent to spectroscopic measurements of protein samples in GdmCl. b, The linear 
dependence of !G on [GdmCl] (m-value) was used to calculate free energies of denaturation 
(!!!!!!!! ). 
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Although the [GdmCl]50% at equilibrium for CG6 is ~1.2 M less than EGFP 
and CG1 the !!!!!!!!  for EGFP (~5.1 kcal mol-2), CG1 (~5.5 kcal mol-1) and CG6 
(~5.5 kcal mol-1) were similar. The free energy of denaturation calculated for EGFP 
agrees closely to previous equilibrium unfolding experiments (5.16 kcal mol-1) [111] 
and with the value determined by monitoring fluorescence during unfolding (5.28 
kcal mol-1) (Chapter 4, section 4.2.6.2). Under oxidizing conditions haem appeared to 
have no affect on the !!!!!!!!  values for EGFP, CG1 or CG6.  
The observation that CG6 has a similar !!!!!!!!  to EGFP and CG1, given its 
decreased [GdmCl]50%, is due to an increase in the dependence of !!!!!!  on [GdmCl] 
(m-value) (Table 6.2). The m-value is a measure of the dependence of !G on 
[GdmCl]. Both EGFP and CG1 have m-values of ~1.9 kcal mol-1M-1 (Table 6.2) 
whilst the !!!!!!  for CG6 has a much higher dependence on [GdmCl], as is evident 
by its increased m-value of ~3.8 kcal mol-1M-1. This two-fold increase in m-value 
indicates that denatured CG6 is less compact and structured than denatured EGFP and 
CG1 or the degree to which an intermediate state is populated has been changed. 
As discussed in Chapter 4 (Section 4.2.6.2. and 4.3.3) analysis of equilibrium 
unfolding data with a 2-state model does not take into account the presence of an 
intermediate state and can therefore result in an underestimation of the m-value if an 
intermediate state is populated. Further equilibrium unfolding studies would be 
required to ascertain 3-state unfolding and a more accurate representation of the 
impact of domain insertion on EGFP stability and folding. 
 
6.2.1.4 Thermal denaturation of EGFP, apo-CG1 and apo-CG6 
To assess the effect of cyt b562 domain insertion on the thermostability of the 
EGFP domain, protein samples (1 µM) were slowly heated (1 °C/min) from room 
temperature (25 °C) to 98 °C whilst monitoring fluorescence using a qPCR machine 
(Section 2.6.2.5) (Fig 6.6). There are two phases to the thermal denaturation curves 
(Fig 6.6), the first slow phase is due to a negative dependence of EGFP fluorescence 
with increasing temperature, as seen in previous studies [146, 147]. The second phase 
is a sharp transition from the native to denatured state, from which melting 
temperatures are calculated.  
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Fig 6.6 Thermal denaturation of EGFP, apo-CG1 and apo-CG6. Fluorescence emission 
was monitored during temperature ramping from 25-98 °C at 1 °C/min using a qPCR thermal 
cycler. Melting temperatures (Tmapp) are listed in Table 6.3.  
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Apparent melting temperatures (Tmapp) calculated from the fluorescence data 
(Table 6.2) show that the apo form of the cyt b562 fusion to the N-terminus of EGFP 
(CG1) does not alter the melting temperature of the EGFP domain (Fig 6.6). Both 
EGFP and apo-CG1 had a calculated melting temperature of 84 °C. In comparison, 
insertion of cyt b562 into EGFP (CG6) reduced the melting temperature of the apo-
form by 10 °C to 74 °C, implying that cyt b562 domain insertion into EGFP at position 
Y39 reduces the thermal stability of EGFP.  
Given that the thermal denaturation of EGFP, CG1 and CG6 was irreversible 
(data not shown) accurate thermodynamic parameters cannot be determined. 
Therefore any potential formation of aggregates may result in the underestimation of 
Tmapp values. 
 
6.2.2 Crystallographic structure of holo-CG6 
 To understand the molecular basis of the efficient fluorescence quenching in 
the CG6 cyt b562-EGFP integral fusion variant, described in detail in Chapter 5, the 
holo form was crystallized. Holo-CG6 protein samples (10 mg/ml in 50 mM Tris-
HCl, pH 8.0, 150 mM NaCl and 256 µM haem) were screened for crystal formation 
by the sitting drop vapour diffusion method with incubation at 4 °C. The crystal of 
holo-CG6 was obtained from 0.1 M MES/NaOH, pH 6.4, 200 mM magnesium acetate 
and 20% (w/v) PEG 8000. 
 X-ray diffraction data were collected on the Diamond Light Source beamline 
I02 thanks to Dr Anna Piasecka. The crystallographic statistics are shown in Table 
6.3. Structure determination was performed in collaboration with Dr. Matthias 
Bochtler and Dr. Honorta Czapi!ska. The full methods for structure determination are 
outlined in Section 2.7.2.  
 Crystals grew in space group P2(1) and contained three molecules of the 
fusion protein in the asymmetric unit. Two of molecules were very well ordered. 
However, the third had high temperature factors (Chain C), particularly for the EGFP 
domain. Routine molecular replacement was used to orient and position the EGFP and 
cyt b562 domains for the two well-ordered copies of the molecule in the asymmetric 
unit. The poorly ordered third molecule in the asymmetric unit did not give significant 
molecular replacement signals and was found during refinement (Section 2.7.2).  
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 A R-Free value of 27.7 % indicates that the models determined for the three 
molecules in the asymmetric unit are a good representation of the experimental data. 
Given that the third molecule in the asymmetric unit was poorly ordered and has high 
temperature factors, the R-Free value would not reduce any more with further 
refinement.  
 The EGFP and cyt b562 domain sit next to each other in the integral fusion 
scaffold (Fig 6.7) connected by a shorter single glycine ‘inner linker’ and a longer 
Gly-Gly-Ser ‘outer linker’ (Fig 6.7). The difference in the length of the linkers are 
important for the arrangement of the two domains with respect to one another and are 
discussed in more detail in Section 6.2.2.2. The individual EGFP and cyt b562 domains 
in the three molecules were very similar to previously solved structures of EGFP and 
cyt b562 (Fig 6.8) as was evident from RMSD values over the backbone atoms of 0.31-
0.38 Å or 0.78-0.82 Å respectively (Table 6.4). This showed that insertion of cyt b562 
into EGFP in the tight turn between !-strands 2 and 3 has not affected the overall 
structures of the EGFP or cyt b562 domains.  
 Due to the third molecule (chain C) in the asymmetric unit having high 
temperature factors detailed analysis of the CG6 structure has only been performed 
using chain A or chain B. 
 
6.2.2.1 EGFP and cyt b562 domain arrangement in the CG6 crystal structure 
 In all three molecules in the asymmetric unit the crystal structures indicated 
that the two domains are arranged in a side-by-side manner adopting a “V” shape (Fig 
6.9 a). Structural alignment of the EGFP domains from each molecule in the 
asymmetric unit showed some variation in the hinge angle between the domains (up 
to 23° for different pairs (Fig 6.9 a), but with the inter-domain contacts largely 
remaining the same (Section 6.2.2.3). The RMSD across all backbone atoms for the 
three different molecules (2.5-4.8 Å) highlights the difference of the position of the 
cyt b562 domains with respect to the EGFP domain (Table 6.5). The difference in 
hinge angle between the two domains seen in the three molecules might suggest some 
flexibility between the two domains. In principle, the crystal could select the most 
compact conformation from a continuum that might range from closed to fully open. 
  
 
 
207 
Table 6.3 Crystallographic statistics for CG6 
Space group P1 2(1) 1 
a (Å) 64.8 
b (Å) 125.2 
c (Å) 89.3 
! (°) 90.4 
Resolution range (Å) 30 - 2.75 
Total reflections 136754    
Unique reflections 36793    
Completeness (%) (last shell) 99.3 (100.0) 
I/" (last shell) 19.9 (2.4) 
R(sym) (%) (last shell) 3.4 (32.4) 
B(iso) from Wilson (Å2) 80.5 
 
Protein atoms excluding H  7996 
Solvent molecules 98 
R-factor (%) 23.4 
R-free (%) 27.7 
Rmsd bond lengths (Å) 0.017 
Rmsd angles (°) 1.8 
Ramachandran core region (%) 92.7 
Ramachandran allowed region (%) 6.6 
Ramachandran additionally allowed region 
(%) 0.1 
Ramachandran disallowed region (%) 0.6 
 
 
 
 
Fig 6.7 EGFP and cyt b562 domain arrangement in the crystal structure of CG6. Cartoon representation of CG6 is shown from a side on view (left) and 
top down view (right). The EGFP domain is shown in green with the cyt b562 domain shown in red. The single glycine ‘inner linker’ and Gly-Gly-Ser ‘outer 
linker’ are shown in black. The EGFP domain chromophore and haem bound to the cyt b562 domain are shown in stick representation coloured by CPK. 
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Fig 6.8 Superposition of CG6, EGFP and cyt b562 structures. Cartoon representations of 
CG6 (green) superposed on wild type EGFP (blue, structure determined in Chapter 5) and 
wild type cyt b562 (red, PDB:256B).  
 
 
 
 
Table 6.4. RMSD measurements between EGFP or cyt b562 and the 3 molecules on CG6 
in the asymmetric unit. 
  EGFP
a Cyt b
562
a 
CG6 
Chain A 0.31 0.78 
Chain B 0.32 0.82 
Chain C 0.38 0.78 
a All RMSD values are in Å 
 
 
 
 
Table 6.5 RMSD measurements between all three molecules of CG6 in the asymmetric 
unit 
Molecule Aa Ba Ca 
A 0 4.82 2.50 
B 4.82 0 3.14 
a All RMSD values are in Å 
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 The V-shape of the fusion protein positions the chromophores of EGFP and 
cyt b562 close together (Fig 6.9 b). The distance between them is approximately 17 Å, 
and thus smaller than the distance that could be expected for a more open 
arrangement of the domains. The two chromophores lie in the same plane with the 
angle between them being approximately 45° (Figure 6.1 b). 
 
6.2.2.2 Importance of linker length to CG6 domain arrangement 
 The different length of the linkers plays a critical role towards fixing the V-
shape of the fusion protein. The short inner linker between R148 (R106cytb) and G150 
(G40GFP) consists of a single glycine that is located in a loop between the N-terminal 
end of !-strand 3 in EGFP and the C-terminal "-helix of cyt b562 (Fig 6.10). The 
shorter inner linker is positioned essentially the same in all three molecules in the 
asymmetric unit (Fig 6.10) and is likely to have less flexibility than the outer linker, 
therefore forming a turn allowing the two domains to align side by side (Fig 6.10).  
 The longer outer linker (Fig 6.10 a) between F39 (Y39FGFP) and A43 (A1cytb) 
consisting of the Gly-Gly-Ser tripeptide, has increased flexibility as is evident from 
the three different cyt b562 domain arrangements (Fig 6.9). The longer outer linker is 
positioned differently in all three molecules, and provides the flexibility required for 
the two domains to arrange side-by-side (Fig 6.10 b). A shorter linker in its place 
would result in reduced conformational flexibility between the two domains 
potentially producing a more open conformation.  
 
6.2.2.3 EGFP and cyt b562 domain arrangement of CG6 in solution 
 To ascertain the relevance of the CG6 domain arrangement observed in the 
crystal structure small angle X-ray scattering (SAXS) analysis was performed on CG6 
in solution to determine the domain arrangement. The experimental intensity data (Fig 
6.11) were compared to predicted fits to data for three different domain arrangement 
models (performed by Dr Michal Gajda at EMBL): The two domains aligned side-by-
side, at right angles to one another or aligned to form a long rod (Fig 6.11). An 
excellent fit was observed for the side-by-side domain arrangement (#2 = 0.98) as also 
xx 
 
  
 
 
Fig 6.9 Superposition of the 3 CG6 molecules in the asymmetric unit. a, The 3 molecules were aligned by the EGFP domains (green cartoon) with the 
chromophore shown in stick representation. The cytochrome domains are shown in cartoon representation coloured red, yellow and blue. Unless stated 
otherwise the structure used for representation of CG6 has the cyt b562 domain coloured red. b, Interchromophore distances between the EGFP domain 
chromophore and the cyt b562 bound haem in the three molecules of the asymmetric unit.  
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Fig 6.10 Structure of the inner and outer linkers joining the EGFP domain to the cyt b562 domain in CG6. a, Cartoon representation of CG6 with the 
EGFP domain in green, the cyt b562 domain in red and the linkers in black. Inset, Close up view of the inner and outer linkers. The inner linker comprises of a 
single glycine residue (G149) whilst the longer outer linker comprises of a Gly-Gly-Ser tripeptide (sticks: black). b, Close up view of the linker region for all 
three CG6 molecules in the asymmetric unit highlighting the difference in the conformation of the linkers between the different molecules (A, B and C). 
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observed in the crystal structure (Fig 6.7) but not for the other models (!2 = 1.92 or 
3.03). The SAXS data support the relevance of the crystallographic data in solution. 
Therefore, the V-shaped domain arrangement appears to be at least predominant (or 
even exclusively present) in solution. 
 
6.2.2.4 EGFP-cyt b562 domain interface in CG6 
 The side-by-side domain arrangement of EGFP and cyt b562 in CG6 brings the 
two domains in close proximity to one another creating a domain-domain interface. 
The interface between the cyt b562 and EGFP is remarkably hydrophilic (Fig 6.12) and 
does not look like a typical naturally evolved protein interaction surface. Altogether, 
the interface between the cyt b562 and EGFP domains extends over an area of 
approximately 700-800 Å2 and buries about 1400-1600 Å2 of solvent accessible 
surface.  
 Many favourable contacts are observed between the two domains (Fig 6.12). 
Among these, at least one salt bridge is consistently formed between one of the haem 
carboxylate groups and the guanidino group of R181 (R71GFP) (Fig 6.12 a and b). The 
guanidino group of R181 also forms hydrogen bond interactions with the hydroxyl 
group of S42 (linker), which is also in hydrogen bonding distance of a haem 
carboxylate group (Fig 6.12 a). In the second molecule (Chain B) there is a hydrogen 
bond between the guanidino group of R181 to the main chain O atom of G40 (linker) 
and from the main chain N atom of S42 (linker) to one of the haem carboxylate 
groups (Fig 6.12 b). Again depending on the molecule in the asymmetric unit, one of 
the haem carboxylate groups forms a hydrogen bond with T333 (T223GFP) (Fig 6.12 
a). In both molecules there is consistently a hydrogen bond interaction between the 
guanidino group of R148 (R106cytb) and the amide O of Q312 (Q202GFP) (Fig 6.12 a 
and b). In both molecules there is consistenly a hydrogen bond formed between the 
K151 side chain "-amino group and the main chain O of Q145. 
 Although there are a high proportion of hydrophilic interactions between 
EGFP and cyt b562 there are also more conventional protein-protein contacts. For 
example, R148 (R106cytb) stacks favourably against F331 (F221GFP) (Fig 6.12 a and 
b). 
 
 
 
 
 
 
 
 
 
 
Fig 6.11 Domain arrangement of CG6 in solution determined by SAXS analysis. SAXS experimental intensity data were compared to predicted fits for 
domain arrangement models of (a) a side-by-side arrangement, (b) the two domains at right angles to one another and (c) for a fully elongated rod 
arrangement.  
 
a b c 
 
 
 
 
 
 
Fig 6.12 Interdomain and linker interactions. The polar interactions (black dashed lines) between residues from the EGFP domain (green sticks), cyt b562 
domain (red sticks) and the linking residues (black sticks) within (a) molecule A or (b) molecule B of the asymmetric unit for CG6. Haem is shown as sticks 
with CPK colouring with the coordinated iron molecule shown as an orange sphere.  
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6.2.2.5 Effect of cyt b562 domain insertion on EGFP chromophore local 
environment 
The crystal structure determined for EGFP (Chapter 4) identified an altered 
hydrogen-bonding network between the chromophore and residues in its immediate 
vicinity. In particular a tridental electron density was observed for residue E222 that 
was successfully modeled by two side chain conformations (Fig 4.3). In both 
conformations a hydrogen bond between S65 and Y66 observed in wt GFP, was 
interrupted between the corresponding T65 toY66 of EGFP (Fig 4.3).  
Similarly in CG6 the hydrogen bond chain between T175 (T65EGFP) and Y176 
(Y66EGFP) through E330 (E222EGFP), S313 (S205EGFP) and a conserved water 
molecule is interrupted between E330 and S313 (Fig 6.13 a). The Fo-Fc electron 
density map generated after molecular replacement and refinement of CG6 did not 
exhibit the tridental density observed for E222 in EGFP (Fig 6.13 b). This is probably 
due to the lower resolution of the CG6 structure (2.75 Å) with respect to the EGFP 
structure (1.35 Å) determined in Chapter 4. Instead E330 is modeled by a single side 
chain conformation with hydrogen bonds between its carboxylate group to a 
conserved water molecule and to the hydroxyl group of S313 (Fig 6.13 a). The 
hydroxyl group of S313 in turn forms a hydrogen bond chain to Y176 through a 
conserved water molecule also coordinated via a hydrogen bond to the main chain O 
of N254 (N146EGFP) as seen in EGFP. 
The same hydrogen-bonding network observed in EGFP (Fig 4.3) between 
residues N146, H148, R168 and T205 to the chromophore are also present between 
the corresponding residues in CG6 (Fig 6.13). In CG6 the hydroxyl group of T311 
(T205EGFP) forms a direct hydrogen bond to the phenolate group of Y176 (Y66EGFP) 
and also forms a hydrogen bond to the main chain N of H256 (H148EGFP). A hydrogen 
bond between the side chain of H148 and the main chain O of R168 seen in EGFP is 
also seen in CG6 with further interaction by a hydrogen bond formed between the 
amide group of N254 (N146EGFP) and the main chain O of R276 (R168EGFP) (Fig 6.13 
a). A side chain N of H256 (H148EGFP) also forms a direct hydrogen bond interaction 
with the phenolate of the chromophore. All of the polar interactions between the 
chromophore phenolate group and surrounding resdidues is sufficient to stabilize a 
charge on the phenolate, given that E330 (E222EGFP) is neutral.  
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Fig 6.13 EGFP chromophore local environment in CG6. a, The crystal structure for CG6 
(molecule B) is shown in cartoon representation with the EGFP domain (green), cyt b562 
domain (red). Residues making polar interactions (black dashed lines) are shown as sticks 
coloured corresponding to the domain they originate from. Inset: Close up view of residues 
participating in polar interactions. Conserved water molecules are labeled as w. b, Fo-Fc 
electron density map for the chromophore and residue E330 (sticks) contoured to 1!.  
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The residues that contribute to the hydrogen bond network around the 
chromophore of CG6 are in close proximity to the EGFP cyt b562 domain-domain 
interface with some adjacent residues (Q312 and F331) contributing to the domain 
interface (Fig 6.13 a). The interaction between residues Q312 (Q204EGFP) and F331 
(F223EGFP) with R148 (R106cytb) may be the reason for only a single conformation of 
the E330 carboxylate group. However, a higher resolution structure would be required 
to identify if there are two conformations for the E330 side chain or not. 
The hydrogen bonding network in both of the well ordered molecules in the 
asymmetric unit (chain A and chain B) were the same and although there are slight 
differences in the domain-domain interface between the two molecules (Fig 6.12) it 
does not effect the chromophore environment. 
 
6.2.2.6 Effect of domain insertion on haem binding to the cyt b562 domain. 
As described in Section 6.2.1.1 cyt b562 domain insertion has very little effect on the 
overall structure of the EGFP domain or the cyt b562 domain in CG6 (Fig 6.8, Table 
6.4). In wild-type cyt b562 the haem moiety is bound non-covalently, with the haem 
iron coordinated between the sulphur atom of the M7 side chain and a N atom from 
the H102 side chain (Fig 6.14 a). In CG6 the haem moiety is coordinated in the same 
manner between the sulphur atom of M49 and the N atom of H144 (Fig 6.14 b). The 
only difference between the haem molecule bound to wt cyt b562 and CG6 is a slight 
difference in the position of one of the haem propanoate groups (Fig 6.14).  
The major difference between the haem binding environment in wt cyt b562 
and CG6 is that haem is more surface exposed when bound to wt cyt b562 (Fig 6.14 c). 
In CG6 one side of the haem binding pocket is covered by the EGFP domain, 
therefore making the haem less solvent accessible (Fig 6.14 d). 
 
6.3 Discussion 
 Domain insertion provides a general approach for structurally and spatially 
linking normally disparate proteins so that the function of one protein is coupled to 
another; it provides a mechanism to artificially construct novel biomolecular switches 
for use in synthetic biology, biosensing or even as novel energy transducers in 
bionanotechnology. From a protein engineering perspective, the challenge lies in 
xxxxx  
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Fig 6.14 Haem binding environment in wild type cyt b562 and CG6. a, cartoon 
representation of wild type cyt b562 (red, PDB:256B) with haem and its axial ligands, M7 and 
H102, shown as sticks. b, Cartoon representation of CG6 with the EGFP domain in green, the 
cyt b562 domain in green and the linkers in black. Haem and its axial ligands, M49 and H144, 
are shown as sticks. c, Molecular surface representation for wild type cyt b562 with haem 
shown as sticks. d, Molecular surface representation for CG6 (coloured the same as in b), 
with haem shown as sticks.  
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predicting sites within the accepting protein that not only tolerate insertion of a whole 
domain but also couple the functions of the two proteins. The use of directed 
evolution to sample a diverse range of domain insertion sites and domain linking 
sequences coupled with screening for linked functionality has provided a useable 
approach that has met with some success [31, 32, 37]. However, little is known how 
in these constructed protein scaffolds that the key facet of functional coupling is 
achieved at the molecular level and how such a domain insertion can influence 
stability and folding. This in turn hinders our ability to generate suitable scaffold 
models that could form the basis of designing optimal protein switches. Therefore, 
retrospective structural analysis coupled with folding studies of directly evolved 
protein constructs is very valuable.  
 
6.3.1 EGFP and cyt b562 domain arrangement in CG6 
Domain insertion could be considered to be a largely disruptive mutational 
event, given that the continuity of the polypeptide chain for the protein accepting the 
domain insert is broken. Dogma dictates that insertion positions are likely to be 
restricted to inherently flexible regions such as loops and traditionally rational 
sequence insertion approaches have focused on such loops [121, 147, 148]. The 
majority of the cyt b562-EGFP integral fusion proteins identified previously (Chapter 
5) conform to this dogma. CG6 on the other hand has cyt b562 inserted within a more 
structurally constricted site; a !-turn linking strands 2 and 3 of EGFP (Chapter 5, Fig 
5.5). Insertion at this position did not appear to disrupt the functions of the individual 
proteins significantly, with CG6 having comparable brightness to EGFP and affinity 
for haem to cyt b562 (Table 5.3). 
 Three possible EGFP-cyt b562 domain arrangements could be envisaged (Fig 
6.11 a, b and c): a linear arrangement, one domain lying perpendicular to other or the 
side-by-side arrangement. The former two would be considered most likely to form as 
the linkers require a less constrained structure and the two domains are still essentially 
independent of each other. The side-by-side arrangement would require a defined 
hinge point structure and even interaction between the domains to maintain this 
configuration. However, the side-by-side arrangement is the most desirable as the 
structures and hence functions of the domains are more likely to be intimately linked. 
The determined structure of CG6 reveals that the EGFP and cyt b562 domains take up 
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the side-by-side arrangement through a molecular hinge at the linker regions (Fig 6.7, 
Fig 6.9 and Fig 6.10). The observed CG6 domain arrangement is not a crystal artefact 
as SAXS data confirmed that the V-shape domain arrangement is relevant in solution 
(Fig 6.11). 
 Critical to the side-by-side placement of the domains are the linker sequences 
separating the EGFP and cyt b562 domains. The differential sequence length at the two 
interdomain linking points (Fig 6.10) introduces a constrained molecular pivot point. 
The single amino acid linker forms the acute inner turn while the longer linker forms 
the outer turn (Fig 6.10). Without the differential linker lengths it is unlikely that the 
two domains could assume their relative positions. Gly40 occupies a confined 
environment and replacement with a longer linker may not be tolerated sterically in 
the current conformation and introduce additional flexibility between the two 
domains. Several favourable interactions are also formed between the residues in the 
longer outer linker to residues from both the EGFP domain and the cyt b562 domain, 
further stabilizing the domain arrangement (Fig 6.12). 
 The side-by side configuration is reinforced by interdomain interaction. The 
domain interface is largely comprised of hydrophilic contacts (Fig 6.12), atypical of 
naturally evolved domain/subdomain interfaces. Residues outside the linking 
sequences are important contributors to the domain interface. For example, one of 
these residues, R181 (R71EGFP) from the EGFP domain, forms a salt bridge to the 
haem propionate group. While some limited focus is given to arbitrary linking 
sequences when constructing linked domains very little consideration is given to 
domain interactions, as these are generally difficult to anticipate. From a design 
perspective, we have shown by retrospective analysis of a directed evolved domain 
insert scaffold that domain placement is essential for maximised functional coupling 
(in this case energy transfer); linker sequences together with domain interactions are 
essential in achieving this.  
 
6.3.2. Domain arrangement facilitates energy transfer 
Haem quenches fluorescence through energy transfer but critical to transfer 
efficiency is the positioning of the two chromophores; addition of haem alone to 
EGFP (Chapter 5, Fig 5.14) or the simple fusion of cyt b562 to the termini of EGFP is 
not sufficient for maximal energy transfer (Chapter 5, Fig 5.9) [33, 82]. The structure 
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of CG6 provides an explanation for the high efficiency energy transfer between the 
protein-bound haem and the EGFP chromophore.  
The side-by-side domain arrangement forms the characteristic V-shape 
conformation (Fig 6.7). This domain arrangement results in an interchromophore 
distance of ~17 Å (Fig 6.9 b). The previously calculated R0 (the Förster radius at 
which energy transfer is 50% efficient) for the chromophores of cytochrome b562 and 
EGFP is 46 Å [33]. As energy transfer efficiency (E) is related to the 
interchromophore donor-acceptor distance (r) through the inverse 6th power by the 
equation E= 1/1+(r/R0)6 and r is determined to be ~17 Å (Fig 6.9 b), E is 99.7%. This 
is in line with observed near total quenching of fluorescence of holo-CG6 (Chapter 5, 
Fig 5.9). 
High energy transfer efficiency is confirmed through analysis of the 
fluorescence lifetimes in the presence and absence of haem through the relationship 
E= 1-(!holo/!apo), where !holo and !apo represent the lifetimes in the presence and 
absence of haem. As the !holo for CG6 is essentially 0 (Chapter 5, Table 5.3), E is 
100%. The energy transfer efficiency and the distances between chromophores in this 
new scaffold are comparable to natural energy transfer systems, such as the light 
harvesting complexes. EGFP is known to undergo photoinduced electron transfer 
[149-151] and cyt b562 is capable of facilitating conductance over distances of 10-30Å 
between gold electrode [85, 86]. Thus, the new CG6 protein scaffold may act as a 
starting point for a simple bio-based light harvesting system that could be integrated 
with inorganic devices [150]. 
 
6.3.3 Effect of cyt b562 domain insertion on the chromophore local environment 
 As mentioned previously extensive hydrogen bonding networks exist between 
the chromophore and residues in its immediate vicinity in GFP and its structural and 
functional relatives (Chapter 4) [62, 99]. For green fluorescent proteins this hydrogen-
bonding network is responsible for maintaining the protonation state of the 
chromophore tyrosyl group and is therefore intimately linked to the spectral properties 
[62, 152]. 
Crystal structure determination of EGFP (Chapter 4) showed two altered 
hydrogen bonding networks between the chromophore and surrounding residues with 
respect to wt GFP (Chapter 4, Fig 4.3). The differential hydrogen bond networks are 
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formed by two conformations of the E222 carboxylate side chain (Chapter 4, Fig 4.3). 
Analysis of the probable chromophore hydrogen-bonding network in CG6 was 
comparable to that of one of the networks observed for EGFP (Fig 6.13). Only a 
single conformation for the side chain of E330 is modelled in CG6 as the resolution is 
not high enough to determine if two conformations exist, therefore there appears to be 
a single predominant hydrogen-bonding network formed, similar to one of the 
networks in EGFP (Fig 4.3 ai). 
Given that residues adjacent to those involved in the chromophore 
environment hydrogen bond network are part of the domain-domain interface, may 
play a role in constricting the E330 carboxylate side chain into a single conformation. 
However, to confirm this notion a higher resolution structure would need to be 
determined for CG6. 
 
6.3.4 Structural insight into CG6 oxidant sensing properties 
The crystal structure of CG6 also provides an insight into some of its observed 
redox-dependent switching properties. Upon haem binding to the cyt b562 domain of 
CG6 very little structural change was observed (Fig 6.1), therefore the structures for 
the apo and holo forms could be considered equivalent. The oxidation state-dependent 
affinity of haem for cyt b562 in CG6 is maintained with fluorescence quenching 
occurring at lower haem concentrations under reducing conditions (Chapter 5, Fig 
5.9). As the structure of the cyt b562 domain of CG6 is almost identical to that of wt 
cyt b562 (RMSD ~0.75Å over all backbone atoms, Fig 6.8) and haem binds to CG6 in 
a similar manner to cyt b562 (Fig 6.14) it is not unexpected that redox-dependent 
affinity is retained. The oxidation state dependent haem affinity coupled with the high 
signal gain on haem dissociation makes CG6 an attractive sensor of changes from the 
normally reducing conditions inside the cell to oxidising that accompanies several 
important biological events. Real-time analysis showed that while initial binding and 
fluorescence quenching under reducing conditions was rapid, on changing to 
oxidising conditions signal gain was slow (Chapter 5, Fig 5.11 a). 
 The CG6 structure provides a plausible explanation for the slow haem 
dissociation kinetics (Chapter 5, Fig 5.11 a). Haem lies at the domain interface 
making additional interactions with the protein via the propionate groups (Fig 6.12) 
and restricting access to the solvent (Figure 6.14 d). Thus, these structural features are 
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likely responsible for the low dissociation rate. In comparison, the head-to-tail fusion 
variant CG1 displays fast H2O2 dissociation kinetics (Chapter 5, Fig 5.11 d) that is 
likely due to the haem being freely accessible to the solvent and probable lack of 
contacts between the haem propionate groups and residues in either the linkers or the 
EGFP domain.  
 
6.3.5 Effect of cyt b562 domain insertion on EGFP stability 
 Although several domain insertion scaffolds, with GFP as the accepting 
domain have been developed, studies on the effects of domain insertion on the 
stability of the integral domain fusion scaffolds have been neglected. Here, we have 
shown that despite the insertion of the cyt b562 domain into a tight !-turn of EGFP, the 
free energy of denaturation for the integral domain fusion scaffold, CG6, is 
comparable to that of EGFP (Table 6.2). The mechanism by which CG6 unfolds 
however appears to be altered with respect to EGFP as was evident from a 1.2 M 
decrease in the [GdmCl]50% value at equilibrium (Table 6.2) and the >two-fold 
increase in m-value. The increased m-value indicates an increase in unfolding 
cooperativity with respect to EGFP, implying a single unfolding step, in contrast to 
previous work on the unfolding of GFPs which have suggested unfolding by a two 
step process [71, 113].  
 Chemical induced denaturation of CG6 showed there to be a decrease in the 
[GdmCl]50% value (Table 6.2) with respect to EGFP and the terminal fusion CG1. 
Similarly thermal stability for EGFP appeared to be decreased by cyt b562 domain 
insertion. The melting temperature for CG6 was 10 °C lower than that for EGFP or 
the terminal fusion CG1. This data agrees with previous studies on the insertion of 
antibody binding loops into superfolder GFP (sfGFP) with the majority of insertions 
resulting in decreased thermal stability [147]. 
 
6.3.6 Conclusion 
 We have provided a molecular explanation of how the functions of two 
normally disparate proteins can be coupled through a directed evolution domain 
insertion process. The side-by-side domain arrangement results in high efficiency 
energy transfer from the chromophore of EGFP to the haem moiety of cyt b562 
comparable to that of natural systems through optimisation of chromophore 
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arrangement. Critical to the domain organisation are the linker sequences and domain 
interactions. Whilst domain insertion appeared to have decreased the thermal stability 
of the EGFP domain and decreased the concentration of GdmCl required to denature 
the protein, an increase in the cooperativity of unfolding resulted in similar levels of 
stability to that of EGFP alone. Retrospective structural analysis coupled with folding 
studies has thus proved valuable in understanding the molecular features of a directly 
evolved protein scaffold not present in nature and provides the basis by which to 
engineer future scaffolds for use as novel and useful biological components.  
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Chapter 7: Rational design of cyt b562-EGFP chimeras to generate novel 
fluorescent ratiometric redox sensors  
7.1 Introduction 
Free radicals and other reactive oxygen species (ROS) such as HO!-, O2!- and 
H2O2 are produced across a wide range of physiological processes [153]. An excess of 
ROS is harmful to cells as it can cause oxidative damage to DNA, lipids and proteins, 
which can result in cell death [154]. Oxidative stress can be caused endogenously by a 
build up of ROS as a by-product of aerobic respiration or exogenously caused by 
exposure to UV light [155] or extremes in environmental conditions such as 
temperature [155].  
ROS also play vital cellular roles as signaling molecules modulating many 
important processes such as, activation of transcription factors (Apoptosis inducing 
factor [156], NF-!B and AP-1), protein tyrosine phosphatases, caspases [157], 
GTPases (Ras) [154] and chaperones [153]. ROS also play an important role in the 
immune response; upon phagocytosis of bacteria or other cellular debris (produced by 
apoptosis or necrosis) by macrophages a respiratory burst results in the over 
production of ROS (O2.- and H2O2) used by the cell to break down and digest the 
pathogen or cell debris and activate further signaling pathways controlling the 
inflammatory response [158]. Therefore, given the importance and general interest in 
cellular redox processes a biosensor for reporting cellular redox changes is highly 
desired. 
Studies have shown that cysteine residues play a key role in redox sensing 
[159] and can be used as a biosensor trigger for cell redox state; under oxidizing 
conditions disulphide bonds form whereas the free thiol is retained under normal 
cellular reducing conditions. Switching between disulphide-thiol forms can cause 
conformational changes within proteins, which can modulate protein output (function) 
[160]. For example under oxidizing conditions the bacterial chaperone Hsp-33 
undergoes a conformational change due to the formation of two disulphide bridges, 
causing a metal (Zn2+) binding site to unfold, revealing a hydrophobic patch for 
unfolding proteins to bind to [161-163]. Likewise formation of intramolecular 
disulphide bonds in the tetrameric bacterial transcription factor OxyR triggers its 
ability to bind DNA [164].  
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The redox sensing properties of cysteine residues have been exploited in 
fluorescent proteins to generate redox state sensitive fluorescent probes such as 
roGFPs [165-167]. Two cysteine residues (S147C and Q204C) were incorporated into 
adjacent !-strands of the !-barrel structure in close proximity to the fluorophore (Fig 
7.1) [165-168]. Under oxidizing conditions intramolecular disulphide bonds are 
formed altering the spectral characteristics of the parent fluorescent protein. Under 
reducing conditions roGFP2 has a single excitation maxima at 490 nm. Under 
oxidizing conditions there is a decrease in the amplitude of the 490 nm maxima and 
the appearance of an excitation maxima at 400 nm [154, 165]. The altered spectral 
properties upon disulphide formation is due to a shift in the position of the S205 
hydroxyl group, altering the hydrogen bond network surrounding the chromophore, 
therefore modulating the chromophore phenolate protonation state (Fig 7.1). 
The redox midpoint potential of roGFP2 was determined to be -272 mV [165]. 
Further mutations have generated several different variants with varying redox 
midpoint potentials, ranging from -229 to -287 mV [166], and increased response 
rates to oxidants and reducing agents [167]. Given that the redox midpoint potentials 
for proteins catalytically active in establishing the thiol-disulphide equilibrium range 
from -270 mV to -122 mV [166], there is a clear need to extend the range of midpoint 
potentials of roGFP like proteins to be used as quantitative reporters. Increased 
response rates to oxidants such as H2O2 are also a desired quality for improved time 
resolution of signaling events instigated by H2O2 bursts [167]. 
Using the directed evolution approach described in Chapter 3, domain 
insertion of cyt b562 into EGFP between residue N146 and S147 resulted in two 
variants, CG8 and CG15, having altered spectral properties with respect to EGFP 
(Chapter 5, Fig 5.7). Both variants had two excitation maxima at ~400 nm and ~488 
nm, implying domain insertion had altered the ratio of the EGFP fluorophore in the 
protonated or deprotonated forms. CG8 and CG15 only differed in primary sequence 
by two amino acids due to the ORF-3 cybC DNA cassette used to generate them (Fig 
7.2 ). CG15 contained the S147C mutation seen in the roGFPs (Fig 7.2). Therefore it 
was investigated if introduction of a second cysteine residue, in close vicinity to the 
S147C mutation site of CG15 instilled ratiometric redox sensitive properties. This 
chapter therefore describes the rational design approach to introducing secondary 
xxxx  
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Fig 7.1 Crystal structures of reduced and oxidized roGFP2. Reduced roGFP2 (pdb:1JC0, 
green cartoon) and oxidized roGFP2 (pdb:1JC1, red cartoon) with residues responsible for 
forming the hydrogen-bonding network (black dashed lines) with the fluorophore shown in 
sticks. 
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Fig 7.2 DNA and protein sequences for EGFP, inter domain linkers, CG8 and CG15. The triplet nucleotide removed from the egfp gene (white) crosses 
two codons coding for N146 and S147. The cybC DNA cassette used to keep the domain insert constructs in frame contains a single random nucleotide (N) 
and two random nucleotides (NN) at the 5’ and 3’ end of the cassette respectively. The random nucleotides reconstitute the codons coding for residues at 
positions 146 and 147 of EGFP, resulting in the substitution mutations N146K and S147N in CG8 and S147C in CG15.  
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cysteine mutations to the cyt b562-EGFP integral domain fusion scaffold, CG15. 
Spectral and biophysical characterization has been performed to characterise the 
redox sensing properties of four different CG15 double cysteine mutants (CG15CC). 
 
7.2 Results 
7.2.1 Rational design of CG15 double cysteine mutants 
Rational design approaches to protein engineering often require that a prior 
knowledge of the protein structure and function is known to make informed decisions 
of which residues to mutate. Given that there is currently no determined crystal 
structure for CG15, identifying which residues to mutate to cysteines was performed 
using a molecular model. The crystal structure for the cyt b562 (pdb:256B) domain was 
inserted into the crystal structure for EGFP (determined in Chapter 4) between 
residues N146 and S147 (Fig 7.3). The two domains were separated by GlyGlySer 
linkers at the N- and C-terminal ends of the cyt b562 domain (Fig 7.3). Residue S147 
was then mutated to a cysteine residue and the CG15 model was energy minimized 
using the in built auto-sculpture tool in MacPyMol. 
Using the CG15 molecular model it was possible to design which secondary 
residues to mutate to cysteines with the potential of forming disulphide bonds with 
C147 (Fig 7.3). Residue C147 is positioned with its side chain on the solvent exposed 
side of the EGFP !-barrel. Therefore the criteria for residues selected as potential 
candidates for disulphide bond formation with C147 are: (1) they should be in close 
proximity to C147 and (2) their side chains must be on the solvent exposed side of the 
!-barrel. Although the CG15 structure is a molecular model and represents only a 
possible conformation and arrangement of the two domains with respect to one 
another it was possible to identify four residues that fit the required criteria. Ideally, 
the switch between the free thiol and disulphide bond should alter the hydrogen bond 
network associated with the chromophore and thus change the ratio of absorbance at 
400 nm and 488 nm. 
The first selected was N146, which is next to C147 in the primary sequence of 
EGFP but separated by the cyt b562 insertion in CG15. In the CG15 model, these two 
residues lie adjacent to one another (Fig 7.3). Mutation of N146 to a cysteine and 
xxxxxxx 
 
Fig 7.3 Model of CG15 structure and CG15 cysteine substitution positions. a, Model of CG15 with the EGFP domain (green cartoon) and the haem (CPK 
sticks) bound cyt b562 domain (red cartoon) linked together by GlyGlySer linkers (GGS: black sticks) between residues N146 and S147 of EGFP. CG15 with 
the substitution mutation S147C (CPK sticks) together with residues selected by rational design to be mutated to cysteines (CPK sticks) highlighted. Cro 
stands for chromophore. b, Close up view of CG15 double cysteine models with the cyt b562 domain and linkers removed for clarity. CG15 models were made 
using MacPyMol. 
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formation of a disulphide bond with C147 would bridge the gap between the N-
terminal end of the GlyGlySer linker, at the N-terminus of the cyt b562 domain, and 
the C-terminal end of the GlyGlySer linker, at the C-terminus of cyt b562 domain. 
Formation of a disulphide bond between these two residues would potentially 
reconnect the break in !-strand 7 caused by the insertion of cyt b562. 
Two residues a single amino acid apart from one another in !-strand 8, 
adjacent to !-strand 7 containing residue C147, were also selected (K166 and R168). 
Both residues have side chains external to the !-barrel of the EGFP domain and are in 
close proximity (~8 Å) to C147 in the CG15 molecular model (Fig 7.3). The last 
residue selected was Q204, which is the same residue used in the roGFPs. The Q204C 
mutation in CG15 would act as a control and comparison to roGFP2, to see the effect 
a cyt b562 domain insertion has on the redox sensing ability of this double cysteine 
mutant. 
The cysteine mutations were introduced into the gene encoding CG15 by site 
directed mutagenesis (Section 2.4.3). Combinations of primers were used to introduce 
TGC codons, coding for cysteine, at the required positions within the CG15 gene to 
produce variants CG15N146C, CG15K166C, CG15R168C and CG15Q204C. DNA sequence 
analysis of CG15CC genes, isolated from E. coli BL21 (DE3) Gold cells (Table 2.1), 
confirmed the presence of the desired mutations. 
The CG15N146C, CG15K166C, CG15R168C and CG15Q204C variants were 
expressed in E. coli TUNER™ (DE3) cells grown at 20 °C in M9 minimal media 
(Section 2.1.4) supplemented with 100 µg/ml ampicillin and 150 µM IPTG. 
Expressed protein was purified as previously described for cyt b562-EGFP integral 
domain scaffolds (Chapter 5, section 5.2.4). The purified samples were used for all 
spectral characterization. 
 
7.2.2 Effect of double cysteine mutations on CG15 spectral properties. 
7.2.2.1 Analysis of the UV-visible absorption properties of CG15 and  variants 
under reducing and oxidising conditions. 
To determine if the new combination of cysteine residues in each of the  
variants introduced redox sensitive properties into the basic CG15 scaffold, UV-Vis 
absorbance spectra were measured in the presence of either an oxidant (H2O2) or 
reductant (DTT). Each of the mutants have altered absorption spectra with respect to 
 
 
233 
EGFP (For EGFP spectra see Chapter 4, section 4.2.3) and CG15 (Fig 7.4). All 
variants retained the two absorption maxima of ~400 nm and ~490 nm observed for 
CG15 but with differing intensity ratios at the two !max values, dependent on the 
presence of DTT or H2O2. Variants CG15N146C, CG15K166C and CG15R168C displayed a 
similar change to their absorption spectra with the 400 nm peak decreasing and the 
~490 nm peak increasing in intensity in the presence of H2O2 (Fig 7.4). The 
magnitude of change in the absorption spectra does, however, differ between 
CG15N146C, CG15K166C and CG15R168C with the highest magnitude change observed 
for CG15N146C and the smallest observed for CG15K166C (Fig 7.4). The absorption 
spectra for CG15Q204C changes in the opposite direction to the other CG15CC mutants; 
in the presence of H2O2 the ~400 nm absorption peak increases in amplitude whilst its 
~490 nm absorption peak decreases (Fig 7.4)  
Molar absorption extinction coefficients were calculated for CG15, 
CG15N146C, CG15K166C, CG15R168C and CG15Q204C at both absorption maxima (~400 
nm and ~488 nm) under reducing (10 mM DTT) and oxidizing conditions (0.02% 
(v/v) H2O2) (Table 7.1). Under reducing conditions the molar absorption extinction 
coefficients at ~400 and ~490 nm for all of the double cysteine mutants are very 
similar. This implies that under reducing conditions every CG15CC variant has a 
similar ratio of chromophore in the protonated and deprotonated state. However, the 
difference in molar absorption extinction coefficients, at ~400 and ~490 nm, under 
oxidizing conditions showed greater variation (Table 7.1). This is indirect evidence 
that formation of disulphide bonds between the two cysteines in each variant is 
modulating the ratio of chromophore in the protonated or deprotonated state, therefore 
altering the absorption spectra. 
The most significant observed difference between the variants was under 
oxidising conditions (Table 7.1). Under oxidizing conditions the molar absorption 
extinction coefficient for CG15N146C at 490 nm increased to 19,000 M-1cm-1 from 
14,200 M-1cm-1 and red shifted by 5 nm from 485 nm (Table 7.1). The molar 
absorption extinction coefficient at 403 nm decreased to 8,600 M-1cm-1 from 12,200 
M-1cm-1 and blue shifted by 5 nm (Table 7.1). This is a change in ~400 nm:490 nm 
ratio of 2.6-fold (" values, Table 7.1).  
Under oxidising conditions, CG15K166C displayed a 6 nm blue shift in the !max 
xxxxxxx  
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Fig 7.4 UV-visible absorption spectra for CG15 and  variants. UV-visible absorption 
spectra for 5 µM CG15 and CG15CC varianst (as indicated in the figure) were measured in the 
presence of either 10 mM DTT (black line) or 0.02% (v/v) H2O2 (red line) to induce reducing 
or oxidizing conditions, respectively. Black arrows indicate the direction of change in the 
amplitudes of the absorption peaks from reducing to oxidizing conditions. 
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Table 7.1 UV-visible absorption spectral characteristics 
Variant 
!max (nm)a " (mM-1cm-1)b 
#absc 
Holo-chimera 
!max (Ox/Red)d 
(nm) Red Ox Red Ox 
CG15 416 (487) 408 (487) 17.3 (15.2) 18.4 (14.8) 1.1 417/426 
CG15N146C 403 (485) 490 (398) 14.2 (12.2) 19.0 (8.6) 2.6 417/426 
CG15K166C 403 (488) 492 (397) 14.6 (12.7) 14.0 (11.8) 1.4 416/426 
CG15R168C 402 (488) 490 (399) 16.2 (12.8) 15.8 (12.2) 1.6 416/426 
CG15Q204C 403 (486) 402 (478) 16.7 (13.6) 19.4 (6.5) 2.4 417/426 
Cyt b562 - - - - - 417/428 
a Red and Ox stand for reduced and oxidized respectively and are shown on a white or grey 
background respectively. !max for absorption maxima with lower amplitudes are shown in 
brackets and red text. 
b Millimolar absorption extinction coefficients calculated at !max values stated for each 
variant. 
c Dynamic range value is the maximum #-fold change in absorption peak ratio 
d !max values determined in the presence of equimolar haem 
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at 403 nm to 397 nm and a decrease in the molar absorption extinction coefficient 
from 14,600 M-1cm-1 to 11,800 M-1cm-1. Simultaneously the molar absorption 
extinction coefficient at 488 nm (12,700 M-1cm-1) increased to 14,000 M-1cm-1 and 
exhibited a red shift in the !max by 4 nm to 492 nm (Table 7.1). This is a change in the 
~400 nm:490 nm ratio of 1.4-fold (" values, Table 7.1). 
Variant CG15R168C showed a change in molar absorption extinction 
coefficients in between that of CG15N146C and CG15K166C, and showed only very 
minor red and blue shifts in the !max values at ~400 and ~490 nm between oxidizing 
and reducing conditions (Table 7.1). Its molar absorption extinction coefficient at 
~400 nm decreased from 16,200 M-1cm-1 to 12,200 M-1cm-1, whilst at ~490 nm the 
molar absorption extinction coefficient increased from 12,800 M-1cm-1 to 15,800 M-
1cm-1, equating to a 1.6-fold change in excitation ratio. 
CG15Q204C switched 403 nm and 490 nm ratio in the opposite direction to 
those of the other variants (Fig 7.4). Under oxidizing conditions the molar absorption 
extinction coefficient at ~400 nm exhibits an increase to 19,400 M-1cm-1 from 16,700 
M-1cm-1 under reducing conditions. Simultaneously the extinction coefficient at ~490 
nm decreases from 13,600 M-1cm-1 to 6,500 M-1cm-1 (Table 7.1). In the presence of 
DTT (10 mM) the less intense of the two absorption maxima has a !max of 486 nm. In 
the presence of H2O2 (0.02% (v/v)) this !max blue shifts by 8 nm to 478 nm, whilst the 
!max for the major maxima essentially remains the same under reducing and oxidizing 
conditions. (Table 7.1).  
In comparison to all the double cysteine mutants, CG15 exhibited only minor 
changes in molar absorption extinction coefficients; 18,400 M-1cm-1 at 408 nm to 
17,300 M-1cm-1 and 14,800 M-1cm-1 at 487 nm to 15,200 M-1cm-1 under oxidizing and 
reducing conditions respectively (Table 7.1). The observation that CG15 exhibited 
only very small changes in molar absorption extinction coefficients under oxidizing 
and reducing conditions implies that a second cysteine residue is required in close 
proximity to C147 in order to elicit a significant change in the spectral properties. 
CG15 did however exhibit an 8 nm blue shift in its !max from 416 nm under reducing 
conditions to 408 nm under oxidizing conditions, whilst its !max value for its low 
intensity absorption maxima at 487 nm remained the same under both reducing and 
oxidizing conditions (Table 7.1).  
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7.2.2.2 The haem binding properties of CG15CC variants. 
 As shown in section 5.2.4 (Fig 5.9), haem quenches CG8 fluorescence. 
Therefore, it is expected that CG15 and its associated variants should retain their 
ability to bind haem. To probe the capacity of CG15N146C, CG15K166C, CG15R168C and 
CG15Q204C variants to bind haem, the UV-visible absorption spectra were determined 
in the presence of haem (Fig 7.5). Absorption spectra of purified protein samples were 
measured in the absence or presence of equimolar haem under reducing and oxidizing 
conditions (Fig 7.5). All the variants exhibited absorption spectra similar to that of 
wild type holo-cyt b562, with !max values of 426 nm and ~417 nm under reducing and 
oxidizing conditions respectively (Table 7.1), implying the haem binding environment 
has not been altered by the cysteine substitution mutations. 
 Given that the fluorescence of the cyt b562-EGFP chimeras is quenched when 
haem binds to the cyt b562 domain and ratiometric redox sensing requires a fluorescent 
signal, no further spectroscopic analysis on the effect of haem on the spectral 
properties of each CG15CC variant was performed. 
 
7.2.2.3 Effect of redox state on the fluorescence properties of CG15 and the 
CG15CC variants.  
To determine the influence of redox conditions on the fluorescence spectra of 
CG15 and the CG15CC variants, purified protein samples were incubated for 24 hr at 
25 °C with either DTT or H2O2, to induce reducing or oxidizing conditions 
respectively. The buffer was degassed prior to use and the samples incubated in an 
airtight container under anaerobic conditions (Section 2.6.1.10), to minimize any 
effects of air oxidation.  
The changes to the excitation spectra for each variant mirrored those observed 
for the absorbance spectra (Fig 7.6). Under oxidizing conditions variants CG15N146C, 
CG15K166C and CG15R168C all showed an increase in intensity for the ~490 nm 
excitation maxima and a decrease in the ~400 nm excitation maxima intensity (Fig 
7.6). Again in contrast, CG15Q204C exhibited the opposite change in excitation spectra 
with the ~400 nm excitation maxima increasing and the ~490 nm excitation maxima 
decreasing in intensity in the presence of oxidant. As with the absorption spectrum for 
CG15, the excitation spectrum also shows a very small change (~10%) in the 
excitation maxima intensity ratio (Fig 7.6, Table 7.2).   
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Fig 7.5 UV-visible absorption spectra of holo-CG15 and holo-CG15CC variants. UV-
visible absorption spectra of 5 µM holo-CG15 or holo-CG15CC variants (as indicated in the 
figure were measured in the presence of 1 mM ascorbic acid (black line) or 1 mM KNO3 (red 
line) for reducing and oxidizing conditions respectively, in the absence (solid lines) and 
presence (dashed lines) of equimolar haem. 
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Fig 7.6 Excitation and emission spectra for CG15 and CG15CC variants. All fluorescence spectra were measured with 50 nM protein under reducing 
(black lines) and oxidizing (0.003% v/v H2O2; red lines) conditions. Excitation spectra (top panels) were measured whilst monitoring fluorescence emission at 
530 nm. Emission spectra (bottom panels) were measured after excitation at either 400 nm (solid lines) or 490 nm (dashed lines). Excitation spectra were 
normalized to a value of 1 at their isosbestic point. 
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Table 7.2 Fluorescence spectral properties 
Variant 
Reduceda Oxidiseda !iso (nm) 
530nm em "ex
b 
!ex (nm) !em (nm) !ex (nm) !em (nm) 
CG15 402 (489) 514 (513) 488 (401) 514 (513) 435 1.1 
CG15N146C 492 (401) 512 (515) 489 (399) 509 (511) 445 5.0 
CG15K166C 492 (399) 512 (514) 490 (399) 513 (511) 446 2.9 
CG15R168C 488 (399) 511 (514) 490 (400) 511 (512) 445 3.2 
CG15Q204C 397 (488) 512 (511) 401 (490) 514 (513) 436 3.1 
a !ex and !em values in brackets and red text are for excitation/emission maxima with the lower 
intensity  
b !iso is the isosbestic point wavelength determined from excitation spectral scans whilst 
monitoring emission at 530 nm 
c Dynamic range value is the maximum "-fold change in excitation peak ratio 
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Under reducing conditions, the !em for all the variants red shifted by ~2-4 nm 
on excitation at ~400 nm compared to the !em on excitation at ~490 nm (~512 nm) 
(Table 7.2). Although there are also minor shifts in the !ex for all variants between 
oxidising and reducing conditions, all the excitation peak ratios for the CG15CC 
variants were calculated from intensity values at either 400 nm or 490 nm. For 
CG15N146C, CG15K166C and CG15R168C a 490:400 nm ratio was used where as for 
CG15Q204C a 400:490 nm ratio is used, given that its excitation maxima switch in the 
opposite direction to the other variants. The ratio of the maximum (in the presence of 
H2O2) to minimum (in the presence of DTT) values of the excitation ratios is defined 
as the dynamic range, and is a useful measure of the maximum signal to noise ratio 
[165]. 
The dynamic range for the roGFPs vary from 2.4 – 7.8 dependent on the 
mutations incorporated to the parent protein (usually roGFP1 or roGFP2). The 
dynamic ranges for CG15K166C, CG15R168C and CG15Q204C are all towards the lower 
range with !ex values of 2.9, 3.2 and 3.1 respectively (Table 7.2). CG15N146C in 
contrast has a higher dynamic range (!ex = 5) than the other variants (Table 7.2), 
which is more comparable to the value for roGFP2 (!ex = 5.8).  
 
7.2.3 Effect of cysteine substitution on CG15 oligomeric state. 
The introduction of additional surface exposed cysteine residues into CG15 
runs the potential risk of forming intermolecular rather than intramolecular disulphide 
bonds. Formation of intermolecular disulphide bonds could alter the excitation 
maxima ratio or spectral properties of the CG15CC variants hindering their use as 
efficient ratiometric redox sensors. It was therefore important to determine the 
oligomeric state of CG15N146C, CG15K166C, CG15R168C and CG15Q204C by analytical 
size exclusion chromatography. 
A standard curve for the relationship between molecular weight and elution 
volume from a Superdex™ 200 gel filtration column was determined (Appendix C) 
using the BioRad gel filtration standards, as described previously (Chapter 6, section 
6.2.1.6). From this the elution volume for the CG15CC variants at different 
concentrations under oxidizing and reducing conditions, could be related to the 
molecular weight of that species.  
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The CG15CC samples were applied to the column at either 10, 25, 50 µM 
concentrations under reducing or oxidizing conditions. The elution volumes (Table 
7.3) were determined from the absorbance peaks of the elution profiles (Fig 7.7). The 
elution volumes for all the major elution peaks for all variants only differed by up to 
~0.1 ml, equivalent to ~1200 Da. The average calculated molecular weights for all the 
variants (~40 – ~41 kDa) agreed closely to their theoretical molecular weights (~39 
kDa, calculated from their primary sequence) under reducing and oxidizing 
conditions, except for CG15K166C (Table 7.3).  
At the highest tested protein concentration (50 µM) under oxidizing conditions 
CG15K166C, a very low intensity peak was observed at 13.73 ml, which is equivalent 
to an estimated molecular weight of ~76 kDa (Table 7.3). This agrees closely to the 
theoretical molecular weight for a CG15K166C dimer (~78 kDa). The difference in 
absorption between the elution peak at 13.731 ml and ~15.06 ml however would 
indicate an estimated monomer:dimer ratio of ~1000:36 confirming that the dimer is a 
minority form. Given that a protein species elutes at a smaller elution volume under 
oxidizing conditions but not reducing conditions it is probable that the dimer is 
formed by an intermolecular disulphide bond rather than a tendency for CG15K166C to 
dimerize naturally at higher concentrations (>50 µM).  
Although CG15K166C exhibits the tendency to form intermolecular disulphide 
bonds at high concentrations (>50 µM) the redox sensing properties could still be 
assessed as 50-fold less protein (1 µM) is used when determining the standard redox 
midpoint potentials (see 7.2.4). It is highly unlikely that intermolecular disulphide 
bonds will be formed under oxidizing conditions at such a low concentration.  
 Despite the potential dimerization of CG15K166C at higher 
concentrations the elution profiles for CG15N146C, CG15K166C and CG15R168C are 
essentially symmetrical and do not exhibit the elution volume shift observed for wild 
type EGFP with increasing concentration (Chapter 4, Fig 4.11). This implies that the 
inherent weak tendency of EGFP to dimerize at high concentrations has potentially 
been eliminated by insertion of the cyt b562 domain between residues N146C and 
S147C of EGFP. In contrast the elution profile for CG15Q204C is asymmetric with a 
hip in the profile with an estimated elution volume ~15.7 ml, equivalent to a 
calculated molecular weight of ~29.5 kDa. The protein species eluting at this volume 
x  
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Fig 7.7 Size exclusion chromatography of CG15CC variants. Samples of variants (as 
indicated in figure) were applied to a SuperdexTM 200 gel filtration column and the elution of 
the protein samples monitored by absorbance at 488 nm for CG15N146C, CG15K166C and 
CG15R168C or 400 nm for CG15Q204C. Protein concentrations of 10 µM (solid black line), 25 
µM (dashed line) or 50 µM (dotted line) were applied to the column under reducing (1 mM 
DTT; black) or oxidizing (0.0034% (v/v) H2O2; red) conditions. The elution of CG15N146C, 
CG15K166C and CG15R168C from the column was monitored, by absorbance at 488 nm, and 
CG15Q204C monitored at 400 nm. At these wavelengths all variants have an appreciable 
absorbance under oxidizing and reducing conditions. 
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Table 7.3 Size exclusion chromatography analysis 
Variant Redox statea 
Concentration 
(µM) 
Elution 
Volume 
(ml)b 
Calculated 
Mw (Da)c 
Average 
Mw 
(Da)d 
Estimated 
Mw (Da)e 
CG15N146C 
Ox 
10 uM 15.1 40580 
40667 39109 25 uM 15.1 40730 
50 uM 15.1 40690 
Red 
10 uM 15.1 40710 
40623 39111 25 uM 15.1 40580 
50 uM 15.1 40580 
       
CG15K166C 
Ox 
10 uM 15.1 40660 
40927 39095 25 uM 15.1 41040 
50 uM 15.1 41080 
50 uM 13.7 76680 76680 78190 
Red 
10 uM 15.0 41450 
41267 39097 25 uM 15.1 41040 
50 uM 15.1 41310 
       
CG15R168C 
Ox 
10 uM 15.1 40660 
41047 39067 25 uM 15.1 41290 
50 uM 15.1 41190 
Red 
10 uM 15.0 41410 
41203 39069 25 uM 15.1 41160 
50 uM 15.1 41040 
       
CG15Q204C 
Ox 
10 uM 15.1 40260 
40523 39095 25 uM 15.1 40620 
50 uM 15.1 40690 
Red 
10 uM 15.1 40620 
40707 39097 25 uM 15.1 40750 
50 uM 15.1 40750 
aOx and Red stand for oxidized and reduced respectively 
bElution volumes determined from peak absorbance at either 488 or 400 nm (Fig 7.7) 
dependent on variant (see main text) 
cMolecular weights calculated using standard curve (Appendix C) 
dAverage calculated molecular weights over the different concentrations 
eEstimated molecular weight from primary sequence 
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is present at all concentrations under reducing and oxidizing conditions and is 
potentially a contaminating protein remaining after purification or more likely a 
degradation product.  
 
7.2.4 Determination of CG15CC redox midpoint potentials 
 One of the key parameters of any cellular redox biosensor is redox midpoint 
potential and its relationship with cellular values. To determine the redox midpoint 
potentials of CG15CC variants, titration of redox buffers was performed. Given that the 
relative intensities of the two distinct !ex values (Fig 7.6) are dependent on the 
solution oxidation state, titration with DTT redox buffers allows the redox midpoint 
potential to be determined (Fig 7.8). Using the excitation maxima ratio between 490 
nm and the isosbestic point (Table 7.2) for CG15N146C, CG15K166C and CG15R168C or 
CG15Q204  between 400 nm and the isosbestic point, the proportion of CG15CC protein 
in the reduced form can be calculated in different buffers. The buffers themselves 
comprise of different ratios of oxidized DTT (DTTox) and reduced DTT (DTTred) 
(total concentration of DTTred + DTTox = 1 mM in ratios of 10:0 to 0:10) (Fig 7.7). 
The redox midpoint potentials for the CG15CC variants were determined from 
the equilibrium constant obtained by fitting a theoretical curve to a plot of the fraction 
of reduced protein versus the concentration ratio of reduced DTT to oxidized DTT 
(Fig 7.9) (see section 2.6.1.10 for methods and equations used).  
Given that size exclusion chromatography confirmed the formation of 
intramolecular disulphide bonds only (see 7.2.3), at a protein concentration of 1 µM, 
the redox equilibria data could be fit to a two-state model (Section 2.6.1.10, Equation 
8) (Fig 7.9). The redox potential of the CG15CC variants at pH 7.0 and 30 °C could 
then be calculated using the Nernst equation (Section 2.6.1.10, Equation 9) with the 
standard reduction potential value for DTT (!!!!""!! !  of -323 mV [169]. The 
calculated redox midpoint potentials for all the CG15CC variants were more reducing 
than that for roGFP2 (-272 mV)[165], and ranged from -301 to -319 mV (Table 7.4). 
In particular variant CG15N146C has a redox midpoint potential of -319 mV, which is 
the most reducing midpoint potential described to date for a ratiometric fluorescent 
redox sensing protein.  
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Fig 7.8 Excitaton spectra of CG15CC in various DTT redox buffers. Excitation spectra of 
CG15CC variants (as indicated in the figure) whilst monitoring emission at 530 nm in various 
DTT redox buffers (total concentration of DTTred + DTTox = 1 mM with DTTox:DTTred ratios 
of 10:0 to 0:10) 
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Fig 7.9 Redox midpoint determination of CG15CC variants. Apparent redox midpoint 
potentials were determined by plotting the fraction of reduced protein against the 
[DTTred]:[DTTox] ratios and fitting the data to titration curves. 
 
 
 
 
 
 
 
 
 
Table 7.4 Redox properties of CG15CC variants 
Variant Eo' (mV)a kDTT (min-1)b kH2O2 (min
-1)c 
CG15N146C -319±4 0.59±0.02 2.48±0.11 
CG15K166C -301±5 0.47±0.01 0.65±0.01 
CG15R168C -311±5 0.12±0.00 0.69±0.01 
CG15Q204C -306±5 0.28±0.00 1.05±0.02 
a Redox midpoint potential calculated from titration against 1mM DTT (Fig 7.10) 
b Reduction rate constant  
c Oxidation rate constant 
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7.2.5 CG15CC variant redox kinetics 
 In order for high temporal sensing of changes in redox state the kinetics of 
oxidation and reduction are important factors to consider. In vitro rates for the 
reaction between CG15CC variants with either DTT or H2O2 were determined by the 
change in fluorescence excitation ratio over time after the addition of excess oxidizing 
(0.0034% (v/v) H2O2) or reducing (1 mM DTT) agent. To assure the starting protein 
samples were either fully oxidized or fully reduced, 10 µM protein samples were 
incubated in either 1 mM DTT or H2O2 for 2 hours at 30 °C. The protein samples 
were then diluted to a final concentration of 0.5 µM in fresh redox agent free buffer.  
The fraction of reduced protein was plot against time and the data fit to single 
exponential functions (Section 2.6.1.11, Equation 10) to determine pseudo first-order 
rate constants (Fig 7.10). The reduction rate constants (kDTT) for the CG15CC variants 
ranged from ~0.12 - ~0.59 min-1 (Table 7.4) and were comparable to published values 
for different roGFP variants (0.10-0.66 min-1)[167]. CG15R168C has the slowest kDTT 
value of 0.12 min-1 (Table 7.4), similar to the reduction rates for the majority of the 
roGFP variants (0.10-0.31 min-1). CG15Q204C has a kDTT rate constant 2.3-fold faster 
than that of CG15R168C at 0.28 min-1 (Table 7.4). CG15N146C and CG15K166C have the 
fastest reduction rate constants of 0.59 and 0.47 min-1 respectively (Table 7.4), similar 
to the fastest reduction rates measured for the roGFP variants (0.32-0.68 min-1). 
 The oxidation rate constants (kH2O2) for CG15
K166C and CG15R168C are very 
similar at 0.65 and 0.69 min-1, whilst CG15Q204C was oxidized slightly quicker with a 
kH2O2 value of 1.04 min
-1 (Table 7.4). Variant CG15N146C was oxidized up to 3.8-fold 
faster than the other variants as was evident from its kH2O2 value of 2.48 min
-1 (Table 
7.4). This is also a faster observed response to H2O2 than any other roGFP studied to 
date, with the fastest until now being 2.05 min-1 [167]. 
 
7.2.6 CG15CC variant pH sensitivity 
 Although the S65T mutation of EGFP confers it with ~six-fold increase in 
fluorescence intensity at ~488 nm [72] it has also been shown to make several 
fluorescent proteins pH sensitive [170]. Changes in pH alter the spectral properties of 
the S65T GFPs and at pH < 5.0 rapid loss of fluorescence is observed [170]. Cyt b562 
domain insertion into EGFP between residues N146 and S147 could also have 
xxxxxxx  
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Fig 7.10 Oxidation and reduction kinetics of CG15CC variants. The fraction of reduced 
protein determined from excitation maxima ratios was monitored over time after the addition 
of an excess of a, 1 mM DTT or b, 1mM H2O2. Fluorescence excitation intensities at 400 and 
490 nm were measured over 20 mins while monitoring emission at 530 nm, after the addition 
of DTT or H2O2 to initiate reduction or oxidation respectively.  Pseudo first-order rate 
constants were determined by fitting the data to single exponential functions. 
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increased the chromophores sensitivity to changes in pH. Given that the CG15CC 
mutants have the S65T mutation in the EGFP domain and any redox state 
measurements rely on the spectral properties of the proteins the pH sensitivity was 
investigated.  
 Samples of each variant were incubated for 24 hrs in phosphate buffers with a 
range of pHs (4 – 9), with either 1 mM DTT or 1 mM H2O2 to induce reducing or 
oxidizing conditions respectively. All buffers were degassed and the samples were 
incubated in an airtight container under anaerobic conditions to reduce any effects by 
air oxidation. Excitation spectra were measured whilst monitoring fluorescence 
emission at 530 nm (Fig 7.11). The excitation intensity decreased at both excitation 
maxima for all variants with decreasing pH, under reducing and oxidizing conditions 
(Fig 7.11). 
The 490:400 nm excitation ratio for CG15N146C, CG15K166C and CG15R168C or 
400:490 nm ratio for CG15Q204C were also plot against pH and showed that under 
reducing conditions the excitation ratios did not significantly alter across the pH range 
(Fig 7.12). However, under oxidizing conditions all variants exhibited a dependence 
between the excitation ratios and decreasing pH (Fig 7.12). CG15K166C and CG15R168C 
both showed the biggest dependence between pH and their excitation ratios under 
oxidizing conditions, with the excitation ratio decreasing steadily below a pH = 9.0. 
CG15Q204C also showed a decrease in its excitation ratio below a pH = 8.0, although 
not to the same degree as CG15K166C or CG15R168C. CG15N146C was the most pH 
stable of all the variants only showing a decrease in the excitation ratio under 
oxidizing conditions below a pH = 7.0.  
 
7.3 Discussion 
In this Chapter, a series of ratiometric redox biosensors that can be genetically 
encoded have been produced and have the potential to be used within the cell. The 
ability to construct custom genetically-encoded biomolecular switches whose 
properties change in response to a desired input opens new possibilities for generating 
sensitive, non-invasive cell-based biosensors to report on important biological 
processes. Such biosensors have a range of potential applications, including 
monitoring cellular events to the screening of therapeutic drugs.  
 
  
 
Fig 7.11. Effect of pH on CG15CC excitation spectra. Excitation spectra for the CG15CC variants (as indicated in figure) at different pHs (as indicated in 
figure) under reducing (1 mM DTT, top panels) or oxidising (0.0034% (v/v) H2O2, bottom panels). 
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Fig 7.12 Effect of pH on excitation peak ratio. Excitation peak ratios calculated for the 
CG15CC variants (as indicated in the figure) under reducing (1 mM DTT, black line) or 
oxidising (0.0034% (v/v) H2O2, red lines) conditions at different pHs. 
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Specifically, our aim is to construct GFP-based sensors for the biologically 
important area of redox sensing. Oxidative stress and the production of reactive 
oxygen species (ROS) alter cellular balance and damage cell components, leading to 
disease, including cancer [171]. However, ROS also plays essential roles in cell 
processes (e.g. cellular defence, apoptosis and as a secondary messenger in signal 
transduction). Therefore, maintaining the correct balance between ROS production 
and consumption is critical to the cell. Drug screening also routinely uses changes in 
cellular redox state to assess the non-specific effects of early drug candidates.  
Traditional approaches for detecting changes in cellular redox conditions are 
hampered by the lack of reliable non-invasive methods. Redox-sensitive chemical 
dyes are one of the most widely used products for sensing cellular oxidation state 
[172]. However, these have several drawbacks: oxidation of the probe is irreversible, 
the probe’s optical response may also be due to other cellular radicals (e.g. NO 
radical) [172], the dyes may produce further toxic radicals, and they can be sensitive 
to photo-oxidation [172]. The dyes also readily cross membranes so targeting to 
specific cellular locations is not possible. 
Other procedures for monitoring cell redox state are generally invasive, 
difficult to implement and have limitations in detection eg. measuring the amounts of 
the reduced and oxidised forms of natural cell redox mediators such as glutathione 
[165]. However, cells need to be harvested meaning that single cells cannot be 
analysed. Another approach is to link a reporter protein such as GFP to a redox 
regulated promoter system. However there will be transcriptional and translational 
delay, potential for “noise” due to a leaky promoter or changes to other cellular events 
and the output is non-reversible as signal is only removed by reporter breakdown. 
Monitoring the transcriptional activity of genes associated with redox regulation via 
changes in mRNA levels is also used but this again has many of the above problems. 
Therefore, genetically encoded biosensors based around GFP that can monitor 
fluctuations were sort through the use of protein engineering to overcome the 
problems associated with these traditional approaches. 
Introduction of two cysteine residues in close proximity to the GFP 
chromophore attributed redox sensing properties to the proteins, termed roGFPs. 
Changes in redox state mediated the oxidation or reduction of the cysteine residues 
resulting in altered spectral properties (Section 7.1). Cysteine residues have been 
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shown to play an important role in allowing proteins to respond to ROS [159]. The 
cellular redox state can be attributed in many cases to the ratio of disulphide to free 
thiol groups of proteins and small molecules such as glutathione. It therefore stands to 
reason that introduction of cysteine residues into protein scaffolds will elicit redox 
sensing properties and are a suitable sensing system for monitoring changes in redox 
state in vivo. 
The roGFPs have redox midpoint potentials that range from -229 mV to -299 
mV with various oxidation and reduction rates [165, 167]. However, the development 
of redox sensors with redox midpoint potentials outside of this range with quicker 
response rates to oxidants would be most advantageous for high time resolution in 
different cellular compartments. 
Here, we have described how a basic domain insert scaffold termed CG15 that 
is redox agent inert (Fig 7.4 and Fig 7.6) can be adapted through the use of molecular 
modeling and rational protein engineering that responds to changes in redox 
conditions. The domain insert between EGFP residues N146 and S147 provide the 
initial important fluorescence properties: two excitation maxima at ~400 nm and ~488 
nm, potentially due to mixed populations of CG15 with either a protonated or 
deprotonated fluorophore respectively. The ratios of the two excitation maxima have 
been made to be dependent on redox state by the incorporation of cysteine residues at 
various positions within CG15 (Fig 7.3), capable of forming intramolecular disulphide 
bonds with C147 native to CG15. 
 
7.3.1 Redox sensing properties of CG15CC variants 
 The CG15Q204C contains a double cysteine mutation at the same residue in 
EGFP (147 and 204) as that of a recently developed GFP-based redox sensor roGFP2 
[165]. The major difference between the two is the domain insertion between residue 
N146 and C147. Insertion of the cyt b562 domain at this position could potentially alter 
the pKa values of the cysteine thiol groups therefore altering the redox sensing 
properties of CG15Q204C with respect to roGFP2. The absorbance and fluorescence 
intensity at 490 nm for both CG15Q204C (Fig 7.4 and Fig 7.6) and roGFP2 [165] 
decreases in the presence of oxidant whist the excitation maxima at ~400 nm 
increases. This would suggest that in both these cases, the formation of a disulphide 
bond promotes the formation of the protonated form of the chromophore.  
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 Crystal structure analysis of roGFP2 identified the molecular basis for the 
oxidant induced altered spectral properties. Under reducing conditions no disulphide 
bond is formed between C147 and C204 allowing a hydrogen-bonding network to 
exist between the fluorophore and its surrounding residues (Fig 7.1 a) similar to that 
of S65T-GFP (Chapter 1, Fig 1.12 b). This hydrogen-bonding network is capable of 
stabilizing a negative charge on the phenolate group of the fluorophore (Y66), 
responsible for the excitation maxima at 490 nm [62, 69, 173]. Under oxidizing 
conditions the disulphide bond formed causes a very minor shift in residue S205 
resulting in an extended hydrogen-bonding network (Fig 7.1 b) similar to that of wt 
GFP (Chapter 1, Fig 1.12 a). The hydroxyl of T65 is linked to the phenolate of Y66 
by hydrogen bonds through the side chains of E222, S205 and a conserved water 
molecule [69]. In this conformation, a proton can be shuffled from the carboxylate of 
E222 to the phenolate group of Y66 [69]. Protonation of the fluorophore results in an 
excitation maxima at 400 nm with a decrease in intensity of the 495 nm excitation 
maxima. 
  In contrast, CG15N146C, CG15K166C, and CG15R168C appear to promote the 
ionized chromophore when forming the local disulphide bond, as suggested by the 
increase in intensity at 488 nm and decrease at 400 nm in the presence of oxidant (Fig 
7.6). This is potentially due to the relative position of the second introduced cysteine 
residue to C147, native to CG15. In CG15K166C and CG15R168C the mutated residues 
are in !-strand 8 adjacent to !-strand 7 that contains C147 (Fig 7.13). Formation of a 
disulphide bond between C147 and either K166C or R166C (in CG15K166Cor 
CG15R168C) is less likely to cause a shift in the position of residue S205 but could 
potentially cause a shift in the position of residue H148, preferentially stabilizing a 
negative charge on the chromophore therefore resulting in an increase in the 488 nm 
excitation maxima (Fig 7.13). Similar changes in the local environment around the 
chromophore upon the formation of a disulphide bond between C146 and C147 in 
CG15N146C could also potentially give a preference to charge stabilization on the 
fluorophore, given that C146, S147 and H148 are all adjacent to one another on the 
same !-strand (S7) (Fig 7.13). Therefore, depending on which residue is mutated to 
partner C147 will influence the protonated state of the chromophore thus the 
fluorescence properties. These fluorescence properties are in turn influenced by the 
chemical state of the two cysteine pairs.   
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Fig 7.13 Cysteine mutation positions within a model of CG15 tertiary structure. Relative 
cysteine mutations (CPK sticks) have been introduced into the model structure of CG15 
highlighting their positions with respect to C147, native to CG15. Residues H148 (red sticks) 
and S205 (blue sticks) have been shown as they play an important role in modulating the 
protonation state of the fluorophore (Cro: green sticks). !-strands 7, 8 and 10 are labeled S7, 
S8 and S9 respectively. For clarity the cyt b562 domain and GlyGlySer linkers have been 
removed. A full model of CG15 can be seen in Fig 7.3. Formation of disulphides between 
C147 and either C146, C166 or R168 are likely to have an effect on the position of H148 
potentially promoting charge stabilization on the chromophore. Formation of a disulphide 
between C147 and C204 has an effect on the position of the S205 side chain promoting the 
protonated form of the chromophore. 
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Comparison of the UV-visible absorption spectra (Fig 7.4) and fluorescence 
excitation spectra (Fig 7.6) showed distinct differences in the intensity of the 
absorption maxima to those of the excitation maxima under reducing conditions for 
CG15N146C, CG15K166C and CG15R168C. In the UV-visible absorption spectra the ~400 
nm absorption maxima is predominant where as in the excitation spectra the ~490 nm 
excitation maxima is predominant. The discrepancy between the different spectra 
indicates that under reducing conditions either the quantum yield (QY) at ~400 nm is 
decreased, the QY at ~490 nm is increased or both.  
Quantum yield determination against a 9-aminoacridine standard (for QY 
determination at 400 nm) and a fluorescein standard (for QY determination at 490 
nm) would be required to confirm this. Modulation of the quantum yield by 
disulphide formation may be due to insertion of the cyt b562 domain affecting the local 
structure adjacent to the chromophore. External solvent could potentially access the 
internal environment surrounding the chromophore and quench the chromophore in 
the excited state thereby reducing the quantum yield.  
 
7.3.2 CG15CC variant redox midpoint potential and redox kinetics. 
The redox midpoints determined for the CG15CC variants are the most 
reducing identified to date for ratiometric fluorescent redox sensors (>300 mV) (Fig 
7.9 and Table 7.4). Studies using roGFPs have identified the basal redox potential of 
the cytoplasm in HeLa cells to be more reducing than previously thought with values 
between -315 - -325 mV [154, 166], dependent on which roGFP sensor was used. 
These sensors were also used to identify the redox potential inside mitochondria to be 
more reducing than the cytoplasm at -360 mV [165]. Given that the redox midpoint 
potentials for the roGFPs are <300 mV, accurately measuring redox potentials above 
these values (especially in mitochondria) would be hard to achieve. Here, we have 
shown that all of the CG15CC redox sensors have redox midpoint potentials >300 mV 
(Fig 7.9 and Table 7.4) and therefore makes them more suitably placed for 
measurements of redox potential around these values. This implies that they could 
potentially be the most sensitive sensors to increases in cellular oxidants providing a 
much higher resolution for measurements of cellular redox state in more reducing 
cellular compartments (cytoplasm and mitochondria).  
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The observation that CG15N14C has fast oxidation and reduction kinetics of 
2.48 and 0.59 min-1 respectively is probably due to the two cysteine residues 
(EGFPC146 and EGFPC147) being in very close proximity to one another (Fig 7.13). In 
wt GFP the residues at positions 146 and 147 are adjacent to one another and 
connected by a peptide bond, forming part of !-strand 7. If these residues were 
mutated to cysteines, formation of disulphides under oxidising conditions may not 
elicit the structural change required for modulation of the chromophore protonation 
state. In the case of CG15N146C !-strand 7 is separated between residues C146 and 
C147 by the cyt b562 domain insertion (Fig 7.14), therefore formation or breaking of a 
disulphide bond potentially reconnects or separates the !-strand respectively (Fig 
7.14). Therefore, insertion of the cyt b562 domain at this position is potentially critical 
for the function of this particular redox sensing GFP, allowing for a new residue to be 
sampled (N146) for mutation to a cysteine. To assess if the insertion of cyt b562 at this 
position is critical for the results observed here the N146C and S147C mutations 
could be introduced into EGFP alone and used as a comparison to the CG15N146C 
variant. The redox kinetics for CG15N146C determined here are the fastest described to 
date in comparison to the roGFP variants [167].  
The redox midpoint potential and redox kinetics for roGFP variants have been 
shown to be highly dependent on the number of positively charged residues in the 
immediate vicinity of the disulphide forming cysteines, by modulating their pKa 
values [159, 166, 167]. The more positively charged residues in the cysteine local 
environment confers increased rates of oxidation and reduction [167], and more 
oxidizing midpoint potentials [166]. It is therefore not surprising that CG15K166C and 
CG15R168C have decreased oxidation rate constants (0.65 and 0.69 min-1 respectively) 
with respect to CG15N146C (2.48 min-1), as they both have a positively charged residue 
substituted for a cysteine. Both residues K166 and R168 are in close proximity to 
C146 in CG15N146C and could be having a positive effect on its redox rates, although 
these residues do not appear to have conferred a more oxidizing midpoint potential. 
CG15Q204C has no positively charged residues in the EGFP domain in close proximity 
to it and could therefore account for the ~two-fold decrease in oxidation and reduction 
rate constants with respect to CG15N146C. 
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Fig 7.14 Model of reduced and oxidized CG15N146C. Models of reduced CG15N146C (left) 
and oxidized CG15N146C (right). Formation of a disulphide between C146 and C147 (EGFP 
numbering) essentially reconstitutes !-strand 7 where as under reducing conditions the !-
strand is separated. 
 
  
!"#$%
!"#&%
!"#$%
!"#&%
'()*+()%!,"-."#$!% /01)12()%!,"-."#$!%
 
 
260 
 It is possible that with further substitution of residues surrounding the 
cysteines of the CG15CC variants for more positively charged residues the redox rates 
could be enhanced more than they already have been. It is also possible that the redox 
midpoint potential for the CG15CC variants could be altered to provide a toolbox of 
fluorescent redox sensors that sample a wide range of midpoint potentials.  
 
7.3.3 CG15CC variant pH sensitivity 
 Given that all of the CG15CC variants are sensitive to changes in pH it would 
be advantageous to mutate these variants further to eradicate their pH sensitivity. As 
mentioned previously (Section 7.2.6) it is known that the S65T mutation of EGFP, 
and other green fluorescent proteins, confers pH sensitivity [170]. Therefore to 
potentially reduce the pH sensitive nature of the CG15CC variants the T65 residue of 
the fluorophore could be mutated back to a serine. However, in doing so the excitation 
ratios, dynamic range and redox midpoint potential could be altered. 
 The cyt b562 domain insertion may also be playing a role in the pH sensitivity 
of the chromophore by disrupting the local structure adjacent to the chromophore. 
Disrupting the structure of the !-strands in this region of EGFP may allow solvent to 
access the interior environment surrounding the chromophore influencing its 
protonation state. To determine if it is the S65T mutation, the cyt b562 domain 
insertion or both that is responsible for the pH sensitivity would require mutating the 
T65 residue back to a serine or by inserting the cyt b562 domain into wt GFP and 
assessing the pH sensitivity. 
Given that there are currently no crystal structures for the CG15CC variants 
makes it difficult to identify the exact molecular mechanism behind their redox 
sensing properties and pH sensitivity. Once crystal structures have been determined 
and the precise EGFP and cyt b562 domain arrangement is known it will be easier to 
further rationally design the sensors to potentially improve their function and 
eradicate their pH sensitivity. 
 Although all the variants exhibited pH sensitivity, the excitation peak ratios of 
CG15N146C were stable above a pH=7.0 therefore could still be an adequate in vivo 
redox sensor, given that generally physiological pH is >7. The S65T mutation is also 
in roGFP2, which has been shown to be successfully used in vivo to measure redox 
state in different cellular compartments for both mammalian [154, 165] and plant cells 
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[170].Therefore the fact that the CG15CC variant spectral properties are sensitive 
below a pH of ~7 may not eliminate them as suitable in vivo redox sensors. 
 
7.3.4 Conclusion 
In conclusion, we have demonstrated here that using a computer aided rational design 
approach a directly evolved protein scaffold, CG15, has been further engineered for 
ratiometric fluorescent redox sensing. In particular variant CG15N146C exhibited the 
most reducing redox midpoint potential and the fastest response rates to H2O2 
developed to date, with the potential for further enhancement with additional 
mutations. In particular, one benefit would be to mutate the residues that coordinate 
haem (M7 and H105 of the cyt b562 domain) so as to eradicate any haem mediated 
fluorescence quenching. Despite the pH sensitivity of CG15N146C below a pH=7.0 it 
would still potentially make a useable in vivo cellular sensor for redox state. 
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Chapter 8: General discussion and conclusion 
8.1 The strength and weakness of the MuDel transposon directed evolution 
approach 
Directed evolution has many benefits over rational design approaches towards 
protein engineering. A detailed knowledge of protein structure and function is not 
required as many different mutational events can be sampled in a single reaction and 
variants with desired properties selected for [38]. Also mutations can be sampled that 
may not be intuitively selected during rational design. 
 The transposon based directed evolution approach described in this Thesis 
(Chapter 3) has many strengths over other available directed evolution approaches as 
well as rational design approaches. Firstly, the MuDel system is capable of sampling a 
diverse range of insertion sites throughout a target gene, pivotal to directed evolution 
methods (Fig 3.6). Other directed evolution approaches such as introducing random 
breaks in target DNA by either enzymatic or chemical cleavage have been shown to 
result in libraries with site-specific bias [38, 48]. It has been demonstrated here that 
other transposon base techniques such as the Tn5 system (Fig 3.6) and in other studies 
with the Tn7 tansposon system [174] that libraries are produced with target site 
preference, reducing their usefulness for producing libraries with extensive diversity.  
 After creation of a transposon insertion library most transposons can be 
removed by restriction digestion to introduce single random breaks into the target 
gene. Whilst with the majority of transposon systems the bulk of the transposon is 
removed from the library, the transposase recognition elements (TREs) and target site 
duplications (introduced due to the mechanism of transposition) are left behind (Fig 
1.8) [47]. This can be useful for probing sites within proteins that are tolerant to 
peptide insertions but there is no control over the coding sequence inserted [47]. 
 As demonstrated here the MuDel transposon system is not limited by this 
problem. Removal of MuDel from a DNA library after transposition, by MlyI 
restriction digestion, removes the entire transposon including its TREs, the target site 
duplication and a triplet nucleotide from the target gene (Fig 3.1 a). This alone can be 
used to sample single amino acid deletion mutations throughout a target protein 
(Section 3.2.6). The random break introduced by MuDel removal is also well defined 
unlike with other directed evolution approaches for introducing random breaks into 
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target genes (DNAse I or Ce(IV)-EDTA), which can result in multiple breaks per 
molecule of DNA, nested deletions and tandem duplications [32]. 
 Given that controlled blunt ended breaks can be introduced randomly 
throughout a target gene provides the strength of the MuDel system, allowing full 
control of downstream mutagenesis techniques for sampling single amino acid 
deletions (Chapter 3 and Chapter 4), domain insertions (Chapter 3 and Chapter 5) or 
for the incorporation of non-natural amino acids to increase the chemical diversity of 
proteins (Chapter 1, Fig 1.9) [50]. 
 Owing to the nature of transposition and subsequent removal by MlyI 
restriction digestion the blunt ended breaks produced randomly throughout the target 
gene are not always in frame (Table 3.1 and Section 3.2.7). However, DNA cassettes 
encoding whole protein domains for insertion into the random breaks can be designed 
with additional random nucleotides at their 5’ and 3’ ends allowing all three reading 
frames to be sampled within the library, as demonstrated here (Table 3.2). This also 
gives the freedom to design and encode the linking peptides to separate the two 
domains in the resulting integral fusion scaffold. Although in the past limited 
importance has been placed on the linking peptides separating two domains of an 
integral fusion scaffold [34] it has been demonstrated here (Chapter 6) that they play a 
critical role in the magnitude of functional coupling achieved (discussed in more 
detail in Section 8.3). 
 Taking all these benefits into account validates the strength of the MuDel 
system for creating diverse DNA libraries that provide the freedom and control to 
create sub-libraries sampling different mutational events that target the polypeptide 
backbone and residue side chains. The only weakness of the MuDel transposon 
method is that the initial library generation can be time consuming, however, this is 
far outweighed by the benefits of the technique. 
 Creation of a MuDel insertion library in the target gene, egfp, has been 
described in detail in Chapter 3 and was used to sample single amino acid deletions 
(Section 3.2.6) and cyt b562 domain insertions throughout EGFP (Section 3.2.7). 
Between the two libraries 139 unique sites within EGFP were sampled for 
mutagenesis. However, with improved high throughput screening techniques it is 
possible that even more sites could have been identified for mutational sampling, 
allowing the full potential of the MuDel insertion library to be exploited.  
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8.2 Protein engineering through single amino acid deletion mutagenesis 
Although dogma suggests that amino acid deletions are detrimental to protein 
structure and therefore function (Chapter 1, section 1.2.2), causing registry shifts in 
organized secondary structure (Chapter 1, Fig 1.1), it has been demonstrated here 
(Chapter 4) that they can also be beneficial. Until now there has been a lack of 
directed evolution techniques capable of introducing single amino acid deletion 
mutations randomly throughout a target protein [39]. For this reason there has been 
relatively little investigation into the value of deletion mutations and their effects on 
protein structure and function. 
Whilst deletion mutations have been studied in EGFP prior to this 
investigation they were rationally localized to particular loops or towards the N- or C- 
termini of GFP [122, 123, 125]. However, for the majority of cases more than a single 
amino acid was deleted at a time, which was shown to be detrimental to GFP 
fluorescence [122, 123, 125]. Using the MuDel transposon based directed evolution 
approach it has been possible to sample single amino acid deletion mutations 
throughout EGFP (Fig 4.4 and Fig 4.5). Screening of the EGFP! library identified 
novel EGFP variants with increased protein fluorescence conferred to cell cultures 
with respect to EGFP (Fig 4.6). In particular deletion of residue G4, D190 or A227 
from EGFP resulted in a marked increase in fluorescence observed in cell cultures 
(Fig 4.8). Further analysis identified the effects of the mutations were not due to 
altered fluorescence properties of EGFP (Table 4.5) but were elicited through 
increased stability (Fig 4.13 and Table 4.8) or improved folding (Fig 4.14 and Table 
4.8). 
 Of the three variants studied in detail the G4! mutation in particular was 
identified as being the most beneficial of the deletion mutations, dramatically 
increasing protein production levels (Fig 4.9 a) increasing protein stability (Fig 4.6 
and Table 4.8), improving folding (Fig 4.7) and increasing the fluorescence observed 
in cell cultures more than any of the other mutations (Fig 4.8). The effects of the G4! 
mutation was also demonstrated to be transferrable to other variants identified from 
the library increasing their cellular fluorescence (Fig 4.9 b). The effects of the G4! 
mutation were also not just specific to EGFP with the incorporation of this mutation 
into EYFP also resulting in increased cellular fluorescence (Fig 4.9 b). These 
observations indicate that the G4! mutation is having a generic effect on fluorescent 
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proteins and should potentially be incorporated into all fluorescent proteins to 
improve their folding and stability
8.3 Creation of artificial biomolecular switches through domain insertion
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8.4 Rational design of a directly evolved integral domain fusion scaffold
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8.5 Protein engineering through polypeptide backbone mutagenesis
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8.6 Future work 
8.6.1 Determination of EGFP! structures by X-Ray crystallography
 
 
269 
8.6.2 Further rational design of the CG6 integral domain fusion scaffold
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8.6.3 Determination of CG15CC variants structure by X-ray crystallography. 
 Whilst a molecular model for CG15 was developed to aid the design process 
of the double cysteine mutants of CG15, it does not shed any light on the mechanism 
of ratiometric fluorescent redox sensing. Although changes in the excitation maxima 
in the presence of an oxidant or reductant is indirect evidence for the formation and 
breaking of disulphide bonds in the vicinity of the chromophore there is currently no 
structural evidence confirming this. Therefore structure determination of the CG15CC 
variants under reducing and oxidizing conditions would confirm the formation of 
disulphide bonds between the two introduced cysteine residues and would also 
provide an explanation for the changes in the spectral characteristics observed at the 
molecular level.  
 The crystal structures would also help towards understanding what affect the 
cyt b562 domain insertion plays in the redox sensing mechanism. Having crystal 
structures for the CG15CC variants would also help towards identifying potential sites 
for rational design to further improve the redox kinetics or to alter their redox 
midpoint potentials. This can be achieved by increasing the reactivity of the cysteine 
residues by modulating the thiol group pKa values with the introduction of basic 
substitution mutations in their close vicinity. 
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Appendices 
Appendix A. Superdex™ 75 analytical size exclusion chromatography standards 
 
 
Appendix A. Analytical size exclusion chromatography standards and standard curve. a, 
Elution profile for BioRad gel filtration standards (Section, 2.6.2.1, Table 2.1). Elution of 
protein standards from a Superdex™ 75 gel filtration column was monitored by absorbance at 
280 nm. b, Standard curve of log(Mw) against Kav. Kav values are calculated using Equation 
11 (Section 2.6.2.1). 
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Appendix B. Triplet nucleotide deletions positions sampled during domain insertion 
library construction that resulted in out of cyt b562 domains. 
Variant TNDa Variant TNDa 
NF196 4 TGA 8 NF29 259 CCG 263 
NF120 28 CCG 32 NF54 259 CCG 263 
NF15 46 TGG 50 NF174 281 CCA 285 
NF179 59 CGG 63 NF03 309 GAC 313 
NF48 71 CGG 75 NF52 311 CGG 315 
NF12 72 GGC 76 NF113 317 CTA 321 
NF183 86 CGT 90 NF166 319 ACA 323 
NF51 91 CCG 95 NF152 328 GCG 332 
NF86 91 CCG 95 NF121 347 GGG 351 
NF159 91 CCG 95 NF44 371 CGA 375 
NF138 92 CGG 96 NF87 377 GAA 381 
NF154 93 GGC 97 NF163 379 AGG 383 
NF79 94 GCG 97 NF30 382 GCA 386 
NF43 101 CGA 105 NF06 413 GGG 417 
NF158 101 CGA 105 NF143 414 GGG 418 
NF34 107 CGA 111 NF47 424 TGG 428 
NF11 108 GAT 112 NF94 434 CTA 437 
NF33 112 CCA 116 NF164 440 CAG 444 
NF55 112 CCA 116 NF04 443 CCA 447 
NF103 112 CCA 116 NF146 452 CTA 456 
NF170 112 CCA 116 NF68 463 CCG 467 
NF119 116 CTA 120 NF141 463 CCG 467 
NF134 118 ACG 122 NF132 487 AGG 491 
NF137 118 ACG 122 NF175 503 CCG 507 
NF41 127 TGA 131 NF131 515 CGA 519 
NF112 143 CTG 147 NF207 521 CGG 525 
NF194 143 CTG 147 NF147 522 GGC 526 
NF18 151 CCG 155 NF206 539 CGA 543 
NF202 151 CCG 155 NF27 540 GAC 544 
NF126 171 TGG 175 NF169 603 CTG 607 
NF190 171 TGG 175 NF203 620 CCT 624 
NF208 171 TGG 175 NF185 634 CCA 637 
NF101 215 CAG 219 NF93 660 CTG 664 
NF182 217 GCC 221 NF76 661 TGC 665 
NF70 250 TCT 254 NF88 712 ACA 716 
a Gene numbering is for the egfp gene [107]. The triplet nucleotide displayed is the sequence deleted 
upon removal of the transposon, MuDel, by restriction digestion. TND stands for triplet nucleotide 
deletion. 
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Appendix C. Superdex™ 200 analytical size exclusion chromatography 
standards 
 
 
 
Appendix C. Analytical size exclusion chromatography standards and standard curve. a, 
Elution profile for BioRad gel filtration standards (Section, 2.6.2.1, Table 2.1). Elution of 
protein standards from a Superdex™ 200 gel filtration column was monitored by absorbance 
at 280 nm. b, Standard curve of log(Mw) against Kav. Kav values are calculated using 
Equation 11 (Section 2.6.2.1). 
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